Miruvor
Sign up
The short answer

What studies of CBT and psychotherapy found

302papers on CBT and psychotherapy
8,715people in 82 studies testing CBT and psychotherapy alone
29randomised trials, the strongest kind of study

At a glance, by condition

Long COVID: C Might help, very uncertain

Based on the strongest evidence, randomised trials and compared with another group, not randomised and studies with no comparison group and the randomised trial (very low certainty): 19 of 28 findings are C.

13 outcomes rated · see each below

ME/CFS: C Might help, very uncertain

Based on the strongest evidence, compared with another group, not randomised and studies with no comparison group and randomised trials and the randomised trial (very low certainty): 20 of 26 findings are C.

11 outcomes rated · see each below

Both together: C Might help, very uncertain

Based on the strongest evidence, the randomised trial and studies with no comparison group (very low certainty): 5 of 8 findings are C.

7 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: For long COVID, CBT and psychotherapy might help some people, but research can’t show it yet. For ME/CFS, CBT and psychotherapy might help some people, but research can’t show it yet. For long COVID and ME/CFS studied together, CBT and psychotherapy might help some people, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 302 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. CBT and psychotherapy · Long COVID is hereCBT and psychotherapy · ME/CFS is hereCBT and psychotherapy · Both together is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Symptoms

Fatigue8 studies · 407 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (398 in all); the studies disagree; effect size 0.58 (moderate).

Randomised trials4 studies · 398 people with results

Fatigue improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (398 in all)
  • The studies disagree
  • Effect size 0.58 (moderate)

How big was the difference?

0.58, moderate. The effect size compares CBT and psychotherapy with cau.

Compared with another group, not randomised83 started · 71 with outcome data · five-week · five-week, inpatient

No clear difference in fatigue.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in long COVID. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance

Studies with no comparison group3 studies · 84 people with results

Fatigue improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance

Combination: CBT and psychotherapy + Respiratory physiotherapy / pulmonary rehabilitation + interactive digital resource32 randomised

The breath and mind connection in young people with post-COVID syndrome: feasibility and acceptability of a pilot randomised co-designed intervention. (2026): 11-item Chandler Fatigue Score (0–33), no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

Combination: CBT and psychotherapy64 in the study · 51 started · 63 with outcome data

Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial. (2024): Fatigue (FSS), better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 8 studies
  1. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. (2023)

    People in the study
    114 randomised
    Dose
    planned duration of 17 weeks; mean duration 18.7 (SD, 2.3) weeks, mean number of interactions between therapist and patient 11.8 (SD, 3.5)
    Outcome
    CIS-fatigue Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial. (2026)

    People in the study
    53 randomised · 52 started · 52 analysed
    Dose
    eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis
    Outcome
    Fatigue (FSS) Fatigue Severity Scale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  3. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial. (2025)

    People in the study
    130 randomised · 125 started · 122 analysed
    Dose
    four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention
    Outcome
    MFIS psychosocial fatigue subscale 21-item Modified Fatigue Impact Scale (MFIS-21)
    Effect
    worse
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  4. Which cognitive-behavioural factors play a role in the reduction of post-COVID-19 fatigue following cognitive behavioural therapy and care as usual? A secondary analysis of the ReCOVer study. (2026)

    People in the study
    114 randomised · 110 analysed
    Dose
    tailored, modular treatment targeting up to seven putative perpetuating factors; blended format consisting of therapist contact and online modules
    Outcome
    Fatigue severity (CIS-fatigue) Checklist Individual Strength
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  5. Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study. (2026)

    People in the study
    83 started · 71 with outcome data
    Dose
    five-week, inpatient
    Outcome
    Fatigue (FSS) Fatigue Severity Scale
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: time between T0 and T1 The time interval between T0 and T1 was included as a covariate because it differed significantly between the intervention and the control group.
    Selection of participants
    Moderate. comparison group: non-randomized; control group declined inpatient treatment but had indication (PHQ-9 ≥ 10) The control group consisted of post-COVID patients for whom there was an indication for inpatient psychosomatic treatment (depressive symptoms in self-assessment: PHQ-9 ≥ 10), but who declined to take up the treatment.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: intervention lost to follow-up n = 10; control lost to follow-up n = 5; interim analysis excluded protocol deviations
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  6. Cognitive behavioural therapy for severe fatigue following COVID-19 in adolescents: a serial single-case observational study of five consecutively referred patients. (2025)

    People in the study
    5 in the study
    Dose
    —
    Outcome
    fatigue severity fatigue severity subscale of the Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  7. [Fatigue and sensorimotor instability : Neurologically controlled conversion of post-COVID-19 patients]. (2024)

    People in the study
    78 in the study
    Dose
    Q2-2023 bis Q4-2023
    Outcome
    Fatigue
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  8. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    fatigue
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Cognition (brain fog)5 studies · 231 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (346 in all); the studies disagree.

Randomised trials3 studies · 346 people with results

Cognition (brain fog) improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on cognition (brain fog) in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (346 in all)
  • The studies disagree

Studies with no comparison group2 studies · 6 people with results (few people)

Cognition (brain fog) improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on cognition (brain fog) in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (6 in all)
  • Not all results were tested against chance

Combination: CBT and psychotherapy + Physical therapy / physiotherapy1 in the study

Case Report: Overlap Between Long COVID and Functional Neurological Disorders. (2021): subjective cognitive complaints, better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

Combination: CBT and psychotherapy64 in the study · 51 started · 63 with outcome data

Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial. (2024): Illness cognitions (ICQ) Helplessness, better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

Combination: CBT and psychotherapy + Cognitive rehabilitation

Effects of cognitive training and group psychotherapy on cognitive performance of post COVID-19 patients: an exploratory and non-randomized clinical trial. (2024): Story Memory (SM), better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 5 studies
  1. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial. (2025)

    People in the study
    130 randomised · 125 started · 122 analysed
    Dose
    four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention
    Outcome
    BRIEF-A (GEC) time-by-group interaction Behaviour Rating Inventory of Executive Function (BRIEF-A)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. (2023)

    People in the study
    114 randomised
    Dose
    planned duration of 17 weeks; mean duration 18.7 (SD, 2.3) weeks, mean number of interactions between therapist and patient 11.8 (SD, 3.5)
    Outcome
    CIS-conc problems concentrating Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Which cognitive-behavioural factors play a role in the reduction of post-COVID-19 fatigue following cognitive behavioural therapy and care as usual? A secondary analysis of the ReCOVer study. (2026)

    People in the study
    114 randomised · 110 analysed
    Dose
    tailored, modular treatment targeting up to seven putative perpetuating factors; blended format consisting of therapist contact and online modules
    Outcome
    anticipated adverse consequences of activity Tampa Scale of Kinesiophobia
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Cognitive behavioural therapy for severe fatigue following COVID-19 in adolescents: a serial single-case observational study of five consecutively referred patients. (2025)

    People in the study
    5 in the study
    Dose
    —
    Outcome
    difficulty concentrating Checklist Individual Strength
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    brain-fog
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Depression7 studies · 229 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (36 in all).

The randomised trial36 randomised · 12 successive weeks · 30 minutes, 3 sessions/week for 12 successive weeks

Depression improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on depression in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (36 in all)

Compared with another group, not randomised83 started · 71 with outcome data · five-week · five-week, inpatient

Depression improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on depression in long COVID. Improvement · very low certainty C

  • Serious risk of bias (ROBINS-I)

Studies with no comparison group5 studies · 140 people with results

Depression improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on depression in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • The studies disagree
  • The paper's own effect size: -0.46 (Cohen's d)

Combination: CBT and psychotherapy64 in the study · 51 started · 63 with outcome data

Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial. (2024): Depression (PHQ-9), no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 7 studies
  1. Effect of Cognitive Behavioral Therapy on Depression and Functional Outcomes in Patients with Post Covid-19: A Randomized Controlled Trial (2024) preprint

    People in the study
    36 randomised
    Dose
    30 minutes, 3 sessions/week for 12 successive weeks
    Outcome
    Beck Depression Inventory (BDI) Beck Depression Inventory
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study. (2026)

    People in the study
    83 started · 71 with outcome data
    Dose
    five-week, inpatient
    Outcome
    Depressive symptoms (PHQ-9) Patient Health Questionnaire-9
    Effect
    better
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: time between T0 and T1 The time interval between T0 and T1 was included as a covariate because it differed significantly between the intervention and the control group.
    Selection of participants
    Moderate. comparison group: non-randomized; control group declined inpatient treatment but had indication (PHQ-9 ≥ 10) The control group consisted of post-COVID patients for whom there was an indication for inpatient psychosomatic treatment (depressive symptoms in self-assessment: PHQ-9 ≥ 10), but who declined to take up the treatment.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: intervention lost to follow-up n = 10; control lost to follow-up n = 5; interim analysis excluded protocol deviations
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  3. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial. (2026)

    People in the study
    53 randomised · 52 started · 52 analysed
    Dose
    eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis
    Outcome
    Depressive symptoms (PHQ-9) Patient Health Questionnaire-9 (PHQ-9)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  4. Management of post-COVID-19 depression among patients of Western Uttar Pradesh of Northern India. (2023)

    People in the study
    156 randomised
    Dose
    eight therapeutic sessions
    Outcome
    Pre- and post-score of exp. on BDI-II Beck Depression Inventory (BDI-II)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. The Effects of a Mindfulness-Based Intervention on Depression and Anxiety in the Long-COVID Population. (2025)

    People in the study
    8 started · 8 with outcome data
    Dose
    six-week virtual group therapy protocol
    Outcome
    PHQ-9 scores Patient Health Questionnaire (PHQ)-9
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  6. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    PHQ-9 Patient Health Questionnaire-9
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  7. Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study. (2025)

    People in the study
    12 in the study
    Dose
    eight 1-hour individual online sessions, weekly
    Outcome
    ODSIS scores at 6-month follow-up Overall Depression Severity and Impairment Scale (ODSIS)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Pain3 studies · 80 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); not all results were tested against chance.

Studies with no comparison group3 studies · 80 people with results

Pain improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on pain in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance

Combination: CBT and psychotherapy + Physical therapy / physiotherapy1 in the study

Case Report: Overlap Between Long COVID and Functional Neurological Disorders. (2021): chest pain, no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 3 studies
  1. [Fatigue and sensorimotor instability : Neurologically controlled conversion of post-COVID-19 patients]. (2024)

    People in the study
    78 in the study
    Dose
    Q2-2023 bis Q4-2023
    Outcome
    Schmerzen
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  2. Corona With Lyme: A Long COVID Case Study. (2023)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    severity and frequency of associated myalgias, headaches, and scalp allodynia
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  3. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    headaches
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Low mood or anxiety3 studies · 50 people took part in CBT and psychotherapy Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); not all results were tested against chance; the studies disagree.

Studies with no comparison group3 studies · 50 people with results

Studies disagree about low mood or anxiety.

Studies disagree about whether CBT and psychotherapy helps low mood or anxiety. Mixed results · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • The studies disagree

Combination: CBT and psychotherapy + Respiratory physiotherapy / pulmonary rehabilitation + interactive digital resource32 randomised

The breath and mind connection in young people with post-COVID syndrome: feasibility and acceptability of a pilot randomised co-designed intervention. (2026): Strengths and Difficulties Questionnaire, Impact Score, no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 3 studies
  1. Effectiveness of Internet-Based Group Supportive Psychotherapy on Psychic and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post COVID-19 Syndrome Patients. (2023)

    People in the study
    96 randomised · 77 started · 37 analysed
    Dose
    3 sessions in 1 week, 1-2 hours per session, groups consisting of 6-8 people
    Outcome
    Session 1 Psychic, mean (SD) visual analogue scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  2. The long wave of COVID-19: a case report using Imagery Rehearsal Therapy for COVID-19-related nightmares after admission to intensive care unit. (2023)

    People in the study
    1 in the study
    Dose
    four-session
    Outcome
    DASS stress The Depression Anxiety Stress Scale–21 (DASS-21)
    Effect
    worse (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  3. Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study. (2025)

    People in the study
    12 in the study
    Dose
    eight 1-hour individual online sessions, weekly
    Outcome
    Positive Temperament (PT) Multidimensional Emotional Disorder Inventory
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Breathlessness2 studies · 28 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (52 in all); effect size 0.57 (moderate).

The randomised trial53 randomised · 52 started · 52 analysed · M = 14 weeks, SD = 1 week · eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis

Breathlessness improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on breathlessness in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (52 in all)
  • Effect size 0.57 (moderate)

How big was the difference?

0.57, moderate. The effect size compares CBT and psychotherapy with 16-week wait-list control (wlc) condition.

Studies with no comparison group1 in the study · 3-month follow-up · twelve, individual, 60 min video sessions, over a period of five months (few people)

Breathlessness improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on breathlessness in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 2 studies
  1. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial. (2026)

    People in the study
    53 randomised · 52 started · 52 analysed
    Dose
    eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis
    Outcome
    Respiratory symptoms (SBQTM-LC “Breathing”) Symptom Burden QuestionnaireTM for Long Covid (SBQTM-LC)
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    breathlessness
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Autonomic symptoms3 studies · 142 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; 89 people in all; a small benefit can't be ruled out; effect size 0.46 (small).

Randomised trials2 studies · 89 people with results

No clear difference in autonomic symptoms.

The evidence is very uncertain about the effect of CBT and psychotherapy on autonomic symptoms in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • 89 people in all; a small benefit can't be ruled out
  • Effect size 0.46 (small)

How big was the difference?

0.46, small. The effect size compares CBT and psychotherapy with 16-week wait-list control (wlc) condition.

Studies with no comparison group78 in the study · Q1-2021 bis Q4-2023 · Q2-2023 bis Q4-2023

Autonomic symptoms improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on autonomic symptoms in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
See the 3 studies
  1. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial. (2026)

    People in the study
    53 randomised · 52 started · 52 analysed
    Dose
    eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis
    Outcome
    Cardiovascular symptoms (SBQTM-LC “Circulation”) Symptom Burden QuestionnaireTM for Long Covid (SBQTM-LC)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Effectiveness of Internet-Based Group Supportive Psychotherapy on Psychic and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post COVID-19 Syndrome Patients. (2023)

    People in the study
    96 randomised · 77 started · 37 analysed
    Dose
    3 sessions in 1 week, 1-2 hours per session, groups consisting of 6-8 people
    Outcome
    HRV Heart Rate Variability
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  3. [Fatigue and sensorimotor instability : Neurologically controlled conversion of post-COVID-19 patients]. (2024)

    People in the study
    78 in the study
    Dose
    Q2-2023 bis Q4-2023
    Outcome
    Kardiopulmonale/autonome Dysfunktion
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Anxiety4 studies · 92 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from controlled studies: serious risk of bias (ROBINS-I); the change wasn't shown to be more than chance.

Compared with another group, not randomised83 started · 71 with outcome data · five-week · five-week, inpatient

No clear difference in anxiety.

The evidence is very uncertain about the effect of CBT and psychotherapy on anxiety in long COVID. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance

Studies with no comparison group3 studies · 21 people with results

Anxiety improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on anxiety in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (21 in all)
  • Not all results were tested against chance
  • The studies disagree

Combination: CBT and psychotherapy64 in the study · 51 started · 63 with outcome data

Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial. (2024): Anxiety (GAD-7), no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 4 studies
  1. Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study. (2026)

    People in the study
    83 started · 71 with outcome data
    Dose
    five-week, inpatient
    Outcome
    Anxiety symptoms (GAD-7) Generalized Anxiety Disorder Scale-7
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: time between T0 and T1 The time interval between T0 and T1 was included as a covariate because it differed significantly between the intervention and the control group.
    Selection of participants
    Moderate. comparison group: non-randomized; control group declined inpatient treatment but had indication (PHQ-9 ≥ 10) The control group consisted of post-COVID patients for whom there was an indication for inpatient psychosomatic treatment (depressive symptoms in self-assessment: PHQ-9 ≥ 10), but who declined to take up the treatment.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: intervention lost to follow-up n = 10; control lost to follow-up n = 5; interim analysis excluded protocol deviations
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  2. The Effects of a Mindfulness-Based Intervention on Depression and Anxiety in the Long-COVID Population. (2025)

    People in the study
    8 started · 8 with outcome data
    Dose
    six-week virtual group therapy protocol
    Outcome
    GAD-7 scores Generalized Anxiety Disorder (GAD)-7 scale
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  3. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    GAD-7 Generalised Anxiety Disorder Assessment-7
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  4. Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study. (2025)

    People in the study
    12 in the study
    Dose
    eight 1-hour individual online sessions, weekly
    Outcome
    OASIS scores at 6-month follow-up Overall Anxiety Severity and Impairment Scale (OASIS)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Sleep2 studies · 60 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 122 people found no clear difference; a small benefit can't be ruled out.

The randomised trial130 randomised · 125 started · 122 analysed · pre-, 2- and 8-month post-intervention · four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention

No clear difference in sleep.

The evidence is very uncertain about the effect of CBT and psychotherapy on sleep in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 122 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group1 in the study · four-session IRT · four-session (few people)

Sleep improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on sleep in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 2 studies
  1. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial. (2025)

    People in the study
    130 randomised · 125 started · 122 analysed
    Dose
    four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention
    Outcome
    PSQI global score Pittsburgh Sleep Quality Inventory (PSQI)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. The long wave of COVID-19: a case report using Imagery Rehearsal Therapy for COVID-19-related nightmares after admission to intensive care unit. (2023)

    People in the study
    1 in the study
    Dose
    four-session
    Outcome
    PSQI Pittsburgh Sleep Quality Index (PSQI)
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Post-exertional malaise2 studies · 32 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 52 people found no clear difference; a small benefit can't be ruled out.

The randomised trial53 randomised · 52 started · 52 analysed · M = 14 weeks, SD = 1 week · eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis

No clear difference in post-exertional malaise.

The evidence is very uncertain about the effect of CBT and psychotherapy on post-exertional malaise in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 52 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group5 in the study · 12 weeks after the start of CBT (few people)

Post-exertional malaise improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on post-exertional malaise in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (5 in all)
  • Not all results were tested against chance

Combination: CBT and psychotherapy + Physical therapy / physiotherapy1 in the study

Case Report: Overlap Between Long COVID and Functional Neurological Disorders. (2021): post-exertional malaise, no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 2 studies
  1. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial. (2026)

    People in the study
    53 randomised · 52 started · 52 analysed
    Dose
    eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis
    Outcome
    Post-exertional malaise (DSQ-2 PEM) DePaul Symptom Questionnaire-2 (DSQ-2)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Cognitive behavioural therapy for severe fatigue following COVID-19 in adolescents: a serial single-case observational study of five consecutively referred patients. (2025)

    People in the study
    5 in the study
    Dose
    —
    Outcome
    frequency of post-exertional malaise (PEM)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Daily functioning7 studies · 327 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (382 in all); the studies disagree.

Randomised trials4 studies · 382 people with results

Daily functioning improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on daily functioning in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (382 in all)
  • The studies disagree

Studies with no comparison group3 studies · 84 people with results

Daily functioning improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on daily functioning in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • The paper's own effect size: −0,61 (Cohens d)

Combination: CBT and psychotherapy + Physical therapy / physiotherapy1 in the study

Case Report: Overlap Between Long COVID and Functional Neurological Disorders. (2021): returned to his studies and social activities, better (not tested).

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 7 studies
  1. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. (2023)

    People in the study
    114 randomised
    Dose
    planned duration of 17 weeks; mean duration 18.7 (SD, 2.3) weeks, mean number of interactions between therapist and patient 11.8 (SD, 3.5)
    Outcome
    SF-36 physical functioning Short Form Health Survey
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial. (2025)

    People in the study
    130 randomised · 125 started · 122 analysed
    Dose
    four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention
    Outcome
    WPAI interaction Work Productivity and Activity Impairment
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Which cognitive-behavioural factors play a role in the reduction of post-COVID-19 fatigue following cognitive behavioural therapy and care as usual? A secondary analysis of the ReCOVer study. (2026)

    People in the study
    114 randomised · 110 analysed
    Dose
    tailored, modular treatment targeting up to seven putative perpetuating factors; blended format consisting of therapist contact and online modules
    Outcome
    self-reported activity Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Effect of Cognitive Behavioral Therapy on Depression and Functional Outcomes in Patients with Post Covid-19: A Randomized Controlled Trial (2024) preprint

    People in the study
    36 randomised
    Dose
    30 minutes, 3 sessions/week for 12 successive weeks
    Outcome
    Katz Index of Independence in Activities of Daily Living
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  5. Cognitive behavioural therapy for severe fatigue following COVID-19 in adolescents: a serial single-case observational study of five consecutively referred patients. (2025)

    People in the study
    5 in the study
    Dose
    —
    Outcome
    impaired physical functioning Child Health Questionnaire-87
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  6. [Fatigue and sensorimotor instability : Neurologically controlled conversion of post-COVID-19 patients]. (2024)

    People in the study
    78 in the study
    Dose
    Q2-2023 bis Q4-2023
    Outcome
    Functional Reach Test (FRT) Functional Reach Test
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  7. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    WSAS Work and Social Adjustment Scale
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms4 studies · 136 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; 89 people in all; a small benefit can't be ruled out; effect size 0.43 (small).

Randomised trials2 studies · 89 people with results

No clear difference in overall symptoms.

The evidence is very uncertain about the effect of CBT and psychotherapy on overall symptoms in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • 89 people in all; a small benefit can't be ruled out
  • Effect size 0.43 (small)

How big was the difference?

0.43, small. The effect size compares CBT and psychotherapy with 16-week wait-list control (wlc) condition.

Compared with another group, not randomised83 started · 71 with outcome data · five-week · five-week, inpatient

No clear difference in overall symptoms.

The evidence is very uncertain about the effect of CBT and psychotherapy on overall symptoms in long COVID. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance

Studies with no comparison group1 in the study · 3-month follow-up · twelve, individual, 60 min video sessions, over a period of five months (few people)

Overall symptoms improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on overall symptoms in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance

Combination: CBT and psychotherapy + Respiratory physiotherapy / pulmonary rehabilitation + interactive digital resource32 randomised

The breath and mind connection in young people with post-COVID syndrome: feasibility and acceptability of a pilot randomised co-designed intervention. (2026): Wellness Score (0–100%), no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

Combination: CBT and psychotherapy + Physical therapy / physiotherapy1 in the study

Case Report: Overlap Between Long COVID and Functional Neurological Disorders. (2021): mild symptoms persisted limiting physical activities, no clear difference.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 4 studies
  1. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial. (2026)

    People in the study
    53 randomised · 52 started · 52 analysed
    Dose
    eight group and five individual sessions, Sessions were mostly scheduled on a weekly basis
    Outcome
    Overall somatic symptom burden (PHQ-15) Patient Health Questionnaire-15
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Effectiveness of Internet-Based Group Supportive Psychotherapy on Psychic and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post COVID-19 Syndrome Patients. (2023)

    People in the study
    96 randomised · 77 started · 37 analysed
    Dose
    3 sessions in 1 week, 1-2 hours per session, groups consisting of 6-8 people
    Outcome
    SCL-90 Symptom Checklist-90
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  3. Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study. (2026)

    People in the study
    83 started · 71 with outcome data
    Dose
    five-week, inpatient
    Outcome
    Post-COVID symptoms (PCS score) Post-COVID syndrome score
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: time between T0 and T1 The time interval between T0 and T1 was included as a covariate because it differed significantly between the intervention and the control group.
    Selection of participants
    Moderate. comparison group: non-randomized; control group declined inpatient treatment but had indication (PHQ-9 ≥ 10) The control group consisted of post-COVID patients for whom there was an indication for inpatient psychosomatic treatment (depressive symptoms in self-assessment: PHQ-9 ≥ 10), but who declined to take up the treatment.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: intervention lost to follow-up n = 10; control lost to follow-up n = 5; interim analysis excluded protocol deviations
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Low. a pre-specified primary outcome in a registered study
  4. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    PHQ-15
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Quality of life3 studies · 131 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 122 people found no clear difference; a small benefit can't be ruled out.

The randomised trial130 randomised · 125 started · 122 analysed · pre-, 2- and 8-month post-intervention · four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention

No clear difference in quality of life.

The evidence is very uncertain about the effect of CBT and psychotherapy on quality of life in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 122 people found no clear difference; a small benefit can't be ruled out

Compared with another group, not randomised83 started · 71 with outcome data · five-week · five-week, inpatient

No clear difference in quality of life.

The evidence is very uncertain about the effect of CBT and psychotherapy on quality of life in long COVID. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance

Studies with no comparison group1 in the study · 3-month follow-up · twelve, individual, 60 min video sessions, over a period of five months (few people)

Quality of life improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on quality of life in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 3 studies
  1. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial. (2025)

    People in the study
    130 randomised · 125 started · 122 analysed
    Dose
    four 90-min in-person sessions, 1 week apart, 1 week apart; 30-min reactivation session 1 month after the end of the intervention
    Outcome
    QLSI and EQ-5D-5L interaction
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study. (2026)

    People in the study
    83 started · 71 with outcome data
    Dose
    five-week, inpatient
    Outcome
    Health-related quality of life - physical domain (SF-36) Short Form Health-Survey-36
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: time between T0 and T1 The time interval between T0 and T1 was included as a covariate because it differed significantly between the intervention and the control group.
    Selection of participants
    Moderate. comparison group: non-randomized; control group declined inpatient treatment but had indication (PHQ-9 ≥ 10) The control group consisted of post-COVID patients for whom there was an indication for inpatient psychosomatic treatment (depressive symptoms in self-assessment: PHQ-9 ≥ 10), but who declined to take up the treatment.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: intervention lost to follow-up n = 10; control lost to follow-up n = 5; interim analysis excluded protocol deviations
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  3. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. (2022)

    People in the study
    1 in the study
    Dose
    twelve, individual, 60 min video sessions, over a period of five months
    Outcome
    COV19-QoL
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

ME/CFS

Symptoms

Fatigue53 studies · 6,929 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; the studies disagree.

Randomised trials16 studies · 2,565 people with results

Fatigue improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • The studies disagree

Compared with another group, not randomised4 studies · 243 people with results

Fatigue improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in ME/CFS. Improvement · very low certainty C

  • Risk of bias couldn't be judged for most results (ROBINS-I: no information)
  • Not all results were tested against chance
  • The studies disagree

Studies with no comparison group33 studies · 5,712 people with results

Fatigue improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • Only people who finished were analysed
  • The studies disagree
  • The paper's own effect size: 1.12 (effect size)

Combination: CBT and psychotherapy + Biofeedback159 randomised · 96 started · 92 analysed

Biofeedback and cognitive behavioral therapy for Egyptian adolescents suffering from chronic fatigue syndrome (2015): Fatigue severity (checklist score %), better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

Combination: CBT and psychotherapy + Medication + Relaxation therapy + Massage + Hyperthermia and sauna + Extended water fasting (3+ days) + Graded exercise therapy (GET)1 in the study

Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome. (2001): fatigue, better (not tested).

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 53 studies
  1. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. (2012)

    People in the study
    135 randomised · 131 analysed
    Dose
    21 interactive modules, once a week and thereafter once every 2 weeks
    Outcome
    Fatigue severity (CIS-20, range 8–56) checklist individual strength-20
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial. (2018)

    Same trial, also reported in: Internet-Based Cognitive Behavioral Therapy in Stepped Care for Chronic Fatigue Syndrome: Randomized Noninferiority Trial. (2019) (CIS fatigue severity noninferiority, SC-protocol-driven feedback vs TAU)

    People in the study
    240 randomised · 234 analysed
    Dose
    seven modules, at least fortnightly
    Outcome
    Fatigue severity Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Implementing a minimal intervention for chronic fatigue syndrome in a mental health centre: a randomized controlled trial. (2012)

    Same trial, also reported in: Implementation of stepped care for patients with chronic fatigue syndrome in community-based mental health care: outcomes at post-treatment and long-term follow-up. (2019) (fatigue severity)

    People in the study
    123 randomised
    Dose
    booklet (58 pages), email once every 2 weeks
    Outcome
    CIS fatigue severity Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. (2001)

    Same trial, also reported in: Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005) (Fatigue severity (checklist individual strength))

    People in the study
    278 randomised · 241 analysed
    Dose
    16 sessions of 1 h, over 8 months
    Outcome
    CIS fatigue severity at 8 months (CBT vs support groups and CBT vs natural course) checklist individual strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  5. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. (2011)

    Same trial, also reported in: Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. (2012) (clinically significant reduction in fatigue)

    Same trial, also reported in: Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. (2015) (fatigue (CFQ))

    People in the study
    641 randomised
    Dose
    —
    Outcome
    fatigue (Chalder fatigue questionnaire score) Chalder fatigue questionnaire
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  6. Effect of Prolong Life With Nine Turn Method on chronic fatigue syndrome clinical symptoms and roles of gut microbiota: A exploratory randomized controlled trial. (2026)

    People in the study
    96 randomised
    Dose
    once a week for one hour
    Outcome
    MFI-20 total score Multidimensional Fatigue Inventory-20
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  7. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. (2006)

    People in the study
    153 randomised
    Dose
    eight meetings, each lasting 2 hours, fortnightly
    Outcome
    Perceived fatigue Borg Perceived Fatigue Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Low
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  8. Online treatment of myalgic encephalomyelitis / chronic fatigue syndrome in adolescents: a parallel groups randomised controlled trial comparing specialist cognitive behaviour therapy to activity management (2025)

    People in the study
    314 randomised
    Dose
    19 modules, over six months; email consultations typically every two weeks
    Outcome
    CIS fatigue severity subscale at six months Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  9. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. (2011)

    People in the study
    69 randomised · 58 analysed
    Dose
    12 weekly group meetings held in 2-hour sessions
    Outcome
    POMS-Fatigue subscale Profile of Mood States
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  10. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions. (2021)

    People in the study
    236 randomised
    Dose
    8 weekly therapy sessions and a booster session 4 weeks after the eighth session, 8 weeks
    Outcome
    Chalder Fatigue Questionnaire
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  11. Illness beliefs and treatment outcome in chronic fatigue syndrome. (1998)

    People in the study
    60 randomised
    Dose
    13 sessions
    Outcome
    fatigue
    Effect
    better (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  12. Effects of the Prolong Life With Nine Turn Method (Yan Nian Jiu Zhuan) Qigong on Brain Functional Changes in Patients With Chronic Fatigue Syndrome in Terms of Fatigue and Quality of Life. (2022)

    People in the study
    34 randomised · 30 analysed
    Dose
    lectures or psychological consultations 1 h, once a week; WeChat video lectures for 30 min daily on the remaining 6 days of the week
    Outcome
    MFI-20 Multi-dimensional Fatigue Inventory 20
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  13. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. (1993)

    People in the study
    90 randomised
    Dose
    six sessions
    Outcome
    Fatigue subscale Profile-of-Mood States (POMS) questionnaire
    Effect
    better (not tested)
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  14. Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: long-term follow-up of an RCT. (2012)

    People in the study
    63 randomised · 44 started · 44 analysed
    Dose
    13 one-hour sessions, delivered every fortnight
    Outcome
    Fatigue (Chalder Fatigue Scale) Chalder Fatigue Questionnaire
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  15. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. (2001)

    People in the study
    60 randomised · 53 started · 53 analysed
    Dose
    13 sessions
    Outcome
    Score (<4) on Fatigue Questionnaire — at 5-year follow-up Fatigue Questionnaire
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  16. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial. (2008)

    People in the study
    66 randomised · 61 analysed
    Dose
    10 sessions, over a period of 5 months
    Outcome
    Fatigue severity at follow-up: CBT group versus no-treatment group Checklist Individual Strength
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  17. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. (2005)

    People in the study
    67 in the study
    Dose
    12 two-hour sessions, 12 two-hour sessions during 6 months
    Outcome
    Fatigue (CIS fatigue) Checklist Individual Strength
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    NI. adjustment for confounding isn't reported
    Selection of participants
    Moderate. comparison group: non-randomised allocation: patients allocated to CBGT until the first group was full; later groups consisted partly of patients from the waiting list condition and partly of recently referred patients Patients were allocated to CBGT until the first group was full. The next groups consisted partly of patients from the waiting list condition and partly of recently referred patients.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Two patients dropped out during treatment; no post-test data available from these patients Two patients dropped out during treatment. No post-test data are available from these patients.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified primary outcome
  18. CBT Based Group Therapy for Patients With Chronic Fatigue Syndrome (CFS) (2019)

    People in the study
    30 in the study · 28 started · 28 with outcome data
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    physical fatigue
    Effect
    better
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: stated in the result 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in the GCBT.
    Selection of participants
    Moderate. comparison group: same participants acted as their own waiting list control 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in the GCBT.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: one participant refused one measure; very little missing data; many informant global outcome measures not returned one participant refused to fill in one of the measures as he “disagreed with its theoretical assumptions,” hence there is very little missing data.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified secondary outcome
  19. A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. (1994)

    People in the study
    —
    Dose
    weekly in groups of three to seven or individually for a total of six therapy sessions over a period of 6-9 weeks
    Outcome
    fatigue severity (between groups at treatment termination) Fatigue Severity Scale
    Effect
    better
    Risk of bias
    ROBINS-I: Serious
    Confounding
    NI. adjustment for confounding isn't reported
    Selection of participants
    Moderate. comparison group: those refusing therapy were assigned to the no-treatment group those refusing therapy were assigned to the no-treatment group.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: depression group: four subjects dropped out early and did not participate further Four subjects dropped out early in the course oftherapy and did not participate further in the study.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  20. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome. (2016)

    People in the study
    171 in the study · 148 with outcome data
    Dose
    Fourteen sessions, the first 12 of these being typically weekly or fortnightly
    Outcome
    CGI positive change at posttreatment Clinical Global Impression (CGI)
    Effect
    worse (not tested)
    Risk of bias
    ROBINS-I: No information
    Confounding
    Moderate. adjusted for: anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence change in anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence covariates entered as fixed effects
    Selection of participants
    Moderate. comparison group: patient preference Patient preference drove choice of therapy
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Ten CBT patients and seven GET patients dropped out without agreement; three patients each from CBT and GET ended therapy with therapist consent; prorated by adding a mean score value for missing items if a maximum of two scores were missing; data withdrawn if no consent at all three data points Ten CBT patients and seven GET patients dropped out of therapy without first agreeing to do so with their therapist. Three patients each from CBT and GET ended therapy with the consent of their therapist.
    Measurement of outcomes
    Moderate. administered or clinician-rated; assessors blinded: NI
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  21. Internet-Based Cognitive Behavioral Therapy for Chronic Fatigue Syndrome Integrated in Routine Clinical Care: Implementation Study. (2019)

    People in the study
    100 in the study · 99 started
    Dose
    7 modules, 6 months
    Outcome
    Fatigue severity (CIS) Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  22. A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up. (2018)

    People in the study
    305 in the study
    Dose
    each lasting 30–60 min, 1–2 times daily
    Outcome
    Fatigue scale Chalder Fatigue Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  23. Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study. (2012)

    People in the study
    63 in the study
    Dose
    six half-hour fortnightly telephone sessions and two follow-up sessions
    Outcome
    Fatigue (Chalder Fatigue Questionnaire Total) Chalder Fatigue Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  24. Therapist effects in routine psychotherapy practice: an account from chronic fatigue syndrome. (2011)

    People in the study
    374 in the study
    Dose
    10 to 15 sessions, manualized; therapists encouraged to structure each session and the entire intervention as outlined in the manual
    Outcome
    fatigue Chalder Fatigue Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  25. The Relationship Between Childhood Trauma and the Response to Group Cognitive-Behavioural Therapy for Chronic Fatigue Syndrome. (2020)

    People in the study
    105 in the study
    Dose
    12 group sessions, 3 individual sessions, and one group session for partners, each session lasting 2 h
    Outcome
    CIS total Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  26. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study. (2024)

    People in the study
    297 in the study
    Dose
    one half day
    Outcome
    CIS-20 total score Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  27. Cognitive behaviour therapy for chronic fatigue syndrome in adults: face to face versus telephone treatment: a randomized controlled trial. (2012)

    People in the study
    80 randomised
    Dose
    up to 15 sessions, The first two sessions lasted up to 11/2 hours in order to complete a detailed assessment. Subsequent sessions were between 50 minutes and 1 hour
    Outcome
    Fatigue Chalder Fatigue Scale
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  28. Effectiveness of Cognitive Behavioural Therapy on Sleep Outcome for Patients With Chronic Fatigue Syndrome in a Routine Clinical Service. (2026)

    People in the study
    217 in the study
    Dose
    up to 16 sessions, average duration was around 60 minutes
    Outcome
    Fatigue (CFS) fatigue questionnaire (CFS)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  29. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. (2009)

    People in the study
    41 in the study
    Dose
    12–15 sessions
    Outcome
    Chalder Fatigue Scale (0–33)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  30. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? (2007)

    People in the study
    112 in the study · 96 with outcome data
    Dose
    —
    Outcome
    CIS-fatigue Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  31. Group Cognitive Behavioural Therapy for Chronic Fatigue Syndrome: A Pilot Study (2005)

    People in the study
    6 in the study
    Dose
    10 sessions of one hour spread over 18 weeks
    Outcome
    Fatigue Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  32. Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK. (2020)

    People in the study
    995 in the study
    Dose
    fortnightly for 8 to 10 months
    Outcome
    Chalder Fatigue Questionnaire scores Chalder Fatigue Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  33. The role of the therapeutic relationship in cognitive behaviour therapy for chronic fatigue syndrome. (2013)

    People in the study
    232 in the study · 297 started · 217 with outcome data
    Dose
    approximately 12 sessions during 6 months
    Outcome
    independent contribution of changes in therapy relationship during therapy to post-treatment fatigue
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  34. Cognitive behavior therapy in patients with chronic fatigue syndrome: the role of illness acceptance and neuroticism. (2013)

    People in the study
    80 in the study
    Dose
    twelve, 2-hour sessions, and a session was held every 2 weeks
    Outcome
    fatigue severity Checklist interpersonal attachment strength (CIS)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  35. Acceptance and commitment therapy for chronic fatigue syndrome : a case series approach (2016)

    People in the study
    6 in the study
    Dose
    Each week, a section of text from the book 'Get out of your mind and into your life' (Hayes and Smith, 2005) , was sent via email or post to participants, weekly
    Outcome
    fatigue levels Chalder Fatigue Questionnaire
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  36. Mechanisms of change underlying the efficacy of cognitive behaviour therapy for chronic fatigue syndrome in a specialist clinic: a mediation analysis. (2014)

    People in the study
    389 in the study
    Dose
    —
    Outcome
    fatigue Chalder Fatigue Questionnaire (CFQ)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  37. An Acceptance and Commitment Therapy (ACT) intervention for Chronic Fatigue Syndrome (CFS): A case series approach (2017)

    People in the study
    6 in the study
    Dose
    a section of text sent weekly via email or post
    Outcome
    Chalder Fatigue Questionnaire
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  38. Generalized Worry in Patients With Chronic Fatigue Syndrome Following Cognitive Behavioral Therapy: A Prospective Cohort Study in Secondary Care. (2022)

    People in the study
    726 in the study · 470 started · 470 with outcome data
    Dose
    between 12 to 16 individual 1-hour sessions plus four follow-up appointments; "Patients are usually offered between 12 to 16 individual 1-hour sessions with an experienced CBT therapist, plus four follow-up appointments."
    Outcome
    Mediation Effects of Avoidance Behavior and Fear-Avoidance Beliefs on the Association Between Worry, Fatigue and Work and Social Adjustment (fear-avoidance beliefs)
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  39. Implementing cognitive behavioral therapy for chronic fatigue syndrome in a mental health center: a benchmarking evaluation. (2008)

    People in the study
    143 in the study · 84 started · 112 with outcome data
    Dose
    16 one-hour sessions, over a period of 6 to 8 months
    Outcome
    Fatigue Severity Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  40. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome (2007)

    People in the study
    2 in the study
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    physical and mental fatigue
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  41. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? (2010)

    People in the study
    84 in the study · 82 with outcome data
    Dose
    12–15 sessions
    Outcome
    Chalder Fatigue Scale (0–33), mean (S.D.) Chalder Fatigue Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  42. Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice. (2014)

    People in the study
    200 in the study · 140 with outcome data
    Dose
    Between 6 and 20 sessions were attended, with a mean of 15.3 sessions (SD 1⁄4 3.7)
    Outcome
    Scoring 18 or higher on the CFQ Chalder fatigue questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  43. Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity? (2009)

    People in the study
    30 in the study · 17 started · 11 with outcome data
    Dose
    6–32 visits (median 5 12), weekly or biweekly over a period of 7–35 weeks
    Outcome
    fatigue impact (FSS) Fatigue Severity Scale
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  44. Coniunctio--in bodily and psychic modes: dissociation, devitalization and integration in a case of chronic fatigue syndrome. (1997)

    People in the study
    1 in the study
    Dose
    first year twice-weekly sessions; second and third years three sessions a week
    Outcome
    energy returned slowly but steadily
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  45. The process of cognitive behaviour therapy for chronic fatigue syndrome: which changes in perpetuating cognitions and behaviour are related to a reduction in fatigue? (2013)

    People in the study
    232 in the study · 183 with outcome data
    Dose
    approximately 12 one-hour sessions during 6 months
    Outcome
    change in fatigue severity during CBT (uncontrolled Cohen's d) Checklist Individual Strength
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  46. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. (2019)

    People in the study
    583 in the study · 511 with outcome data
    Dose
    —
    Outcome
    Fatigue severity1 Checklist Individual Strength (CIS)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  47. Effectiveness of Internet-Based Cognitive Behavior Therapy (Fatigue in Teenagers on the Internet) for Adolescents With Chronic Fatigue Syndrome in Routine Clinical Care: Observational Study. (2021)

    People in the study
    384 in the study · 328 started
    Dose
    21 interactive treatment modules
    Outcome
    Fatigue severity score reduced on average by 23.8 points to 26.0 Checklist Individual Strength
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  48. Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety. (2020)

    People in the study
    10 in the study · 8 with outcome data
    Dose
    twelve individual face-to-face 60 minute sessions, twelve individual sessions
    Outcome
    Chalder Fatigue Score Chalder Fatigue Questionnaire
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  49. P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome (2004)

    People in the study
    70 in the study
    Dose
    12-15 sessions over 6 months
    Outcome
    fatigue
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  50. Effectiveness of stepped care for chronic fatigue syndrome: a randomized noninferiority trial. (2010)

    People in the study
    171 randomised
    Dose
    e-mail at least every 2 weeks
    Outcome
    Effect size
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  51. Cognitive behavior therapy for chronic fatigue syndrome: a case study. (1999)

    People in the study
    1 in the study
    Dose
    22 sessions within 14 months. Three follow-up sessions followed in the next 7 months, 22 sessions within 14 months; three follow-up sessions in the next 7 months
    Outcome
    CIS-fat Checklist Individual Strength
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  52. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. (2017)

    People in the study
    1 in the study
    Dose
    eight 60 minute sessions in addition to two assessment sessions
    Outcome
    Chalder Fatigue Scale
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  53. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    CIS-20 total score Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Low mood or anxiety21 studies · 1,319 people took part in CBT and psychotherapy Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; the studies disagree; randomised trials found mixed results.

Randomised trials8 studies · 1,079 people with results

Studies disagree about low mood or anxiety.

Studies disagree about whether CBT and psychotherapy helps low mood or anxiety. Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • The studies disagree

Compared with another group, not randomised2 studies · 95 people with results

Studies disagree about low mood or anxiety.

Studies disagree about whether CBT and psychotherapy helps low mood or anxiety. Mixed results · very low certainty C

  • Serious risk of bias (ROBINS-I)
  • The studies disagree

Studies with no comparison group11 studies · 777 people with results

Low mood or anxiety improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on low mood or anxiety in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • Only people who finished were analysed
  • The paper's own effect size: 1.06 (Cohen's d)
See the 21 studies
  1. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. (2006)

    People in the study
    153 randomised
    Dose
    eight meetings, each lasting 2 hours, fortnightly
    Outcome
    SF-36 mental health summary scale Short Form with 36 Items
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Low
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    High
  2. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial. (2018)

    Same trial, also reported in: Internet-Based Cognitive Behavioral Therapy in Stepped Care for Chronic Fatigue Syndrome: Randomized Noninferiority Trial. (2019) (SCL-90 psychological distress)

    People in the study
    240 randomised · 234 analysed
    Dose
    seven modules, at least fortnightly
    Outcome
    Psychological distress Symptom Checklist 90
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. (2001)

    People in the study
    278 randomised · 241 analysed
    Dose
    16 sessions of 1 h, over 8 months
    Outcome
    Psychological wellbeing (symptom checklist 90) at 8 months symptom checklist 90
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions. (2021)

    People in the study
    236 randomised
    Dose
    8 weekly therapy sessions and a booster session 4 weeks after the eighth session, 8 weeks
    Outcome
    SF-36 subscale mental health mean difference
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  5. Illness beliefs and treatment outcome in chronic fatigue syndrome. (1998)

    People in the study
    60 randomised
    Dose
    13 sessions
    Outcome
    mood
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  6. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. (2011)

    People in the study
    69 randomised · 58 analysed
    Dose
    12 weekly group meetings held in 2-hour sessions
    Outcome
    POMS-total mood disturbance Profile of Mood States
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  7. Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: long-term follow-up of an RCT. (2012)

    People in the study
    63 randomised · 44 started · 44 analysed
    Dose
    13 one-hour sessions, delivered every fortnight
    Outcome
    Adjustment (child SDQ total) Strengths and Difficulties Questionnaire Total Difficulties score
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  8. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. (2001)

    People in the study
    60 randomised · 53 started · 53 analysed
    Dose
    13 sessions
    Outcome
    Score (<4) on General Health Questionnaire — at 5-year follow-up General Health Questionnaire
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  9. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. (2005)

    People in the study
    67 in the study
    Dose
    12 two-hour sessions, 12 two-hour sessions during 6 months
    Outcome
    Psychological distress (SCL-90) Symptom Checklist 90
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    NI. adjustment for confounding isn't reported
    Selection of participants
    Moderate. comparison group: non-randomised allocation: patients allocated to CBGT until the first group was full; later groups consisted partly of patients from the waiting list condition and partly of recently referred patients Patients were allocated to CBGT until the first group was full. The next groups consisted partly of patients from the waiting list condition and partly of recently referred patients.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Two patients dropped out during treatment; no post-test data available from these patients Two patients dropped out during treatment. No post-test data are available from these patients.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified secondary outcome
  10. CBT Based Group Therapy for Patients With Chronic Fatigue Syndrome (CFS) (2019)

    People in the study
    30 in the study · 28 started · 28 with outcome data
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    depressive symptoms (hospital anxiety and depression scale [HADS-D]) hospital anxiety and depression scale
    Effect
    better
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: stated in the result 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in the GCBT.
    Selection of participants
    Moderate. comparison group: same participants acted as their own waiting list control 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in the GCBT.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: one participant refused one measure; very little missing data; many informant global outcome measures not returned one participant refused to fill in one of the measures as he “disagreed with its theoretical assumptions,” hence there is very little missing data.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified secondary outcome
  11. The Cognitive Behavioral Treatment of Depression and Low Self-Esteem in the Context of Pediatric Chronic Fatigue Syndrome (CFS/ME): A Case Study. (2015)

    People in the study
    1 in the study
    Dose
    weekly for four sessions; fifth session after a month; sixth session (follow-up) 2 months later
    Outcome
    depression subscale of the RCADS at follow-up Revised Children’s Anxiety and Depression Scale—Self-report
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  12. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? (2010)

    People in the study
    84 in the study · 82 with outcome data
    Dose
    12–15 sessions
    Outcome
    General Health Questionnaire (0–36), mean (S.D.) General Health Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  13. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study. (2024)

    People in the study
    297 in the study
    Dose
    one half day
    Outcome
    PANAS positive affect Positive and Negative Affect Schedule
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  14. Group Cognitive Behavioural Therapy for Chronic Fatigue Syndrome: A Pilot Study (2005)

    People in the study
    6 in the study
    Dose
    10 sessions of one hour spread over 18 weeks
    Outcome
    General Health Questionnaire at 3-month follow-up General Health Questionnaire
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  15. Coniunctio--in bodily and psychic modes: dissociation, devitalization and integration in a case of chronic fatigue syndrome. (1997)

    People in the study
    1 in the study
    Dose
    first year twice-weekly sessions; second and third years three sessions a week
    Outcome
    unexpected sense of ‘freedom’
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  16. 'A life I can cope with'. An alternative model of cognitive behavioural therapy (CBT) for CFS/ME. (2022)

    People in the study
    13 in the study
    Dose
    between 6 and 10 sessions (median = 6)
    Outcome
    less distressed and more hopeful about living with the illness
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  17. Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety. (2020)

    People in the study
    10 in the study · 8 with outcome data
    Dose
    twelve individual face-to-face 60 minute sessions, twelve individual sessions
    Outcome
    HADS-A Hospital Anxiety and Depression Scale-Anxiety
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  18. P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome (2004)

    People in the study
    70 in the study
    Dose
    12-15 sessions over 6 months
    Outcome
    psychiatric symptorm
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  19. Chronic fatigue syndrome and women: can therapy help? (1992)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    emotional life became calmer, more manageable, and more satisfying
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  20. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. (2017)

    People in the study
    1 in the study
    Dose
    eight 60 minute sessions in addition to two assessment sessions
    Outcome
    Hospital Anxiety and Depression Scale – Anxiety Hospital Anxiety and Depression Scale (HADS)
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  21. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    Positive affect Positive and Negative Affect Schedule (PANAS)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Cognition (brain fog)8 studies · 1,228 people took part in CBT and psychotherapy Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (312 in all); the studies disagree; randomised trials found mixed results.

Randomised trials3 studies · 312 people with results

Studies disagree about cognition (brain fog).

Studies disagree about whether CBT and psychotherapy helps cognition (brain fog). Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (312 in all)
  • The studies disagree

Studies with no comparison group5 studies · 1,126 people with results

Cognition (brain fog) improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on cognition (brain fog) in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • The studies disagree
See the 8 studies
  1. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. (2006)

    People in the study
    153 randomised
    Dose
    eight meetings, each lasting 2 hours, fortnightly
    Outcome
    Recall (total words recalled, correct words recalled) short-form neurocognitive battery
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Low
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  2. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005)

    People in the study
    71 randomised · 69 analysed
    Dose
    10 individual sessions, over five months
    Outcome
    Impaired concentration
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. (1993)

    People in the study
    90 randomised
    Dose
    six sessions
    Outcome
    Confusion subscale Profile-of-Mood States (POMS) questionnaire
    Effect
    worse (not tested)
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  4. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study. (2024)

    People in the study
    297 in the study
    Dose
    one half day
    Outcome
    CIS-20 concentration Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. Mechanisms of change underlying the efficacy of cognitive behaviour therapy for chronic fatigue syndrome in a specialist clinic: a mediation analysis. (2014)

    People in the study
    389 in the study
    Dose
    —
    Outcome
    fear avoidance beliefs Cognitive Behavioural Responses to Symptoms Questionnaire (CBRSQ)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  6. The Process of Change in Pain During Cognitive-Behavior Therapy for Chronic Fatigue Syndrome. (2015)

    People in the study
    142 in the study
    Dose
    —
    Outcome
    self-efficacy Self-Efficacy Scale
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  7. Cognitive behavior therapy for chronic fatigue syndrome: a case study. (1999)

    People in the study
    1 in the study
    Dose
    22 sessions within 14 months. Three follow-up sessions followed in the next 7 months, 22 sessions within 14 months; three follow-up sessions in the next 7 months
    Outcome
    CIS-con Checklist Individual Strength
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  8. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    CIS-20 Concentration Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Sleep4 studies · 328 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (216 in all); the studies disagree.

Randomised trials3 studies · 216 people with results

Sleep improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on sleep in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (216 in all)
  • The studies disagree

Studies with no comparison group217 in the study · discharge, 3-month, 6-month, and 12-month follow-up · up to 16 sessions, average duration was around 60 minutes

Sleep improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on sleep in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
See the 4 studies
  1. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005)

    People in the study
    71 randomised · 69 analysed
    Dose
    10 individual sessions, over five months
    Outcome
    Unrefreshing sleep
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. (2011)

    People in the study
    69 randomised · 58 analysed
    Dose
    12 weekly group meetings held in 2-hour sessions
    Outcome
    unrefreshing sleep Centers for Disease Control (CDC) Symptom Inventory for Chronic Fatigue Syndrome
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. Prolong Life with Nine Turn Method Qigong on Chronic Fatigue Syndrome in Terms of Calcitonin Gene Related Peptide and Folic Acid Levels (2022)

    People in the study
    90 randomised · 89 analysed
    Dose
    one hour each week, 30 minutes every day on WeChat
    Outcome
    sleep duration Pittsburgh Sleep Quality Index
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Effectiveness of Cognitive Behavioural Therapy on Sleep Outcome for Patients With Chronic Fatigue Syndrome in a Routine Clinical Service. (2026)

    People in the study
    217 in the study
    Dose
    up to 16 sessions, average duration was around 60 minutes
    Outcome
    Sleep latency (minutes) Pittsburgh Sleep Quality Index (PSQI)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Post-exertional malaise1 study · 29 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (69 in all).

The randomised trial71 randomised · 69 analysed · 10 sessions of therapy over five months · 10 individual sessions, over five months

Post-exertional malaise improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on post-exertional malaise in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (69 in all)
See the 1 study
  1. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005)

    People in the study
    71 randomised · 69 analysed
    Dose
    10 individual sessions, over five months
    Outcome
    Tiredness after exercise
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
Anxiety7 studies · 723 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 153 people found no clear difference; a small benefit can't be ruled out.

The randomised trial153 randomised · eight meetings, each lasting 2 hours, fortnightly · eight meetings, each lasting 2 hours, fortnightly

No clear difference in anxiety.

The evidence is very uncertain about the effect of CBT and psychotherapy on anxiety in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 153 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group6 studies · 671 people with results

Anxiety improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on anxiety in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • Only people who finished were analysed
  • The studies disagree
  • The paper's own effect size: /C00.32 (Cohen’s d)
See the 7 studies
  1. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. (2006)

    People in the study
    153 randomised
    Dose
    eight meetings, each lasting 2 hours, fortnightly
    Outcome
    Mood (alertness, hedonic tone, anxiety) short-form neurocognitive battery
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Low
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  2. Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study. (2012)

    People in the study
    63 in the study
    Dose
    six half-hour fortnightly telephone sessions and two follow-up sessions
    Outcome
    Anxiety Spence Children's Anxiety Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  3. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study. (2024)

    People in the study
    297 in the study
    Dose
    one half day
    Outcome
    GAD-7 generalized anxiety
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  4. Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity? (2009)

    People in the study
    30 in the study · 17 started · 11 with outcome data
    Dose
    6–32 visits (median 5 12), weekly or biweekly over a period of 7–35 weeks
    Outcome
    BAI Beck Anxiety Inventory
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome (2007)

    People in the study
    2 in the study
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    anxiety levels
    Effect
    no clear difference
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  6. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. (2017)

    People in the study
    1 in the study
    Dose
    eight 60 minute sessions in addition to two assessment sessions
    Outcome
    Health Anxiety Inventory Health anxiety Inventory (HAI)
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  7. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    Generalized anxiety
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Pain9 studies · 552 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; no confidence interval shows an important benefit is ruled out; the studies disagree.

Randomised trials4 studies · 1,260 people with results

No clear difference in pain.

The evidence is very uncertain about the effect of CBT and psychotherapy on pain in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • No confidence interval shows an important benefit is ruled out
  • The studies disagree

Compared with another group, not randomised67 in the study · between baseline and 6 months · 12 two-hour sessions, 12 two-hour sessions during 6 months

No clear difference in pain.

The evidence is very uncertain about the effect of CBT and psychotherapy on pain in ME/CFS. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance
  • Effect size 0.13 (very small)

How big was the difference?

0.13, very small. The effect size compares CBT and psychotherapy with waiting list condition (wl).

Studies with no comparison group4 studies · 146 people with results

Pain improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on pain in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • The studies disagree

Combination: CBT and psychotherapy + Biofeedback159 randomised · 96 started · 92 analysed

Biofeedback and cognitive behavioral therapy for Egyptian adolescents suffering from chronic fatigue syndrome (2015): Headache, better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 9 studies
  1. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions. (2021)

    People in the study
    236 randomised
    Dose
    8 weekly therapy sessions and a booster session 4 weeks after the eighth session, 8 weeks
    Outcome
    SF-36 subscale bodily pain mean difference
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005)

    People in the study
    71 randomised · 69 analysed
    Dose
    10 individual sessions, over five months
    Outcome
    Muscle pain
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. (2024)

    People in the study
    314 randomised
    Dose
    supported by individualised written, asynchronous electronic consultations with a clinical psychologist/cognitive-behavioural therapy practitioner
    Outcome
    pain
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial. (2014)

    People in the study
    641 randomised
    Dose
    —
    Outcome
    Muscle pain
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Some concerns
    Measurement of the outcome
    High
    Selection of the reported result
    High
  5. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. (2005)

    People in the study
    67 in the study
    Dose
    12 two-hour sessions, 12 two-hour sessions during 6 months
    Outcome
    Daily observed pain
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    NI. adjustment for confounding isn't reported
    Selection of participants
    Moderate. comparison group: non-randomised allocation: patients allocated to CBGT until the first group was full; later groups consisted partly of patients from the waiting list condition and partly of recently referred patients Patients were allocated to CBGT until the first group was full. The next groups consisted partly of patients from the waiting list condition and partly of recently referred patients.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Two patients dropped out during treatment; no post-test data available from these patients Two patients dropped out during treatment. No post-test data are available from these patients.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified secondary outcome
  6. The Process of Change in Pain During Cognitive-Behavior Therapy for Chronic Fatigue Syndrome. (2015)

    People in the study
    142 in the study
    Dose
    —
    Outcome
    Pain intensity self-observation list
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  7. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome (2007)

    People in the study
    2 in the study
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    pain
    Effect
    no clear difference
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  8. Cognitive behavior therapy for chronic fatigue syndrome: a case study. (1999)

    People in the study
    1 in the study
    Dose
    22 sessions within 14 months. Three follow-up sessions followed in the next 7 months, 22 sessions within 14 months; three follow-up sessions in the next 7 months
    Outcome
    DOP Self-observation list daily functioning
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  9. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. (2017)

    People in the study
    1 in the study
    Dose
    eight 60 minute sessions in addition to two assessment sessions
    Outcome
    Pain scores Visual Analogue Scale (VAS)
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Depression13 studies · 1,178 people took part in CBT and psychotherapy Uncertain –
Low certainty

Why this grade: Uncertain, low certainty, from randomised trials: some concerns about bias (RoB 2); few people (90 in all); helped less than dle + cbt, an active treatment; not a sign of harm.

The placebo trial90 randomised · 4 months · six sessions

Depression improved less than with the comparison treatment.

CBT and psychotherapy helped depression less than dle + cbt in the one comparison. Uncertain · low certainty –

  • Some concerns about bias (RoB 2)
  • Few people (90 in all)
  • Helped less than dle + cbt, an active treatment; not a sign of harm

Compared with another group, not randomised2 studies · 95 people with results

Studies disagree about depression.

Studies disagree about whether CBT and psychotherapy helps depression. Mixed results · very low certainty C

  • Serious risk of bias (ROBINS-I)
  • The studies disagree

Studies with no comparison group10 studies · 1,100 people with results

Depression improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on depression in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • Only people who finished were analysed
  • The paper's own effect size: /C00.28 (Cohen’s d)

Combination: CBT and psychotherapy + Medication + Relaxation therapy + Massage + Hyperthermia and sauna + Extended water fasting (3+ days) + Graded exercise therapy (GET)1 in the study

Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome. (2001): depressive moods, better (not tested).

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 13 studies
  1. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. (1993)

    People in the study
    90 randomised
    Dose
    six sessions
    Outcome
    Depression subscale Profile-of-Mood States (POMS) questionnaire
    Effect
    worse (not tested)
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  2. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. (2005)

    People in the study
    67 in the study
    Dose
    12 two-hour sessions, 12 two-hour sessions during 6 months
    Outcome
    Depression (BDI) Beck Depression Inventory
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    NI. adjustment for confounding isn't reported
    Selection of participants
    Moderate. comparison group: non-randomised allocation: patients allocated to CBGT until the first group was full; later groups consisted partly of patients from the waiting list condition and partly of recently referred patients Patients were allocated to CBGT until the first group was full. The next groups consisted partly of patients from the waiting list condition and partly of recently referred patients.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Two patients dropped out during treatment; no post-test data available from these patients Two patients dropped out during treatment. No post-test data are available from these patients.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified secondary outcome
  3. CBT Based Group Therapy for Patients With Chronic Fatigue Syndrome (CFS) (2019)

    People in the study
    30 in the study · 28 started · 28 with outcome data
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    depressive symptoms (Beck depression inventory-fast screen for medical individuals [BDI-FS]) Beck depression inventory-fast screen for medical individuals
    Effect
    better
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: stated in the result 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in the GCBT.
    Selection of participants
    Moderate. comparison group: same participants acted as their own waiting list control 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in the GCBT.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: one participant refused one measure; very little missing data; many informant global outcome measures not returned one participant refused to fill in one of the measures as he “disagreed with its theoretical assumptions,” hence there is very little missing data.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified secondary outcome
  4. Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study. (2012)

    People in the study
    63 in the study
    Dose
    six half-hour fortnightly telephone sessions and two follow-up sessions
    Outcome
    Depression Birleson Feelings Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up. (2018)

    People in the study
    305 in the study
    Dose
    each lasting 30–60 min, 1–2 times daily
    Outcome
    BDI depression score at 1-year follow-up Beck Depression Inventory
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  6. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. (2009)

    People in the study
    41 in the study
    Dose
    12–15 sessions
    Outcome
    Beck Depression Inventory (0–62) Beck Depression Inventory
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  7. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome (2007)

    People in the study
    2 in the study
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    depressive symptoms
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  8. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? (2010)

    People in the study
    84 in the study · 82 with outcome data
    Dose
    12–15 sessions
    Outcome
    Beck Depression Inventory (0–62), mean (S.D.) Beck Depression Inventory
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  9. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study. (2024)

    People in the study
    297 in the study
    Dose
    one half day
    Outcome
    PHQ-9 depression Patient Health Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  10. Cognitive behavior therapy for chronic fatigue syndrome: a case study. (1999)

    People in the study
    1 in the study
    Dose
    22 sessions within 14 months. Three follow-up sessions followed in the next 7 months, 22 sessions within 14 months; three follow-up sessions in the next 7 months
    Outcome
    BDI Beck Depression Inventory
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  11. Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity? (2009)

    People in the study
    30 in the study · 17 started · 11 with outcome data
    Dose
    6–32 visits (median 5 12), weekly or biweekly over a period of 7–35 weeks
    Outcome
    BDI Beck Depression Inventory
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  12. Chronic fatigue syndrome and women: can therapy help? (1992)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    alleviate longstanding symptoms of depression
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  13. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    Depression Patient Health Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Overall symptoms31 studies · 2,675 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; the studies disagree.

Randomised trials13 studies · 2,580 people with results

Overall symptoms improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on overall symptoms in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • The studies disagree

Compared with another group, not randomised171 in the study · 148 with outcome data · Fourteen sessions; first 12 typically weekly or fortnightly; sessions 13 or 14 follow-up or booster · Fourteen sessions, the first 12 of these being typically weekly or fortnightly

No clear difference in overall symptoms.

The evidence is very uncertain about the effect of CBT and psychotherapy on overall symptoms in ME/CFS. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance

Studies with no comparison group17 studies · 1,149 people with results

Overall symptoms improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on overall symptoms in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • Only people who finished were analysed
  • The studies disagree

Combination: CBT and psychotherapy + Medication + Relaxation therapy + Massage + Hyperthermia and sauna + Extended water fasting (3+ days) + Graded exercise therapy (GET)1 in the study

Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome. (2001): symptoms, better (not tested).

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 31 studies
  1. Illness beliefs and treatment outcome in chronic fatigue syndrome. (1998)

    People in the study
    60 randomised
    Dose
    13 sessions
    Outcome
    improved at 6-month follow-up Medical Outcomes Survey physical functioning scale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled treatment trial. (2010)

    Same trial, also reported in: Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: long-term follow-up of an RCT. (2012) (Global functioning)

    People in the study
    63 randomised
    Dose
    Thirteen 1-h sessions, every 2 weeks
    Outcome
    Mother-reported Global Improvement
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. The Qigong of Prolong Life With Nine Turn Method Relieve Fatigue, Sleep, Anxiety and Depression in Patients With Chronic Fatigue Syndrome: A Randomized Controlled Clinical Study. (2022)

    Same trial, also reported in: Can prolong life with nine turn method (Yan Nian Jiu Zhuan) Qigong alleviates Fatigue, Sleep quality, Depression and anxiety on Patients with Chronic Fatigue Syndrome: a Randomized, Controlled, Clinical Study ? (2021) (between-group difference in total effective rate)

    People in the study
    90 randomised · 89 analysed
    Dose
    1 h weekly lectures or psychological consultations; 30 min daily on the remaining 6 days, once a week in-person and supervised online during the remaining 6 days at home, over 12 consecutive weeks
    Outcome
    Overall efficacy evaluation
    Effect
    worse
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  4. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. (2012)

    People in the study
    135 randomised · 131 analysed
    Dose
    21 interactive modules, once a week and thereafter once every 2 weeks
    Outcome
    Self-rated improvement§
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  5. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005)

    People in the study
    71 randomised · 69 analysed
    Dose
    10 individual sessions, over five months
    Outcome
    Self rated improvement§
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  6. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions. (2021)

    People in the study
    236 randomised
    Dose
    8 weekly therapy sessions and a booster session 4 weeks after the eighth session, 8 weeks
    Outcome
    SF-36 subscale general health mean difference
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  7. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. (2011)

    Same trial, also reported in: Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. (2015) (perceived health change (PCGI))

    Same trial, also reported in: Recovery from chronic fatigue syndrome after treatments given in the PACE trial. (2013) (Number needed to treat for trial recovery)

    People in the study
    641 randomised
    Dose
    —
    Outcome
    clinical global impression: much better or very much better in overall health clinical global impression scale
    Effect
    better (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  8. Online treatment of myalgic encephalomyelitis / chronic fatigue syndrome in adolescents: a parallel groups randomised controlled trial comparing specialist cognitive behaviour therapy to activity management (2025)

    Same trial, also reported in: Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. (2024) (Clinical Global Impression scale)

    People in the study
    314 randomised
    Dose
    19 modules, over six months; email consultations typically every two weeks
    Outcome
    Clinical Global Impression scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  9. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. (2011)

    People in the study
    69 randomised · 58 analysed
    Dose
    12 weekly group meetings held in 2-hour sessions
    Outcome
    total CFS Symptom Severity Centers for Disease Control (CDC) Symptom Inventory for Chronic Fatigue Syndrome
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  10. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. (1993)

    People in the study
    90 randomised
    Dose
    six sessions
    Outcome
    Visual analogue score visual analogue scales
    Effect
    worse (not tested)
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  11. Chronic Fatigue Syndrome in Adolescents: treatment, clinical features and epidemiology (2013)

    People in the study
    135 randomised
    Dose
    —
    Outcome
    Recovery rate
    Effect
    better (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  12. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. (2018)

    People in the study
    641 randomised
    Dose
    up to 15 therapy sessions, over 36 weeks
    Outcome
    recovery rates
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  13. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. (2001)

    People in the study
    60 randomised · 53 started · 53 analysed
    Dose
    13 sessions
    Outcome
    Self-rating on global improvement scale of “much better” or “very much better” — at 5-year follow-up
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  14. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome. (2016)

    People in the study
    171 in the study · 148 with outcome data
    Dose
    Fourteen sessions, the first 12 of these being typically weekly or fortnightly
    Outcome
    CBT vs GET effectiveness on fatigue, anxiety, depression, and physical functioning
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence change in anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence covariates entered as fixed effects
    Selection of participants
    Moderate. comparison group: patient preference Patient preference drove choice of therapy
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Ten CBT patients and seven GET patients dropped out without agreement; three patients each from CBT and GET ended therapy with therapist consent; prorated by adding a mean score value for missing items if a maximum of two scores were missing; data withdrawn if no consent at all three data points Ten CBT patients and seven GET patients dropped out of therapy without first agreeing to do so with their therapist. Three patients each from CBT and GET ended therapy with the consent of their therapist.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  15. Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice. (2014)

    People in the study
    200 in the study · 140 with outcome data
    Dose
    Between 6 and 20 sessions were attended, with a mean of 15.3 sessions (SD 1⁄4 3.7)
    Outcome
    Meeting Oxford criteria
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  16. A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up. (2018)

    People in the study
    305 in the study
    Dose
    each lasting 30–60 min, 1–2 times daily
    Outcome
    Clinical changes after intervention
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  17. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. (2009)

    People in the study
    41 in the study
    Dose
    12–15 sessions
    Outcome
    CBT was moderately effective, with significant reductions in fatigue, disability and psychiatric symptoms
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  18. P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome (2004)

    People in the study
    70 in the study
    Dose
    12-15 sessions over 6 months
    Outcome
    Clinical Global Impression (very much better or much better) Clinical Global Impression
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  19. Cognitive behavior therapy for chronic fatigue syndrome: a case study. (1999)

    People in the study
    1 in the study
    Dose
    22 sessions within 14 months. Three follow-up sessions followed in the next 7 months, 22 sessions within 14 months; three follow-up sessions in the next 7 months
    Outcome
    SCL-tot Symptom Checklist
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  20. Implementing cognitive behavioral therapy for chronic fatigue syndrome in a mental health center: a benchmarking evaluation. (2008)

    People in the study
    143 in the study · 84 started · 112 with outcome data
    Dose
    16 one-hour sessions, over a period of 6 to 8 months
    Outcome
    Patients clinically significantly improved
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  21. The percieved effectiveness of the use of cognitive behavioural therapy in the treatment of clients diagnosed with Myalgic Mncephalomyelitis/Chronic Fatigue Syndrome (also known as ME/CFS) (2008)

    People in the study
    7 in the study
    Dose
    —
    Outcome
    no improvement in their health after the CBT treatment
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  22. Coniunctio--in bodily and psychic modes: dissociation, devitalization and integration in a case of chronic fatigue syndrome. (1997)

    People in the study
    1 in the study
    Dose
    first year twice-weekly sessions; second and third years three sessions a week
    Outcome
    managed the loss of her own flat without upset or ME
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  23. The role of the therapeutic relationship in cognitive behaviour therapy for chronic fatigue syndrome. (2013)

    People in the study
    232 in the study · 297 started · 217 with outcome data
    Dose
    approximately 12 sessions during 6 months
    Outcome
    patients no longer severely fatigued and impaired after therapy Checklist Individual Strength; Sickness Impact Profile
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  24. 'A life I can cope with'. An alternative model of cognitive behavioural therapy (CBT) for CFS/ME. (2022)

    People in the study
    13 in the study
    Dose
    between 6 and 10 sessions (median = 6)
    Outcome
    lack of change on physical symptoms
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  25. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and early maladaptive schemas: A single case study (2018)

    People in the study
    1 in the study
    Dose
    initially
    Outcome
    physically more able and appeared happier
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  26. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? (2007)

    People in the study
    112 in the study · 96 with outcome data
    Dose
    —
    Outcome
    No longer met the inclusion criteria for fatigue severity and the level of disabilities
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  27. Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. (2008)

    People in the study
    125 in the study · 112 started
    Dose
    16 sessions, 16 sessions in a period of 8 months
    Outcome
    recovered
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  28. Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety. (2020)

    People in the study
    10 in the study · 8 with outcome data
    Dose
    twelve individual face-to-face 60 minute sessions, twelve individual sessions
    Outcome
    at least one primary outcome
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  29. Chronic fatigue syndrome and women: can therapy help? (1992)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    psychotherapy helped Claire
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  30. 'I became more aware of my actions'-A qualitative longitudinal study of a health psychological group intervention for patients with myalgic encephalomyelitis/chronic fatigue syndrome. (2023)

    People in the study
    10 in the study
    Dose
    eight 2‐h sessions over 16 weeks and one follow up‐meeting at 3 months postintervention
    Outcome
    Experience of goals achieved second and third interview
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  31. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. (2017)

    People in the study
    1 in the study
    Dose
    eight 60 minute sessions in addition to two assessment sessions
    Outcome
    gains maintained
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Quality of life13 studies · 1,376 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; no confidence interval shows an important benefit is ruled out; the studies disagree.

Randomised trials7 studies · 1,456 people with results

No clear difference in quality of life.

The evidence is very uncertain about the effect of CBT and psychotherapy on quality of life in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • No confidence interval shows an important benefit is ruled out
  • The studies disagree

Studies with no comparison group6 studies · 897 people with results

Quality of life improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on quality of life in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
See the 13 studies
  1. Online treatment of myalgic encephalomyelitis / chronic fatigue syndrome in adolescents: a parallel groups randomised controlled trial comparing specialist cognitive behaviour therapy to activity management (2025)

    Same trial, also reported in: Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. (2024) (quality-adjusted life-years)

    People in the study
    314 randomised
    Dose
    19 modules, over six months; email consultations typically every two weeks
    Outcome
    QALYs Quality-adjusted life years
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. (2006)

    People in the study
    153 randomised
    Dose
    eight meetings, each lasting 2 hours, fortnightly
    Outcome
    HUI3 overall utility score health utilities index
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Low
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  3. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. (2001)

    People in the study
    278 randomised · 241 analysed
    Dose
    16 sessions of 1 h, over 8 months
    Outcome
    Quality of life (EuroQol) at 8 months visual analogue scale of the EuroQol
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. (1993)

    People in the study
    90 randomised
    Dose
    six sessions
    Outcome
    Quality-of-Life score visual analogue scales
    Effect
    worse
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  5. Effects of the Prolong Life With Nine Turn Method (Yan Nian Jiu Zhuan) Qigong on Brain Functional Changes in Patients With Chronic Fatigue Syndrome in Terms of Fatigue and Quality of Life. (2022)

    Same trial, also reported in: Prolong Life with Nine Turn Method Qigong on Chronic Fatigue Syndrome in Terms of Calcitonin Gene Related Peptide and Folic Acid Levels (2022) (Physical function)

    People in the study
    34 randomised · 30 analysed
    Dose
    lectures or psychological consultations 1 h, once a week; WeChat video lectures for 30 min daily on the remaining 6 days of the week
    Outcome
    SF-36 Short Form 36-item Health Survey
    Effect
    worse
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  6. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. (2012)

    People in the study
    641 randomised · 570 analysed
    Dose
    up to 15 individual therapy sessions
    Outcome
    QALY gain quality-adjusted life years (QALYs)
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  7. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. (2011)

    People in the study
    69 randomised · 58 analysed
    Dose
    12 weekly group meetings held in 2-hour sessions
    Outcome
    QOLI raw scores Quality of Life Inventory
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  8. Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. (2008)

    People in the study
    125 in the study · 112 started
    Dose
    16 sessions, 16 sessions in a period of 8 months
    Outcome
    utility score (Euroqol) Euroqol-5d
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  9. Cognitive behavior therapy in patients with chronic fatigue syndrome: the role of illness acceptance and neuroticism. (2013)

    People in the study
    80 in the study
    Dose
    twelve, 2-hour sessions, and a session was held every 2 weeks
    Outcome
    MQoL 36-item Short Form Health Survey (SF-36)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  10. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study. (2024)

    People in the study
    297 in the study
    Dose
    one half day
    Outcome
    SF-36 physical composite score MOS 36-item Short Form Health Survey
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  11. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? (2007)

    People in the study
    112 in the study · 96 with outcome data
    Dose
    —
    Outcome
    Normal health perception Medical Outcomes Survey Short Form-36
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  12. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome (2007)

    People in the study
    2 in the study
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    quality of life
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  13. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    SF-36 Physical MOS 36-item Short Form Health Survey
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Daily functioning44 studies · 5,861 people took part in CBT and psychotherapy Worse F
Very low certainty

Why this grade: Worse, very low certainty, from controlled studies: serious risk of bias (ROBINS-I).

Randomised trials13 studies · 2,400 people with results

Daily functioning improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on daily functioning in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • The studies disagree

Compared with another group, not randomised67 in the study · between baseline and 6 months · 12 two-hour sessions, 12 two-hour sessions during 6 months

Daily functioning was worse with CBT and psychotherapy.

The evidence is very uncertain about the effect of CBT and psychotherapy on daily functioning in ME/CFS. Worse · very low certainty F

  • Serious risk of bias (ROBINS-I)

Studies with no comparison group30 studies · 4,896 people with results

Daily functioning improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on daily functioning in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • Only people who finished were analysed
  • The studies disagree
  • The paper's own effect size: 0.64 (effect size)

Combination: CBT and psychotherapy + Biofeedback159 randomised · 96 started · 92 analysed

Biofeedback and cognitive behavioral therapy for Egyptian adolescents suffering from chronic fatigue syndrome (2015): School attendance (hours/month), better.

Shown, not counted: CBT and psychotherapy was given together with other treatments.

Combination: CBT and psychotherapy + Medication + Relaxation therapy + Massage + Hyperthermia and sauna + Extended water fasting (3+ days) + Graded exercise therapy (GET)1 in the study

Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome. (2001): rehabilitation into work, better (not tested).

Shown, not counted: CBT and psychotherapy was given together with other treatments.

See the 44 studies
  1. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. (2012)

    People in the study
    135 randomised · 131 analysed
    Dose
    21 interactive modules, once a week and thereafter once every 2 weeks
    Outcome
    Physical functioning (CHQ-CF87, range 0–100) child health questionnaire
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Implementing a minimal intervention for chronic fatigue syndrome in a mental health centre: a randomized controlled trial. (2012)

    Same trial, also reported in: Implementation of stepped care for patients with chronic fatigue syndrome in community-based mental health care: outcomes at post-treatment and long-term follow-up. (2019) (physical functioning)

    People in the study
    123 randomised
    Dose
    booklet (58 pages), email once every 2 weeks
    Outcome
    SF-36 physical functioning Medical Outcomes Survey Short Form-36
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. (2024)

    Same trial, also reported in: Online treatment of myalgic encephalomyelitis / chronic fatigue syndrome in adolescents: a parallel groups randomised controlled trial comparing specialist cognitive behaviour therapy to activity management (2025) (SF-36 Physical Function subscale (SF-36-PFS) at six months)

    People in the study
    314 randomised
    Dose
    supported by individualised written, asynchronous electronic consultations with a clinical psychologist/cognitive-behavioural therapy practitioner
    Outcome
    mean difference in physical function at 6 months 36-item Short Form Health Survey Physical Function subscale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  4. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. (2001)

    Same trial, also reported in: Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. (2005) (Functional impairment (SF-36 physical functioning))

    People in the study
    278 randomised · 241 analysed
    Dose
    16 sessions of 1 h, over 8 months
    Outcome
    SIP functional impairment at 8 months (CBT vs support groups and CBT vs natural course) sickness impact profile
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  5. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. (2011)

    Same trial, also reported in: Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. (2012) (clinically significant reduction in disability)

    Same trial, also reported in: Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. (2015) (physical functioning (SF-36PF))

    People in the study
    641 randomised
    Dose
    —
    Outcome
    physical function (short form-36 subscale score) short form-36 physical function subscale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  6. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions. (2021)

    People in the study
    236 randomised
    Dose
    8 weekly therapy sessions and a booster session 4 weeks after the eighth session, 8 weeks
    Outcome
    SF-36 physical function
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  7. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. (2006)

    People in the study
    153 randomised
    Dose
    eight meetings, each lasting 2 hours, fortnightly
    Outcome
    SF-36 physical health summary scale Short Form with 36 Items
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Low
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    High
  8. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial. (2018)

    Same trial, also reported in: Internet-Based Cognitive Behavioral Therapy in Stepped Care for Chronic Fatigue Syndrome: Randomized Noninferiority Trial. (2019) (SIP8 disabilities)

    People in the study
    240 randomised · 234 analysed
    Dose
    seven modules, at least fortnightly
    Outcome
    Overall functional impairment Sickness Impact Profile 8
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  9. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled treatment trial. (2010)

    Same trial, also reported in: Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: long-term follow-up of an RCT. (2012) (School attendance)

    People in the study
    63 randomised
    Dose
    Thirteen 1-h sessions, every 2 weeks
    Outcome
    Physical Functioning score SF-36
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  10. Illness beliefs and treatment outcome in chronic fatigue syndrome. (1998)

    People in the study
    60 randomised
    Dose
    13 sessions
    Outcome
    functional impairment
    Effect
    better (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  11. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. (1993)

    People in the study
    90 randomised
    Dose
    six sessions
    Outcome
    nonsedentary physical activity
    Effect
    no clear difference
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  12. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. (2001)

    People in the study
    60 randomised · 53 started · 53 analysed
    Dose
    13 sessions
    Outcome
    Score (>83) on Medical Outcomes Study Short-Form General Health Survey physical functioning scale — at 5-year follow-up Medical Outcomes Study Short-Form General Health Survey
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  13. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial. (2008)

    People in the study
    66 randomised · 61 analysed
    Dose
    10 sessions, over a period of 5 months
    Outcome
    Physical functioning at follow-up: CBT group versus no-treatment group Short-Form General Health Survey
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  14. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. (2005)

    People in the study
    67 in the study
    Dose
    12 two-hour sessions, 12 two-hour sessions during 6 months
    Outcome
    Functional impairment (SIP-8) Sickness Impact Profile
    Effect
    worse
    Risk of bias
    ROBINS-I: Serious
    Confounding
    NI. adjustment for confounding isn't reported
    Selection of participants
    Moderate. comparison group: non-randomised allocation: patients allocated to CBGT until the first group was full; later groups consisted partly of patients from the waiting list condition and partly of recently referred patients Patients were allocated to CBGT until the first group was full. The next groups consisted partly of patients from the waiting list condition and partly of recently referred patients.
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Two patients dropped out during treatment; no post-test data available from these patients Two patients dropped out during treatment. No post-test data are available from these patients.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    Moderate. a pre-specified primary outcome
  15. A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up. (2018)

    People in the study
    305 in the study
    Dose
    each lasting 30–60 min, 1–2 times daily
    Outcome
    SF36, physical function Short Form Health Survey-36
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  16. The Relationship Between Childhood Trauma and the Response to Group Cognitive-Behavioural Therapy for Chronic Fatigue Syndrome. (2020)

    People in the study
    105 in the study
    Dose
    12 group sessions, 3 individual sessions, and one group session for partners, each session lasting 2 h
    Outcome
    physical functioning Medical Outcomes Short Form 36 Health Status Survey
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  17. Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study. (2012)

    People in the study
    63 in the study
    Dose
    six half-hour fortnightly telephone sessions and two follow-up sessions
    Outcome
    School attendance
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  18. Cognitive behaviour therapy for chronic fatigue syndrome in adults: face to face versus telephone treatment: a randomized controlled trial. (2012)

    People in the study
    80 randomised
    Dose
    up to 15 sessions, The first two sessions lasted up to 11/2 hours in order to complete a detailed assessment. Subsequent sessions were between 50 minutes and 1 hour
    Outcome
    Physical function (MOS) Medical Outcomes Survey: short form (physical functioning subscale)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  19. Therapist effects in routine psychotherapy practice: an account from chronic fatigue syndrome. (2011)

    People in the study
    374 in the study
    Dose
    10 to 15 sessions, manualized; therapists encouraged to structure each session and the entire intervention as outlined in the manual
    Outcome
    disability Work and Social Adjustment Scale
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  20. Internet-Based Cognitive Behavioral Therapy for Chronic Fatigue Syndrome Integrated in Routine Clinical Care: Implementation Study. (2019)

    People in the study
    100 in the study · 99 started
    Dose
    7 modules, 6 months
    Outcome
    Physical functioning (SF-36) Short Form-36
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  21. Effectiveness of Cognitive Behavioural Therapy on Sleep Outcome for Patients With Chronic Fatigue Syndrome in a Routine Clinical Service. (2026)

    People in the study
    217 in the study
    Dose
    up to 16 sessions, average duration was around 60 minutes
    Outcome
    Physical functioning (SF-36) Short-Form Health Survey (SF-36)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  22. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. (2009)

    People in the study
    41 in the study
    Dose
    12–15 sessions
    Outcome
    SF–36 physical functioning scale (0–100) Medical Outcomes Survey Short Form-36
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  23. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? (2007)

    People in the study
    112 in the study · 96 with outcome data
    Dose
    —
    Outcome
    SF-36 physical functioning Medical Outcomes Survey Short Form-36
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  24. Implementing cognitive behavioral therapy for chronic fatigue syndrome in a mental health center: a benchmarking evaluation. (2008)

    People in the study
    143 in the study · 84 started · 112 with outcome data
    Dose
    16 one-hour sessions, over a period of 6 to 8 months
    Outcome
    Physical Functioning Short Form (Physical Functioning Scale) of the Rand-36
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  25. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? (2010)

    People in the study
    84 in the study · 82 with outcome data
    Dose
    12–15 sessions
    Outcome
    SF-36 physical functioning scale (0–100), mean (S.D.) Medical Outcomes Survey (MOS) Short-Form 36-item (SF-36)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  26. The Process of Change in Pain During Cognitive-Behavior Therapy for Chronic Fatigue Syndrome. (2015)

    People in the study
    142 in the study
    Dose
    —
    Outcome
    actual physical activity actometer
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  27. Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK. (2020)

    People in the study
    995 in the study
    Dose
    fortnightly for 8 to 10 months
    Outcome
    Work and Social Adjustment Scale scores Work and Social Adjustment Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  28. Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice. (2014)

    People in the study
    200 in the study · 140 with outcome data
    Dose
    Between 6 and 20 sessions were attended, with a mean of 15.3 sessions (SD 1⁄4 3.7)
    Outcome
    <65 SF-36 medical outcomes short form physical functioning subscale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  29. Group Cognitive Behavioural Therapy for Chronic Fatigue Syndrome: A Pilot Study (2005)

    People in the study
    6 in the study
    Dose
    10 sessions of one hour spread over 18 weeks
    Outcome
    Work and Social Adjustment Scale (SAS) Work and Social Adjustment Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  30. Mechanisms of change underlying the efficacy of cognitive behaviour therapy for chronic fatigue syndrome in a specialist clinic: a mediation analysis. (2014)

    People in the study
    389 in the study
    Dose
    —
    Outcome
    social adjustment (WASA) Work and Social Adjustment Scale (WASA)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  31. Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. (2008)

    People in the study
    125 in the study · 112 started
    Dose
    16 sessions, 16 sessions in a period of 8 months
    Outcome
    number of real worked hours
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  32. Generalized Worry in Patients With Chronic Fatigue Syndrome Following Cognitive Behavioral Therapy: A Prospective Cohort Study in Secondary Care. (2022)

    People in the study
    726 in the study · 470 started · 470 with outcome data
    Dose
    between 12 to 16 individual 1-hour sessions plus four follow-up appointments; "Patients are usually offered between 12 to 16 individual 1-hour sessions with an experienced CBT therapist, plus four follow-up appointments."
    Outcome
    Mediation Effects of Avoidance Behavior and Fear-Avoidance Beliefs on the Association Between Worry, Fatigue and Work and Social Adjustment (indirect effect)
    Effect
    worse
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  33. Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity? (2009)

    People in the study
    30 in the study · 17 started · 11 with outcome data
    Dose
    6–32 visits (median 5 12), weekly or biweekly over a period of 7–35 weeks
    Outcome
    physical functioning (SF-36PF) Short Form-36 Physical Function Subscale
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  34. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. (2019)

    People in the study
    583 in the study · 511 with outcome data
    Dose
    —
    Outcome
    Physical functioning2 Short Form Health Survey (SF-36)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  35. P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome (2004)

    People in the study
    70 in the study
    Dose
    12-15 sessions over 6 months
    Outcome
    disability
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  36. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome (2007)

    People in the study
    2 in the study
    Dose
    8 consecutive weeks of 2.5-hour sessions
    Outcome
    physical functioning
    Effect
    no clear difference
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  37. Effectiveness of stepped care for chronic fatigue syndrome: a randomized noninferiority trial. (2010)

    People in the study
    171 randomised
    Dose
    e-mail at least every 2 weeks
    Outcome
    Effect size
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  38. Home-based family focused rehabilitation for adolescents with severe Chronic Fatigue Syndrome. (2019)

    People in the study
    6 in the study · 5 with outcome data
    Dose
    The number of treatment sessions given during the treatment phase varied between 23 and 51 with a mean of 33 sessions, Sessions ranged in length between one and two hours
    Outcome
    return to education
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  39. Coniunctio--in bodily and psychic modes: dissociation, devitalization and integration in a case of chronic fatigue syndrome. (1997)

    People in the study
    1 in the study
    Dose
    first year twice-weekly sessions; second and third years three sessions a week
    Outcome
    capacity to share the parenting of her infant son and her stepson
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  40. The Cognitive Behavioral Treatment of Depression and Low Self-Esteem in the Context of Pediatric Chronic Fatigue Syndrome (CFS/ME): A Case Study. (2015)

    People in the study
    1 in the study
    Dose
    weekly for four sessions; fifth session after a month; sixth session (follow-up) 2 months later
    Outcome
    attending school more regularly
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  41. Cognitive behavior therapy for chronic fatigue syndrome: a case study. (1999)

    People in the study
    1 in the study
    Dose
    22 sessions within 14 months. Three follow-up sessions followed in the next 7 months, 22 sessions within 14 months; three follow-up sessions in the next 7 months
    Outcome
    SIP Sickness Impact Proxle
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  42. Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety. (2020)

    People in the study
    10 in the study · 8 with outcome data
    Dose
    twelve individual face-to-face 60 minute sessions, twelve individual sessions
    Outcome
    SF-36a Short Form-36
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  43. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. (2017)

    People in the study
    1 in the study
    Dose
    eight 60 minute sessions in addition to two assessment sessions
    Outcome
    employment
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
  44. Predictors of treatment response trajectories in chronic fatigue syndrome (2023)

    People in the study
    297 in the study
    Dose
    17 individual 50-minute reimbursed CBT sessions (15 regular sessions + 2 booster sessions), group psychoeducation session (one half day) and 17 individual 50-minute reimbursed CBT sessions
    Outcome
    CIS-20 Activity Checklist Individual Strength
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Both together

Symptoms

Anxiety1 study · 15 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (15 in all); only people who finished were analysed.

Studies with no comparison group24 in the study · 15 with outcome data · eight weeks · eight modules during eight weeks, one module per week with weekly support from a therapist

Anxiety improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on anxiety in ME/CFS or long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (15 in all)
  • Only people who finished were analysed
See the 1 study
  1. Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study. (2025)

    People in the study
    24 in the study · 15 with outcome data
    Dose
    eight modules during eight weeks, one module per week with weekly support from a therapist
    Outcome
    GAD-7 (anxiety symptoms) Generalized Anxiety Disorder-7
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Depression1 study · 15 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (15 in all); only people who finished were analysed.

Studies with no comparison group24 in the study · 15 with outcome data · eight weeks · eight modules during eight weeks, one module per week with weekly support from a therapist

Depression improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on depression in ME/CFS or long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (15 in all)
  • Only people who finished were analysed
See the 1 study
  1. Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study. (2025)

    People in the study
    24 in the study · 15 with outcome data
    Dose
    eight modules during eight weeks, one module per week with weekly support from a therapist
    Outcome
    BDI-II (depressive symptoms) Beck Depression Inventory-II
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Low mood or anxiety1 study · 15 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (15 in all); only people who finished were analysed.

Studies with no comparison group24 in the study · 15 with outcome data · eight weeks · eight modules during eight weeks, one module per week with weekly support from a therapist

Low mood or anxiety improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on low mood or anxiety in ME/CFS or long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (15 in all)
  • Only people who finished were analysed
See the 1 study
  1. Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study. (2025)

    People in the study
    24 in the study · 15 with outcome data
    Dose
    eight modules during eight weeks, one module per week with weekly support from a therapist
    Outcome
    IES-6 (post-traumatic stress symptoms) Impact of Event Scale-6
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Fatigue2 studies · 79 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 129 people found no clear difference; a small benefit can't be ruled out.

The randomised trial160 randomised · 129 analysed · at six months after baseline (outcome) · six sessions of up to one hour each

No clear difference in fatigue.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in ME/CFS or long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 129 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group24 in the study · 15 with outcome data · eight weeks · eight modules during eight weeks, one module per week with weekly support from a therapist

Fatigue improved.

The evidence is very uncertain about the effect of CBT and psychotherapy on fatigue in ME/CFS or long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (15 in all)
  • Only people who finished were analysed
See the 2 studies
  1. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. (2001)

    People in the study
    160 randomised · 129 analysed
    Dose
    six sessions of up to one hour each
    Outcome
    Fatigue
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Some concerns
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study. (2025)

    People in the study
    24 in the study · 15 with outcome data
    Dose
    eight modules during eight weeks, one module per week with weekly support from a therapist
    Outcome
    KEDS-9 (fatigue and exhaustion) Karolinska Exhaustion Disorder Scale-9
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Cognition (brain fog)1 study · 50 people took part in CBT and psychotherapy Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 103 people found no clear difference; a small benefit can't be ruled out.

The randomised trial103 randomised · 10-week web-based program · 10 modules, 10-week web-based program

No clear difference in cognition (brain fog).

The evidence is very uncertain about the effect of CBT and psychotherapy on cognition (brain fog) in ME/CFS or long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 103 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. The Role of Psychological Flexibility in Health-Related Quality of Life Among Patients With Persistent Physical Symptoms Associated With Indoor Environment and Chronic Fatigue - 9-Month Follow-Up of a Randomized Controlled Trial. (2026)

    People in the study
    103 randomised
    Dose
    10 modules, 10-week web-based program
    Outcome
    Thought suppression (WBSI) White Bear Suppression Inventory
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
Sleep1 study · 15 people took part in CBT and psychotherapy Worse F
Very low certainty

Why this grade: Worse, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (15 in all); only people who finished were analysed.

Studies with no comparison group24 in the study · 15 with outcome data · eight weeks · eight modules during eight weeks, one module per week with weekly support from a therapist

Sleep was worse with CBT and psychotherapy.

The evidence is very uncertain about the effect of CBT and psychotherapy on sleep in ME/CFS or long COVID. Worse · very low certainty F

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (15 in all)
  • Only people who finished were analysed
See the 1 study
  1. Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study. (2025)

    People in the study
    24 in the study · 15 with outcome data
    Dose
    eight modules during eight weeks, one module per week with weekly support from a therapist
    Outcome
    ISI (insomnia symptoms) Insomnia Severity Index
    Effect
    worse
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Quality of life1 study · 50 people took part in CBT and psychotherapy Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (103 in all).

The randomised trial103 randomised · 10-week web-based program · 10 modules, 10-week web-based program

Quality of life improved more than in the comparison group.

The evidence is very uncertain about the effect of CBT and psychotherapy on quality of life in ME/CFS or long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (103 in all)
See the 1 study
  1. The Role of Psychological Flexibility in Health-Related Quality of Life Among Patients With Persistent Physical Symptoms Associated With Indoor Environment and Chronic Fatigue - 9-Month Follow-Up of a Randomized Controlled Trial. (2026)

    People in the study
    103 randomised
    Dose
    10 modules, 10-week web-based program
    Outcome
    Health-related quality of life (HRQoL) 15D-questionnaire
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low

Side effects

Stopping because of side effects18 studies
Side effects studies reported5 kinds
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Worse symptoms or a flare16 studies
Fatigue13 studies
Anxiety or irritability4 studies
Trouble sleeping2 studies
Headache1 study

Systematic reviews

Reviews pool earlier studies. Each shows when it was published and how far its search went.

Meta-analysisPublished 2024Search date not stated

Is the effect of cognitive behaviour therapy for chronic fatigue syndrome (ME/CFS) moderated by the presence of comorbid depressive symptoms? A meta-analysis of three treatment delivery formats. (2024)

“In internet-based CBT, ME/CFS patients with comorbid depressive symptoms benefit less, making face-to-face CBT currently the first-choice delivery format for these patients.”
“Internet-based CBT should be further developed to improve its effectiveness for ME/CFS patients with depressive symptoms.”

All papers

  1. Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial.2008 · placebo trial · 72 randomised
    Summary

    This three-armed randomised clinical trial included 72 patients with chronic fatigue complaints; 65 of the 72 fulfilled Oxford criteria and 29 fulfilled CDC criteria. Participants were recruited at a specialist clinic, partly by general-practitioner referral and partly by screening. The study compared a comprehensive cognitive–behavioural treatment (CCBT) programme for 12 weeks (two 1.5 h group sessions per week: cognitive–behavioural therapy 1.5 h and body awareness therapy 1.5 h, plus a self-managed exercise programme) with double-blind mirtazapine (standard dose 15–45 mg, allowing lower dose) or inactive placebo. After 12 weeks, treatment continued for another 12 weeks in a mixed crossover–combination design. Primary outcomes were the Fatigue Scale and Clinical Global Impression (CGI); secondary measures included the Hamilton Rating Scale for Depression (HRSD), Subjective Health Complaint inventory (SHC), 36-item Short Form Health Survey (SF–36) and cardiorespiratory fitness. At 12 weeks, the CCBT group showed significant improvement compared with the mirtazapine and placebo groups on the Fatigue Scale (P=0.014) and CGI (P=0.001). At 24 weeks, the group initially receiving CCBT followed by mirtazapine showed significant improvement compared with the placebo-plus-CCBT reference group on the Fatigue Scale (P50.001), CGI (P=0.002), HRSD (P=0.018) and SHC pseudoneurology sub-scale (P=0.011). The SF–36 mental sub-scale showed significant improvement for mirtazapine for 24 weeks plus CCBT for 12 weeks (P=0.045). Secondary outcome measures showed overall improvement with no significant difference between treatment groups. All patients taking mirtazapine and 45% of patients taking placebo reported at least one adverse event. In the mirtazapine group, sedation was 56%, increased appetite 31%, weight increase 33% and restless legs syndrome 19%; in the placebo group, headache 17%, sedation 11%, weight increase 11% and insomnia 11%. Harms withdrawal counts are not reported.

  2. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.1993 · placebo trial · 90 randomised
    Summary

    This double-blind, randomized, placebo-controlled four-cell trial enrolled 90 adult outpatients with chronic fatigue syndrome. Patients received eight biweekly intramuscular injections of dialyzable leukocyte extract or placebo, with or without six outpatient cognitive-behavioral therapy sessions; the other psychologic comparator was clinic attendance. Treatment lasted 4 months, with follow-up at 7 months. The analysed groups were DLE plus CBT (n = 20), DLE plus clinic (n = 25), placebo plus CBT (n = 21), and placebo plus clinic (n = 22). Outcomes included visual analogue/Quality-of-Life scores, activity diaries, Karnofsky performance scores, Profile-of-Mood States subscales, T-cell subsets, and delayed-type hypersensitivity skin testing. The authors report that all four treatment groups had a very similar outcome. The only significant difference between groups was greater improvement in the Quality-of-Life score for DLE plus CBT, increasing from 458 at baseline to 520 at the end of treatment and 596 at 3 months' follow-up (F = 1.49, p <0.05); the authors state this was not likely to indicate a treatment effect of clinically relevant magnitude. Analyses comparing all DLE with placebo and all CBT with control did not show significant differences. Up to one third of each group reported greater than 1 SD of improvement. Minor injection-site discomfort was reported by 34 of 45 DLE recipients (76%) and 19 of 43 placebo recipients (44%; p <0.05); one DLE recipient had a pruritic skin eruption that did not necessitate discontinuation. No other adverse effects were reported or detected by laboratory screening. Two patients withdrew voluntarily.

  3. Effect of Prolong Life With Nine Turn Method on chronic fatigue syndrome clinical symptoms and roles of gut microbiota: A exploratory randomized controlled trial.2026 · randomised trial · 96 randomised
    Summary

    This 8-week randomized clinical trial took place at Shanghai University of Traditional Chinese Medicine and enrolled 96 patients with chronic fatigue syndrome; the paper reports 28 males (29.1%) and 68 females (70.8%). Participants were randomly allocated to cognitive behavioral therapy (CBT) or the Prolong Life With Nine Turn Method (PLWNT) for 8 weeks. The CBT group had 34 participants in the analysed data and the PLWNT group 40. Six participants in the CBT group withdrew; the paper lists pregnancy, transportation constraints, gut microbiota contamination, or inability to adhere to the treatment protocol. The paper also reports 16 participants with elevated body temperature at baseline and states their data were excluded from the analysis. The primary outcome was change in MFI-20 total score from baseline to week 8. The CBT group showed a mean reduction of −9.53 (95% CI, −12.66 to −6.40) and the PLWNT group −12.02 (95% CI, −15.88 to −8.17); the between-group difference was −2.50 (95% CI, −7.74 to 2.74), p=0.346. The paper states: 'No statistically significant between-group differences in MFI-20 score changes were observed at week 8.' The PLWNT group showed statistically significant improvements from baseline in all MFI-20 subtype scores and GSRS subtype scores at weeks 4 and 8; with the exception of GSRS reflux scores at week 8, no statistically significant between-group differences were observed across all secondary outcomes. The paper states that no adverse events were reported. The authors list limitations including the single-center design and exclusive recruitment of Chinese patients.

  4. Efficacy of a psychotherapeutic group intervention for patients with Post-COVID-19 condition: a randomized controlled trial (PsyLoCo study).2026 · randomised trial · 48 randomised · 29 analysed
    Summary

    PsyLoCo tested a manual-guided group psychotherapy for adults with Post-COVID-19 condition and persisting functionally impairing symptoms in an outpatient psychosomatic setting at University hospital Magdeburg, Germany. Forty-eight patients were included (IG n = 21; CG n = 27). The intervention comprised 10 bi-weekly sessions of 50 min each; the control condition was treatment as usual with delayed group treatment. The primary outcome was somatic symptom burden (SSS-8); secondary outcomes were depressive symptoms (PHQ-9) and anxiety symptoms (GAD-7); childhood maltreatment (CTS) was examined as a moderator. Complete-case ANCOVA models included 29 patients for SSS-8 and 28 for PHQ-9 and GAD-7. No significant efficacy of the psychotherapeutic group intervention over TAU was observed for SSS-8 (β = − 2.20, SE = 1.25, 95% CI [− 4.77, 0.38], t(27) = − 1.75, p = .091), PHQ-9 (β = − 1.77, SE = 1.51, 95% CI [− 4.87, 1.33], t(26) = − 1.18, p = .251), or GAD-7 (β = − 0.81, SE = 1.47, 95% CI [− 3.84, 2.22], t(26) = − 0.55, p = .588). CTS was no moderator for the intervention effect. Baseline symptom severity predicted post-randomization outcomes during the randomized phase (p < .001). Harms were assessed non-systematically; the paper does not report withdrawal counts for harms. Follow-up was three-month.

  5. Which cognitive-behavioural factors play a role in the reduction of post-COVID-19 fatigue following cognitive behavioural therapy and care as usual? A secondary analysis of the ReCOVer study.2026 · randomised trial · 114 randomised · 110 analysed
    Summary

    This secondary analysis of the two-arm ReCOVer randomised trial examined which cognitive-behavioural variables mediate fatigue reduction after cognitive behavioural therapy for fatigue (CBT-F) versus care as usual (CAU) in post-COVID-19 fatigue. A total of 114 individuals were randomized to CBT-F (n = 57) or CAU (n = 57); 110 were analysed. Recruitment took place in six participating hospitals in the Netherlands, by healthcare providers, and by self-referral. CBT-F was a tailored, modular treatment delivered in a blended format of therapist contact and online modules. CAU patients had no access to CBT-F but were not restricted in seeking care. Assessments were at baseline and directly post-CBT-F or post-CAU (T1, 19 weeks after randomization). Fatigue severity (CIS-fatigue) fell from 47.8 (5.5) to 30.9 (12.6) with CBT-F and from 47.0 (5.9) to 39.6 (10.9) with CAU. In the final parallel mediation model, increased self-reported activity (ab = -0.46, 95% CI -0.69 to -0.25) and decreased anticipated adverse consequences of activity (ab = -0.22, 95% CI -0.37 to -0.09) were significant mediators; self-efficacy (ab = -0.11, 95% CI -0.28 to 0.02) was not significant. The direct effect was nonsignificant (c' = -0.10, p = .44). Across conditions, changes in self-reported activity (b = 0.59, p < .001) and anticipated adverse consequences (b = 0.24, p < .01) predicted fatigue change; self-efficacy (b = -0.14, p = .07) and sleep problems (b = 0.02, p = .80) were retained but not significant. Harms were not reported. The authors state the study was not powered or designed to identify mediators or predictors.

  6. The Role of Psychological Flexibility in Health-Related Quality of Life Among Patients With Persistent Physical Symptoms Associated With Indoor Environment and Chronic Fatigue - 9-Month Follow-Up of a Randomized Controlled Trial.2026 · randomised trial · 103 randomised
    Summary

    This 9-month follow-up of a randomized controlled trial examined whether internet-delivered acceptance and commitment therapy plus individual case formulation and treatment as usual (iACT + TAU) improved health-related quality of life (HRQoL) compared with TAU alone in adults with persistent physical symptoms associated with indoor environment and/or chronic fatigue syndrome. Participants were recruited nationwide in Finland. A total of 103 participants were randomized: iACT + TAU (n = 50) and TAU (n = 53). iACT + TAU included a 10-week web-based program comprising 10 modules plus TAU; TAU was routine care. HRQoL was measured with the 15D-questionnaire; psychological flexibility measures included the CompACT, WBSI, and CFQ. Outcomes were assessed at baseline, at post-intervention (3 months from baseline), and at 3- and 9-month follow-ups from post-intervention. The paper reports a significant interaction effect for HRQoL from pre- to the 9-month follow-up (Wald χ2(3) = 13.65, p = 0.003). HRQoL increased in the iACT + TAU group (Wald χ2(3) = 14.05, p = 0.003), while there was no significant within-group change in the TAU group (Wald χ2(3) = 5.11, p = 0.164). From pre- to 3-month follow-up, the between-group change was significant (p = 0.008, d = 0.63). At the 9-month follow-up, the between-group effect size was small (d = 0.38), and the change from pre-measurement was no longer significantly different between the groups. PF did not mediate the change in HRQoL. Dropout at the 9-month follow-up was 46% in TAU and 40% in iACT + TAU. Harms were not reported.

  7. Cognitive-behavioral therapy for post COVID-19 condition: A pilot randomized controlled trial.2026 · randomised trial · 53 randomised · 52 started · 52 analysed
    Summary

    This pilot randomized controlled parallel-group trial enrolled N = 53 individuals with post COVID-19 condition (PCC) and randomized them to cognitive-behavioral therapy (CBT) (n = 27) or a 16-week wait-list control (WLC) condition (n = 26). One participant allocated to WLC was excluded after randomization, resulting in an intention-to-treat (ITT) sample of N = 52 (CBT n = 27; WLC n = 25). CBT comprised eight group and five individual sessions; treatment duration if completed was M = 14 weeks, SD = 1 week. Primary outcomes included fatigue (FSS), overall somatic symptom burden (PHQ-15), and respiratory and cardiovascular symptoms (SBQTM-LC “Breathing” and “Circulation”), assessed at pre-assessment, post-assessment, and three-month follow-up. At post-assessment, CBT compared with WLC showed lower fatigue (d = -0.58, p = .045). The WLC group showed a significant increase in overall somatic symptom burden (PHQ-15; d = 0.60, p = .027). Group differences were not statistically significant for PHQ-15 (d = -0.43, p = .184), SBQTM-LC “Circulation” (d = -0.46, p = .102), or SSD-12 (d = 0.08, p = .936). Results for respiratory symptoms were mixed. At 3-month follow-up in participants receiving CBT, no significant changes across outcomes were observed. Seven participants of the ITT sample reported at least one negative effect of psychotherapy (INEP). Treatment satisfaction (CSQ-8) was M = 19.11, SD = 3.05. The authors state limitations including a small sample size (N = 52 of the ITT), no active control condition, and a short follow-up.

  8. Online treatment of myalgic encephalomyelitis / chronic fatigue syndrome in adolescents: a parallel groups randomised controlled trial comparing specialist cognitive behaviour therapy to activity management2025 · randomised trial · 314 randomised
    Summary

    This parallel groups randomised controlled trial asked whether online specialist cognitive behaviour therapy (CBT; FITNET-NHS) improves outcomes compared with online activity management (AM) in adolescents aged 11-17 years with ME/CFS. It took place in a specialist NHS ME/CFS service in the South-West of England, with referrals accepted from across the UK. 314 patients were allocated to CBT (n=155) or AM (n=159). CBT was delivered online over six months using 19 modules; AM was delivered in up to six video calls over approximately six months. The primary outcome was the SF-36 Physical Function subscale at six months; follow-up was at three, six and twelve months post-randomisation. At six months the CBT group reported greater improvement in physical function (adjusted difference in means 8.2, 95% CI 2.7 to 13.6, p=0.003); at twelve months there was no longer evidence of a difference. The CIS fatigue scale showed greater improvement with CBT at six months (difference in means -3.9, 95% CI -6.8 to -1.0), maintained at twelve months, while Chalder Fatigue scores showed similar improvements. The CBT group recovered school time more rapidly, with just over half a day per week more at six and twelve months. One or more adverse events or serious adverse events were reported for 28 (18%) CBT participants and 18 (11%) AM participants; about one quarter of participants in each group experienced a worsening condition. CBT cost more (£1,048).

  9. Cognitive and affective psychoeducation for Long COVID: a randomized controlled trial.2025 · randomised trial · 130 randomised · 125 started · 122 analysed
    Summary

    This randomized controlled trial compared two brief psychoeducational interventions for Long COVID patients with cognitive complaints, conducted in Belgium across several hospital and university sites. Of 130 randomized patients (65 cognitive, 65 affective), 122 were analysed (63 cognitive, 59 affective). Both groups received four 90-min in-person sessions, 1 week apart, plus a 30-min reactivation session 1 month after the intervention: a cognitive intervention targeting metacognition and compensatory strategies, or an affective intervention. Assessments took place pre-intervention and 2 and 8 months post-intervention. Primary outcomes were cognitive complaints (BRIEF-A and MMQ) at 2 months; secondary outcomes included cognitive performance, fatigue, sleep, psychological distress, quality of life and work/activity impairment. Both arms improved over time on the primary outcomes, with no time-by-group interaction (BRIEF-A P = 0.68; MMQ P = 0.85). Reliable improvement on the BRIEF global score occurred in 23 patients (37%) in the cognitive group and 23 (39%) in the affective group; on at least one MMQ subtest in 22 (35%) and 21 (36%). Some secondary improvements were arm-specific. Of 125 who participated, 120 completed all sessions. No harms, unintended effects or adverse events related to the intervention were observed or reported. The authors state that the absence of a control group limits attribution of effects to the interventions.

  10. Effect of Cognitive Behavioral Therapy on Depression and Functional Outcomes in Patients with Post Covid-19: A Randomized Controlled Trial2024 · randomised trial · 36 randomised · preprint
    Summary

    This randomized controlled study examined cognitive behavioral therapy added to a selected physiotherapy program for depression and functional outcomes in post-COVID-19 patients. Thirty-six post-COVID-19 patients were recruited from the outpatient clinic of the Faculty of Physical Therapy and Kasr Al-Ainy University Hospital and randomized into two equal groups. Group A received designed cognitive behavioral therapy plus the same selected physiotherapy program as group B, including balance and endurance training and graduated active exercises. Group B received the selected physiotherapy program alone. Treatment was one hour per session, three sessions per week for 12 successive weeks, with 18 patients per arm. Depression severity was measured with the Beck Depression Inventory (BDI), and functional outcomes with the Katz Index of Independence in Activities of Daily Living, before and after the 12-week intervention. Within group A, BDI showed a 53.03% reduction (p = 0.001) and Katz index a 56.14% improvement (p = 0.001). Within group B, BDI showed a 0.39% reduction (P = 0.43) and Katz index a 10.71% improvement (P = 0.02). Between-group posttreatment comparisons favored group A for BDI (p = 0.001) and Katz index (p = 0.001). Side effects and withdrawals were not reported. The authors state a possible limitation was a small sample size.

  11. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.2024 · randomised trial · 314 randomised
    Summary

    This parallel-group randomised controlled trial enrolled 314 adolescents aged 11-17 years with ME/CFS and no local specialist treatment centre, referred to a specialist service in South West England. Participants were randomly allocated, 155 to FITNET-NHS, a web-based cognitive-behavioural therapy programme supported by individualised written asynchronous electronic consultations, or to Activity Management delivered by videocall. Both treatments were intended to last 6 months. The primary measure was the 36-item Short Form Health Survey Physical Function subscale at 6 months. At 6 months, FITNET-NHS participants had a mean physical function score of 60.5 (standard deviation 29.5, n = 127) versus 50.3 (standard deviation 26.5, n = 138) with Activity Management; mean difference 8.2 (95% confidence interval 2.7 to 13.6, p = 0.003). FITNET-NHS participants attended half a day more school per week at 6 months, maintained at 12 months. There was no strong evidence comorbid mood disorder changed relative effectiveness. Pain and Clinical Global Impression showed similar improvement; fatigue was mixed. At 12 months no clear difference in physical function remained (difference in means 4.4, 95% confidence interval -1.7 to 10.5). Worsening condition measures were met by 39 (25%) FITNET-NHS participants and 42 (26%) Activity Management participants. Costs were £1047.51 greater with FITNET-NHS. The authors report limited sustained impact and higher cost mean it is unlikely cost-effective.

  12. Disentangling pain and fatigue in chronic fatigue syndrome: a resting state connectivity study before and after cognitive behavioral therapy.2024 · randomised trial · 59 started · 72 analysed
    Summary

    Ninety-four female ME/CFS patients and thirty healthy controls were included. Patients were recruited through the Expert Centre of Chronic Fatigue in Nijmegen, The Netherlands, and randomly assigned to CBT (n = 59) or a waiting list (WL; n = 29). CBT consisted of 12–14 individual sessions within ∼6 months. The study examined whether fatigue and pain relate to dissociable resting-state brain networks and whether CBT changes them. Baseline scans were available for 72 ME/CFS patients and 29 controls; follow-up scans for 51 ME/CFS patients (33 CBT, 18 WL) and 25 controls. Compared with WL, CBT reduced CIS-fatigue, POMS-fatigue and pain occurrence and improved daily functioning; RAND-pain and depression did not differ significantly between groups. Out of 33 patients who received CBT and completed both test days, 18 (55%) were successfully treated according to predefined criteria. CBT increased SMN-DMN connectivity compared with WL; no CBT effects were observed for PMN-DMN or SMN-PMN connectivity. Changes in CIS-fatigue, POMS-fatigue and pain occurrence were associated with increased SMN-seed-mPFC connectivity, but change in RAND-pain was not. Side effects and treatment withdrawals were not reported. The authors state that limiting analysis to a priori defined networks may have excluded some pain- or fatigue-related regions.

  13. Response Shift After Cognitive Behavioral Therapy Targeting Severe Fatigue: Explorative Analysis of Three Randomized Controlled Trials.2023 · randomised trial · 222 randomised
    Summary

    Three randomized controlled trials were re-analysed to examine response shift after CBT for severe fatigue. The trials included people with chronic fatigue syndrome (CFS, n = 222), cancer (n = 123), and type 1 diabetes (n = 107), recruited in the Netherlands via an Expert Center for Chronic Fatigue, hospitals and self-referral. Participants were randomized to CBT (internet-based in the CFS and cancer trials; blended in the diabetes trial) or a waitlist control group; CFS CBT n = 149 vs control n = 73, cancer CBT n = 60 vs control n = 63, diabetes CBT n = 49 vs control n = 58. Assessments were before randomization and 5 months (diabetes) or 6 months (CFS and cancer) later. Fatigue severity was measured with the Checklist Individual Strength (range 8–56), alongside fatigue-related cognitions and perceptions. In the CFS trial, overall response shift was indicated (Δχ2 (28) = 45.79, p = .018), with reprioritization for “Physically, I feel exhausted” (Δχ2 (2) = 9.76, p = .007); this was significant in the CBT group (Δχ2 (1) = 10.19, p = .001) but not the control group (Δχ2 (1) = 0.53, p = .467). The impact on that item was Cohen’s d = 0.93, but the decrease in fatigue severity in the CBT group was of the same size with and without response shift (d = −1.12). No significant associations were found between selected mechanism variables and the CFS response shift. The paper reports response shift was indicated in CBT groups but not control groups across all three trials, and did not affect intervention effects. Harms and side effects were not reported. CBT patients who did not start or complete the intervention were excluded (CFS n = 10 (6%), cancer n = 5 (8%), diabetes n = 11 (18%)), as were eight patients who did not complete post-assessment.

  14. Effects of Yijinjing Qigongin Alleviating Fatigue, Sleep Quality, and Health Status on Patients with Chronic Fatigue Syndrome: A Randomized, Controlled, and Parallel Group Clinical Study.2023 · randomised trial · 40 randomised
    Summary

    Forty patients with chronic fatigue syndrome were randomly assigned to a Yijinjing group or a cognitive behavior therapy (CBT) group. The Yijinjing intervention was practiced 6 times per week, with one exercise guided by a teacher of the faculty in the university and another 5 times finished at home over 12 consecutive weeks. The control group received cognitive education, including popular science lectures and psychological counseling related to CFS prevention and treatment for 12 weeks. The abstract does not report where patients were recruited. Multidimensional Fatigue Inventory-20 (MFI-20), Short Form 36-item Health Survey (SF-36), and Pittsburgh Sleep Quality Index (PSQI) were assessed before and after intervention. Intra-group analysis showed that differences in MFI-20, SF-36, and PSQI were statistically significant (p < 0.05) after the 12-week Yijinjing intervention. Compared with the CBT group, differences in MFI-20 and PSQI of the Yijinjing group were statistically significant (p < 0.05), and SF-36 was superior to the CBT group in physical function, bodily pain, general health, and vitality (p < 0.05). The abstract does not report side effects, withdrawals, or the number analysed. The authors state that Yijinjing can significantly improve sleep disorders, fatigue, and quality of life in patients with CFS and is superior to behavioral cognitive education in pain and vitality. The abstract does not report limitations stated by the authors.

  15. Effectiveness of Internet-Based Group Supportive Psychotherapy on Psychic and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post COVID-19 Syndrome Patients.2023 · randomised trial · 96 randomised · 77 started · 37 analysed
    Summary

    This randomized clinical trial tested internet-based group supportive psychotherapy in patients with Post COVID-19 Syndrome (PCS) at Cipto Mangunkusumo National General Hospital. Ninety-six subjects were recruited; 19 were excluded, and 77 were randomly divided into a psychotherapy group (40 subjects) and an education group (37 subjects). Each group received three sessions in one week, 1-2 hours per session. SCL-90, neutrophil lymphocyte ratio (NLR) and heart rate variability (HRV) were measured 1-2 days before and after the intervention. SCL-90 score improved by 17.51 (SD 30.52) in the psychotherapy group and 19.79 (SD 35.10) in the education group, with no significant difference between groups (p = 0.771); SCL-90 improved within both groups (p < 0.0001 for psychotherapy and p = 0.002 for education). NLR changed by -0.14 (SD 1.08) in the psychotherapy group and by 0.22 (SD 1.23) in the education group, with p = 0.178. HRV decreased by 1.02 (SD 14.17) in the psychotherapy group and 3.45 (SD 20.50) in the education group, with p = 0.560; there was no improvement in HRV observed in either group. Both interventions had a significant positive influence on psychosomatic conditions across sessions on a visual analogue scale. Thirty-seven subjects in the psychotherapy group and 34 in the education group completed the study; three subjects in each group did not complete it. The authors state limitations including lack of standardization for the duration and frequency of internet-based group psychotherapy, nighttime sessions with fatigued patients, and that not all subjects were willing to open videos.

  16. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.2023 · randomised trial · 114 randomised
    Summary

    ReCOVer was an investigator-initiated, 2-arm, multicenter randomized controlled trial in the Netherlands. It enrolled 114 patients with severe fatigue 3–12 months after COVID-19, recruited by physicians at 6 participating hospitals, by healthcare providers, and by self-referral; patients were mainly nonhospitalized and self-referred. Participants were randomized 1:1 to CBT (n = 57) or care as usual (n = 57). CBT targeted perpetuating factors of fatigue and was planned for 17 weeks (mean duration 18.7 weeks) as a blended online/face-to-face intervention. The primary outcome was CIS-fatigue; secondary outcomes included proportions no longer severely and/or chronically fatigued, SF-36 physical functioning, WSAS social functioning, PHQ-15 somatic symptoms, and CIS concentration problems, assessed at T1 (19 weeks postrandomization) and T2 (6 months after T1). The overall between-group difference in CIS-fatigue was −8.8 (95% CI, −11.9 to −5.8; P < .001); at T1 it was −9.3 and at T2 −8.4. Secondary outcomes favored CBT. Eight AEs occurred in 7/57 CBT patients, 6 rated possibly related; 20 AEs occurred in 14/57 CAU patients; no serious adverse events were recorded, and there was no indication of deterioration of fatigue following CBT.

  17. Management of post-COVID-19 depression among patients of Western Uttar Pradesh of Northern India.2023 · randomised trial · 156 randomised
    Summary

    This longitudinal prospective study in Aligarh, Uttar Pradesh, India, examined management of post-COVID-19 depression. Through purposive sampling, 156 patients diagnosed with post-COVID-19 depression were enrolled and allocated by chit randomization to experimental (n=92) or control (n=64) groups. Both groups received appropriate pharmacotherapy; the experimental group also received eight therapeutic CBT sessions (psychoeducation, relaxation breathing exercise, cognitive restructuring, activity scheduling), while the control group received treatment as usual and no psychological intervention. Depression was assessed with the Beck Depression Inventory (BDI-II) pre- and post-intervention. Table 2 reports within-group pre-post change for the experimental group M=25.13, SD=9.63, t=25.02, P=0.000, and for the control group M=21.06, SD=7.52, t=22.40, P=0.000. At post-assessment, BDI-II scores were M=8.34 (SD=1.96) in the experimental group and M=15.06 (SD=4.45) in the control group; the between-group comparison was t=-12.69, P=0.000. The abstract states patients receiving medications plus CBT showed significantly better improvement than patients receiving medications only. Harms, side effects, and withdrawals were not reported. The authors state limitations including modest sample size and single-hospital sampling; they also note that because CBT was combined with pharmacotherapy, the improvement cannot be attributed specifically to CBT or antidepressants.

  18. Prolong Life with Nine Turn Method Qigong on Chronic Fatigue Syndrome in Terms of Calcitonin Gene Related Peptide and Folic Acid Levels2022 · randomised trial · 90 randomised · 89 analysed
    Summary

    This preprint reports a randomized controlled study of Prolong Life With Nine Turn Method (PLWNT) Qigong versus cognitive behavioral therapy (CBT) in people with chronic fatigue syndrome (CFS). Ninety participants were recruited and randomized (PLWNT n=45; CBT n=45); 89 completed (PLWNT n=45; CBT n=44). Participants practiced PLWNT for 30 minutes daily at home, with one hour weekly supervised, or received CBT lectures/consultations for one hour weekly plus 30 minutes daily on WeChat, for 12 weeks. The study measured serum CGRP and folic acid and used MFI-20, PSQI and SF-36. In the PLWNT group, the reported mean change from baseline to week 12 was -4.044 (95% CI, -5.063 to -3.026) for total MFI-20, -2.556 (95% CI, -3.673 to -4.608) for PSQI, and 30.111 (95% CI, 19.657 to 40.565) for SF-36. Between-group comparisons in Table 2 reported no significant difference for several domains, including sleep duration (p=0.609), habitual sleep efficiency (p=0.142), sleep disturbance (p=0.783), sleep medicine use (p=0.326), daytime dysfunction (p=0.593), and SF-36 physical function (p=0.825); bodily pain differed (p=0.007). Six participants reported adverse events; one CBT participant withdrew due to shoulder fracture. The authors state limitations including difficulty blinding participants and excluding patients over 60.

  19. Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions.2021 · randomised trial · 236 randomised
    Summary

    Researchers randomly allocated 236 participants aged 18–62 years who met CDC 1994 criteria for CFS to one of three groups. Two intervention groups received either 16 weeks of standard CBT or 8 weeks of I-CBT, and a waiting-list control group waited 16 weeks. Outcomes were repeatedly measured up to 52 weeks from baseline. Physical function was measured with SF-36 Physical Function (0–100) and fatigue with the Chalder Fatigue Questionnaire (0–33). At post-intervention, the additional effect relative to baseline for SF-36 physical function was 14.2 points higher for standard CBT and 6.8 points higher for I-CBT compared with the control group. For fatigue, the additional effect was 5.9 points lower for standard CBT and 4.8 points lower for I-CBT compared with the control group; the I-CBT difference was reported as not statistically significant. At the 1-year follow-up, the two intervention groups did not differ significantly in self-reported physical function and fatigue. In the CGI, 17 (33%) in standard CBT, 15 (26%) in I-CBT, and 5 (8%) in the waiting-list group rated positive change at post-intervention. Negative change was rated by 1 (2%) in standard CBT, 2 (3%) in I-CBT, and 3 (5%) in the waiting-list group. Dropouts during treatment due to fatigue were 3 in standard CBT and 1 in I-CBT. No serious adverse reactions were recorded in any group. The authors state the waiting-list group was not scored at 1-year follow-up and the intervention groups had different assessment points.

  20. Can prolong life with nine turn method (Yan Nian Jiu Zhuan) Qigong alleviates Fatigue, Sleep quality, Depression and anxiety on Patients with Chronic Fatigue Syndrome: a Randomized, Controlled, Clinical Study ?2021 · randomised trial · 135 randomised · 134 analysed · preprint
    Summary

    This randomized controlled trial with three parallel groups enrolled 135 people with chronic fatigue syndrome recruited on WeChat or posters at Shanghai University of Traditional Chinese Medicine and Yueyang Hospital; 134 completed. Participants were randomly divided into PLWNT Qigong (45), CBT (44 analysed), and a healthy control group (45) that received no treatment and maintained daily life. PLWNT and CBT lasted 12 weeks, with weekly one-hour supervised sessions and 30 minutes daily practice or online study on the remaining 6 days. Outcomes were MFI-20 (primary), PSQI and HADS (secondary), measured at baseline and post-intervention. MFI-20 decreased after 12 weeks in PLWNT and CBT (p<0.001); PSQI and HADS improved within both groups, with overall sleep quality, subject sleep quality, sleep latency, sleep duration, sleep disturbance and daytime dysfunction improved (p<0.05), while habitual sleep efficiency and sleep medicine using showed no significant between-group difference (p>0.05). Changes in MFI-20, PSQI and HADS were greater in PLWNT than CBT but without statistical significance. The abstract reported no significant difference between PLWNT and CBT, but the results text reported a significant difference in total effective rate (P<0.05), with 62.22% for PLWNT and 50% for CBT. Six participants reported 6 adverse events; two were definitely or probably related to exercises with mild symptoms. One CBT participant withdrew due to shoulder fracture.

  21. Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial.2020 · randomised trial · 89 randomised · 76 analysed
    Summary

    This paper reports the initial 12-month internal pilot of a UK randomized controlled trial of internet-delivered treatment for adolescents aged 11-17 years with CFS/ME who had no access to local specialist treatment. Adolescents were referred by their general practitioner to a specialist pediatric CFS/ME service in South West United Kingdom, and recruitment and treatment were remote. Of 150 potentially eligible referrals, 89 were recruited: 44 were randomized to FITNET-NHS, a web-based modular CFS/ME-specific CBT program with individualized clinical psychologist e-consultations, and 45 to activity management (AM) delivered via Skype by a CFS/ME clinician. Both treatments were designed to last approximately 6 months. The pilot's primary outcomes were recruitment, the proportion providing 6-month outcome data, and qualitative acceptability. A total of 76 out of 89 patients provided 6-month outcome data; the abstract reports 75 out of 89 for 6-month outcome data, and the results report 75 out of 89 for 12-month outcome data. Two out of 89 actively withdrew. No serious adverse events were reported by the 89 participants; nonserious health events were reported by 10, and 1 adverse event was assessed as possibly related to trial treatment, with CFS/ME symptoms worsening. Qualitative interviews found web-based treatment acceptable overall but identified advantages and disadvantages of remote methods; most participants did not feel 3 Skype AM calls were enough, and AM was increased to 6 sessions from November 2017 onward. The authors state recruitment and retention via remote methods were feasible and acceptable.

  22. Internet-Based Cognitive Behavioral Therapy in Stepped Care for Chronic Fatigue Syndrome: Randomized Noninferiority Trial.2019 · randomised trial · 363 randomised
    Summary

    This three-arm randomized noninferiority trial asked whether stepped care with internet-based cognitive behavioral therapy (I-CBT) first, followed by face-to-face (f2f) CBT when needed, was noninferior to treatment as usual (f2f CBT after a waiting period) for chronic fatigue syndrome (CFS). It enrolled 363 adult CFS patients referred to a tertiary treatment center and randomized 121 to each of three arms: I-CBT with protocol-driven feedback, I-CBT with feedback on demand, or treatment as usual. Patients started I-CBT for 6 months; they stepped up to f2f CBT if still severely fatigued or disabled. Outcomes included CIS fatigue severity, SIP8 disabilities, SF-36 physical functioning, SCL-90 psychological distress, clinically significant improvement, and therapist time. Noninferiority was indicated: the upper CI bound for fatigue difference was 3.81 for protocol-driven feedback and 4.25 for feedback on demand versus TAU. Secondary outcomes showed no significant differences (P=.11 to P=.79). Clinically significant improvement occurred in 49 out of 121 (40%) in protocol-driven feedback, 61 (50%) in feedback-on-demand, and 53 out of 115 in TAU; differences were not significant (P=.39 and P=.51). Abstract-reported therapist time was less for stepped care than TAU (P<.001), but intention-to-treat medians did not differ significantly (P=.64 and P=.93). Approximately half of patients meeting step-up criteria for f2f CBT after I-CBT did not continue. Side effects were not reported and the authors state they did not provide dropout data.

  23. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial.2018 · randomised trial · 240 randomised · 234 analysed
    Summary

    The trial randomised 240 adults with chronic fatigue syndrome (CFS) to protocol-driven internet-based CBT, feedback-on-demand internet-based CBT, or a waiting list (80 per arm). iCBT consisted of seven modules; median treatment length was 27 weeks for both iCBT conditions, and mean waiting time was 26 weeks for the waiting list. Assessments were at 6 months post-randomisation, and 234 patients completed the primary outcome. Compared with the waiting list, fatigue severity (CIS) was lower after protocol-driven iCBT (B = −8.3, 97.5% CI −12.7 to −3.9, P < 0.0001) and after feedback-on-demand iCBT (B = −7.2, 97.5% CI −11.3 to −3.1, P < 0.0001). There was no significant difference between the two iCBT conditions on fatigue (B = −1.2; P = 0.5589) or on all outcome measures (P = 0.3–0.9). Both iCBT groups had less overall functional impairment and psychological distress than the waiting list; physical functioning improved significantly only with feedback-on-demand iCBT. Fatigue scores in the normal range were 29/80 (36%) with protocol-driven iCBT versus 12/80 (15%) with waiting list, and 34/80 (43%) with on-demand iCBT versus 12/80 (15%). Adverse events were reported by 4 of 38 (11%) in the protocol-driven condition, 7 of 39 (18%) in the on-demand condition, and 12 of 46 (26%) in the control condition; no serious adverse events were reported, and there was no significant difference in clinically significant exacerbation. In the protocol-driven condition 4 of 80 (5%) and in the on-demand condition 6 of 80 (8%) did not start the intervention. The authors state that effects were assessed only 6 months post-randomisation.

  24. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT.2018 · randomised trial · 641 randomised
    Summary

    This reanalysis used the PACE trial FOIA dataset. Participants were 641 adults with mild-to-moderate CFS defined by the Oxford criteria, randomised into four groups. All were offered at least three medical consultations. Control received no further treatment; CBT, GET, and Adaptive Pacing Therapy each received up to 15 therapy sessions over 36 weeks. At 52 weeks, protocol-specified overall improvement was 20% for CBT, 21% for GET, and 10% for Control. The CBT–Control contrast had p = .015 and the GET–Control contrast p = .010; with the six planned comparisons, the Bonferroni-adjusted threshold was 0.008, and neither comparison reached it. Available-case improvement was 22% CBT, 21% GET, and 11% Control. Protocol-defined recovery was 7% CBT, 4% GET, and 3% Control; the effect was not significant (p = 0.14 intent-to-treat; p = 0.10 available case). SF36 physical-function improvement was 44% Control, 48% CBT, and 61% GET. CFQ improvement was 13% Control, 26% CBT, and 24% GET. Long-term follow-up excluding patients who received additional GET or CBT found no significant treatment-group effect on SF-36 Physical Function (F(3,291) = 0.70, ns) or Chalder Fatigue (F(3,291) = 0.17, ns). Adverse-event measures were collected; the extracted data contain no event counts.

  25. Long-term economic evaluation of cognitive-behavioural group treatment versus enhanced usual care for functional somatic syndromes.2017 · randomised trial · 120 randomised
    Summary

    This long-term economic evaluation followed 120 patients from the STreSS-1 randomised trial at Aarhus University Hospital, Denmark (2005 to 2008). Patients had functional somatic syndromes such as fibromyalgia and chronic fatigue syndrome, and met criteria for severe multi-organ bodily distress syndrome; 54 were randomly assigned to STreSS and 66 to enhanced usual care (EUC). STreSS was a manualised group CBT programme of nine modules, each 3.5 h, delivered over 4 months, plus the same thorough clinical assessment as EUC. EUC was usual care by primary care physicians and specialists, enhanced by that assessment. The study compared healthcare and indirect costs from Danish registers for 12 months before and up to 40 months after randomisation, and QALYs from SF-6D over 16 months. Additional treatment costs for STreSS were 1545 € (95% BCI 1358 to 1731). During the 4-month treatment period, total healthcare costs were higher with STreSS than EUC (2369 € vs 976 €, ASL<0.001). In the three years after treatment, STreSS had lower healthcare costs (all ASL below 0.05), and third-year total cost savings were 7,184 € (95% CI 2,271 to 12,096, p=0.004). STreSS patients accrued 0.035 more QALYs (95% CI 0.00006 to 0.070). Clinically significant improvement in physical health was 46% with STreSS vs 27% with EUC, and in somatic symptoms 45% vs 17%. The probability of cost-effectiveness at 25,000 to 35,000 € per QALY was 93-95% from a healthcare perspective and 50-55% from a societal perspective. Three patients (6%) discontinued treatment.

  26. Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial.2017 · randomised trial · 122 randomised · 109 analysed
    Summary

    This multi-centre, two-arm RCT took place at four rehabilitation centres in the Netherlands, inviting patients between December 2008 and January 2011. It included 122 patients with chronic fatigue syndrome; 62 were randomised to multidisciplinary rehabilitation treatment (MRT) and 60 to cognitive behavioural therapy (CBT). MRT was given for 6 months with 44.5 face-to-face contact hours; CBT was given for 6 months with 16 face-to-face contact hours. Outcomes were assessed at baseline, 4, 14, 26 and 52 weeks. Data from 109 patients (57 MRT and 52 CBT) were analysed; 13 patients (5 MRT and 8 CBT) were excluded because less than 75% of TiC-P questionnaires were available, and 17 questionnaires were imputed. At 52 weeks, fatigue on the CIS was significantly lower with MRT (estimated effect -6.48, 95% CI -11.54 to -1.42). The QALY difference was not significant (0.09, 95% CI -0.02 to 0.19). SF-36 estimates were 3.53 (95% CI -0.67 to 7.74) for PCS and 1.36 (95% CI -2.28 to 5.00) for MCS. Healthcare costs were significantly higher with MRT (difference €5,681, 95% CI €4,632 to €6,793), as were societal costs (difference €5,389, 95% CI €2,488 to €8,091); patient and family costs and productivity costs were not significantly different. The ICER was €856 per unit on the CIS fatigue subscale and €11,8074 per QALY. MRT had a 94–99% likelihood of being more cost-effective using fatigue/quality of life, and a 5% and 29% likelihood using QALY at thresholds of €27,000 and €60,000. No harms, side effects, or adverse events were reported.

  27. Multidisciplinary rehabilitation treatment or cognitive behavioural therapy for patients with chronic fatigue syndrome2016 · randomised trial · 122 randomised · 112 analysed
    Summary

    This two-arm, pragmatic, multi-centre randomised controlled trial compared multidisciplinary rehabilitation treatment (MRT) with cognitive behavioural therapy (CBT) in 122 patients with chronic fatigue syndrome at four rehabilitation centres in the Netherlands. Participants were randomly assigned to CBT (N = 60) or MRT (N = 62); both treatments took 6 months to complete. Outcomes were assessed before treatment and at 26 and 52 weeks after treatment initiation. Primary outcomes were fatigue on the Checklist Individual Strength fatigue subscale and health-related quality of life on the Short-Form 36. At 26 weeks, 114 participants completed assessment (55 CBT, 59 MRT); at 52 weeks, 112 completed assessment (55 CBT, 57 MRT). MRT was significantly more effective than CBT in reducing fatigue at 52 weeks: the estimated difference was -5.69 (95% CI -10.62 to -0.76; P = 0.02). At 26 weeks the difference was -3.02 (95% CI -8.07 to 2.03; P = 0.24). Patients showed an improvement in quality of life over time, but between-group differences were not significant. Self-efficacy and achievement of personal goals increased more in the MRT group; at 52 weeks differences were 1.89 (0.40 to 3.38; P = 0.01) and -17.28 (-26.95 to -7.62; P = 0.001). At 52 weeks, 37 MRT participants (66.1%) were satisfied versus 22 CBT participants (40.0%; P = 0.006). In total, 18 participants (12 CBT, six MRT) withdrew from treatment; two (one CBT, one MRT) reported an increase in complaints and three did not experience improvement.

  28. The planning, implementation and publication of a complex intervention trial for chronic fatigue syndrome: the PACE trial.2015 · randomised trial · 640 randomised
    Summary

    The PACE trial was a four-arm randomised trial in 640 patients with chronic fatigue syndrome recruited from six clinics in England and Scotland. It compared specialist medical care (SMC) alone with SMC plus adaptive pacing therapy (APT), cognitive–behavioural therapy (CBT), or graded exercise therapy (GET). Treatment duration was not reported. Co-primary outcomes were fatigue and physical disability; outcomes were assessed at baseline, mid-therapy, the end of the main treatment phase, 1-year follow-up and long-term follow-up 2.5 years after randomisation. CBT and GET led to significantly greater improvements in both fatigue and physical disability than either SMC or APT. Adjusted effect sizes ranged from 0.5 to 0.8. There were no significant differences between APT and SMC in either primary outcome. Almost all participants (98%) provided some outcome data, and 95% provided outcome data at 12 months, with no significant differences between arms in missing data. Only 8% of participants dropped out of treatment, again with no significant difference between treatment arms. Between 82 and 88% of participants who received a therapy alongside SMC said they were satisfied, whereas 50% reported being satisfied with SMC alone. There were no significant differences in any safety measures between treatment arms. The cost of one quality-adjusted life-year (QUALY) gained was £18 374 for CBT and £23 615 for GET. The authors state that having two primary outcomes complicated the analysis, although the size of the trial gave sufficient power.

  29. Randomised controlled trial of cognitive behaviour therapy delivered in groups of patients with chronic fatigue syndrome.2015 · randomised trial · 204 randomised
    Summary

    This pragmatic randomised controlled trial enrolled 204 adult patients with chronic fatigue syndrome from an outpatient clinic who were willing to receive group therapy. Patients were randomised to CBT in groups of 8 patients and 2 therapists (n = 68), CBT in groups of 4 patients and 1 therapist (n = 68), or a waiting list (n = 68). The intervention consisted of 14 group sessions of 2 h within a period of 6 months; the comparison was a waiting list for individual CBT for CFS. Primary outcomes were fatigue severity, overall impairment and physical functioning; psychological distress was secondary. At the second assessment, the combined intervention group (n = 136) compared with the waiting list (n = 68) had fatigue severity 33.5 versus 46.6 (treatment effect –13.8), overall impairment 800 versus 1,389 (effect –623), physical functioning 74.4 versus 63.3 (effect 14.1) and psychological distress 135 versus 153 (effect –22.1); all treatment effects were reported as significant at p < 0.001. Subgroup analyses for large and small groups versus the waiting list also reported significant effects. Improvement in fatigue severity occurred in 67 (49.3%) versus 6 (8.8%), improvement on all primary outcomes in 52 (38.2%) versus 2 (2.9%), and normal functioning on all primary outcomes in 21 (15.4%) versus 1 (1.5%). Thirty-four (17%) patients were lost to follow-up and 18 discontinued the intervention. Potential harms were not assessed.

  30. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.2015 · randomised trial · 641 randomised · 604 started · 481 analysed
    Summary

    This long-term follow-up of the PACE trial surveyed participants with chronic fatigue syndrome (CFS) recruited from six secondary care clinics in the United Kingdom. In the trial, 641 participants were randomly allocated to specialist medical care (SMC) alone or SMC plus adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), given in one-to-one sessions (maximum 14 sessions) during the first six months, with an additional booster session offered at nine months. Questionnaires were sent to 604 participants; 481/604 (80%) returned usable questionnaires and were included in the analysis. Median time from randomisation to follow-up was 31 months (range 24 to 53 months). Fatigue and physical functioning were measured with self-report scales, with secondary measures of impairment in daily activities and perceived health change. The improvements in fatigue and physical functioning reported by participants allocated to CBT or GET at the final trial assessment were sustained. There were no significant differences between randomised groups in mean fatigue scores at long-term follow-up. Physical functioning was better in those allocated to CBT compared with APT (6.4, 95% CI 0.4 to 12.4, p = 0.035). Participants originally allocated to APT reported further improvements in fatigue, physical functioning, and impairment in daily activities from final trial assessment to long-term follow-up. The authors state limitations including incomplete response rate, variation in follow-up duration, self-rated outcomes, and additional treatment after the trial.

  31. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial.2014 · randomised trial · 641 randomised
    Summary

    To compare the effects of PACE trial treatments on pain in CFS, sometimes called ME. In total, 641 patients were recruited from secondary-care specialist CFS clinics in the UK. APT (n=159), CBT (n=161) and GET (n=160) were each added to specialist medical care (SMC) and compared with SMC alone (n=160); treatment duration was not reported, and measures were assessed at week 52. Outcomes included frequency of muscle and joint pain (0–4), other CDC painful symptoms, and fibromyalgia criteria. Less frequent muscle pain was reported with CBT versus SMC (mean difference 0.38, p=0.02), GET versus SMC (0.42, p=0.01), and GET versus APT (0.37, p=0.01). Less joint pain was reported with CBT versus APT (0.35, p=0.02) and GET versus APT (0.36, p=0.02); unadjusted joint-pain comparisons with SMC were p=0.14 for CBT and p=0.12 for GET. GET versus SMC reduced fibromyalgia (12.3% difference, p=0.01), and GET versus APT reduced fibromyalgia (9.4% difference, p=0.04). One participant withdrew consent; dropouts were 5%. Harms were not reported. The authors state they could not compare CBT and GET and that pain was measured by frequency, not severity; the hospital-based sample may affect generalisability.

  32. Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome.2014 · randomised trial · 641 randomised · 640 analysed
    Summary

    This four-arm randomised trial compared specialist medical care (SMC) alone with SMC plus adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET) in 641 people with chronic fatigue syndrome (CFS) recruited from six secondary care CFS clinics in England and Scotland. Participants received up to 15 sessions of therapy if allocated to a therapy arm and at least 3 sessions of SMC; follow-up was up to one year, with adverse-event interviews at 12, 24 and 52 weeks after randomisation. One participant withdrew consent, leaving 640 in the analysis. Non-serious adverse events were common: the median (quartiles) number was 4 (2, 8) per participant, with no significant difference between treatment arms (P = .47). Serious adverse events and reactions were infrequent. Physical function deteriorated in 39 (25%) participants after APT, 15 (9%) after CBT, 18 (11%) after GET, and 28 (18%) after SMC (P < .001), with no significant differences in worsening fatigue. The authors also reported no statistically significant differences between arms in those who had an SAE, SAR, or deterioration by CGI score. Limitations included differences in NSAE reporting frequency between centres, self-rated deterioration measures, and inability to model the full distribution of NSAEs.

  33. Recovery from chronic fatigue syndrome after treatments given in the PACE trial.2013 · randomised trial · 641 randomised · 640 started · 640 analysed
    Summary

    This secondary analysis of the PACE trial compared recovery after four treatments in 641 participants recruited from six secondary care CFS clinics in England and Scotland; 640 were studied. All met Oxford criteria for CFS. Participants received specialist medical care (SMC) alone or SMC plus adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), with follow-up 52 weeks after randomization. Recovery was defined operationally using fatigue, physical function, case criteria and global change measures. Trial recovery was 22% (32/143) after CBT, 22% (32/143) after GET, 8% (12/149) after APT and 7% (11/150) after SMC. Clinical recovery proportions were similar. Adjusted odds ratios for trial recovery were 3.36 (1.64–6.88) for CBT v. APT, 3.38 (1.65–6.93) for GET v. APT, 3.69 (1.77–7.69) for CBT v. SMC and 3.71 (1.78–7.74) for GET v. SMC; APT v. SMC was 1.10 (0.47–2.58), with no significant difference. The number needed to treat for trial recovery was 7 for both CBT and GET. Some data were missing for 6% of those receiving APT and SMC and 11% for those receiving CBT and GET. Side effects and withdrawals were not reported.

  34. Chronic Fatigue Syndrome in Adolescents: treatment, clinical features and epidemiology2013 · randomised trial · 135 randomised
  35. Internet-based therapy for adolescents with chronic fatigue syndrome: long-term follow-up.2013 · randomised trial · 135 randomised · 112 analysed
    Summary

    This long-term follow-up study followed participants of the FITNET trial, which enrolled 135 adolescents aged 12 to 18 years with chronic fatigue syndrome between January 2008 and February 2010. The trial randomly assigned participants to FITNET, an Internet-based cognitive behavioral therapy program, or usual care; usual care consisted mainly of individual or group-based rehabilitation programs, face-to-face CBT, and graded exercise therapy with a physical therapist. Treatment in the randomized part lasted 6 months. For this follow-up, 127 potential participants were invited and 112 completed assessment (88.2%), after a mean follow-up of 2.7 6 0.5 years (range: 1.7–3.8 years). Outcomes were fatigue severity (CIS-20), physical functioning (CHQ-CF87), school/work attendance, self-rated improvement, and recovery. At follow-up, 66 (58.9%) adolescents had recovered. Recovery based on original randomization was 64.4% with FITNET versus 52.8% with usual care (P = .251); receiving FITNET versus no FITNET was 58.2% versus 53.6% (P = .515). Recovery rates were 64% in the Direct Start FITNET group (n = 59 at LTFU), 52% in the cross-over group (n = 25), and 53.6% in the Usual Care Only group (n = 28). Relapses occurred in 5 (8.5%) Direct Start FITNET participants, 4 (16%) cross-over participants, and 3 (10.7%) Usual Care Only participants. 8 participants dropped out before this follow-up study. Side effects were not reported. The authors state that the scope of the LTFU was to assess sustainability of FITNET treatment rather than to compare FITNET with usual care.

  36. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial.2012 · randomised trial · 135 randomised · 131 analysed
    Summary

    This randomised controlled trial compared Fatigue In Teenagers on the interNET (FITNET), an internet-based cognitive behavioural treatment, with usual care in adolescents with chronic fatigue syndrome at a tertiary treatment centre in the Netherlands. 135 adolescents were enrolled: 68 were assigned to FITNET and 67 to usual care; 67 and 64, respectively, were analysed. FITNET consisted of 21 interactive modules with e-consult support and lasted a mean of 26·2 weeks (SD 7·3). Usual care included cognitive behavioural therapy (44 [66%]) and physical treatment (33 [49%]). Primary outcomes were school attendance, fatigue severity, and physical functioning at 6 months. At 6 months, school attendance was 84·3% with FITNET versus 51·7% with usual care; fatigue severity was 24·0 versus 42·3; physical functioning was 88·5 versus 70·1. Full school attendance was reported in 50 (75%) versus 10 (16%), absence of severe fatigue in 57 (85%) versus 17 (27%), and normal physical functioning in 52 (78%) versus 13 (20%). No serious adverse events were reported. Of 68 assigned FITNET, four (6%) stopped treatment early. No significant differences in recovery rates were noted between the five FITNET therapists (p=0·917). The authors state they could not provide detailed data about the specific interventions in the usual care group.

  37. Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: long-term follow-up of an RCT.2012 · randomised trial · 63 randomised · 44 started · 44 analysed
    Summary

    This 24 month follow-up of a randomised controlled trial compared family-focused CBT with psycho-education for adolescents with chronic fatigue syndrome recruited from a specialist service. In the original trial, 63 11 to 18-year olds were randomly assigned: 32 to family-focused CBT (13 one-hour sessions delivered every fortnight) and 31 to psycho-education (four one-hour sessions over six months). Forty-four participants took part in the follow-up study: 24 in the CBT group and 20 in the psycho-education group. At 24 months, at least 70% school attendance was reported by 90% in the CBT group and 84% in the psycho-education group; the difference was not statistically significant (OR 1.286, 95% CI 0.183 to 9.021, p=0.80). Recovery was 79% with CBT compared with 64% with psycho-education (Fisher's exact test p=0.34). Child SDQ scores at 24 months were 9.63 with CBT and 13.61 with psycho-education (F=6.49, p=0.02); maternal SDQ scores were 8.16 and 14.00 (F=4.52, p=0.04). In the psycho-education group, maternal SDQ scores increased between six and 24 months (t=5.19, p=<0.01), indicative of a decrease in functioning; the CBT group decrease was not statistically significant (t=-0.91, p=0.38). Impairment improved in both groups (CBT p=0.01; psycho-education p=0.03). No significant group differences were reported for fatigue, physical functioning, global functioning or satisfaction. Harms were not reported for the CBT group, and withdrawals for harms were not reported. Fourteen declined follow-up and five were not contactable; the authors state a 30% attrition rate may have resulted in insufficient power.

  38. Implementing a minimal intervention for chronic fatigue syndrome in a mental health centre: a randomized controlled trial.2012 · randomised trial · 123 randomised
    Summary

    This randomized controlled trial tested guided self-instruction, a minimal intervention based on cognitive behaviour therapy for chronic fatigue syndrome (CFS), delivered by psychiatric nurses in a community-based mental health centre. One hundred and twenty-three patients were randomly assigned to guided self-instruction (n = 62) or a waiting list (n = 61). The intervention used a booklet (58 pages) and email contact once every 2 weeks, and took at least 20 weeks; the waiting list received the intervention after a delay of 6 months. Outcomes were measured at baseline and 6 months after baseline with the Checklist Individual Strength (CIS) fatigue severity, SF-36 physical and social functioning, and the Brief Symptom Inventory (BSI). After 6 months, fatigue decreased more with guided self-instruction (mean difference -8.1, 95% CI -3.8 to -12.4, p<0.01). Significant clinical improvement in fatigue occurred in 18/55 (33%) versus 5/56 (9%) (OR 5.0, 95% CI 1.69-14.57, p<0.01). There was no significant difference in physical functioning (7.37, 95% CI -0.9 to 15.65, p=0.08), social functioning (7.81, 95% CI -3.24 to 18.86, p=0.16) or psychological distress (-0.10, 95% CI -0.2 to 0.09, p=0.30). In a post-hoc subgroup with SF-36 physical functioning <70 at baseline, fatigue (mean difference -9.9, 95% CI -5.4 to -14.3, p<0.01) and physical functioning (9.05, 95% CI 0.2-17.9, p<0.05) differed; social functioning did not (10.05, 95% CI -2.5 to 22.6, p=0.11). Post-treatment assessment was completed by 55 and 56 patients; 7 and 5 did not want to complete the second assessment. Side effects and worsening were not reported.

  39. Cognitive behaviour therapy for chronic fatigue syndrome in adults: face to face versus telephone treatment: a randomized controlled trial.2012 · randomised trial · 80 randomised
    Summary

    The trial assessed whether face-to-face cognitive behaviour therapy (CBT) was more effective than telephone CBT for adults aged 18–65 with chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) recruited from consecutive referrals to the CFS Research and Treatment Unit at the South London and Maudsley NHS Trust in London. Eighty participants were randomized to face-to-face CBT (n = 35) or telephone CBT (n = 45). Face-to-face CBT consisted of up to 15 sessions; telephone CBT consisted of one face-to-face session of up to 3 hours and 13 fortnightly phone appointments of half an hour’s duration. Outcomes included physical functioning, fatigue, social adjustment, global improvement and satisfaction, measured before treatment, after treatment, and 3, 6 and 12 months after completing treatment. Fatigue, social adjustment and physical function improved from baseline to post-treatment in both groups. The groups did not differ significantly on fatigue (z = –1.31, p = .19), social adjustment (z = –1.57, p = .117) or physical function (z = 0.56, p = .576). At 12 months, social adjustment reduced versus post-treatment (p = .013) and physical function increased (p = .043). Global improvement and satisfaction showed no significant between-group differences at post-treatment, 6 months or 12 months. Twenty-eight of 35 face-to-face participants and 30 of 45 telephone participants received treatment; six telephone participants did not start and one face-to-face participant no longer wished to participate as she felt better. Overall attrition was 46.25%. Side effects were not reported. Limitations stated were high dropout and non-completion of measures.

  40. Towards an evidence-based treatment model for cognitive behavioral interventions focusing on chronic fatigue syndrome.2012 · randomised trial · 169 randomised · 139 analysed
    Summary

    This paper reanalyzed data from a previously conducted randomized controlled trial to develop a treatment model for cognitive behavioral interventions focusing on chronic fatigue syndrome (CFS). The original trial compared a low intensity cognitive behavioral intervention with a waiting list control group. Of 169 patients included in the original trial, 30 were excluded because they did not complete the second assessment of the hypothesized mediators, leaving 139 patients in the present study; 64 patients (46%) received the guided self-instructions. The intervention used written self-instructions combined with e-mail contact with a trained therapist; treatment duration was not reported. The study measured fatigue severity, disability, focus on symptoms, perceived problems with activity, and sense of control over fatigue. The test of model A confirmed that treatment significantly reduced the level of fatigue and disability. Treatment did not significantly affect the focus on symptoms. A decrease in perceived problems with activity and an increase in sense of control over fatigue both significantly mediated the effect of the intervention. The mediators explained 73% of the total treatment effect on fatigue and 75% of the total treatment effect on physical functioning. Harms and withdrawals for harms were not reported. The authors state that the mediators were not assessed while treatment was proceeding, which limits causal inference.

  41. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial.2011 · randomised trial · 641 randomised
    Summary

    This randomised trial enrolled 641 patients meeting Oxford criteria for chronic fatigue syndrome from six secondary-care clinics in the UK. Participants were assigned to specialist medical care (SMC) alone (160), or SMC plus adaptive pacing therapy (APT; 160), cognitive behaviour therapy (CBT; 161), or graded exercise therapy (GET; 160). Outcomes were assessed up to 52 weeks after randomisation. Primary outcomes were participant-rated fatigue (Chalder fatigue questionnaire) and physical function (short form-36 subscale). Compared with SMC alone, mean fatigue scores at 52 weeks were 3·4 points lower for CBT (p=0·0001) and 3·2 points lower for GET (p=0·0003), but did not differ for APT (0·7 points lower; p=0·38). Mean physical function scores were 7·1 points higher for CBT (p=0·0068) and 9·4 points higher for GET (p=0·0005), but did not differ for APT (3·4 points lower; p=0·18). Compared with APT, CBT and GET were associated with less fatigue (CBT p=0·0027; GET p=0·0059) and better physical function (CBT p=0·0002; GET p<0·0001). Serious adverse reactions were recorded in two (1%) of 159 in APT, three (2%) of 161 in CBT, two (1%) of 160 in GET, and two (1%) of 160 in SMC alone. There were more serious adverse events in GET than SMC (p=0·0433); treatment dropouts did not differ (p=0·50). A minority (≤9% in every group) rated themselves much worse or very much worse, which did not differ between groups.

  42. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome.2011 · randomised trial · 69 randomised · 58 analysed
    Summary

    This randomized controlled pilot study tested a 12-week group Cognitive Behavioral Stress Management (CBSM) intervention in people with chronic fatigue syndrome (CFS). Sixty-nine people with CFS diagnosed by physical exam and interview by a physician were randomized: 44 to CBSM and 25 to a psychoeducational (PE) seminar control. CBSM consisted of 12 weekly group meetings in 2-hour sessions; PE was a half-day seminar scheduled during the 6th week of the CBSM group. Both groups received a workbook and three relaxation tapes. Thirty-eight participants received CBSM and 20 received PE. Eleven were lost to follow-up (CBSM N = 6; PE N = 5), leaving a final sample of 58 for statistical analyses. Participants completed the Perceived Stress Scale, Profile of Mood States, Quality of Life Inventory, and CDC symptom checklist pre- and post-intervention. The paper reports a significant group × time interaction for perceived stress (F(1, 53)= 5.07, p=.028), POMS-total mood disturbance (F(1, 51)= 4.12, p= .048), overall QOLI category scores (F(1, 49)= 10.65, p=.002), QOLI raw scores (F(1, 49)= 4.0, p=.05), QOLI T scores (F(1, 49)= 4.0, p=.05), total CFS symptom severity (F(1, 56) = 4.32, p= .042), and unrefreshing sleep (F(1, 52)=6.59, p < .01), with CBSM reported as showing greater improvements or decreases than PE. There was no group × time effect on total CFS symptom frequency. The POMS-Fatigue subscale was reported as significant but marginal (F (1, 51) = 3.53, p = .06). Side effects are not reported.

  43. Does a decrease in avoidance behavior and focusing on fatigue mediate the effect of cognitive behavior therapy for chronic fatigue syndrome?2011 · randomised trial · 270 randomised · 219 analysed
    Summary

    This study reanalysed a randomized controlled trial to test whether decreases in avoidance behavior and focusing on fatigue mediate the effect of cognitive behavior therapy (CBT) for chronic fatigue syndrome (CFS). In total, 270 patients were randomly assigned to CBT, nondirective counseling, or no intervention; the two control groups were approached as one. CBT consisted of sixteen 1-h sessions over 8 months; nondirective counseling was spread over 8 months; the no-intervention group was free to do what it found appropriate. Two hundred nineteen patients completed assessment before and after treatment or the control period and were analysed; 51 did not complete the second assessment of coping strategies and were excluded. The analysed group included 73 in the CBT arm. Setting was not reported. Measures included a modified Pain Coping Inventory, the Checklist Individual Strength fatigue severity subscale, and the Sickness Impact Profile. The multivariate treatment effect on changes in coping was significant (Wilks lambda 0.94, p .005). Focusing on fatigue decreased significantly more in the treatment group than in the control group; avoidance of activity (p .762) and avoidance of aversive stimuli (p .333) were not significantly changed. Mediation analysis showed partial mediation for fatigue and complete mediation for impairment; mean mediation effects were −0.74 (confidence interval −1.89 to −0.08) for fatigue and −67.92 (confidence interval −165.45 to −21.01) for impairment. Side effects and harms were not reported.

  44. Cognitive behavioural therapy and psycho-education for chronic fatigue syndrome in young people: reflections from the families' perspective.2010 · randomised trial · 16 randomised · 18 started
    Summary

    This qualitative study asked why families took part and what they experienced after family-focused CBT versus psycho-education (PE) for chronic fatigue syndrome (CFS) in young people. Sixteen young people and sixteen parents who had participated in a CFS therapy trial at King’s College London were interviewed by telephone around three years after therapy; 7 young people had received CBT and 9 PE, and 9 parents had been involved in CBT and 7 in PE. Treatment duration is not reported. Semi-structured interviews and inductive thematic analysis examined pre-therapy expectations, therapy experiences and views on effectiveness. Generally, participants found both CBT and PE acceptable and helpful; behavioural aspects of CBT (e.g. goal-setting, graded activity) were found helpful. Very few differences were found between themes from CBT and PE participants, but every young person who experienced CBT described therapy as helpful, whereas participants who strongly opposed the therapy approach had all experienced PE. Most felt therapy was a stepping-stone towards normal life, although many felt recovery was incomplete; the majority described ongoing symptoms and limitations, while all the young peoples’ health had dramatically improved post-therapy. Negative experiences related to the therapy setting and feeling inappropriately labeled; travelling and sessions left young people feeling drained and struggling to participate fully. Withdrawal counts are not reported.

  45. Possible detrimental effects of cognitive behaviour therapy for chronic fatigue syndrome.2010 · randomised trial · 508 randomised
    Summary

    This pooled reanalysis used data from 3 randomised controlled trials of cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS). In total, 508 patients participated. Patients were randomly assigned to CBT or to control conditions: care as usual, guided support groups, or a waiting list. CBT was delivered as cognitive behaviour therapy or as guided self-instructions based on the CBT protocol; treatment duration was not reported. Symptom deterioration was rated by patients and measured as deterioration in fatigue, pain, functional impairment and psychological distress, from baseline to postmeasurement just after the CBT or control condition. The frequency of symptom deterioration varied from 2 to 12% in patients receiving CBT and from 7 to 17% in the control group. For clinically significant deterioration, table counts included self-rated change 7/109 (6%) with CBT and 31/183 (17%) in controls; CIS fatigue 7/211 (3%) and 21/297 (7%); DOF 5/207 (2%) and 30/294 (10%); SIP 3/176 (2%) and 16/263 (6%). The authors state no measure showed a significantly higher frequency of symptom deterioration in the CBT group; in 3 comparisons CBT patients reported significantly less deterioration. Maximum deterioration in psychological distress was 77 during CBT and 74 in control. Dropout or not starting treatment was 19% in the trials of Knoop et al. and Stulemeijer et al., and 25% in the study of Prins et al. Limitations stated were that pooling might have obscured differences between trial populations, high dropout, and that control-group constitution can affect RCT outcomes.

  46. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled treatment trial.2010 · randomised trial · 63 randomised
    Summary

    This randomized controlled treatment trial compared family-focused cognitive behaviour therapy (CBT) with behaviourally oriented psycho-education in adolescents with chronic fatigue syndrome (CFS) referred to King’s College Hospital, London. Sixty-three participants were randomized: 32 to family-focused CBT and 31 to psycho-education. Family-focused CBT comprised 13 one-hour sessions every 2 weeks over 6 months; psycho-education comprised four sessions over a 6-month period. School attendance was the primary outcome, assessed at the end of treatment and at 3, 6 and 12 months follow-up, with the main outcome point at the 6-month follow-up. At that point the CBT group did not differ significantly from the psycho-education group in school attendance: mean 73.4 (S.D. 34.0) versus 64.9 (S.D. 45.6), mean difference 8.5 (95% CI x12.3 to 29.3), p=0.42. The authors report both groups improved similarly and there were no statistical differences between groups on secondary outcomes; they note a trend for greater satisfaction with family-focused CBT. During follow-up, one participant who received family-focused CBT was admitted to hospital with depression after discharge; discontinued intervention was n=1 for CBT and n=2 for psycho-education, and lost to follow-up was n=0 and n=4 respectively. The authors state this was a proof-of-concept trial and that sessions would ideally have been rated independently to check treatment fidelity.

  47. Effectiveness of stepped care for chronic fatigue syndrome: a randomized noninferiority trial.2010 · randomised trial · 171 randomised
    Summary

    This randomized noninferiority study compared stepped care with care as usual for chronic fatigue syndrome (CFS) in 171 patients referred for CBT to a tertiary treatment facility. Stepped care (analysed N = 84) was guided self-instruction, with e-mail at least every 2 weeks for at least 16 weeks, followed by additional CBT if the patient desired it. Care as usual (analysed N = 85) was a waiting list of 6 to 12 months followed by regular CBT of 14 sessions over 6 months. Outcomes were fatigue severity (Checklist Individual Strength), disabilities (Sickness Impact Profile) and physical functioning (SF-36), assessed at baseline, after guided self-instruction or waiting, and after CBT. The fatigue-severity difference between groups was 0.2 (95% CI -3.9 to 4.3); the upper bound 4.3 was within the critical interval of 5.2, and there were no significant differences for fatigue severity, disabilities, or physical functioning. Clinically significant improvement in fatigue occurred in 41/84 (49%) with stepped care and 41/85 (48%) with care as usual. Patients continuing CBT needed a mean of 10.9 sessions after guided self-instruction versus 14.5 sessions with care as usual; median therapist time was 420 min versus 720 min. Forty-eight patients in the guided self-instruction condition and 19 in the waiting-list condition declined further therapy. Missing assessments after guided self-instruction and after CBT were six and six in stepped care, and four and two in care as usual. Side effects were not reported.

  48. How does cognitive behaviour therapy reduce fatigue in patients with chronic fatigue syndrome? The role of physical activity.2010 · randomised trial · 270 randomised · 211 analysed
    Summary

    This paper reanalysed three randomized controlled trials to test whether the effect of cognitive behaviour therapy (CBT) on fatigue in chronic fatigue syndrome is mediated by an increase in physical activity. Per trial, 270 patients were assigned to CBT, a guided support group or a natural course condition; 169 to guided self-instructions or a waiting list control condition; and 69 to CBT or a waiting list condition. CBT consisted of 16 sessions of 1 h over 8 months, written self-instructions combined with email contact with a trained therapist, or 10 sessions of 1 h over 5 months. Physical activity was assessed with actigraphy (Actometer worn around the ankle for 12 consecutive days) and fatigue with the Checklist Individual Strength. Included in the analyses were 211, 132 and 58 patients. Fatigue reduced significantly more in the treatment group than in the control group in all samples (path c, p<0.001 in each). However, CBT did not produce a significant change in physical activity in any of the samples (path a; p 0.693, p 0.999, p 0.257), and there was also no significant relationship between changes in physical activity and changes in fatigue (path b). The 95 % CI of the mean mediation effect included zero in all samples. Side effects and withdrawals were not reported. Among the stated limits: a substantial amount of patients did not complete actigraphy at second assessment and had to be excluded, and the exact role of physical activity in CBT for CFS remains to be determined.

  49. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial.2008 · randomised trial · 66 randomised · 61 analysed
    Summary

    This long-term follow-up of a randomized, controlled trial contacted 66 adolescents with chronic fatigue syndrome who had previously participated in a trial comparing cognitive behavioral therapy (CBT) with a waiting-list condition. Fifty participants had received CBT (10 sessions over a period of 5 months); 16 had refused CBT after the waiting period and formed a no-treatment group. Data were complete for 61 patients at follow-up (CBT group: 47; no-treatment group: 14). The mean follow-up time was 2.1 years (range: 3 months to 6 years and 8 months). Outcomes were fatigue severity (Checklist Individual Strength), physical functioning (Short-Form General Health Survey), and school and/or work attendance. In the CBT group, there was no significant change in fatigue severity from final assessment to follow-up (28.7 to 27.9; p = .764). Physical functioning increased (72.1 to 83.3; p = .001), and school/work attendance increased (79.0 to 92.2; p = .033). In the no-treatment group, fatigue did not change significantly (41.6 to 39.2; p = .539), physical functioning improved (57.8 to 69.8; p = .030), and attendance did not change significantly (64.9 to 68.8; p = .793). At follow-up, the CBT group was less fatigued (mean difference /H1100211.3; p = .009), had higher physical functioning (mean difference 13.5; p = .037), and had higher school/work attendance (mean difference 23.%; p = .002) than the no-treatment group. Clinically significant fatigue improvement occurred in 32/50 (64) versus 5/16 (31; p = .02). Three patients (16%) withdrew from therapy after the waiting-list condition; 2 (12.5%) in the no-treatment group did not return follow-up questionnaires. Side effects were not reported. The authors state the follow-up time varied widely and the untreated group was small.

  50. Guided self-instructions for people with chronic fatigue syndrome: randomised controlled trial.2008 · randomised trial · 171 randomised
    Summary

    This randomised controlled trial tested a minimal intervention based on cognitive–behavioural therapy for chronic fatigue syndrome against a waiting-list condition. Patients referred for CBT to a tertiary care facility were eligible; all met Centers for Disease Control and Prevention criteria for chronic fatigue syndrome. A total of 171 patients participated: 85 were allocated to guided self-instructions and 86 to the waiting-list condition. The intervention was a self-instruction booklet with information about chronic fatigue syndrome and weekly assignments, with email or telephone contact at least once every 2 weeks with a CBT therapist; the programme took at least 16 weeks. The waiting period was 6–12 months depending on treatment capacity. Outcomes at second assessment included CIS fatigue severity, SIP8 total score, SF–36 physical functioning and clinically significant improvement. The intervention group was significantly less fatigued (mean 38.9 v. 46.4), reported fewer disabilities (mean 1079 v. 1319), scored higher on SF–36 physical functioning (mean 65.9 v. 60.2), and more often showed clinically significant improvement in fatigue (27% v. 7%). The interaction between condition and SIP8 total score was significant (B=3.533, t=2.250, P=0.026), with the treatment effect more than halved for patients with an SIP8 score 1 standard deviation above the mean. 13 patients did not start self-instructions; 6 in the intervention and 4 in the waiting-list condition did not complete the second assessment (3 of the 6 also did not start treatment). Side effects and worsening were not reported.

  51. The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance.2007 · randomised trial · 278 randomised · 233 analysed
    Summary

    This secondary analysis used data from two previous randomised controlled trials of cognitive behavioural therapy (CBT) for chronic fatigue syndrome (CFS). The adult trial enrolled 278 patients and compared CBT with natural course and a support group; neuropsychological test data were available for 233 patients (78 CBT, 76 natural course, 79 support group). Assessments were at baseline, 8 and 14 months. The adolescent trial randomly assigned 69 patients to CBT or a waiting list condition; neuropsychological data were available for 67 patients (33 CBT, 34 waiting list), with assessments at baseline and 5 months. Self-reported cognitive impairment was measured with CIS-conc and, in adults, SIP-ab; adolescents also used SOCI. Information speed was measured with simple and choice reaction time tasks, and adults completed the SDMT. In adults, the decrease in CIS-conc was significantly greater after CBT than with natural course (p,0.001) and support group (p=0.001). SIP-ab decreased significantly more after CBT than with natural course (p=0.004); the difference from support group did not reach significance (p=0.055). In adolescents, CIS-conc and SOCI decreases were significantly larger in the CBT group. Neuropsychological test performance did not improve: adult reaction time p=0.783, SDMT p=0.484, adolescent reaction time p=0.714. Harms were not reported. The authors state a methodological problem was missing neuropsychological data at the second assessment.

  52. Is cognitive behaviour therapy for chronic fatigue syndrome also effective for pain symptoms?2007 · randomised trial · 96 randomised
    Summary

    This study used data from two previous CBT studies, one of 96 adult CFS patients and one adolescent CBT study in which 35 adolescents were in the CBT group and 32 started CBT, to ask whether CBT for CFS also changes pain. Adults received CBT for CFS in 16 sessions over 6 months; adolescents received 10 sessions over 5 months. The adolescent comparison was a waiting list condition (n = 34). Pain severity was measured with a daily self-observation list (DOP; daily score 0 to 16) at baseline and post-treatment; adults also completed the McGill Pain Questionnaire. Fatigue was measured with the Checklist Individual Strength, and physical activity with an actometer. DOP decreased from baseline to post-treatment in both adult and adolescent CFS patients. Recovered adults had a mean DOP change of -2.01 versus -0.22 in non-recovered adults, reported as statistically significant; recovered adolescents had -3.76 versus 0.14 (p = 0.006). A normal pain level was reached by 36/63 recovered adults (57%) versus 3/33 non-recovered adults (9%), reported as significantly more. In the adolescent comparison, DOP change was -2.21 with CBT versus -0.36 with waiting list (p = 0.017), and 56% versus 29% had pain within the healthy range (p = 0.04). Recovered adults reported less pain in neck and/or shoulders, legs, arms and chest. Change in fatigue predicted change in pain in adults (b = 0.61) and adolescents (b = 0.55, p = 0.002), both reported as significant; other change scores were not related. Baseline DOP predicted change in fatigue in adults (b = -0.26, p = 0.011) but not adolescents (b = -0.09, p = 0.612). Three adolescents did not start CBT; side effects were not reported. The authors state that medication effects could not be properly analysed, that significance was not corrected for multiple analyses, and that findings need replication.

  53. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.2006 · randomised trial · 153 randomised
    Summary

    This three-arm randomised trial tested group cognitive behavioural therapy (CBT) incorporating graded activity scheduling in adults with chronic fatigue syndrome/myalgic encephalopathy referred by their GP. A total of 153 patients were recruited: 52 to CBT, 50 to education and support (EAS) and 51 to standard medical care (SMC). Both group treatments consisted of eight meetings, each lasting 2 hours, held fortnightly. Outcomes were assessed at baseline and 6 and 12 months after first assessment. The primary outcome was the SF-36 physical and mental health summary scales; other measures included the Chalder fatigue scale, Hospital Anxiety and Depression Scale, General Health Questionnaire and walking tests. The SF-36 physical health summary scale did not differ significantly between groups. Patients in the CBT group had significantly higher mental health scores than the SMC group (difference +4.35, 95% CI +0.72 to +7.97, p = 0.019). The Chalder fatigue score was 3.16 lower with CBT than EAS (95% CI –5.59 to –0.74, p = 0.011). Walking speed for CBT increased by 1.77 shuttles compared with EAS and by 2.83 shuttles compared with SMC. Twelve patients failed to attend for the 12-month follow-up and 19 patients attended one follow-up, but not both. The paper did not report side effects or withdrawals for harms.

  54. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial.2005 · randomised trial · 71 randomised · 69 analysed
    Summary

    Seventy one adolescents aged 10-17 years with chronic fatigue syndrome, referred to a paediatrics outpatient clinic, were randomly allocated to immediate cognitive behaviour therapy (n = 36) or to a waiting list (n = 35). Two were excluded after randomisation because the diagnosis was incorrect, and analyses were based on 69. Therapy comprised 10 individual sessions over five months, with protocols for relatively active or passive activity patterns. All participants were assessed again after five months. At five months, 29 in the therapy group and 33 on the waiting list completed assessment. The therapy group had a greater decrease in fatigue severity (difference in decrease on checklist individual strength 14.5, 95% confidence interval 7.4 to 21.6), a greater increase in SF-36 physical functioning (17.3, 6.2 to 28.4), and a greater increase in school attendance (18.2, 0.8 to 35.5). They also had greater decreases in tiredness after exercise, impaired concentration, unrefreshing sleep, muscle pain, and headache; the waiting list reported increased prevalence of impaired concentration, unrefreshing sleep, and muscle pain. Clinically significant improvement was 21/35 versus 7/34 for fatigue, 22/35 versus 8/34 for physical functioning, 19/33 versus 10/34 for full school attendance, and 25/35 versus 15/34 for self rated improvement. There were no significant differences in all primary outcomes between the passive and active treatment protocols. Six patients (19%) withdrew from therapy; six dropped out during treatment, three of them did not finish the second assessment. The method of collecting harms was not reported. The authors state limits including relatively small final samples.

  55. Effect of psychiatric disorders on outcome of cognitive-behavioural therapy for chronic fatigue syndrome.2005 · randomised trial · 270 randomised · 264 analysed
    Summary

    This study asked whether psychiatric disorders affect the outcome of cognitive–behavioural therapy (CBT) for chronic fatigue syndrome (CFS). It reports a randomised controlled CBT trial of 270 individuals with CFS. Participants were assessed with a structured psychiatric interview at baseline; the data of 264 participants were analysed (6 were omitted, owing to missing data). Outcome measures were assessed at baseline, 8 and 14 months. The paper reports fatigue severity (Dutch Checklist Individual Strength), functional impairment (Sickness Impact Profile), depression (Beck Depression Inventory) and psychological distress (Symptom Checklist). In the outcome variables fatigue severity and functional impairment, neither main effects of current psychiatric diagnosis nor interaction effects of trial condition and current psychiatric diagnosis were found. Participants with a current psychiatric diagnosis had outcomes almost identical to those without. For depression and psychological distress, main effects of current psychiatric diagnosis were found but no interaction effects of trial condition and psychiatric diagnosis; both groups had similar difference scores from baseline to post-test and follow-up. The authors report that equal treatment effects of CBT were found for participants with and without current psychiatric disorders. Harms and withdrawals were not reported.

  56. Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomized trial in primary care.2004 · randomised trial
    Summary

    This was a randomized trial followed by a prospective cohort study in 22 general practices in London and South East England. GPs referred 144 patients aged 16 to 75 years with unexplained fatigue of >3 months for the therapy trial; 123 were randomized to CBT (N=63) or GET (N=60). A further 40 patients received a booklet plus usual care (BUC) in the prospective cohort. Only 36 (29%) conformed to CDC criteria for CFS. Treatment was six 45-min sessions over 12 weeks. The primary outcome was fatigue on a Likert scale (maximum score 33), with assessments at baseline and at 3 and 8 months. Intention-to-treat data were available for 117/123 patients, 59/63 in CBT and 58/60 in GET; full data were available for 31/40 BUC patients. Mean fatigue scores at outcome combining 3 and 8 month data were 13.9 (S.D.=7.0) in CBT and 15.1 (S.D.=8.1) in GET; after adjustment the mean difference was x1.3 (CI=x3.9to1.3), with no significant difference between groups. Recovery by Chalder criteria was 30/59 (51%) following CBT and 28/58 (48%) following GET; by Cleare criteria it was 30/59 (51%) and 33/58 (57%). At outcome one-half of patients had clinically important fatigue in both randomized groups, but patients in the group offered CBT were less anxious. Two patients died before outcome; one suicide occurred in a patient allocated CBT who received four sessions. Individual fatigue scores increased in 2/59 (3%) receiving CBT and 7/58 (12%) receiving GET.

  57. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial.2001 · randomised trial · 160 randomised · 129 analysed
    Summary

    This randomised trial took place in ten general practices in London and the South Thames region, recruiting between 1996 and 1998. It included 160 primary-care patients with chronic fatigue of three months' duration or more; 45 (28%) met CDC criteria for chronic fatigue syndrome. Patients were allocated 80 to counselling and 80 to cognitive behaviour therapy (CBT). Both arms were offered six sessions of up to one hour. Patients were assessed before treatment, after therapy, and at six months after baseline. At six months, 129 patients returned questionnaires. In the all-patient multiple-imputation analysis adjusted for baseline scores, the fatigue treatment effect was 1.04 (95% CI -1.7 to 3.7), a non-significant trend in favour of counselling. Anxiety (-0.22, 95% CI -1.4 to 1.0), depression (0.22, 95% CI -1.0 to 1.4), and social adjustment (-0.05, 95% CI -2.5 to 2.4) showed no significant differences. The CBT group was significantly more satisfied with therapy (39 versus 32; 95% CI of difference 1.9 to 12.6). Fifty-one (64%) counselling and 55 (69%) CBT patients completed all six sessions; 29 counselling and 25 CBT patients completed fewer than six, citing reasons such as not tired any more, too busy to come, or did not find therapy useful. Side-effect data were not reported. The authors stated a post hoc CFS analysis lacked power and noted limitations of historical controls.

  58. Illness beliefs and treatment outcome in chronic fatigue syndrome.1998 · randomised trial · 60 randomised
    Summary

    This randomized controlled trial enrolled 60 patients attending a fatigue clinic who met criteria for chronic fatigue syndrome. Patients were randomized to 13 sessions of either cognitive behavior therapy (CBT), which included planned, graded activity and rest, or a control treatment of relaxation, 30 patients per group. Twenty-seven CBT patients and 26 relaxation patients completed treatment and were followed up for 6 months after treatment ended. The main outcome was improvement on the Medical Outcomes Survey physical functioning scale at 6-month follow-up. At 6-month follow-up, 19 (70%) CBT patients improved compared with 5 (19%) relaxation patients (p<0.001). Between-group comparisons showed CBT was superior to relaxation in improving functional impairment and fatigue, but not mood, which improved similarly in both groups. Improved patients showed significant reductions in fatigue symptoms and fatigue severity. Causal attributions did not change significantly in either group and were not associated with outcome. At posttreatment, fewer CBT than relaxation patients agreed that they should avoid exercise when tired, 9 (33%) vs 21 (81%), and that doing less helps fatigue, 6 (22%) vs 15 (58%). Belief that exercise is harmful decreased similarly in both groups. Side effects were not reported. The authors state limitations including that beliefs were measured after randomization and the direction of causality has not been established.

  59. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.1997 · randomised trial · 60 randomised · 53 analysed
    Summary

    This randomized controlled trial compared cognitive behavior therapy (graded activity and cognitive restructuring) with relaxation for chronic fatigue syndrome. Patients were recruited from consecutive referrals by primary care physicians and consultants to a hospital clinic specializing in chronic fatigue syndrome. Sixty patients joined; 30 were assigned to cognitive behavior therapy and 30 to relaxation. Each patient received 13 treatment sessions over 4 to 6 months. Treatment was completed by 53 patients. Outcome measures covered functional impairment, fatigue, mood, and global improvement, with follow-up to 6 months. At 6-month follow-up, 19 of the patients receiving cognitive behavior therapy and five of those receiving relaxation were improved. Among treatment completers, 70% in the cognitive behavior therapy group achieved good outcomes compared with 19% in the relaxation group. The paper reports no significant differences between groups on the General Health Questionnaire and Beck Depression Inventory. Five relaxation patients (but no cognitive behavior therapy patients) rated themselves as worse. Seven patients (12%) dropped out; three withdrew from cognitive behavior therapy and four from relaxation, with reasons including feeling too ill and finding relaxation exercises overly tiring. The authors state limitations including use of a single therapist and outcome assessment depending largely on self-rated measures.

  60. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial.1996 · randomised trial · 60 randomised
    Summary

    This randomised controlled trial with final assessment at 12 months took place in an infectious diseases outpatient clinic. It included 60 consecutively referred patients meeting consensus criteria for chronic fatigue syndrome. Patients received medical care, described as assessment, advice, and follow up in general practice. Those in the cognitive behaviour therapy arm were offered 16 individual weekly sessions in addition to medical care. The comparison arm received medical care only. The paper reports proportions of patients who achieved normal daily functioning (Karnofsky score 80 or more) and a clinically significant improvement in functioning (change in Karnofsky score 10 points or more) by 12 months after randomisation. An intention to treat analysis found that 73% (22/30) of cognitive behaviour therapy recipients achieved a satisfactory outcome, compared with 27% (8/30) of patients given only medical care; the difference was 47 percentage points (95% confidence interval 24 to 69). The improvement in disability among patients given cognitive behaviour therapy continued after completion of therapy. Illness beliefs and coping behaviour previously associated with a poor outcome changed more with cognitive behaviour therapy than with medical care alone. All randomised patients completed treatment. Side-effect counts are not reported. The text does not state limitations.

  61. Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study.2026 · compared with another group · 83 started · 71 with outcome data
    Summary

    This prospective non-randomized controlled trial evaluated a five-week inpatient psychosomatic program for patients with confirmed post-COVID syndrome recruited from the Post-COVID Center at the University Hospital Erlangen between December 2022 and May 2025. After exclusions, 83 patients remained in the intervention group and 56 in the control group at baseline; 71 intervention and 49 control patients were analysed. The intervention was a five-week inpatient program combining depth-psychological and cognitive-behavioral therapy, with individual and group psychotherapy, mindfulness/relaxation, body and movement therapy, neurocognitive training, tailored physical therapy, and medical care. The control group received treatment-as-usual without inpatient psychosomatic care. Outcomes at baseline (T0) and after five weeks (T1) included post-COVID symptom severity (PCS), fatigue (FSS), depressive symptoms (PHQ-9), anxiety (GAD-7), SF-36 quality of life, and PCQ-2 coping competence. Compared with controls, the intervention group showed significantly larger improvements in depressive symptoms (p = .042), mental health-related quality of life (p = .014), social functioning (p = .005), and overall patient competence (p = .018). No group-by-time interaction effects were found for post-COVID symptom severity, fatigue, anxiety, or physical health-related quality of life. Within the intervention group, fatigue (p = .029, d = 0.275) and anxiety (p = .008, d = 0.324) improved significantly. At T1, 10 intervention and 5 control patients were lost to follow-up. Patients who discontinued treatment did so for personal, non-clinical reasons. Side effects were not reported.

  62. Co-occurrence of severe fatigue and insomnia: implications for the outcome of cognitive behavioural therapies.2025 · compared with another group · 241 in the study · 233 with outcome data
  63. [Cross-sector Management of Medical Treatment and Integrated Forms of Therapy for Post-COVID-19 Patients with Fatigue and Sensorimotor Instability].2025 · compared with another group · 78 in the study
    Summary

    This doctor-led intervention and observation study took place at the Post-COVID-19-Center Lausitz (Senftenberg) from Q1-2021 to Q2-2024. From 407 vaccinated nucleocapsid-positive patients available for screening, 78 patients with reduced sensorimotor performance and fatigue took part. Treatment phase 1 (Q1-2021 - Q2-2023) gave stress-controlled training therapy (analog and digital intervention), including a computer-aided training system, a mobile application and a meditation tool with guided relaxation exercises, with at least 2 training units per week. Treatment phase 2 (Q2-2023 - Q4-2023) gave intensified cognitive behavioral therapy to 19 patients from phase 1. A Q2-2024 questionnaire survey included 26 participants and compared participants with and without intensive cognitive behavioral therapy. The paper reports improvements in “fatigue” by around 71%, “sensorimotor instability” by around 56%, “neuropsychiatric symptoms” by around 72%, “cardiopulmonary/autonomic dysfunction” by around 76% and “pain” by around around 14%, and worsening of “secondary psychosomatic symptoms” by around 72%. Overall (N = 78), a therapeutic effect was demonstrated for all motor fatigue parameters; the Functional Reach Test achieved a medium effect size and other motor fatigability parameters small effect sizes. In men, no treatment effect could be demonstrated for the 10 m walk test; in women, there were no treatment effects for the dynamic gait index and monopedal stance. Women showed a very strong deterioration in the “secondary psychosomatic symptoms”. No withdrawal counts or reasons were reported.

  64. Effectiveness of Internet-Based Cognitive Behavior Therapy (Fatigue in Teenagers on the Internet) for Adolescents With Chronic Fatigue Syndrome in Routine Clinical Care: Observational Study.2021 · compared with another group · 384 in the study · 328 started
    Summary

    This observational study in routine clinical care enrolled 384 referred adolescents with CFS/ME at a national referral center; 328 started treatment, 244 received IMP-FITNET (internet-based CBT with 21 interactive modules) and 84 received face-to-face CBT after shared decision-making. Posttreatment assessments were completed by 229 of 244 IMP-FITNET patients and 71 of 84 face-to-face CBT patients. The study compared posttreatment fatigue severity (CIS-20), physical functioning (CHQ-87), school attendance, and recovery with the FITNET RCT benchmark, and compared deterioration with a waiting-list condition. Posttreatment fatigue severity was mean 26.0 (SD 13.8) with IMP-FITNET and 25.8 (SD 12.3) with face-to-face CBT; physical functioning was 88.2 (SD 15.0) and 89.3 (SD 12.8); school attendance was 84.3 (SD 26.5) and 87.1 (SD 23.6); recovery was 58% and 60%. In the IMP-FITNET arm, 173 of 229 (75.5%) had a reliable change index score greater than +1.96 and a CIS score lower than 40; fatigue reduced on average by 23.8 points from 49.8 (SD 5.0) to 26.0 (SD 13.8). Deterioration of fatigue occurred in 3 of 244 (1.2%) IMP-FITNET patients versus 2 of 35 (5.7%) in the waiting-list condition (P=.06); deterioration of physical functioning occurred in 10 of 244 (4.1%) versus 4 of 35 (11.4%) (P=.07). Limitations included confounding by indication, longer time between assessments than in the FITNET RCT, not all RCT outcomes comparable, and higher dropout in routine clinical care.

  65. Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions.2019 · compared with another group · 30 in the study · 28 started · 28 with outcome data
    Summary

    This pragmatic, non-randomized, controlled trial examined group cognitive behavioral therapy (GCBT) in routine clinical practice for people with chronic fatigue syndrome (CFS), sometimes called ME. Participants were 28 consecutive GP referrals to a specialist clinic in North Wales, UK; 30 individuals were assessed as suitable, and 2 withdrew before the intervention for unspecified reasons. The 28 participants acted as their own waiting list control for 8 weeks before receiving 8 consecutive weeks of 2.5-hour GCBT sessions. Measures included physical and mental fatigue, depressive symptoms (BDI-FS and HADS-D), anxiety, hope, optimism, and global self-ratings. The abstract reports significant improvements in physical fatigue (F = 28.31, P < .01, effect size d = 0.52), mental fatigue (F = 7.72, P < .01, effect size d = 0.22), BDI-FS (F = 11.43, P < .01, effect size d = 0.30), HADS-D (F = 16.72, P < .01, effect size d = 0.38), hope (F = 15.15, P < .01, effect size d = 0.36), and optimism (F = 8.17, P < .01, effect size d = 0.23). No significant difference was found for HADS Anxiety scores. At the end of treatment, 24 participants (85.7%) rated themselves better to some degree, while 14.3% (4) rated themselves about the same or worse; 71.4% (20) rated fatigue better and 28.6% (8) the same or worse; 64.3% (18) rated disability/restrictions better and 35.7% (10) the same or worse. Twenty-five (89.3%) were satisfied to some degree, and 64.3% (18) found the intervention very useful. Side effects were not reported. The authors stated limitations including a relatively small sample size and that the results should be viewed with some caution.

  66. CBT Based Group Therapy for Patients With Chronic Fatigue Syndrome (CFS)2019 · compared with another group · 30 in the study · 28 started · 28 with outcome data
    Summary

    This pragmatic, non-randomized, controlled trial examined group cognitive behavioral therapy (GCBT) for adults with chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in a routine UK clinic. Thirty people were assessed as suitable; 2 withdrew before the intervention for unspecified reasons, and 28 took part. Participants acted as their own waiting list control for 8 weeks, then received GCBT for 8 consecutive weeks of 2.5-hour sessions; measures were completed at the start and end of the 8-week intervention. Compared with the waiting period, the paper reports significant improvements in physical fatigue, mental fatigue, BDI-FS and HADS-D depressive symptoms, hope, and optimism (P < .01 for each; physical fatigue F = 28.31, effect size d = 0.52). Quality of life showed a significant result (F = 7.56, P < .01, effect size d = 0.23), but the authors state it was not attributable to the intervention alone. No significant difference was found for HADS Anxiety. At the end of treatment, 24 participants (85.7%) rated themselves better to some degree and 4 (14.3%) about the same or worse; 20 (71.4%) rated fatigue better and 8 (28.6%) the same or worse; 18 (64.3%) rated disability better and 10 (35.7%) the same or worse. Twenty-five (89.3%) were satisfied to some degree; 18 (64.3%) found it “very useful.” Attendance was 90.2%. Side effects were not reported. The authors state limitations including a relatively small sample size and that symptom profiles were not analyzed.

  67. COGNITIVE BEHAVIORAL THERAPY (CBT) VS RELAXATION THERAPY(RT) ON FATIGUE AMONG TEACHING PROFESSIONALS WITH CHRONIC FATIGUE SYNDROME – PILOT STUDY REPORT.2018 · compared with another group · 30 in the study
    Summary

    This pilot study compared cognitive behavioral therapy (CBT) and relaxation therapy (RT) for fatigue in teaching professionals with chronic fatigue syndrome (CFS) at schools in north and central Chennai. It used a quasi experimental with time series design and non-probability convenient and purposive sampling. Thirty teaching professionals with CFS were included, with 10 samples in each of three groups. The CBT group received mindfulness integrated cognitive behavioral therapy for 8 sessions over 8 weeks, each session lasting 1hr. The RT group received Jacobson progressive muscle relaxation technique, breathing technique, rapid relaxation skills and guided imagery for 8 sessions over 8 weeks, each session lasting 1hr. The control group received no treatment; after data collection they were given CBT for 4 weeks with information leaflet. Fatigue was measured with the Krupp LB Fatigue severity scale. During post 1, 2, and 3, the CBT and RT groups showed decrease in fatigue level, and none of them had severe level of fatigue in both groups. In the control group the level of fatigue remained the same in pre test and post test 1, 2, and 3. The paper reports significant improvement in fatigue in both CBT and RT groups compared with control, and better improvement with CBT than RT. Graph mean scores at Post Test 3 were 2.92 for CBT, 3.45 for RT, and 4.48 for control. The paper also states differences were highly significant at p = 0.0001 in all three groups, while stating control fatigue remained the same. Harms and withdrawals are not reported.

  68. Telephone-administered versus live group cognitive behavioral stress management for adults with CFS.2017 · compared with another group · 100 in the study
    Summary

    This secondary analysis compared telephone-delivered group cognitive behavioral stress management (T-CBSM; N=56) with live group CBSM (L-CBSM; N=44) in 100 patients with CFS, using data from two separate trials. L-CBSM comprised 12 weekly in-person group meetings; T-CBSM comprised 10 weekly group meetings held via telephone. Outcomes were Perceived Stress Scale (PSS) scores and CDC CFS Symptom Inventory scores at pre- and post-intervention. Both conditions showed significant reductions in PSS scores, with a large effect for L-CBSM (partial ε2=.16) and a medium effect for T-CBSM (partial ε2=.095); the group-by-time test showed no effect (p=.89). For CFS symptom frequency (p=.01) and severity (p=.001), L-CBSM but not T-CBSM led to reduced symptomatology with large effects (partial ε2=.19 and .23); T-CBSM showed no significant changes over time. Significant group-by-time effects were reported for frequency of PEM (p=.006), fever (p=.005), chills (p=.004), and unrefreshing sleep (p=.032), and for severity of tender lymph nodes (p=.015), PEM (p=.033), chills (p=.035), and unrefreshing sleep (p=.048). Average attended sessions were not different (9.15 versus 8.18, p=.09); attendance was 82% versus 76%, not statistically significant. For L-CBSM, 38/44 provided T2 data; for T-CBSM, 46/56 provided T2 data. Side effects and withdrawals due to harms were not reported.

  69. Guided Self-Help for Patients with Chronic Fatigue Syndrome Prior to Starting Cognitive Behavioural Therapy: a Cohort Study.2017 · compared with another group · 294 in the study · 250 started
    Summary

    Patients with chronic fatigue syndrome (CFS/ME) were recruited consecutively from an outpatient CFS clinic between November 2009 and April 2013. The paper reports 294 participants included in the analysis and 250 who started CBT. All received a self-help pack (a 19-page manual and a 70-page book) at baseline while waiting for CBT; the waiting period was approximately 4-10 weeks after initial assessment. In a post-hoc comparison, 146 participants received a phone call about the self-help materials and 97 did not. CBT was face to face, with a median of approximately 12 active treatment sessions (IQR=5), maximum 29. Questionnaires were completed at baseline, pre-CBT and post-CBT. From baseline to pre-CBT, physical functioning increased 2.7 points (95% CI 0.1 to 5.3, p=.044); fatigue decreased 0.7 points (95% CI -1.7 to 0.3, p=.196) and social adjustment decreased 1.0 point (95% CI -2.1 to 0.1, p=.075), neither statistically significant. From pre-CBT to post-CBT, physical functioning scores were 9.6 points higher (95% CI 6.9 to 12.4, p<.001), social adjustment scores 7.1 points lower (95% CI -6.0 to -8.3, p<.001), and fatigue 8.0 points lower (95% CI -6.9 to -9.1, p<.001). Table 2 showed no statistically significant differences between phone-call and no-phone-call groups at pre-CBT or post-CBT. Over half (58%) reported some use of the self-help pack. Side effects were not reported; the flow diagram lists 39 dropped out and 15 declined CBT. Limits: no control group and no randomisation; non-responders at end of CBT.

  70. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome.2016 · compared with another group · 171 in the study · 148 with outcome data
  71. Chronic fatigue syndrome: comparing outcomes in White British and Black and minority ethnic patients after cognitive-behavioural therapy.2016 · compared with another group · 519 in the study · 405 started · 352 with outcome data
    Summary

    This prospective study compared outcomes after cognitive–behavioural therapy (CBT) in Black and minority ethnic (BME) and White British patients with chronic fatigue syndrome (CFS) at a specialist CFS service in London, UK. The data-set comprised 519 participants, reduced to 405 after exclusions and leaving 352 cases for analysis; the study sample included 67 BME and 285 White British participants. Participants received CBT from a clinical psychologist or CBT therapist, typically one session per fortnight, and each received approximately 12 sessions. Outcomes were self-reported at pre-treatment (baseline) and post-treatment (discharge): fatigue severity (Chalder Fatigue Scale), physical functioning (Short-Form Health Survey) and work/social adjustment (Work and Social Adjustment Scale). Fatigue severity scores decreased by 8.34 points (95% CI 5.10–11.57) in BME participants and by 7.37 points (95% CI 6.17–8.57) in White British participants. Physical functioning scores increased by 11.39 points (95% CI 5.31–17.46) and 9.46 points (95% CI 6.68–12.24), respectively. Work and Social Adjustment Scale scores decreased by 6.01 points (95% CI 3.87–8.16) and 5.75 points (95% CI 4.64–6.87), respectively. There were no significant differences in change scores between groups for fatigue (P=0.777), physical functioning (P=0.821) or work/social adjustment (P=0.339). The total attrition rate was 35.8% (n=126); 17.1% (n=60) dropped out during treatment, and 18.8% (n=66) completed treatment but did not complete discharge questionnaires. Side effects were not reported.

  72. Cognitive behaviour therapy for chronic fatigue syndrome: Differences in treatment outcome between a tertiary treatment centre in the United Kingdom and the Netherlands.2016 · compared with another group
    Summary

    This study compared cognitive behaviour therapy (CBT) outcomes in tertiary chronic fatigue syndrome (CFS) centres in the Netherlands (NL) and United Kingdom (UK). Consecutively referred patients who commenced CBT were included: 293 in NL and 163 in UK; NL used CDC criteria and UK Oxford criteria. Both protocols required 12–15 treatment sessions over six months. Mean treatment duration was 7.7 months (SD 3.5) in NL and 7.8 months (SD 3.0) in UK, with no significant difference; mean sessions were 13.5 (SD 4.1) in NL and 12.5 (SD 2.8) in UK. Patients were not randomised. Outcomes were Chalder Fatigue Questionnaire (CFQ), SF-36 physical functioning and Work and Social Adjustment Scale (WSAS), measured post-treatment; follow-up was on average 3 months after post-assessment. Among completers (CFQ 225 NL/129 UK; SF-36 243/125; WSAS 217/129), Dutch effect sizes were larger: CFQ 1.74 (1.52–1.95) vs 0.99 (0.73–1.25); SF-36 0.99 (0.81–1.18) vs 0.33 (0.08–0.58); WSAS 1.47 (1.26–1.69) vs 0.61 (0.35–0.86); the 95% confidence intervals excluded the other country's estimate. Dropout was 23 in NL (8%) and 11 in UK (7%), with no significant difference. Post-treatment CFQ was missing for 68 NL (23%) and 34 UK (21%). Side effects and worsening were not reported. The authors conclude that effectiveness differed between centres.

  73. Therapist effects and the dissemination of cognitive behavior therapy for chronic fatigue syndrome in community-based mental health care.2012 · compared with another group · 103 in the study
    Summary

    This observational prospective study used routine outcome data from three Dutch community-based mental health care centers (MHCs) to examine therapist effects in manualized cognitive behavior therapy (CBT) for chronic fatigue syndrome (CFS). Ten therapists, all trained and supervised in CBT for CFS, and 103 patients referred by a medical doctor with CFS were included. CBT for CFS included goal setting, fixed sleep-wake cycles, changing focus on bodily symptoms, challenging fatigue-related beliefs, regulating and gradually increasing activity, and personalized goals; treatment duration was not reported. Patients were compared across therapists and MHCs; patients were not randomly allocated to therapists. Fatigue severity was measured with the Checklist Individual Strength fatigue severity subscale (scores 8 to 56; cut-off 35) before and at post-treatment assessment, and therapists' attitude toward evidence-based treatment manuals was assessed before patients were treated. Mean pre-treatment fatigue for the total group was 50.7 (5.2) and mean post-treatment fatigue was 30.4 (15.9). By MHC, mean post-treatment fatigue was 30.0 (14.7) in MHC I (40 patients), 39.3 (12.7) in MHC II (30 patients), and 22.7 (16.1) in MHC III (33 patients). Random effects modeling revealed a significant difference in mean post-treatment fatigue between therapists; the therapist effect accounted for 21% of the variance in post-treatment fatigue, with a variance component estimate of 53.0 (CI 10.3, 164.7). The negative process attitude estimate was 2.7 (CI 0.9, 4.5); positive outcome was -0.4 (CI -1.0, 0.3). Adding treatment setting reduced the therapist variance estimate to 16.4 (CI 0.0, 49.5). Harms, side effects, worsening, and withdrawals were not reported. The authors state that the therapist effect was no longer significant when attitude or treatment setting was added, and confidence intervals were large and overlapped.

  74. Childhood maltreatment and the response to cognitive behavior therapy for chronic fatigue syndrome.2011 · compared with another group · 216 in the study
    Summary

    This cohort study asked whether a history of childhood maltreatment relates to response to cognitive behavior therapy (CBT) for chronic fatigue syndrome (CFS). It included 216 consecutively referred adults at a tertiary CFS clinic who started individual CBT between March 2008 and June 2009. CBT consisted of 12 to 16 individual 1-hour sessions during approximately 6 months. Eighty of the 216 patients reported childhood maltreatment. The study compared patients with and without such a history. Outcomes were fatigue (CIS), disabilities (SIP total), physical functioning (SF36), and psychological distress (SCL total). The paper reports no statistically significant difference between subgroups in the amount of change on any outcome measure. After treatment, patients with childhood maltreatment still had higher limitations and distress: median SIP total 653 vs 401, p<.001; median SCL total 135 vs 120, p=0.001; median SF36 physical functioning 85 vs 90, p=0.03. The uncontrolled Cohen's d for change in CIS fatigue ranged from 1.64 to 2.13. At 6-month follow-up (141 patients), change in fatigue (p=.13) and impairment (p=.12) did not differ significantly. Post-measurement data were missing for 24 patients; harms were not reported.

  75. Cognitive-behaviour therapy for chronic fatigue syndrome: comparison of outcomes within and outside the confines of a randomised controlled trial.2007 · compared with another group
    Summary

    This study compared cognitive-behaviour therapy (CBT) for chronic fatigue syndrome delivered in a randomised controlled trial (RCT) with the same treatment in routine clinical practice. Thirty patients were randomised to CBT in the RCT (13 sessions for an average of 15 h), and 384 patients received routine clinical practice (average of 11 sessions). Outcomes were fatigue (Chalder Fatigue Scale), work and social adjustment, and self-rated global improvement, satisfaction and usefulness, assessed at pre-treatment, post-treatment and 6-month follow-up. From pre-treatment to 6-month follow-up, RCT patients had a larger reduction in fatigue than routine-clinic patients (U=1876.00, p=0:002), but changes from pre- to post-treatment did not differ significantly (U=2744.50, p=0:62); the RCT showed a greater change between post-treatment and follow-up (U=1492.50, p=0:003). Work and social adjustment improved more in the RCT from pre-treatment to follow-up (U=2012.00, p=0:007) and from pre- to post-therapy (U=2083.5, p<0.01), with no significant difference from post-treatment to follow-up (U=1948, p=0:21). At 6-month follow-up, 10/27 (37.0) RCT patients met fatigue caseness versus 145/227 (63.9) routine-clinic patients (McNemar p<0.001; adjusted p=0:003, odds ratio 0.28, 95% confidence interval 0.12–0.66). Global improvement, satisfaction and usefulness ratings were not significantly different (p=0.38, p=0.28, p=0.61). Three of 30 RCT patients dropped out; reasons were one found therapy ineffective, one felt too ill to attend, and one improved and did not want to continue. Side effects were not reported.

  76. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study.2005 · compared with another group · 67 in the study
    Summary

    The study investigated whether cognitive behaviour group therapy (CBGT) was effective in an unselected group of chronic fatigue syndrome (CFS) patients and explored pretreatment characteristics of patients who improved. In a non-randomised waiting list controlled design, 31 patients were allocated to CBGT and 36 to the waiting list condition. All patients fulfilled Fukuda criteria for CFS or idiopathic chronic fatigue. CBGT consisted of 12 two-hour sessions during 6 months, with a graded activity program; the waiting list had no restrictions and was offered CBGT after 6 months. Outcomes included fatigue (CIS), functional impairment (SIP-8), daily observed fatigue and pain, hours working, psychological distress (SCL-90), depression (BDI), physical attributions, self-efficacy, avoidance of activity, focusing on bodily symptoms, and self-rated improvement. Fatigue showed an interaction effect with a p value of 0.099 in favour of CBGT. Functional impairment showed a significant interaction effect (p = 0.004) in favour of the waiting list condition; it did not change after CBGT but declined in the waiting list condition. No significant interaction effects were found for daily observed fatigue, daily observed pain, hours working, psychological well-being and depression. Physical attributions decreased after CBGT and increased in the waiting list condition; avoidance of activity increased after CBGT and decreased in the waiting list condition. Self-rated improvement scores were available from 27 of 29 patients after CBGT; ten (37%) rated themselves as improved. Two patients dropped out during treatment; no post-test data are available from these patients. Side effects were not reported.

  77. Chronic fatigue syndrome: a follow up study.1994 · compared with another group · 47 in the study · 29 with outcome data
    Summary

    This follow-up study examined patients diagnosed with chronic fatigue at the National Hospital for Neurology and Neurosurgery four years earlier. Forty-six of 47 patients were contacted; 29 were interviewed and information on 14 non-respondents came from general practitioners. In the original open, uncontrolled trial, treatment was cognitive behaviour therapy, with antidepressants offered to patients who fulfilled criteria for depression; treatment duration was not reported. The comparison was with patients who refused treatment, and patients were also divided by self-rated global improvement. At follow up, 22 of the interviewed patients had accepted treatment and 17 had successfully completed it; 17 were reported improved at treatment completion, and after four years this improvement was sustained in 14. Three patients discontinued treatment and two felt no benefit at completion. Of five patients who did not successfully complete treatment, none had spontaneously improved at four years. Seven interviewed patients had refused treatment; two made a spontaneous recovery. Using patient and general practitioner reports, 20 of 23 patients who successfully completed treatment remained well, whereas 2 of 16 who refused or did not complete treatment had made a spontaneous recovery. General practitioners reported 6 of 14 non-respondents as well physically and mentally when last seen, and all of these had completed treatment. The authors note a trend for initial treatment response to be associated with continued absence of chronic fatigue syndrome at four years. Limitations stated were the smaller follow-up sample and the uncontrolled, non-blind, non-randomised design.

  78. A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression.1994 · compared with another group
    Summary

    This clinical series evaluated cognitive behavioral intervention for chronic fatigue syndrome (CFS), comparing a CFS-treatment group (n = 22), a primary depression-treatment group (n = 20), and a no-treatment CFS control group (n = 22). CFS outpatients were recruited from a university hospital neurology clinic and a local CFS support group; the depression group was consecutive patients of one author. Treated patients received cognitive behavioral therapy weekly in groups of three to seven or individually, for six therapy sessions over 6-9 weeks; the depression group also received cognitive behavioral therapy but with no references to chronic illness. Outcomes included depression symptom scores, stress symptom scores, fatigue severity scores, and a fatigue-related cognitions scale. In the CFS-treatment group, depression symptom scores showed a trend toward reduction (F = 7.58; P < .058), with no significant change in stress symptom or fatigue severity scores. The higher CES-D CFS-treatment subgroup showed significant reductions in depression, stress, fatigue severity, and fatigue-related thinking; the lower-depression subgroup showed no significant changes in any outcome measure. The depression group showed significant reductions in depression, stress symptom, and fatigue severity scores. No significant changes in any measure occurred in the no-treatment CFS group. At treatment termination, there were no significant differences between groups for depression or stress symptoms; fatigue severity remained significantly elevated for both CFS groups compared with the depression group (P < .0002). Four depression-group subjects dropped out early; two subjects refused the no-treatment group. Side effects were not reported.

  79. Cognitive behavioural therapy for severe fatigue following COVID-19 in adolescents: a serial single-case observational study of five consecutively referred patients.2025 · no comparison group · 5 in the study
    Summary

    This serial single-case observational study enrolled five adolescents with severe fatigue following COVID-19 who were consecutively referred to a tertiary chronic fatigue treatment centre. There was no comparison group; patients received CBT for post-COVID-19 fatigue, and outcomes were compared within the same patients before and after treatment. CBT duration ranged from 27 to 55 weeks. Fatigue severity was assessed weekly with the CIS-fatigue; assessments continued up to 6 weeks after completing CBT. Other questionnaires and self-report items assessed severe fatigue, physical functioning, difficulty concentrating, PEM and school absence. Twelve weeks after starting CBT, three out of five patients had a statistically significant reduction in fatigue severity. Directly post-CBT, all five patients were no longer severely fatigued (CIS-fatigue range 8–32, below the cut-off of 40). Four out of five patients had normal physical functioning (>85%), and four out of five improved in PEM frequency, which ranged from ‘not at all’ to ‘few times a week’. All five patients reported no school absence and no difficulty concentrating. An exploratory analysis found a significant fatigue reduction in one patient (case 3) at 18 weeks after starting CBT (p = .041, d = 0.98). All five included patients completed CBT. Side effects and harms were not reported. The authors note the observational design and small sample size limit definitive conclusions.

  80. Recovery from chronic fatigue syndrome: a reflexive thematic analysis of experiences of people before, during and after treatment.2025 · no comparison group · 19 in the study
    Summary

    This interview-based qualitative study used reflexive thematic analysis to explore how people with chronic fatigue syndrome (CFS) receiving cognitive behavioural therapy (CBT) viewed recovery and whether views differed by treatment stage. A total of 19 people with CFS receiving CBT were recruited from the Persistent Physical Symptoms unit, part of the South London and Maudsley NHS Trust; purposive sampling covered age, gender, ethnicity and treatment stage. Treatment consisted of up to 15 fortnightly sessions, each 50−60 minutes in duration; participants received a mean of 10 sessions (range: 0−18). There was no comparison group. Data came from semi-structured interviews analysed thematically; the paper reports themes rather than between-group effects. Most at the late or post-treatment stage had experienced at least some improvement in symptoms and attributed this to CBT, a healthy lifestyle, Eastern medicine, or a mixture of these. One participant, who was post-treatment, had experienced complete remission of symptoms in addition to an increase in levels of activity. Many participants, particularly those at the late- or post-treatment stages, referred to recovery as individual, personal or idiosyncratic. None had dropped out at the time of interview. Side effects were not reported. The authors state limitations including secondary care recruitment, possible participation bias, unstandardised recursive interviews, the CBT lens, and no lived-experience involvement in analysis.

  81. Prevalence of insomnia and feasibility of a nurse-administered digital cognitive behavioural therapy two years after corona virus disease hospitalisation.2025 · no comparison group · 109 in the study · 94 started · 65 with outcome data
    Summary

    This prospective cohort study examined chronic insomnia after COVID-19 hospitalisation and the feasibility of a nurse-administered digital cognitive behavioural therapy for insomnia (dCBTi) protocol. Patients hospitalised at Akershus University Hospital (Norway) for COVID-19 between February–June 2020 were eligible; 109 consented, 94 were contacted at three months, and 65 remained at twelve months. The dCBTi feasibility study included 10 participants who consented and met; they received a nurse-administered dCBTi protocol with stimulus control, sleep restriction therapy and a digital sleep diary for twelve weeks. There was no comparison group and no randomisation; outcomes were within-arm changes from baseline to post-study among the 5 completers. The Bergen Insomnia Scale improved from 24 to 12 (p-value = 0.036). Subjective sleep efficiency increased by 5.6 from 87.8 to 93.4, but not significantly. Epworth Sleepiness Scale changed from 9 to 6 and subjective sleep quality from 3.14 to 3.28, both not statistically significant; hours of sleep were 6 to 6. The median number of digital sleep diary entries was 73. Ten out of 24 participants reporting chronic insomnia two years after discharge consented to the dCBTi feasibility study; 5 completed the protocol and dropout was reported as 50 %. Other harms were not reported. Authors state limitations: diagnostic interviews by different persons at three and twelve months, low number of feasibility participants, and technical issues in the digital sleep diary communication channel.

  82. Patient-reported treatment outcomes in ME/CFS and long COVID.2025 · no comparison group · 5,451 in the study · 3,925 with outcome data
  83. Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study.2025 · no comparison group · 24 in the study · 15 with outcome data
    Summary

    This within-group feasibility study enrolled 24 adults in Sweden during the final phase of the COVID-19 pandemic; 16 (66.7%) were assessed as probably meeting criteria for post-COVID syndrome. They received individually tailored internet-based cognitive behavioral therapy for eight weeks with weekly therapist support; 15 (62.5%) completed the post-treatment measurement. Participants completed on average 3.96 (SD = 3.38) modules, and 5 (20.8%) completed all eight. Three participants (12.5%) withdrew during treatment; drop-out was 37.5% (9 participants), with three withdrawals mainly attributed to the amount of text and lack of energy or time. From pre- to post-treatment, scores decreased significantly on BDI-II depression (Mdn = 22.00 to 13.00, p = .003), GAD-7 anxiety (Mdn = 5.00 to 4.00, p = .020), SHAI-14 health anxiety (Mdn = 22.00 to 16.00, p = .010), KEDS-9 fatigue/exhaustion (Mdn = 31.00 to 24.00, p = .041), IES-6 post-traumatic stress (Mdn = 10.00 to 3.00, p = .025), and UCLA-LS-R loneliness (Mdn = 46.00 to 42.00, p = .027). CBT knowledge increased (raw p = .014; weighted p = .028). PSS-14 stress, BBQ quality of life, CFQ cognitive functioning, and IFDFW financial stress/well-being showed no significant differences. ISI insomnia scores were higher post-treatment (Mdn = 16.00 vs 15.00, p = .039), but the paired t-test found no significant difference (p = .077, d = 0.49); KEDS-9 was not significant with the paired t-test (p = .057, d = 0.54).

  84. PCE-CfD and Long Covid: An NHS Service Evaluation on the Benefits of Using Person-Centred Experiential Counselling for Depression With People With Long Covid.2025 · no comparison group · 38 in the study · 31 with outcome data
    Summary

    This NHS service evaluation examined person-centred experiential counselling for depression (PCE‐CfD) in people with Long Covid referred through an integrated long-term conditions pathway. It used a non‐experimental cohort design without a comparison group; 38 patients met inclusion criteria, and 31 completed treatment and were analysed. Seven of the 38 did not complete treatment and were discharged and excluded from outcome analyses; one patient's treatment was interrupted because their PCE‐CfD therapist went on long-term sick leave. Treatment was delivered by telephone, online or face-to-face, up to 20 sessions; completers had an average of 10.61 therapy sessions. Before and after treatment, patients completed the PHQ‐9, GAD‐7 and WSAS. Among the 31 completers, mean PHQ‐9 scores were 17.48 before and 7.90 after (p < 0.001); GAD‐7 scores were 11.97 before and 5.42 after (p < 0.001); WSAS scores were 22.61 before and 15.61 after (p = 0.002). Overall recovery was 83.87%, reliable improvement 90.32%, and reliable recovery 77.42%. The authors state the evaluation was based on a small sample in one geographical location of England and was not suitably powered to draw wider inferences.

  85. Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study.2025 · no comparison group · 12 in the study
    Summary

    This single-arm pilot study asked whether a Unified Protocol (UP) psychological program was feasible and clinically useful for adults with long COVID-19 condition and emotional disorders/symptoms. Twelve participants (mean age = 47.92; SD = 13.18) were allocated to the UP psychological intervention; there was no comparison group. Treatment was eight 1-hour individual online sessions delivered weekly. Assessments included satisfaction, mental clinical diagnoses, anxiety (OASIS), depression (ODSIS), emotion dysregulation (DERS), emotional-disorder dimensions (MEDI), and quality of life (EQ-VAS), with a 6-month follow-up. All participants attended the eight sessions and the follow-up appointment, but only eight answered the full 6-month assessment, a 33% assessment-protocol dropout. General satisfaction mean was 9.75; module satisfaction ranged from 7.17 to 9. Six participants no longer met criteria for a mental clinical diagnosis after the intervention. Anxiety scores significantly decreased in eight participants and depressive scores in nine; six maintained anxiety improvement and seven maintained depressive improvement at follow-up. Four participants improved emotion dysregulation and two maintained improvement. Seven participants improved quality of life at post-assessment. Some worsened: one participant’s anxiety and depressive scores worsened at post-assessment, two participants’ anxiety worsened at follow-up, and one participant’s depressive scores worsened at follow-up. Positive Temperament did not significantly improve in any participant. The authors state the sample was smaller than expected, lacked a control group, and had high follow-up assessment dropout.

  86. Positive Effects of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following COVID-19 Are Sustained Up to 1 Year After Treatment.2024 · no comparison group · 57 in the study · 52 started · 52 with outcome data
    Summary

    This letter reports 1-year follow-up of a randomized trial of CBT for post-COVID-19 fatigue. All 57 patients randomized to CBT were eligible; 52 participated. Patients randomized to care as usual were offered CBT and could therefore no longer serve as a control, so this follow-up had no comparison group. The primary outcome was fatigue severity. Secondary outcomes were physical functioning, problems with social functioning, somatic symptom severity, problems concentrating, and proportions no longer severely fatigued, no longer severely fatigued with a reliable change, and not chronically fatigued. Fatigue severity was 47.8 (0.7) at baseline and 33.2 (1.8) at 1 year post-CBT (p < .001; Cohen's d 1.08). Physical functioning was 64.7 (2.4) and 79.7 (3.2) (p < .001; d 0.60); social functioning 24.5 (1.0) and 12.9 (1.7) (p < .001; d 0.98); somatic symptoms 11.4 (0.6) and 8.5 (0.7) (p = .002; d 0.52); problems concentrating 26.6 (0.7) and 19.4 (1.2) (p < .001; d 0.85). These outcomes at 1 year did not differ significantly from 6 months post-CBT. No longer severely fatigued was 28/52 (54%) at 1 year versus 34/54 (63%) at 6 months (p = .342); not chronically fatigued 30/52 (58%) versus 39/54 (72%) (p = .150). Between 6 months and 1 year, 4 patients (8%) reported a reliable and clinically significant deterioration. Harms were not otherwise described, and withdrawals were not reported with harms as a reason. Authors state no control and encourage replication in a larger controlled study.

  87. A description of the development of an innovative multi-component long COVID treatment program based on central sensitization with preliminary patient satisfaction data.2024 · no comparison group · 140 in the study
    Summary

    This cross-sectional study described the first 140 patients treated in a multi-component treatment program for Long COVID that targets Central Sensitization. Patients were diagnosed after an extensive medical evaluation. The program was a 16-h Cognitive Behavioral Therapy treatment program focused on Central Sensitization. There was no comparison group. Function, depression, and pain catastrophizing were assessed using questionnaires, and patient satisfaction measures were taken after completion of the program. Upon admission, the paper reports that patients were significantly impaired in their ability to function; 70% of the patients were depressed, and pain catastrophizing was observed in up to 20% of patients. At the end of the treatment program, patient satisfaction measures were high for the sample. The abstract does not report side effects or withdrawals. The paper notes that no effective treatment exists for the often devastating symptoms of Long COVID. The authors state that further research is needed to explore effectiveness and durability.

  88. Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.2024 · no comparison group · 297 in the study
    Summary

    This cohort study enrolled 297 CFS patients (254 women) in a standardized CBT program at a Leuven, Belgium center between January 2015 and June 2019. Treatment consisted of a group psychoeducation session (one half day) and 17 individual 50-minute CBT sessions (15 regular sessions plus 2 booster sessions); mean treatment length including booster sessions was 15.32 months (SD = 3.69 months). Questionnaires were collected pre-treatment, after sessions 3 and 10, and post-treatment. The study had no comparison group. CIS-20 total fatigue score changed from 112.5 before treatment to 98.1 after treatment (F 25.85, p < 0.001). A reliable change in CIS-20 score occurred in 38.7% of patients, and 81.1% still had a CIS-20 score higher than 76 after treatment. Latent class growth analysis identified four fatigue trajectory classes: no improvement 23%, weak improvement 45%, moderate improvement 23%, and strong improvement 9%. Higher pre-treatment depressive, anxiety, and somatic symptoms, perceived stress, and lower positive affect predicted the no-improvement subgroup. Reductions in anxiety and perceived stress preceded reductions in fatigue; depressive symptoms and fatigue were bidirectional. No changes in SF-36 mental composite score were found. No side-effect events and no withdrawals for harms were reported. The authors state there was no no-treatment control group.

  89. Predictors of treatment response trajectories in chronic fatigue syndrome2023 · no comparison group · 297 in the study
    Summary

    This secondary analysis used records of 297 CFS patients (254 women) enrolled in a standardized CBT program at the Multidisciplinary Diagnostic Centre for CFS in Leuven, Belgium, between January 2015 and June 2019. Patients received a half-day group psychoeducation session and 17 individual 50-minute CBT sessions (15 regular sessions plus 2 booster sessions); mean treatment length including boosters was 15.32 months (SD 3.69). There was no no-treatment control group. Questionnaires were collected before treatment, after sessions 3 and 10, and after session 15; measures included CIS-20 fatigue, SF-36 quality of life, PHQ-15, PHQ-9, GAD-7, PSQ and PANAS. CIS-20 total score was 112.5 before and 98.1 after treatment; 38.7% met the reliable-change threshold, and 81.1% still had a CIS-20 score higher than 76 after treatment. Latent class analysis identified four fatigue trajectories: 23% no improvement, 45% weak improvement, 23% moderate improvement, and 9% strong improvement. No change was found in SF-36 mental composite score. The paper does not report side effects or withdrawals for harms. The authors state the study had no no-treatment control group and was a secondary analysis in a naturalistic setting.

  90. 'I became more aware of my actions'-A qualitative longitudinal study of a health psychological group intervention for patients with myalgic encephalomyelitis/chronic fatigue syndrome.2023 · no comparison group · 10 in the study
    Summary

    This qualitative longitudinal study explored how adults with ME/CFS experienced a CBT-based, tailored health psychological group intervention. Ten patients (nine women and one man) recruited from special-care units took part. The intervention comprised eight 2-h sessions over 16 weeks and one follow-up meeting at 3 months postintervention. There was no comparison group and no randomisation; semistructured interviews were conducted before the intervention, immediately after completion, and at 3 months after completion. Of the 10 participants, six reported reaching all their goals and four partially reaching their goals. In the final interview, 8 of the 10 reported mild physical or cognitive improvement; one of the 10 reported mildly worsened cognitive functioning, regarded as typical fluctuation. In the follow-up interview, a second participant reported worsened functioning attributed to exceeding personal stress tolerance. In the final and follow-up interviews, all participants reported the intervention as useful and none found it harmful; the paper also states none reported experiencing any harm. The authors note conflicting statements about harm in the results. Limitations include a small qualitative sample, voluntary participation, and possible social desirability bias because the first author collected data and delivered the intervention.

  91. 'A life I can cope with'. An alternative model of cognitive behavioural therapy (CBT) for CFS/ME.2022 · no comparison group · 13 in the study
    Summary

    Researchers conducted a qualitative study using grounded theory analysis in an NHS specialist community CFS/ME service. They interviewed 13 adults who had engaged in cognitive behavioural therapy (CBT) aimed at better management of CFS/ME rather than increasing activity. Participants reported attending between 6 and 10 sessions of specialist CBT at the service (median = 6). There was no comparison group. The study measured experiences and did not note change scores. Participants mainly reported lack of change on physical symptoms, and most experienced no change in their CFS/ME over CBT. Those reporting some improvement did not return to pre-illness levels but described fewer relapses. The abstract states reduced fatigue did not seem to be a necessary precondition to managing. Most participants felt less distressed and more hopeful about living with the illness. Many underwent a process of accepting having CFS/ME. All participants found the therapy goal of better management suitable. Harms and withdrawals were not reported. The authors conclude that specialist CBT for CFS/ME may result in improved coping and reduced distress, independently of changes in fatigue. They note limitations including a relatively small sample and incomplete posttherapy data.

  92. Generalized Worry in Patients With Chronic Fatigue Syndrome Following Cognitive Behavioral Therapy: A Prospective Cohort Study in Secondary Care.2022 · no comparison group · 726 in the study · 470 started · 470 with outcome data
    Summary

    This prospective cohort study examined whether generalized worry in chronic fatigue syndrome (CFS) changed after cognitive behavioral therapy (CBT) and how worry was associated with fatigue, anxiety and work and social adjustment. The cohort included 470 patients diagnosed with CFS who received CBT at a secondary care specialist clinic; patients were usually offered between 12 to 16 individual 1-hour sessions plus four follow-up appointments. There was no control group. Measures included the Penn State Worry Questionnaire, Chalder Fatigue Questionnaire, work and social adjustment scale, and Hospital Anxiety and Depression Scale at baseline, discharge, 3-month and 6-month follow-up. At discharge, generalized worry reduced by 3.42 points (95% CI 2.26, 4.57; p < .001) and remained stable at 6-month follow-up. HADS anxiety reduced by 1.61 and depression by 1.68 at discharge. Severe baseline worriers had higher overall fatigue across time-points than mild worriers (p = .026). Severe worriers had worse work and social adjustment than moderate and mild worriers, but the severe versus mild difference was no longer significant after controlling for CFS duration (p = .124). Avoidance/resting behavior mediated the association between baseline worry and work and social adjustment (b = .04, 95% bootstrap CI .012, .081). 2 patients stopped CBT due to self-reported worsening CFS symptoms. The authors state there was no control group and no randomization.

  93. Performance Validity and Outcome of Cognitive Behavior Therapy in Patients with Chronic Fatigue Syndrome.2022 · no comparison group · 1,081 in the study
    Summary

    This was an observational study using archival treatment data from 1081 outpatients with Chronic Fatigue Syndrome who started individual and group face-to-face CBT for CFS, about 12 to 14 sessions during a 6-month period, at a tertiary treatment facility in a university hospital. There was no comparison group. Baseline assessment included the Amsterdam Short-Term Memory test (ASTM); questionnaires measured fatigue severity (CIS fatigue), physical functioning (SF36), functional impairment (SIP total), and psychological distress (SCL-90 total) before and after CBT. The main hypothesis was not confirmed: the total ASTM score was not significantly associated with outcomes at follow-up. Low ASTM performance was related to missing follow-up and fewer completed therapy sessions. Loss to follow-up was 20.53%. Subjects who did not complete follow-up finished fewer therapy sessions than completers (mean scores 8.67 and 14.42; t[1079] = 16.40, p < .01). Baseline and follow-up scores were CIS fatigue 50.51 and 29.83; SF36 physical functioning 57.25 and 80.34; SIP total 1572.31 and 658.07; SCL-90 total 164.56 and 130.71. Harms were not reported. The authors state the study is observational and cannot support causal inferences, and that ASTM findings may not generalize to other PVTs.

  94. Why Should ACT Work When CBT Has Failed? a Study Assessing Acceptability and Feasibility of Acceptance and Commitment Therapy (ACT) for Paediatric Patients With Chronic Fatigue Syndrome/myalgic Encephalomyelitis (CFS/ME)2022 · no comparison group · 19 in the study
    Summary

    This feasibility cohort study asked whether Acceptance and Commitment Therapy (ACT) was feasible and acceptable for paediatric CFS/ME in participants who were still symptomatic after 12 months or 12 sessions of standard treatment. Participants were aged 11–18 years and attended the Royal United Hospitals Bath NHS Foundation Trust Specialist Paediatric CFS/ME Service. All participants were offered six to 12 sessions of ACT; there was no comparison group. Nineteen participants (95% of those approached) were recruited. Retention and recruitment data were analysed, and participants completed questionnaires before, during and after treatment; a selection of participants and their parents were interviewed. Four participants of this hard-to-reach group did not complete treatment. In almost all sessions, participants reported that they felt ‘totally’ listened to in post-session questionnaires (31/33 sessions). Preliminary interviews (n = 12) indicate acceptability of ACT, with all young people and their parents stating that they thought ACT should be offered to this population. Participants particularly commented that the absence of thought challenging was a positive element of ACT; openness to try new approaches and altruistic desire to be in a study was noted. Side effects were not reported. The text did not state limitations.

  95. Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK.2020 · no comparison group · 995 in the study
    Summary

    Data were analysed retrospectively for 995 patients with chronic fatigue syndrome, also known as myalgic encephalomyelitis, referred by a general practitioner or hospital consultant to a specialist outpatient clinic in the UK. All received individual cognitive behavioural therapy, usually up to 20 sessions including follow-up appointments, fortnightly for 8 to 10 months, with a mean of 12 sessions (standard deviation 4.9; range 1–30). There was no control group. Patients completed the Chalder Fatigue Questionnaire, 36-item Short Form Health Survey, Work and Social Adjustment Scale, Hospital Anxiety and Depression Scale, and global improvement and satisfaction ratings, with a three-month follow-up. Fatigue, physical functioning and social adjustment improved over treatment, with effect sizes of |d| = 0.91, |d| = 0.45 and |d| = 0.61, respectively. Improvements were sustained at follow-up, with no significant difference from discharge to follow-up on the 36-item Short Form Health Survey (mean difference = 1, p = 0.82) or Work and Social Adjustment Scale (mean difference = 0.37, p = 1). At discharge, 87% reported at least a little improvement and 2.5% felt worse; at follow-up, 84% reported at least some improvement and 5% felt worse. A two-point or greater improvement in fatigue was reported by 72%, 16% reported at least a two-point increase, and 12% reported little or no change. Drop-out was 31%. Side effects were not reported.

  96. The role of partners' fatigue and the patient-partner relationship in the outcome of cognitive behavioural therapy for chronic fatigue syndrome.2020 · no comparison group · 1,356 in the study · 800 with outcome data
    Summary

    This study examined partner-related factors in adults with chronic fatigue syndrome (CFS) treated with cognitive behavioural therapy (CBT) at a tertiary CFS center. Data from 1356 CFS patients and their partners were used; 800 patients completed CBT and completed post-treatment outcome measures. CBT for CFS usually consisted of two intake sessions and 10–12 treatment sessions over six to eight months and included a graded activity program. No comparison group is reported. Fatigue severity was measured with the Checklist Individual Strength and functional impairment with the Sickness Impact Profile-8. Mean fatigue severity was 50.5 (SD 5.10) at baseline and 29.9 (SD 14.0) after treatment. Mean functional impairment was 1601.0 (SD 570.6) at baseline and 685.68 (SD 675.62) after treatment. Of the 800 patients who completed CBT, 506 (63.2%) showed a clinically significant improvement in fatigue severity; of the 798 patients who completed the SIP questionnaire after treatment, 473 (59.3%) showed a clinically significant improvement in functional impairment. Of the 1356 patients with partner who filled in questionnaires at pre-treatment, 389 (28.7%) did not start treatment and 134 (10.0%) dropped out of treatment. Side effects were not reported. The authors state that with large numbers of participants, small correlations reached statistical significance, and that many correlations were tested so a correction could be argued for.

  97. Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety.2020 · no comparison group · 10 in the study · 8 with outcome data
    Summary

    This case-series with a phased AB design examined CBT-HA for adults with CFS/ME and co-morbid health anxiety at a specialist CFS/ME service, with consecutive referrals. Ten participants were enrolled and started; eight treatment completers were analysed because end-of-therapy measures were missing for two. Treatment was CBT-HA delivered as twelve individual face-to-face 60 minute sessions, with no comparison group reported. Measures included the Chalder Fatigue Questionnaire, Short Health Anxiety Inventory (SHAI), Hospital Anxiety and Depression Scale-Anxiety and -Depression, EQ-5D and Short Form-36. Eight participants completed the full course. All completers showed reliable change (RC) and clinically significant change (CSC) on at least one primary outcome. On the Chalder, six of eight achieved RC and seven of eight CSC; scores changed from 26.70 to 14.90 (change 11.80; Cohen's d 1.47). All eight completers achieved RC and CSC on the SHAI and moved to non-case status; SHAI changed from 26.40 to 14.30 (change 12.10; d 1.28). HADS-A changed from 13.10 to 7.6 (change 5.5; d 1.06), HADS-D from 10.20 to 6.6 (change 3.60; d 0.75), EQ-5D from 8.88 to 7.38 (change 1.5; d 0.93), and SF-36 from 46.88 to 74.38 (change 27.50; d 1.15). Two participants did not complete treatment (withdrawal at session 5 and 6); neither showed point change on the Chalder, SHAI remained the same or reduced by 2 points, and no follow-up SF-36 or EQ-5D data were returned. The paper reports the intervention was unproblematic and protocol driven; no harms were reported. Authors state a RCT with formal diagnostic procedures and control comparisons is needed.

  98. Internet-Based Cognitive Behavioral Therapy for Chronic Fatigue Syndrome Integrated in Routine Clinical Care: Implementation Study.2019 · no comparison group · 100 in the study · 99 started
    Summary

    This observational pre-post study examined stepped care for chronic fatigue syndrome (CFS) in routine care in five mental health care centers in the Netherlands. Of 100 eligible patients, 79 started internet-based cognitive behavioral therapy (I-CBT) as intended, 20 started directly with face-to-face CBT, and one did not start; data of all 100 were analyzed. I-CBT comprised 7 modules over 6 months; patients still severely fatigued or disabled after 6 months were offered additional face-to-face CBT for an expected maximum of 6 months. Outcomes were compared with a benchmark from a randomized controlled noninferiority trial. Fatigue severity (CIS) changed by 12.6 (95% CI 9.7-15.5) at posttreatment; physical functioning (SF-36) by −13.4 (−18.1 to −8.7); social functioning by −20.4 (−27.9 to −12.9); and WSAS limitations by 10.3 (7.8-12.7). After I-CBT only, fatigue changed by 13.2 (95% CI 9.8-16.5). 37/100 had clinically significant improvement. The difference in clinically significant improvement versus the benchmark was not significant (P=.15). 24/79 were assumed dropped out during I-CBT, and one did not start; side effects were not reported. Patients of therapists with high versus low median fatigue change had changes of 15.7 versus 9.0 (P=.02). Therapist attitude correlations were not significant (P=.51).

  99. Investigation into cognitive behavioural therapy for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis2019 · no comparison group · 13 in the study
    Summary

    This grounded theory study interviewed 13 service users with CFS/ME who had engaged in CBT aimed at improved management of their condition. The abstract does not report where participants were recruited from, how long CBT lasted, or whether any comparison group was used; the design had no comparison group and was not randomised. Semi-structured interviews were analysed using grounded theory to build a theory of participants’ experiences. The theory suggested that CBT led to participants feeling more able to cope with CFS/ME, through a shift in perspective arising from the therapy room and taking a more adaptive approach to daily life. The theory also suggested that participants experienced increased acceptance of the condition, which facilitated further adaptive changes. Harms, withdrawals and worsening were not reported in the abstract. The authors state that findings extend existing literature in suggesting that CBT aimed to improve management of CFS/ME may result in improved coping and reduced distress, independently of changes in fatigue. They do not report specific limitations in the abstract; they state that the specific nature of changes and factors facilitating them is not well understood and that clinical and research implications are discussed.

  100. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome.2019 · no comparison group · 583 in the study · 511 with outcome data
    Summary

    Why: to determine which variables predicted long-term outcome after cognitive behavioral therapy (CBT) for chronic fatigue syndrome (CFS). Who: a cohort of 511 CFS patients from four different CBT for CFS studies, i.e. two cohort studies and two RCT's, at the same tertiary CFS treatment center of a university hospital in The Netherlands; of the 583 patients, 511 (88%) filled in the follow-up assessment, and 411/511 (80%) had complete data. What was given: CBT aimed at changing fatigue perpetuating beliefs and behavior, and all patients follow a graded activity program. Follow-up was up to 10years after end of treatment. Measured: fatigue severity (CIS), physical functioning (SF-36) and fatigue scores within normal limits. Found: fatigue severity was 49.62 (5.53) at baseline, 29.73 (13.82) post-treatment and 37.60 (12.76) at follow-up; physical functioning was 55.87 (20.02), 79.53 (20.63) and 73.16 (23.56); fatigue scores within normal ranges were 0 (0%) at baseline, 311 (61%) post-treatment and 188 (37%) at follow-up. Lower fatigue severity at long-term follow-up was predicted by a shorter duration of CFS symptoms and lower fatigue levels at baseline, and lower frustration in response to fatigue and lower fatigue levels directly post-treatment. Better physical functioning at follow-up was predicted by higher sense of control over fatigue, better physical functioning at post-treatment, and being younger at baseline. Harms were not reported, and no withdrawals for harms were recorded. Limits: the study was retrospective, outcome was assessed once, and a large proportion of variance remained unexplained.

  101. Acceptance & Commitment Therapy for ME/CFS (Chronic Fatigue Syndrome) – A feasibility study2019 · no comparison group · 40 in the study
    Summary

    This feasibility study asked whether an Acceptance and Commitment Therapy (ACT)-based behaviour medicine protocol could be delivered to adults with ME/CFS. 40 adult patients, recruited consecutively at a tertiary specialist clinic from 2013 to 2016, started individual treatment: 13 sessions of 45 minutes, delivered weekly to bi-weekly. There was no comparison group. ME/CFS-related disability and psychological flexibility were primary outcomes; ME/CFS symptoms, fatigue, anxiety, depression and health-related quality of life were secondary, collected pre-treatment, mid-treatment, post-treatment and at 3- and 6-month follow-ups. Thirty-two of 40 completed treatment (80%); completers received a mean of 12.38 sessions. Disability decreased by 7.18 from pre- to post-treatment (p<.001, d=0.80) and psychological inflexibility by 10.68 (p<.001, d=1.07); both were reported stable to follow-up. Anxiety decreased by 2.31 (p=.001), SF-36 physical score increased by 4.28 (p=.009), and mental fatigue increased by 1.35 (p=.004). Two participants discontinued because illness severity made travelling and sessions too symptom-exacerbating. Travelling to and from sessions accounted for 80% of reported negative effects; none reported longstanding negative effects or longstanding adverse events. The authors state that efficacy conclusions are tentative without a control condition and that results are not generalizable to the whole ME/CFS population.

  102. A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up.2018 · no comparison group · 305 in the study
    Summary

    This open uncontrolled study asked whether a 4-day group program for chronic fatigue syndrome/myalgic encephalopathy (CFS/ME), diagnosed by Oxford criteria, was followed by changes over 1 year and how satisfied patients were. Three hundred five patients (84% women) recruited from a clinical population referred to a specialist outpatient clinic in Western Norway took part. The program combined education, cognitive group therapy sessions, mindfulness sessions, writing, and daily walking sessions over four days. There was no comparison group. Self-report measures were the Chalder Fatigue Scale, the SF-36 Physical functioning scale, the Beck Depression Inventory, the Beck Anxiety Inventory, and the Client Satisfaction Questionnaire-8. From baseline to 1-year follow-up, mean Fatigue Scale score changed from 24.8 to 16.0, and mean SF-36 Physical functioning from 60.9 to 77.4; the paper reports statistically significant improvements on these measures and on BDI and BAI (all p-values <0.001). At 1 year, 56% still had a bimodal Fatigue Scale score of 4/11 or more. None of the 305 patients dropped out of the 4-day program, and harms were not reported. Satisfaction ratings 1 week after treatment ranged from 3.2 to 3.8 on a 1–4 scale. The authors state that the open design, lack of a control group, and self-report outcomes limit conclusions about the program's effect.

  103. 'It feels sometimes like my house has burnt down, but I can see the sky': A qualitative study exploring patients' views of cognitive behavioural therapy for chronic fatigue syndrome.2017 · no comparison group · 14 in the study · 13 started · 13 with outcome data
    Summary

    This qualitative study explored views of cognitive behavioural therapy (CBT) among patients with chronic fatigue syndrome (CFS) at a specialist outpatient unit. 14 patients consented and 13 were interviewed (41%). All participants received face-to-face CBT guided by a standardized manual; sessions were typically fortnightly, with up to 15 sessions, and follow-up face-to-face sessions were offered at 3 months, 6 months and 12 months after treatment. There was no comparison group. Participants rated satisfaction with CBT outcome and wellbeing post CBT, and interviews were analysed with inductive thematic analysis. Table 2 shows ratings such as 'Very Satisfied' and 'Very Much Better'; one participant rated 'Slightly Dissatisfied' and 'Very Much Worse' and described feeling worse, but said 'not because of CBT'. The authors report that the majority were satisfied and reported marked improvements, yet recovery was generally incomplete. Withdrawals for harms were not reported. The authors state limitations including including only patients approaching the end of CBT or who had completed CBT, and a response rate of 41%.

  104. Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome.2017 · no comparison group · 583 in the study · 511 with outcome data
  105. Neurocognitive improvements after best-practice intervention for chronic fatigue syndrome: Preliminary evidence of divergence between objective indices and subjective perceptions.2016 · no comparison group · 28 in the study · 25 with outcome data
    Summary

    This study examined whether a 12-week outpatient CBT/GET program with graded cognitive activity changed neurocognitive performance in chronic fatigue syndrome. 28 patients were recruited from a tertiary referral clinic in Sydney, Australia; 25 completed the study and were analysed, and 3 were lost to follow-up, including 1 who withdrew from the intervention. Participants received six to eight individual one-hour sessions and were assessed at intake and within two weeks of completion (average time between assessments = 11±1.96 weeks), with no comparison group. Measures included self-reported symptoms and cognitive difficulties, computerised neurocognitive tasks, and cardiac autonomic activity. After the program, participants showed improvements in somatic symptoms, cognitive difficulties, total symptoms, psychological distress, sleep quality, perceived stress, and SF-36 physical and mental composite scores. Task accuracy and response-speed composites improved, as did fatigue ratings after tasks and autonomic reactivity; time to return to resting heart rate was faster. Objective cognitive improvement was not associated with subjective improvement, and improvement did not differ by antidepressant medication use. No side-effect data were reported.

  106. The role of the partner and relationship satisfaction on treatment outcome in patients with chronic fatigue syndrome.2015 · no comparison group · 243 in the study · 204 with outcome data
    Summary

    This cohort study asked whether partners’ solicitous responses and relationship satisfaction affect CBT outcome in chronic fatigue syndrome (CFS). It included 243 consecutively referred patients at the Expert Centre for Chronic Fatigue, Radboud University Nijmegen Centre, between December 2009 and February 2012; 204 completed both pre- and post-treatment assessment. Patients received CBT for CFS, 12–14 sessions over 6–8 months, including a graded physical activity programme. There was no comparison group. Fatigue severity (CIS Fatigue) and functional impairments (SIP-8) were measured post-treatment, about 6 months after the first treatment session, with partner questionnaires at baseline. Of 204 completers, 104 (51%) showed clinically significant improvement in fatigue and 136 (66.7%) in functional impairments. Fatigue severity changed from a mean of 50.76 to 28.21 (change 22.55); SIP-8 changed from 1627.26 to 631.75 (change 995.51); within-group effect sizes were 2.08 and 1.63. Partners’ solicitous responses were associated with less improvement in fatigue (B −0.10, p < 0.05) and functional impairments (B −0.15, p < 0.01). Patients’ relationship dissatisfaction was weakly related to less fatigue improvement (B −0.34, p < 0.10) and was not related to functional impairment. Side effects were not reported; 39 (16%) did not complete the second assessment and 15 (6%) dropped out during treatment, reasons not reported.

  107. Feasibility of delivering CBT-I in chronic fatigue syndrome (CFS)2015 · no comparison group · 15 in the study
    Summary

    This initial feasibility study asked whether CBT-I could be delivered in CFS. Fifteen individuals meeting CDC criteria for CFS received face-to-face CBT-I in a specialist CFS treatment clinic. Treatment comprised six individual weekly sessions including sleep education, sleep efficiency training, individualised sleep scheduling and weekly sleep diaries. All participants received CBT-I; there was no comparison group and the study was not randomised. Patients completed self-report questionnaires pre- and post-treatment (fatigue, pain, mood, sleep preoccupation, insomnia severity, dysfunctional beliefs about sleep), plus a weekly sleep diary and Epworth Sleepiness Scale. Acceptability was assessed through reflective note-taking by the researcher. The study reported that treatment was not acceptable for all patients and not feasible for all patients; attendance to weekly sessions was affected by disabling CFS symptoms. Barriers to adherence included increased symptom focus and perpetuation of symptoms in some patients. For CFS patients with insomnia-related sleep symptoms, the authors reported beneficial effects on self-reported sleep parameters (sleep onset latency, awakenings during the night, sleep efficiency) and improved scores on insomnia, dysfunctional beliefs about sleep and sleep preoccupation following treatment. Counts for these barriers and withdrawals for harms were not reported.

  108. The Process of Change in Pain During Cognitive-Behavior Therapy for Chronic Fatigue Syndrome.2015 · no comparison group · 142 in the study
    Summary

    This single-group study investigated the process of change in pain during cognitive-behavior therapy (CBT) for chronic fatigue syndrome (CFS). One hundred forty-two patients meeting CDC criteria for CFS, reporting pain, and starting CBT were included. CBT aimed at a gradual increase of activity and challenging fatigue-related dysfunctional beliefs; a graded activity program was part of treatment. Measurements were planned pretherapy, at 6, 12, and 18 weeks after starting therapy, and posttherapy; treatment duration was not reported. There was no control group. Pain intensity was measured with a self-observation list, limitations caused by pain with the SF-36 pain subscale, and process variables included physical functioning, focusing on symptoms, self-efficacy, perceived activity, and actual physical activity measured with an actometer. Pain intensity decreased significantly during therapy (M difference _1.95; 95% CI _2.48 to _1.43; P=0.001), and limitations caused by pain decreased significantly (M difference _17.46; 95% CI _21.66 to _13.27; P=0.001). The direction of change between pain and fatigue could not be determined. The abstract states that increased physical functioning and decreased focusing on symptoms explained 4% to 14% of the change in pain; the results text states these process variables explained 14% of the change in fatigue in the first period, 4% in the second, and 7% in the third. Actual changes in physical activity, self-efficacy, and perceived activity did not contribute significantly to lower levels of pain. Response groups were 33 fast, 30 midterm, 35 slow, and 40 nonresponders. The paper did not report side effects, worsening, or withdrawals for harms.

  109. Cortisol output in adolescents with chronic fatigue syndrome: pilot study on the comparison with healthy adolescents and change after cognitive behavioural guided self-help treatment.2014 · no comparison group · 49 in the study · 46 with outcome data
    Summary

    This non-randomised cohort study enrolled 49 adolescents with CFS from a specialist CFS Unit in London and 36 healthy adolescents recruited via local schools. Participants with CFS received telephone-based guided self-help: a self-help manual and up to 6 fortnightly telephone sessions of 30 minutes. Salivary cortisol was measured before treatment and six months after the end of treatment; 46 CFS and 33 healthy controls contributed to the AUCday analysis, and 24 CFS participants returned post-treatment questionnaires and cortisol samples. For treatment outcomes, school attendance rose from 24% to 49% (Z(24)=-2.5, p=0.012). Chalder Fatigue Scale changed from mean=24 (SD=5) to mean=21 (SD=21), not significant (t(23)=1.5, p=0.14). Spence Children’s Anxiety Scale changed from mean=22 (SD=17) to mean=17 (SD14) (t(21)=2.1, p=0.005). Birleson Depression Scale changed from mean=11 (SD=6) to mean=8 (SD=5) (t(23)=2.1, p=0.044). SDQ scales showed no significant changes (Zs<2.0). The text reports that 21 adolescents with CFS showed a significant increase in daily cortisol output after treatment. Side effects were not reported; three participants did not complete treatment.

  110. Mechanisms of change underlying the efficacy of cognitive behaviour therapy for chronic fatigue syndrome in a specialist clinic: a mediation analysis.2014 · no comparison group · 389 in the study
    Summary

    This paper reports a non-randomised cohort of 389 people with chronic fatigue syndrome (CFS) referred to a specialist UK clinic between 2002 and 2006. Participants received cognitive behavioural psychotherapy (CBT); the paper states it was not compared with any other treatment. Treatment lasted to discharge about 8 months after starting, with follow-up at 3, 6 and 12 months after discharge. Measures included the Chalder Fatigue Questionnaire, Work and Social Adjustment Scale (WASA), and Cognitive Behavioural Responses to Symptoms Questionnaire. The paper reports significant decreases in mean fatigue and WASA scores from baseline to discharge; at 6 months effect sizes were fatigue d=-0.57 and WASA d=-0.58. It also reports a small increase in WASA from discharge to the 3-month follow-up (p<0.05). Path analyses were consistent with fear avoidance beliefs at 3 months partially mediating the relationship between avoidance behaviour at discharge and fatigue and social adjustment at 6 months. Attendance fell to 266 (68.4%) at post-treatment, 195 (50.1%) at 6 months and 183 (47%) at 12 months; 36 individuals (9.3%) attended no post-treatment or follow-up sessions. Harms were not reported. Authors state the study was not an RCT and had no comparison treatment.

  111. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.2014 · no comparison group · 76 in the study
    Summary

    Seventy-six ME/CFS patients admitted to the Maes Outpatient Clinics, Belgium, were selected for increased (> 2 SD) IgM responses to 3 OSEs or 3 NO-adducts. In this non-interventional study, all patients took a combination of NAIOS—L-carnitine, coenzyme Q10, taurine + lipoic acid, with or without curcumine + quercitine or N-acetyl-cysteine, zinc + glutamine—continued for 14.3 (±4.2) months. There was no separate comparison group; patients also received other care-as-usual treatments. The study measured FF scores and IgM responses to oleic acid, MDA, Pi, NOW, NO-arginine and NO-cysteinyl. Treatment was followed by significant reductions in IgM responses to oleic acid (F=9.03, p=0.004), MDA (F=13.12, p=0.001), Pi (F=20.28, p<0.001), NO-Cysteinyl (F=10.03, p=0.003), NO-Arginine (F=6.99, p=0.011) and NOW (F=6.19, p=0.016). In patients with endpoint FF<12, oleic acid and Pi responses fell more than in those with endpoint FF≥12. Antidepressant use had no significant effect (F=0.17, p=0.843). Harms were not reported. The authors state the non-interventional design could not standardize NAIOS and that supplement quality, content and bioavailability may have biased results.

  112. Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice.2014 · no comparison group · 200 in the study · 140 with outcome data
    Summary

    This non-randomized cohort included 200 CFS patients treated with CBT at a secondary care CFS unit in routine clinical practice; 140 participants had 6 month follow-up data (response rate 72.2%), and drop-out was 27.8%. Between 6 and 20 sessions were attended, with a mean of 15.3 sessions (SD 3.7). There was no comparison group. Recovery was assessed with Oxford and CDC criteria, the Chalder fatigue questionnaire (CFQ), the SF-36 physical functioning subscale and the Global improvement scale. At 6 month follow-up, 53.1% met Oxford criteria versus 72.7% pre-treatment; 37.5% met CDC criteria versus 52.6%; 62.7% met either Oxford or CDC criteria versus 83.2%; 51.4% scored 18 or higher on the CFQ versus 83.9%; 49.3% scored below 65 on the SF-36 versus 71.1%; 67.9% scored below 83 on the SF-36 versus 87.7%. Feeling much better or very much better was reported by 60.8%, and total recovery by 18.3%. The abstract reports 37.5% no longer met either Oxford or CDC criteria, while results text reports 37.3%. Worse work and social adjustment, unhelpful beliefs about emotions, high depression and older age were associated with reduced odds for recovery. Authors state limitations include non-randomized design, low statistical power, and drop-out as a potential bias.

  113. Implementing evidence-based practice for patients with chronic fatigue syndrome.2014 · no comparison group
    Summary

    This naturalistic study examined whether three Dutch community mental health centres (MHCs) could implement and sustain cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) using an implementation manual. Patients were referred by a general practitioner or consultant with a CFS diagnosis. The centres included 75, 40 and 48 patients; 67, 39 and 47 started treatment. The Eastern MHC sustained CBT for CFS, while the Western and Southern MHCs newly implemented it. At the Southern MHC, face-to-face CBT was delivered in a stepped care programme; 24 of 48 patients had received a low-intensity intervention before face-to-face CBT. Treatment followed a CBT manual and was assessed before and after the treatment period; treatment duration was not reported. There was no comparison group. Fatigue severity was measured with the Checklist Individual Strength and physical functioning with the Short Form Health Survey. Across the three MHCs, effect sizes ranged from 0.88 to 1.76 for fatigue severity and from 0.43 to 1.23 for physical functioning. Intention-to-treat clinically significant improvement was 26 (39%) at the Eastern, 26 (67%) at the Western and 9 (24%) at the Southern MHC. The Eastern and Western MHCs had effect sizes within the statistical benchmark; the Southern MHC had significantly lower effect sizes than the benchmark. Dropout from intention-to-treat to second assessment was reported as 23/66 (35%), 6/39 (15%) and 6/38 (16%). Harms were not reported. The authors state the naturalistic design lacked proper control conditions and that no follow-up data were available.

  114. The role of the therapeutic relationship in cognitive behaviour therapy for chronic fatigue syndrome.2013 · no comparison group · 232 in the study · 297 started · 217 with outcome data
    Summary

    This study examined the role of the therapy relationship in cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) and whether its effect is independent of changes in fatigue-perpetuating factors. In a cohort, 297 patients started CBT, 232 gave informed consent, and 217 completed the post-treatment measurement at a tertiary CFS specialist care centre. Ten patients dropped out before informed consent and fifty-five refused to participate. Treatment was CBT for CFS, approximately 12 sessions during 6 months, and included gradually increasing physical activity. There was no control group. Fatigue was measured with the Checklist Individual Strength fatigue severity subscale (range 8–56); therapy relationship and fatigue-perpetuating factors were measured at the start of therapy, three times during CBT and at the end. Baseline outcome expectations and agreement about the content of therapy predicted post therapy fatigue. Patient-rated therapy relationship added 25% of explained variance in post-treatment fatigue (F = 19.1, p = 0.001); therapist-rated variables added 3.5% and did not improve the model significantly (F = 2.8, p = 0.09). In 183 patients with at least two interim measurements, changes in patient-rated therapy relationship added 6% (p = 0.004) and 10% (p = 0.001); therapist ratings added 3% (p = 0.39) and 2% (p = 0.35). Goal agreement was not related to therapy outcome. Side effects and withdrawals for harms were not reported. The authors state limits include no control group, outcome expectations assessed after the first session, possible selection bias, and questionnaires not previously validated.

  115. Cognitive behavior therapy in patients with chronic fatigue syndrome: the role of illness acceptance and neuroticism.2013 · no comparison group · 80 in the study
    Summary

    This pre-post study without a no-treatment control group asked whether group CBT improves mental and physical quality of life, fatigue, and acceptance in chronic fatigue syndrome, and whether baseline acceptance and neuroticism predict change. Eighty patients (73 women and 7 men) from the general internal medicine outpatient clinic of Ghent University Hospital, invited in 2009-2011, received cognitive behaviour group therapy: twelve 2-hour sessions every 2 weeks for 6 months. Post-treatment data were collected at the end of treatment; there was a mean of 12.4 months between pre and post measurement. Patients self-reported MQoL and PQoL (SF-36), fatigue severity (CIS), acceptance (ICQ), and neuroticism (NEO-FFI; pre-treatment only). Acceptance improved from 11.73 to 13.91, fatigue from 6.43 to 6, MQoL from 50.98 to 57.20, and PQoL from 30.03 to 34.23. Effect sizes were small for MQoL (0.37) and PQoL (0.34), moderate for acceptance (0.61) and fatigue (-0.56). Clinically, 16 patients improved in MQoL and none recovered, 4 deteriorated; 21 improved in PQoL, 6 recovered, 7 deteriorated; 32 improved in fatigue, 13 recovered, 8 became worse; 19 improved in acceptance, 4 recovered, 2 deteriorated. Acceptancepre correlated negatively with MQoLchange (r=-0.32) and acceptancechange (r=-0.40), not PQoLchange (r=-0.03) or fatiguechange (r=0.10). Neuroticismpre correlated positively with MQoLchange (r=.27). Acceptance added 5% variance beyond neuroticism's 7%; the final model explained 10%. Dropout data were excluded; dropout count and side effects were not reported.

  116. The process of cognitive behaviour therapy for chronic fatigue syndrome: which changes in perpetuating cognitions and behaviour are related to a reduction in fatigue?2013 · no comparison group · 232 in the study · 183 with outcome data
    Summary

    This exploratory study asked whether changes in cognitions and behaviour during cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) are related to reductions in fatigue. Consecutively referred patients who started CBT at a tertiary CFS specialist care centre between April 2008 and September 2010 were eligible. Of 232 patients who gave written informed consent, data from 183 were included in the analyses. CBT was given as approximately 12 one-hour sessions during 6 months. There was no control group. Fatigue and possible process variables were measured before treatment, after 6, 12 and 18 weeks, and after treatment. The uncontrolled Cohen's d for change in fatigue severity during CBT was 2.11. Response groups were: 42 fast responders, 44 mid-term responders, 17 slow responders, 24 very slow responders and 52 non-responders. Increases in sense of control over fatigue, perceived activity and self-reported physical functioning, and decreases in focusing on symptoms, explained 20 to 46% of the variance in fatigue; changes in objective activity did not predict levels of fatigue. At the end of therapy, patients most often rated changing sleep–wake rhythm (72%), increasing physical activity (65%), spreading activities more evenly (60%) and helping thoughts (57%) as helpful. Fourteen patients stopped therapy before 12 weeks, 14 stopped because they no longer experienced severe fatigue, and 12 no longer wanted to participate. Side effects were not reported.

  117. Functional improvement is accompanied by reduced pain in adolescent chronic fatigue syndrome.2013 · no comparison group · 83 in the study · 72 with outcome data
    Summary

    Why: to examine pain symptoms in adolescent chronic fatigue syndrome and their relation to treatment focused on fatigue. Who: 83 adolescents (12–18 years) with CFS attending their initial assessment at the University Medical Center Utrecht for the original FITNET trial; for 72 out of 83 (86.7%) participants, algometry and DOP data were complete at 12-month follow-up, and 39 were in the recovered group. What was given: all participants were treated with CBT, either internet-based or face-to-face, with 6 months of treatment and measurements at diagnosis and at 12-month follow-up. Compared with what: this was not a controlled study; groups were defined by whether adolescents had recovered from CFS at 12-month follow-up (recovered vs non-recovered). What was measured: pain threshold with an analog algometer (range 0–11) and self-reported daily observed pain (DOP, score range 0–16). What was found: in the recovered group, average pain threshold was 7.6 (2.3) at follow-up versus 5.8 (1.9) at baseline, and average DOP was 2.0 (2.4) versus 5.0 (3.0), both P value < 0.001. At follow-up the recovered group had a higher average pain threshold than the non-recovered group, mean difference 1.3 (0.2 to 2.4), p=0.019, and lower DOP, mean difference -3.8 (-5.2 to 2.3), <0.001. Harms were not reported. Limits the authors state: because this is not a controlled study, only an association can be concluded.

  118. Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study.2012 · no comparison group · 63 in the study
    Summary

    This non-randomised cohort study enrolled 63 adolescents aged 11 to 18 years with chronic fatigue syndrome (CFS), referred to the King’s College Chronic Fatigue Unit in London. Participants received a telephone-based guided self-help intervention based on cognitive-behavioural principles: six half-hour fortnightly telephone sessions and two follow-up sessions over a period of 3 months. The design included a two-month baseline period and no comparison group. Fatigue and school attendance were primary outcomes; the main time point was 6 months post-treatment, with end of treatment and 3-month follow-up also assessed. Secondary outcomes were impairment, depression, adjustment and anxiety. Global improvement and satisfaction were also examined. Between pre-treatment and 6-month follow-up, fatigue decreased (treatment effect estimate /C05.68, 95% CI /C07.63 to /C03.72; p < 0.001; Cohen’s d 0.79), and the decrease during treatment was larger than during baseline (Wald p = 0.020). School attendance increased (1.38, 95% CI 0.76 to 2.00; p < 0.001; d 0.48), but the treatment-phase increase was not significantly different from baseline (Wald p = 0.589). Impairment, depression, adjustment and anxiety scores were lower at 6 months than pre-treatment; Wald tests for impairment, depression and adjustment did not show significant differences between phases. At end of treatment, 71.4% of adolescents and 79.6% of parents reported some improvement; 66% of adolescents and 70.4% of parents were very or moderately satisfied. Harms and withdrawals for harms were not reported. The authors state limits including lack of a control group, self-report measures and missing data.

  119. Does the heterogeneity of chronic fatigue syndrome moderate the response to cognitive behaviour therapy? An exploratory study.2011 · no comparison group · 236 in the study
    Summary

    This exploratory study asked whether subgroups of chronic fatigue syndrome (CFS) moderate the response to cognitive behaviour therapy (CBT). It included 236 patients with CFS diagnosed using the Oxford criteria, treated with CBT in a specialist CFS clinic in the UK; all were referred from primary care. CBT was delivered individually in 10 to 15 sessions. There was no comparison group. Fatigue was measured with the Chalder Fatigue Scale before and after treatment, and subgroups were defined by latent class analysis (LCA) and latent class regression (LCR). Across all classes, CBT produced a median fatigue improvement of 5 (interquartile range 0–11). LCA found 5 latent classes, which did not differ in the direction of their response to CBT, with all classes showing improvement; the Kruskal-Wallis test did not detect a significant difference in fatigue change between the 5 classes (p = 0.16). LCR identified 4 latent classes, 1 of which predicted a poor response to CBT (median –1, IQR –5 to +3), whereas the other 3 predicted a good outcome (median +7, +4 and +7), accounting for more than 70% of the patients. No harms were reported. The authors state that all measures were self-rated, only one measure of effectiveness was used, alternative diagnostic criteria may have provided different findings, and patients were treated in secondary care, so results cannot be generalised to primary care.

  120. Therapist effects in routine psychotherapy practice: an account from chronic fatigue syndrome.2011 · no comparison group · 374 in the study
    Summary

    This study examined therapist effects in routine cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) in a specialist UK outpatient clinic. Three hundred and seventy-four patients with CFS and 12 cognitive behavioural psychotherapists took part. Patients were referred from primary care and met the Oxford criteria for CFS. Treatment was manualized CBT delivered individually in 10 to 15 sessions; all patients received CBT, with no comparison group. Outcomes were the Chalder Fatigue Scale (score range 0 to 33) and Work and Social Adjustment Scale (score range 0 to 40), assessed pre-therapy, post-therapy, and at 6 months and 1 year after therapy completion. The paper reports a significant non-linear reduction in fatigue scores across time and a non-linear reduction of disability scores across time. Variance explained by therapists, when demographic covariates were accounted for, was 0% for fatigue and under 2% for disability. The results also stated there were no significant differences in any of the patient outcomes between the therapists. Harms and withdrawals for harms were not reported. The authors state that the relatively small number of therapists limits the accuracy of their estimates of therapist variability.

  121. The role of acceptance in chronic fatigue syndrome.2011 · no comparison group · 283 in the study · 150 started · 90 with outcome data
    Summary

    This study examined acceptance in chronic fatigue syndrome (CFS) among patients referred to a specialist CFS Research and Treatment Unit in London. A total of 283 patients were assessed, and the treatment report concerns 150 patients who completed baseline measures and started CBT. CBT was delivered by trained therapists, typically one session per fortnight, with each patient receiving approximately 12 sessions. There was no comparison group. Questionnaires measured fatigue, physical functioning, work and social adjustment, lack of acceptance, perfectionism and depression. Of the original 150 patients, 109 patients (72.67%) completed questionnaires at discharge from CBT and 90 patients (60%) completed their 3-month follow-up questionnaires. At discharge and 3-month follow-up, scores for fatigue, physical functioning, work and social adjustment and lack of acceptance were significantly improved compared with baseline; concern over mistakes was significantly lower at both times. Doubts about actions were lower at discharge than at baseline but the difference between baseline and follow-up was not significant; parental expectations and parental criticism showed no significant change. Change in acceptance was correlated with change in fatigue (r=.327, p=.008), work and social adjustment (r=.408, p=.001) and physical functioning (r=−.248, p=.048). Harms and withdrawals for harms were not reported.

  122. The search for pain relief in people with chronic fatigue syndrome: a descriptive study.2011 · no comparison group · 50 in the study
    Summary

    This descriptive, cross-sectional study asked people with chronic fatigue syndrome (CFS) who experienced pain which complementary/alternative medicine (CAM) and physiotherapy treatments they had tried for pain and how much benefit they perceived. 50 participants were recruited through CFS support groups across Scotland; interviews took place in their homes. 10 participants were severely affected. There was no comparison group; treatment duration and follow-up were not reported. At interview, 18 of 50 were currently receiving treatment for pain, and 3 were receiving physiotherapy. 45 participants reported previously trying 19 different CAM treatments. Acupuncture was the most frequently tried (23 participants); 14 reported benefit, and among 5 severely affected participants, 4 reported relief and 1 reported increased pain. Of 18 who tried massage, 5 reported reduced pain and 13 reported increased pain during treatment or worse the following day. Of 17 who tried reflexology, 9 reported increased pain and 4 found it beneficial. All who tried acupressure, lymphatic drainage, and hyperbaric oxygen reported improvements. 27 participants tried physiotherapy and reported 16 different interventions; spinal mobilisations, TENS, and ultrasound were reported to make no difference. 12 tried graded exercise therapy, and 11 stopped because it increased pain. For cognitive behaviour therapy, 11 reported benefit, 13 did not, and 22 refused. 41 of 50 were taking pain medication; 11 reported it eased pain, and Two were unable to take it due to side effects. Warm baths (29), heat applications (25), lying down/rest (22), and drinking water (17) were reported to ease pain.

  123. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?2010 · no comparison group · 84 in the study · 82 with outcome data
    Summary

    This study asked whether low cortisol predicts a poorer response to cognitive behavioural therapy (CBT) in chronic fatigue syndrome. Eighty-four patients (59 female) entered; 64 were free from psychotropic medication, and 56 medication-free patients provided salivary cortisol. Patients received CBT as usual care, with a standard course of 12–15 sessions; they were retested after 6 months or 15 sessions of therapy, whichever was sooner. There was no untreated control group. Of 82 patients with usable data, 31 were CBT responders (39 %) and 51 non-responders (61 %); 32 were minimally improved (40 %), 17 had no change (18 %), and 2 were minimally, much or very much worse (3 %). Three patients dropped out and were rated as non-responders. Among drug-free patients, responders had higher pretreatment 24-h urinary free cortisol than non-responders (98.2 vs 68.8 nmol/day; 95 % CI 2.2 to 56.6). A flattened diurnal salivary cortisol profile was also associated with a poor response. In a predefined low-cortisol group, response was 28 % versus 43 % in remaining subjects (p=0.16). Side effects/adverse events were not reported. The authors state this was not a trial of CBT and that sample size may have been insufficient.

  124. [Patients' experience with treatment of chronic fatigue syndrome].2009 · no comparison group · 828 in the study
  125. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome.2009 · no comparison group · 41 in the study
    Summary

    This study asked whether cognitive behavioural therapy (CBT) for chronic fatigue syndrome (CFS) would increase salivary cortisol output. 41 patients (26 female) with CDC-defined CFS, aged 18–65, were recruited from referrals to the CFS clinic at King's College Hospital, London. They received CBT, with standard therapy comprising 12–15 sessions; testing was repeated after 6 months or 15 sessions, whichever was sooner. There was no non-treated comparison group; patients were assessed before and after CBT. The main outcome was total 0800–2000h salivary cortisol output (AUC), with mean value and diurnal change as secondary measures. Total output was 68.2 (19.6) before and 79.4 (21.8) after CBT (95% CI for difference 2.6–19.8), and mean value was 6.0 (1.7) before and 6.8 (1.7) after (95% CI 0.12–1.5). Diurnal change was −8.3 (4.6) before and −8.6 (4.8) after (95% CI −2.0–1.4). Fatigue (Chalder 24.8 (6.1) to 21.2 (6.2)), GHQ (17.7 (7.5) to 15.3 (8.0)), BDI (14.9 (9.1) to 12.2 (8.2)), SF-36 physical functioning (39.7 (23.3) to 50.7 (24.8)), SF-36 role limitations (25.8 (33.4) to 44.4 (34.3)) and WSAS (29.0 (7.8) to 25.5 (9.0)) changed significantly. CGI categories (missing data 3) were very much or much improved 18 (47%), minimally improved 13 (34%), no change 4 (11%), and minimally, much or very much worse 3 (8%). There was no differential effect of responder status on salivary cortisol measures. Side effects and withdrawals due to harms were not reported.

  126. Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity?2009 · no comparison group · 30 in the study · 17 started · 11 with outcome data
    Summary

    This multiple case study examined outpatient graded-activity oriented CBT in relatively high-functioning people with chronic fatigue syndrome (CFS). Prospective participants with a previously established physician-based CFS diagnosis were screened by telephone. Of 30 participants who screened into the study, 13 dropped out before the first face-to-face appointment and six dropped out after the first appointment; eleven out of 17 participants completed treatment. Treatment consisted of 6–32 visits scheduled weekly or biweekly over 7–35 weeks and included gradual walking increases, pacing, relaxation training, sleep scheduling, and cognitive coping skills. There was no comparison group. Outcomes included global change, Fatigue Severity Scale (FSS), Short Form-36 Physical Function Subscale (SF-36PF), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), actigraphy, the 6-minute walking test, and walking diaries. Global change ratings were very much improved (two), much improved (two), improved (five), and no change (two). Clinically significant improvement was found for 6 of 11 for fatigue impact, 3 of 11 for physical functioning, 4 of 11 for anxiety, and 3 of 11 for depression. Mean FSS was 5.93 to 5.20; SF-36PF 49.44 to 58.18; BDI 14.27 to 10.09; BAI 14.64 to 10.55; actigraphy 224696.90 to 203916.67; 6-minute walk 486.64 to 486.09. Of nine participants reporting any global improvement, actigraphy declined for four, increased for three, and did not significantly change for two. No participant reported symptom exacerbations related to assigned exercise; the dropout rate after the first treatment session was 35.3%.

  127. The percieved effectiveness of the use of cognitive behavioural therapy in the treatment of clients diagnosed with Myalgic Mncephalomyelitis/Chronic Fatigue Syndrome (also known as ME/CFS)2008 · no comparison group · 7 in the study
    Summary

    This qualitative study asked why: to investigate how effective people with ME/CFS perceived cognitive behavioural therapy (CBT) to be, because CBT is being recommended more and more as a treatment for ME/CFS. Seven ME/CFS sufferers that had received CBT as a treatment for ME/CFS participated in an open-ended telephone interview; the data were analysed using thematic data analysis. There was no comparison group and no randomisation. The study reports perceived improvement in health after CBT rather than a measured clinical outcome. The majority of the volunteers, 57.1 %, found that they had no improvement in their health after the CBT treatment. Of these 57.1 %, they all reported difficulties with the therapist either not believing the volunteer's explanation of their illness, or, if they had knowledge of the illness, still pushing them into exertion that would have caused them to relapse. The 42.9% of people that reported an improvement in their health after the therapy all said that the therapists were understanding, had knowledge of ME/CFS and were non-judgemental and empathic. The paper does not report any withdrawals related to harms. It does not report a follow-up period or a duration of CBT. The authors state no limitations in the abstract.

  128. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome.2008 · no comparison group
    Summary

    This study tested whether cerebral atrophy in chronic fatigue syndrome (CFS) is reversible with cognitive behavioural therapy (CBT). Twenty-nine female CFS patients were willing to take part; 22 were analysed, alongside 22 matched healthy controls. Patients received CBT for on average 16 sessions of 1 h over 6–9 months, with a structured physical activity program and work rehabilitation schedule; controls were assessed at a comparable time interval. Structural brain imaging measured grey matter volume, with cognitive speed, physical activity, fatigue and disability also assessed. In CFS patients, grey matter volume changed from 669.4 (14.4) to 674.1 (15.1) ml, change +4.7 (2.3), P = 0.025; controls changed –0.21 (1.7), and the Group X Time interaction was t(2,41) = 1.82, P = 0.038. Regional increases were reported in left (PFWE = 0.010, PFDR = 0.025) and right (PFWE = 0.005, PFDR = 0.011) inferior frontal gyrus, t(21) = 5.49. CRT changed from 348 (14.2) to 329 (11.5) ms, change –19.4 (8.4), P = 0.032; WAIS-dst did not significantly improve, P = 0.18; SRT did not change, P = 0.30. Mean actometer score changed from 63.5 (4.6) to 73.2 (3.5), P = 0.056; CIS fatigue from 48.4 (1.3) to 29.3 (2.9); SIP total from 1334 (124) to 550 (115). Of 29 patients, four withdrew from CBT, one was not willing to participate in the follow-up scan, one was excluded for poor MR image quality, and one had somatic comorbidity during treatment.

  129. Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis.2008 · no comparison group · 125 in the study · 112 started
    Summary

    This was a prospective, non-controlled before-and-after study in a mental health center in the East of The Netherlands. Patients with CFS were referred by their GP or a medical specialist. The paper included 125 patients; 112 started treatment. Treatment was CBT for CFS, with a protocol of 16 sessions over 8 months, and included a structured graded activity program. There was no comparison group. Outcomes included recovery based on fatigue severity, Euroqol utility/QALYs, medical consumption, work productivity and costs. After treatment, 46 of 125 patients (37%) were recovered. The mean gained QALY per patient was 0,03. Mean Euroqol utility was 0.57 (SD 0.27) at intake and 0.65 (SD 0.30) post treatment, with a change of 0.078 (95% CI 0.03 to 0.09; p < 0.001). Total medical costs decreased from € 1.112 to € 810 per six months (95% CI -€ 784 to -€ 26); total non-medical costs decreased from € 1.249 to € 1.012 (95% CI -€ 813 to € 271). From the health care perspective, mean costs per patient per six months were € 1.117 before and € 2.586 after (95% CI € 958 to € 1.876), and the COR was € 5.320 per recovered CFS patient. Of 112 patients who started treatment, 28 dropped out quickly after intake; of 84 who followed treatment, 12 dropped out half way or later and 72 finished. At 8 months follow up, 74 of 84 treated patients filled in the questionnaire and 10 failed to do this. Side effects were not reported.

  130. Implementing cognitive behavioral therapy for chronic fatigue syndrome in a mental health center: a benchmarking evaluation.2008 · no comparison group · 143 in the study · 84 started · 112 with outcome data
    Summary

    This clinical evaluation used a benchmark strategy without a comparison group. It took place in an outpatient mental health center (MHC) in the Netherlands; patients were referred by a GP or another physician. One-hundred forty-three CFS patients were referred. Of these, 112 showed up at intake and appeared to have CFS, and 84 patients started treatment. Treatment was CBT for CFS, prescribed as 16 one-hour sessions over a period of 6 to 8 months. Outcomes were fatigue severity on the CIS-20 and physical functioning on the Rand-36, measured before treatment and at follow-up; the paper also reports patients clinically significantly improved at posttreatment. In the intention-to-treat group (N = 112), mean fatigue severity was 48.7 at intake and 35.4 at follow-up, and mean physical functioning was 53.5 at intake and 69.1 at follow-up. Forty-six patients (41.1%) were clinically significantly improved. The fatigue effect size was 1.12 (95% CI 0.85, 1.38), and the physical functioning effect size was 0.64 (95% CI 0.38, 0.89). Eighteen patients did not show up at intake, 28 decided after intake not to start treatment, and 12 dropped out during treatment; the total dropout rate was 36%. Four patients gave as a dropout reason too much pain or other complaints during treatment. The authors state two criteria were not met: monitoring and therapist pretherapy training.

  131. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome?2007 · no comparison group · 112 in the study · 96 with outcome data
    Summary

    This single-group cohort study asked whether recovery from chronic fatigue syndrome (CFS) is possible after cognitive behavioural therapy (CBT). Of 112 CFS patients with a pre-treatment assessment at a university medical centre, 3 did not start CBT, 13 dropped out during treatment, and 96 completed pre- and post-treatment assessment. All received CBT for CFS per a protocol described elsewhere; duration was not reported, and there was no control group. After treatment, 73 of the 95 patients who rated improvement (77%) reported no or significantly fewer symptoms. Mean CIS-fatigue decreased from 50.0 to 30.3 (change –19.7, p < 0.001), SF-36 physical functioning increased from 51.8 to 76.3 (change 24.5, p < 0.001), and SIP8 decreased from 1,448 to 682 (change –766, p < 0.001). In total, 66 patients (69%) no longer met the inclusion criteria for fatigue severity and disability, and 69% no longer met the CDC criteria for CFS. Recovery ranged from 23 to 59% across definitions; 23% fully recovered under the most comprehensive definition. Twenty-two of 96 patients had a medical co-morbidity with higher CIS-fatigue (35.8 vs 28.6, p = 0.034) and lower SF-36 physical functioning (66 vs 80, p = 0.016). Fewer patients with co-morbidity recovered for level of fatigue (23% vs 55%, p = 0.007), no physical disability (41% vs 65%, p = 0.046), no disabilities in all domains (9% vs 31%, p = 0.040), and normal fatigue plus no physical disability (23% vs 50%, p = 0.024); social, perception and combined differences were not significant. Side effects were not reported.

  132. Group Cognitive Behavioural Therapy for Chronic Fatigue Syndrome: A Pilot Study2005 · no comparison group · 6 in the study
    Summary

    This pilot study examined group cognitive behavioural therapy (CBT) for chronic fatigue syndrome (CFS). Six patients who met the Centre for Disease Control criteria for CFS were selected from a CBT waiting list after tertiary referral from hospital physicians to a liaison psychiatry service. Treatment was 10 sessions of one hour spread over 18 weeks, with no comparison group. Patients were assessed at the first session, the final session, and 3 months after the final session. Between pre-treatment and post-treatment, the paper reports statistical significance on the Fatigue Questionnaire and the Work and Social Adjustment Scale (p < .05). All patients showed an improvement on all questionnaire scores except one who scored the same on the GHQ and another who scored worse on the post-treatment GHQ. At 3-month follow-up, four patients had maintained or improved Fatigue Questionnaire scores, and five recorded GHQ scores better than pre-treatment; the improved Work and Social Adjustment scores seen at post-treatment were not maintained. On global self-ratings, two patients rated overall improvement as “much better” and four as “a little better”; for fatigue, one rated “much better” and five “a little better”. One patient was “very satisfied” and five “moderately satisfied”; one found the programme “very useful”, three “moderately useful” and two “useful”. All participants completed the course, with an overall attendance rate of 86.67%. The authors state limitations including the small sample size, bias in selection and lack of a control group, and note there was no objective measure of outcome that was not self-rated.

  133. P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome2004 · no comparison group · 70 in the study
    Summary

    This single-group before-after study asked whether cognitive behavioural therapy (CBT) affects HPA axis dysfunction in chronic fatigue syndrome (CFS). The researchers recruited 70 patients with CFS who were not taking psychotropic or other medication known to affect the HPA axis. Patients received a standard package of 12-15 sessions of CBT over 6 months; there was no comparison group, and the tests were repeated after treatment. The recorded outcomes were fatigue, psychiatric symptoms, disability and Clinical Global Impression. On completion of CBT, patients reported clinically significant improvement in fatigue, psychiatric symptoms and disability. Overall, 43% of patients were rated as very much better or much better using the Clinical Global Impression. Side effects, withdrawals and worsening were not reported. The authors state that HPA axis dysfunction in CFS is at least partly reversible by CBT, but they also note uncertainty about whether the changes reflect underlying pathophysiology or consequences of the illness itself.

  134. Family cognitive behaviour therapy for chronic fatigue syndrome: an uncontrolled study.2002 · no comparison group · 23 in the study · 18 with outcome data
    Summary

    This uncontrolled study examined family focused cognitive behaviour therapy for 11–18 year olds with chronic fatigue syndrome (CFS), sometimes known as myalgic encephalomyelitis (ME), recruited from consecutive referrals by general practitioners and consultant paediatricians. Twenty three patients were offered treatment; twenty completed treatment and three dropped out after a few sessions. Eighteen completed measures pre and post treatment and at six months follow up. Treatment comprised graded activity, establishing a sleep routine, and cognitive restructuring, delivered fortnightly for up to 15 hourly sessions, with follow ups at three and six months and then one year. There was no comparison group. At six months follow up, 83% of patients (15/18) improved according to the criterion of fatigue <4 and going to school 75% of the time. All 20 who completed treatment had returned to school at six months follow up; 95% were at school full time. Median scores improved for fatigue (from 9.5 to 0.5), social adjustment (from 20.5 to 3), depression (from 8.3 to 3), anxiety (from 7 to 0.5), and total fear (from 35.1 to 20.2). Fear blood/injury, fear social, and fear dysphoria did not reach significance. At post treatment, 92.3% rated themselves very much or much better, and at six months 100% did; 100% reported satisfaction. Typically, during treatment, patients experienced a worsening of symptoms during a viral infection or a stressful event. The authors state the study was non-blind and non-randomised, and results must be interpreted cautiously.

  135. Cognitive behavioral therapy for chronic fatigue syndrome in a general hospital--feasible and effective.2001 · no comparison group · 94 in the study · 80 started · 51 with outcome data
    Summary

    This retrospective questionnaire follow-up study examined cognitive behavior therapy (CBT) for 94 patients with chronic fatigue syndrome/neurasthenia offered CBT by liaison psychiatry services in a general hospital outpatient clinic. CBT included shared understanding, graded exercise, cognitive challenge and problem solving. Of 94 patients, 80 received treatment and 51 commenced treatment, of whom 11 did not complete it; completers attended a median 6 sessions over a median 6-month period. Follow-up was 20 months (range 3–66); response rate was 61%. Therapists rated 46% as moderately improved or recovered; this was 55% of 58 completers versus 23% of 22 dropouts. At follow-up, 18% reported being back to normal (23% of 40 completers), 51% reported being very much or moderately improved, 10% worse and 22% unchanged. 71% of 45 found treatment acceptable; 58% of 48 found it helpful. Symptom, functional and social scores were lower at follow-up at a statistically highly significant level; functional and social reductions were greater in completers than dropouts (P<.05 and P<.02). No significant effect of treatment completion or illness length on symptom-number change was reported. Primary care attendance fell from median 10.5 to 7 (P<.001). Antidepressant prescribing showed no difference (18 vs 17). Twenty-two of 80 dropped out, 14 of 94 did not return, and 11 of 51 did not complete treatment; 5/51 said they were worse. Side effects were not reported. Authors state it was not randomised, used self-report questionnaires and had a 61% response rate.

  136. The relationship between psychosocial variables and treatment outcome in chronic fatigue syndrome1998 · no comparison group · 86 in the study
    Summary

    This retrospective, uncontrolled study was conducted in a specialist tertiary referral outpatient chronic fatigue syndrome (CFS) clinic. It evaluated cognitive behaviour therapy (CBT) for CFS and the relationship between treatment outcome and psychosocial variables including stressful life-events, social support, illness attributions and perfectionism. Eighty-six CFS patients assessed between April '94 and May '96 subsequently completed a course of CBT. The study was based on patients' responses to questionnaires filled in before and after CBT treatment, assessing outcome and psychosocial variables. No comparison group was reported, and the duration of CBT was not reported. Outcome included a measure of functional impairment at 6 month and 1 year follow-ups. Thirtv-five per cent of patients who completed CBT treatment achieved a clinically significant improvement on this measure at 6 month follow-up, and 33 per cent at 1 year follow-up. The abstract also reports considerable evidence for a relationship between the number and severity of stressful life-events experienced since the start of treatment and treatment outcome at 1 year follow-up, and no evidence for a relationship between social support, perfectionism and illness attributions and treatment outcome. Harms, withdrawals and side effects were not reported. The abstract does not state the authors' conclusions or limitations.

  137. Cognitive behaviour therapy in chronic fatigue syndrome.1991 · no comparison group · 50 in the study · 32 started · 27 with outcome data
  138. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Successful Therapeutic Plasma Exchange Treatment After SARS-CoV-2 Infection-A Case Report.2026 · case report · 1 in the study
    Summary

    This single case report describes a 35-year-old female with a 6-year history of ME/CFS who was referred for evaluation regarding plasma exchange therapy. After SARS-CoV-2 infection in 2022 she had transient post-exertional malaise and persistent brain fog and concentration difficulties; raltegravir, started in 2020, was gradually tapered and discontinued during treatment. In January 2024 therapeutic plasma exchange was initiated using the Terumo Optia system with peripheral venous access, each session a 1:1 plasma volume exchange with 5% albumin (3500 mL) and citrate anticoagulation; Table 2 lists nine procedures in total, every 2–4 months, while the text says plasma exchange was initially performed every 2–3 months. Low-dose intravenous immunoglobulin (OCTAGAM) was administered at the end of each cycle. The patient reported marked improvement in fatigue, concentration and cognitive clarity, and at 3 months and 6 months follow-up no signs of symptom recurrence; she also reported improved stamina, weight loss and disappearance of menstrual cycle–related symptom exacerbations. Regular blood gas analyses during the procedures revealed recurrent hypocalcemia as a side effect of citrate anticoagulation, corrected with intravenous calcium, although the paper also states the therapy was well tolerated, with no reported side effects or complications. Antibody levels three months and one month before and 6 months after the first plasma exchange are given in Table 1.

  139. Stress-Related Chronic Fatigue Syndrome: A Case Report with a Positive Response to Alpha-Methyl-P-Tyrosine (AMPT) Treatment.2024 · case report · 1 in the study
    Summary

    This case report followed one male patient with stress-related chronic fatigue syndrome (CFS), diagnosed in 2012, who also later had postural orthostatic tachycardia syndrome (POTS). In 2021 he attended a clinic specializing in CFS and stress, and the report uses medical records he provided, covering over a year of follow-up. The patient was given alpha-methyl-p-tyrosine (AMPT) at 80 to 300 mg bid across two separate periods of treatment. There was no comparison group. The paper reports that the patient said he experienced improvement with AMPT at 80 to 300 mg bid. For daily stress, physical fatigue, and mental fatigue, the patient’s described baseline was 5; the report states that AMPT at 80–200 mg bid (trial 1) 'seemed efficient at reducing fatigue', while a higher dose (300 mg bid) 'did not improve the symptoms'. The paper also reports post-exertional malaise (PEM) while taking AMPT and states it 'appears to be a result of reported increased physical activity in response to feeling “better”'. The patient did not report any additional side effects while taking AMPT. The authors state limitations including no post-AMPT treatment analytics and that a case report reflects individual features and responses.

  140. Corona With Lyme: A Long COVID Case Study.2023 · case report · 1 in the study
    Summary

    This case report describes a previously healthy 26-year-old female medical student living in New York, NY, who developed long COVID after a presumed acute SARS-CoV-2 infection in March 2020, with a concurrent perceived early-disseminated Lyme disease infection. The three-year arc covers numerous trial-and-error treatments: a two-week regimen of doxycycline 100 mg twice a day, metformin escalation alongside diet modifications, graded compression stockings, breathing exercises, increases in caffeine and salt consumption with increased fluid intake, a horizontal cardio exercise program with rest periods, osteopathic manipulative treatment, cognitive behavioral therapy, sleep hygiene improvements, supplements (vitamin C, vitamin D, vitamin B12, B-complex, n-acetyl cysteine, turmeric extract), a two-dose Moderna mRNA COVID-19 vaccination course, and abortive headache therapies (Excedrin or Fioricet and prochlorperazine). The authors report a moderate reduction in cycle length and morning hypoglycemic symptoms with metformin, a moderate reduction in myalgias, headaches and scalp allodynia with osteopathic manipulative treatment, some relief of post-COVID headache, help with headache pain, orthostatic palpitations, fatigue and brain fog from abortive therapies plus caffeine, salt and fluid intake, moderate improvements in fatigue and brain fog in the first 24 hours after the first vaccine dose, moderate symptom alleviation from digital interventions, and small but recognizable differences in fatigue and cognition from sleep hygiene. No improvement in symptoms other than mild reduction in right shoulder pain followed the doxycycline regimen. Supplements provided no discernable benefit. The patient reports full recovery from long COVID with residual blurred vision and oligomenorrhea. Reported harms include worsening blurred vision, palpitations, heat intolerance and near-syncopal events; a moderate increase in fatigue and brain fog with a CGRP antagonist; fatigue exacerbation with traditional exercise rehabilitation; symptom re-exacerbations with compression stockings; and increased headache frequency and duration with n-acetyl cysteine. The abstract describes near-total remission.

  141. The long wave of COVID-19: a case report using Imagery Rehearsal Therapy for COVID-19-related nightmares after admission to intensive care unit.2023 · case report · 1 in the study
    Summary

    This single case study described a 42-year-old woman with long-COVID syndrome and COVID-related nightmares after ICU admission. She was admitted to a 1-month pulmonary rehabilitation program and received a four-session Imagery Rehearsal Therapy (IRT) while also using continuous positive airway pressure (CPAP) therapy. There was no comparison group; outcomes were measured at baseline (T0), 1 month (T1), and 3 months (T2). The Post-Traumatic Growth Inventory total score was 26 at T0, 82 at T1, and 78 at T2. The Pittsburgh Sleep Quality Index score was 12 at T0 and 8 at T1 and T2. Nightmare frequency was 6 at T0 and 4 at T1 and T2; emotional intensity was 4 at T0 and 2 at T1 and T2. Nightmare-related emotional distress remained stable (quite distressing). Sleep efficiency was 84.86% at T0 and 78.79% at T1. Epworth Sleepiness Scale scores were 7 at T0, 12 at T1, and 8 at T2, and the paper reports no trend for daytime sleepiness. DASS stress scores were 0, 4, and 9; anxiety 6, 2, and 11; depression 0, 5, and 4. The patient reported no additional nightmares during the previous week at the conclusion of the session. Side effects were not reported; withdrawals were not reported. The authors state limitations include no controls and a four-session intervention.

  142. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study.2022 · case report · 1 in the study
    Summary

    Why: to describe patient-led integrated cognitive behavioural therapy, including symptom monitoring and graded pacing, for long COVID with comorbid depression and anxiety in primary care. Who: one 36-year-old male referred to an IAPT long COVID assessment hub, who had been hospitalised and treated at stage-3 with CPAP. What was given and for how long: twelve, individual, 60 min video sessions over a period of five months; no comparison group. What was measured: COV19-QoL, PHQ-9, GAD-7, PHQ-15, WSAS, subjective units of discomfort (SUD) and a patient experience questionnaire, with a 3-month follow-up. Found: the paper reports that at the end of therapy the patient showed reliable improvement in all these dimensions (Table 1). Table 1 scores were COV19-QoL 5 pre-treatment, 2 post-treatment, 10 at follow-up; PHQ-9 17, 8, 4; GAD-7 16, 6, 6; PHQ-15 24, 9, 6; WSAS 28, 14, 12. SUD for fatigue and shortness of breath improved from 7 to 4, and overall long COVID symptoms to an SUD of 3. The patient reported his post-COVID normal was now at 75-percent of his pre-COVID normal, had been discharged from specialist care and had started parttime employment. Harms reported were an initial increase in shortness of breath, which stabilised after a week, and a flare-up with more fatigue and breathlessness following gentle gardening. Withdrawals were not reported. Limits the authors state: the study was not controlled, cannot rule out natural recovery, and does not claim generalisability.

  143. Home-based family focused rehabilitation for adolescents with severe Chronic Fatigue Syndrome.2019 · case report · 6 in the study · 5 with outcome data
    Summary

    This was an uncontrolled case series of home-based family-focused rehabilitation, described as CBT, for severe Chronic Fatigue Syndrome in adolescents. Six housebound adolescents aged 11-18, diagnosed by a Paediatrician and referred to a specialist service in secondary care in a hospital trust in the UK, were assessed and treated at home by an experienced cognitive behaviour therapist. Sessions ranged from one to two hours; the number of treatment sessions varied between 23 and 51 with a mean of 33, and treatment took place over between 16 and 35 months with a mean of 24 months. Outcomes were assessed 12 months after discharge from treatment. There was no comparison group. At 12-month follow-up, Table 1 shows N=5. The paper reports that all patients had returned to either school or college; six returned to education on a part-time basis. Physical functioning improved in most patients, fatigue reduced in some, and no adverse effects of the intervention were reported. Global ratings were positive: three patients said they felt very much better, one much better and one a little better; three parents rated their child very much better, two much better and one about the same. Anxiety increased on average during treatment, and some individuals' fatigue levels increased. The authors state that a key limitation is the small sample size within an uncontrolled study design.

  144. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and early maladaptive schemas: A single case study2018 · case report · 1 in the study
    Summary

    This instrumental single case study took place within a clinical context as part of a larger research project examining the relationship between early maladaptive schemas (EMS) and ME/CFS. One woman with a diagnosis of ME/CFS received 20 sessions of therapy. Standard cognitive behavioural therapy (CBT) was initially used for depression; once reduced, schema-focused work commenced, including two chair work. Beck's Depression Inventory measured mood and Young's Schema Questionnaire measured schemas. BDI was 42 at initial, 13 at mid-point, 4 at end of therapy and 3 at follow-up; by session nine the BDI score was 13. By the end of therapy two schemas from the nine endorsed at the start remained at therapeutic significance, while Table 1 reports 4 therapeutically meaningful EMS at end of therapy (source conflict). The client reported improved quality of life and had taken up part-time paid employment; at session 20 she was in paid employment 15 hours a week and planned to increase this to 18 hours. Withdrawals were not reported. At follow-up the author was concerned that Kate's scores for the unrelenting standards schema had increased slightly. The authors state that case studies are criticised for their lack of generalisability and subjective nature.

  145. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study.2017 · case report · 1 in the study
    Summary

    This single-case study reports on one patient with CFS/ME and co-morbid health anxiety who was accepted into a specialist CFS service. The patient received an adapted cognitive behavioural treatment approach based on CBT for health anxiety, contracted as eight 60 minute sessions in addition to two assessment sessions; there was no comparison group. The authors measured fatigue with the Chalder Fatigue Scale, pain with a Visual Analogue Scale, health anxiety with the Health Anxiety Inventory, anxiety and depression with HADS, and also reported SF-36, self-efficacy, Epworth, Fukuda criteria, global impressions, employment and patient ratings. The paper reports Chalder Fatigue scores falling from 11/11 to 0/11 and pain changing from ‘moderate’ at baseline to no pain. Anxiety and health anxiety reduced to sub-clinical levels, and scores across all measures were below clinical thresholds at session eight and at follow up. The patient no longer met Fukuda criteria for CFS at treatment completion, and the abstract states the patient no longer fulfilled criteria for CFS or health anxiety following eight treatment sessions. At 12 month follow-up the global impressions scale indicated ‘very much better’; gains were maintained and the patient had secured employment. The treatment approach was reported as agreeable to the patient. Harms and withdrawals were not reported. The authors note single-case limitations, including that findings cannot be generalized to the broader CFS population.

  146. An Acceptance and Commitment Therapy (ACT) intervention for Chronic Fatigue Syndrome (CFS): A case series approach2017 · case report · 6 in the study
    Summary

    This mixed-method multiple single-case series examined a guided self-help Acceptance and Commitment Therapy (ACT) intervention for six adults with chronic fatigue syndrome (CFS) recruited from an established CFS service in the UK. Participants received sections of an ACT self-help book weekly by email or post for 6 weeks, with weekly telephone calls to check comprehension and adherence, and follow-up three months after completion. There was no comparison group; outcomes were compared with each participant’s baseline. Measures included overall psychological flexibility, the Engaged Living Scale, the acceptance scale of the PHLMS, the Chalder Fatigue Questionnaire, the SF-12 Physical function subscale, and Fitbit-recorded physical activity, plus change interviews. The authors report increased overall psychological flexibility in three of six participants, clinically significant positive change maintained in four out of six on the Engaged Living Scale, clinically significant acceptance change in four participants (two maintained), clinically significant fatigue improvement in five participants (four maintained or further improved), and increased recorded activity in all five participants with analysable Fitbit data (maintained in three). Four participants recommended the text. No adverse effects were noted by any participants. The authors state limitations including limited experimental control and variability across the data.

  147. Acceptance and commitment therapy for chronic fatigue syndrome : a case series approach2016 · case report · 6 in the study
    Summary

    This dissertation reports a mixed-method multiple single-case series in six participants with chronic fatigue syndrome recruited from an established CFS service in the UK. Participants received a six-week self-help Acceptance and Commitment Therapy (ACT) intervention: each week a section of text from 'Get out of your mind and into your life' was sent by email or post, with weekly phone checks. Individual baselines acted as control periods; there was no comparison group, and follow up was at three months. Measures included ACT process questionnaires, the Chalder Fatigue Questionnaire, the SF-12 Physical Function subscale, a Fitbit Zip activity tracker, and change interviews. Significant increases in engaged response style were reported in four out of six participants and maintained at follow up. Overall psychological flexibility improvements were maintained at follow up for three participants. Acceptance scores showed clinically significant change in four participants, with two maintaining this at follow up. Fatigue improved in five participants at post-intervention, with four maintained or further improved at follow up. SF-12 disability appeared to decrease in five participants post-intervention but was not maintained. Recorded physical activity increased in all five participants wearing the monitor, maintained in three. The implicit measure indicated underlying beliefs remained stable. Harms and withdrawals were not reported.

  148. The Cognitive Behavioral Treatment of Depression and Low Self-Esteem in the Context of Pediatric Chronic Fatigue Syndrome (CFS/ME): A Case Study.2015 · case report · 1 in the study
    Summary

    This case report describes one 16-year-old girl with CFS/ME and co-morbid depression who was referred to specialist, multi-disciplinary Child and Adolescent Mental Health Services. She received CBT for depression and CBT for self-esteem as a five-session course delivered over 8 weeks, following a two-session assessment phase; follow-up was 9 weeks post-intervention. There was no comparison group. Depression was measured with the depression subscale of the RCADS. Angela’s score was 21 (T score > 80) at assessment, 10 (T score of 56) by the end of treatment (session 5), and 11 (T score of 60) at session 6 follow-up. By the end of treatment she rated progress toward the goal of managing mood and lifting depression as 7 out of 10, and progress toward improving self-esteem as 8 out of 10. The report also states she was dressing with more care and attending school more regularly. For harms, Angela reported that her sleep pattern was more disrupted, she was feeling more fatigued, and experiencing more pain than previously; the authors state her CFS/ME symptoms were worse and appeared to be exacerbated. The authors state CFS/ME symptoms were not formally measured, which they call a limitation of the case study.

  149. Pragmatic evaluation of group cognitive behavioural therapy for chronic fatigue syndrome2007 · case report · 2 in the study
    Summary

    This paper reports a pragmatic, non-randomised controlled design investigating group cognitive behaviour therapy (GCBT) for people with chronic fatigue syndrome (CFS). In this study 28 people acted as their own waiting list control by completing a range of measures 8 weeks prior to taking part in GCBT. The intervention consisted of 8 consecutive weeks of 2.5-hour sessions. Significant improvements were found compared to the waiting list in physical and mental fatigue and depressive symptoms. Improvements in quality of life, hope and optimism were also found but no improvements were reported for anxiety levels, pain or physical functioning. Global outcome measures revealed that the majority of the patients found the treatment beneficial and were satisfied with the results. The authors state that further research is indicated to improve subgroup identification and refine intervention programmes, and they question the methodological limitations and generalisability of the findings. No information is given on side effects, withdrawals or numbers analysed.

  150. Recovery from chronic fatigue syndrome with modafinil.2004 · case report · 1 in the study
    Summary

    This case report describes one patient with CFS who first presented to his GP and was given a course of modafinil at a dose of 200 mcg mane. There was no comparison group, no randomisation, no blinding and no crossover. The report states that modafinil was successful in treating the patient's debilitating fatigue. Energy levels improved from 20% to 60% of optimum in the space of a few months. The patient was able to return to part-time work and to enjoy a good quality of life. The paper does not report harms, side effects or withdrawals; harms and withdrawals are not reported. It also does not report whether the patient stopped treatment or worsened. The report is a single case, so no between-group results are available. The authors state that whether patients with CFS would need to take modafinil long term needs to be established, and that long-term, double-blind, randomized controlled trials would be warranted to investigate efficacy and safety.

  151. Cognitive behavior therapy for chronic fatigue syndrome: a case study.1999 · case report · 1 in the study
    Summary

    This case study presented one 26-year old woman with Chronic Fatigue Syndrome (CFS) who was referred to the department of Medical Psychology at the University Hospital Nijmegen because of chronic fatigue complaints and severe myalgia. Cognitive behavior therapy (CBT) was based on a model of maintaining factors in CFS and on individual behavioral analyses. Treatment consisted of 22 sessions within 14 months, and three follow-up sessions followed in the next 7 months. Assessments were made at baseline and at 8, 14, 21 and 33 months. Measured variables included fatigue and functional impairment, sense of control, physical activity, somatic attributions, focusing on bodily functions, pain, psychological wellbeing and concentration. During treatment (T1–T3) fatigue and functional impairment decreased and this change was further continued during follow-up (T4); at final follow-up scores were within the range of healthy controls. Sense of control and physical activity increased, while focusing on bodily functions and catastrophic thoughts decreased. Causal somatic attributions did not change during treatment and follow-up. The woman was still suffering from myalgia, which the therapist labeled as a possible consequence of building up activities. The authors noted that experimental analyses of behavior were absent.

  152. A psychodynamic view of the chronic fatigue syndrome. The role of object relations in etiology and treatment.1994 · case report · 2 in the study
    Summary

    Two case reports presented CFS patients referred by infectious disease specialists at a university teaching hospital. Both received long-term (>28 months), intensive (2-3 times per week) psychoanalytic psychotherapy; there was no comparison group. The paper reports within-person changes only. In Case 1, the paper states “A new vitality seemed to infuse his attitude with regard to his career and to the analytic work” and “His activity level increased and his reports of fatigue diminished as well.” It also reports “clinical improvement occurred” and “His reports of fatigue diminished, his work performance improved, and his object relationships appeared to stabilize.” In Case 2, “Over the initial 9 months of treatment there was a gradual improvement in her fatigue symptoms”; she reported “an increase in energy and a reduction in muscle pain,” and the paper reports “major changes over the first 18 months of treatment.” The paper also records worsening: “Mr. B seemed more inhibited, frightened, and mistrustful. The context of his associations shifted back to his physical symptoms and his newly returned fatigue”; and “there was a noticeable deterioration at the time of the therapist’s first vacation.” It records “she began experiencing increasing fatigue as the vacation approached” and “unable to work for several of the days the therapist was absent.” The paper did not report side effects, and did not report withdrawals due to harms.

  153. Psychosocial management of chronic fatigue syndrome in adolescence.1992 · case report · 2 in the study
    Summary

    This paper reports two adolescent cases with chronic fatigue syndrome, drawn from a series of eight adolescents seen in a general paediatric hospital setting over a six month period. Both received a behavioural programme with negotiated rewards for graded mobilisation and strength; no comparison group was reported. In the first case, within two weeks the patient was walking unaided and spending most of his waking hours out of bed; he continued to improve in physical abilities and school activities, had almost returned to his premorbid state of well-being after three months, and at nine months follow-up recovery was complete and sustained. In the second case, within two weeks there was dramatic improvement; he was attending the hospital school and walking up to one or two kilometres without major problems despite persisting CFS symptoms. After discharge he gradually deteriorated, and he and his mother refused further follow-up. Side effects were not reported. The authors did not report limitations.

  154. Chronic fatigue syndrome and women: can therapy help?1992 · case report · 1 in the study
    Summary

    This paper reports a case study of one woman, “Claire,” with chronic fatigue syndrome and Epstein-Barr virus, in psychotherapy with the author. She received insight-oriented psychotherapy; treatment lasted three years. There was no comparison group. The paper reports that psychotherapy helped Claire. It reports that psychotherapy apparently helped her alleviate longstanding symptoms of depression, that her emotional life became calmer, more manageable, and more satisfying, that she had more insight into her previous needs to achieve professionally, and that she was beginning to see her life as approximating “normal” again in terms of health and lack of symptoms. For health over the first 24 months of treatment, the paper reports that her health would appear to improve and then all of a sudden deteriorate. Reported harms include that her health deteriorated during treatment to the point that she felt she had to quit her job, and that she would have a week of overwhelming fatigue and then need complete bedrest. The authors state that it cannot be generalized that insight therapy can help all victims of chronic fatigue syndrome.

  155. The breath and mind connection in young people with post-COVID syndrome: feasibility and acceptability of a pilot randomised co-designed intervention.2026 · combination: given with other treatments · 32 randomised
    Summary

    This randomised pilot trial assessed acceptability and feasibility of a co-designed intervention for children and young people with post-COVID syndrome attending a regional tertiary multidisciplinary service. Thirty-two young people consented and were randomised to standard clinical care (n = 15) or intervention plus standard clinical care (n = 17). The intervention comprised four 3.5-h online group sessions over six months, based on narrative therapy and breathing exercises, plus an interactive digital resource; the comparator received standard clinical care. The primary outcome was the Strengths and Difficulties Questionnaire Impact Score, with secondary outcomes including the Nijmegen questionnaire, Chalder Fatigue, EQ-5D-Y, wellness rating, pulmonary function and exercise testing. The abstract reports no statistically significant improvement in the SDQ over time or between groups. Nearly all secondary outcome measures showed statistically significant improvement over time but not between groups. Thirty-two of 66 eligible young people were recruited; four groups were offered over six months; 17/17 attended one of four possible online workshops. The abstract reports 14/17 completed the session, while the discussion reports 15/17 completed a group. Two did not complete the session (one developed a headache and one struggled with the group environment). Median ratings were 8 for online delivery, 7 for usefulness, 7.5 for sharing ideas and 8 for recommending the group. The authors state the study was not powered to detect change over time.

  156. Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica.2026 · combination: given with other treatments · 2 in the study
    Summary

    This paper reports two case studies from a private psychiatry practice in Jamaica, examining psychological and somatic changes associated with the De La Haye Psilocybin Treatment Protocol (DPTP). Two patients underwent an 8-week outpatient phase of psilocybin-containing mushroom biomass microdoses (1 mg or 2 mg combined psilocybin and psilocin every third day) with psychotherapy every 2 weeks, followed by an optional week 9 therapeutic-dose session (40 mg for Case 1; 60 mg for Case 2). Case 1 presented with depression, anxiety, PTSD and chronic musculoskeletal pain; Case 2 presented with complex PTSD and Long COVID-19 anosmia and ageusia. Both received psychotherapy and an integration session. Follow-up was approximately two months after the therapeutic session; MEQ-30 scores were 99 and 119. Patient reports described improved psychological well-being, reduced shame and social anxiety, reduced shoulder and ankle pain, resolution of diffuse body aches, and an 80-90% return of smell. No serious adverse events were reported, and acute psychedelic effects were not classified as adverse events. The authors state the design lacks a control or comparison group, that validated baseline and follow-up measures were not collected, and that spontaneous improvement cannot be excluded.

  157. Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial.2024 · combination: given with other treatments · 64 in the study · 51 started · 63 with outcome data
    Summary

    This single-group, uncontrolled trial examined feasibility, acceptance, and effectiveness of a CBT-based group program (CBT-PCC) added to routine inpatient neurological rehabilitation for post-COVID-19 condition. It recruited 64 inpatients with a history of mild COVID-19 fulfilling WHO criteria at Kliniken Schmieder Konstanz and Gailingen, Germany. CBT-PCC comprised eight modules of 60 min over four weeks. Participants who attended at least one session (n = 51) completed on average 6.43 of eight modules; 13 (20.3%) attended no session. One participant did not complete pre-intervention assessment and 22 did not complete post-intervention assessment; ITT analysis used n = 63. Post-intervention was after a maximum of four weeks or at discharge. Session evaluation totals ranged from 3.01 to 3.49. At least one adverse event was reported by 85.4% and severe/extremely distressing events by 29.3%. Among pre-post measures, fatigue fell (FSS mean difference −0.38, p = 0.012, dav = 0.33); helplessness fell (−1.08, p = 0.004, dav = 0.39), and acceptance (1.52, p = 0.002, dav = 0.43), perceived benefits (1.34, p < 0.001, dav = 0.49), and self-efficacy (0.25, p = 0.011, dav = 0.33) increased. Somatic symptom distress (p = 0.064), SSD-12 (p = 0.420), depression (p = 0.171), and anxiety (p = 0.175) showed no significant changes; other measures did not yield significant changes. No control group, small sample, and drop-out limit interpretation.

  158. Persistent postural perceptual dizziness (PPPD) in pediatric patients after COVID-19 infection.2024 · combination: given with other treatments · 9 in the study · 8 started · 8 with outcome data
    Summary

    This case series describes 9 adolescent patients with long-COVID and persistent postural-perceptual dizziness (PPPD) referred from a multidisciplinary long-COVID clinic to a pediatric vestibular clinic. Recommended treatment for all PPPD patients included vestibular physical therapy (PT), cognitive behavioral therapy (CBT), and a selective serotonin reuptake inhibitor (SSRI). Eight of 9 agreed to follow-up; follow-up ranged from 1 to 21 months (average: 8.8 months). All 8 patients underwent vestibular PT, attending an average of 27.4 (range: 11–60) sessions over an average of 4.9 (range: 1.5–8) months. 7/8 also underwent CBT with an average of 27 (range: 6–67) sessions, and 5/8 took an SSRI for an average of 7.8 (range: 1–13) months. The paper reports no comparison group. Outcomes included the DHI-pc, the Niigata PPPD questionnaire, and patient-reported percentage change. The average estimated percentage improvement in overall symptoms was 63 % (range 0–100 %), and in activity level was 73 % (range 10–100 %). DHI-pc scores improved in all patients by 18 points on average (range: 2–54; p = 0.017), and the percentage improvement in DHI-pc score was 35 % on average. The average post-treatment Niigata PPPD score was 18.5 (range: 0–50). Dizziness improved in 75 % of patients and remained stable in 25 %. At follow-up all patients attended school 5 days a week, ranging from 3 to 6.5 (average: 4.5) hours per day. None of the patients experienced new symptoms at follow-up; all but 2 experienced set-backs during follow-up. The paper does not report withdrawals, and no withdrawal is described in connection with harms. Authors state limits including selection bias.

  159. Effects of cognitive training and group psychotherapy on cognitive performance of post COVID-19 patients: an exploratory and non-randomized clinical trial.2024 · combination: given with other treatments
    Summary

    This exploratory, non-randomized, non-blinded controlled clinical trial enrolled Post COVID-19 (PC) patients at the Post-COVIDLMU outpatient clinic. A total of 19 PC patients started the intervention group; 15 completed it. The intervention was a weekly group of cognitive training and group psychotherapy for 8 weeks: the first session was 90 min of group psychotherapy, and subsequent sessions were 45 min of group psychotherapy followed by 45 min of cognitive training. A control group of 15 PC patients did not participate in the intervention and underwent two cognitive assessments. Cognitive performance was assessed before and after intervention group participation; the interval was 113.87 days on average in the intervention group and 121.53 days in the control group. Within the intervention group, significant improvements were found for most cognitive measures. Significant time x group interactions were only detected in some dimensions of verbal memory and visuo-spatial construction skills; there was no significant interaction effect in the other 16 variables. Significant time effects were observed for attention, concentration, memory, executive functions, and processing speed. BDI-II depressive symptomatology decreased significantly in the intervention group (p = .004). In the intervention group, 96% found the group helpful, 92% found the topics relevant, 88% were satisfied with the course, and 76% could implement the content in daily lives. On average each patient participated in 5 to 6 of 8 therapy sessions, and six of 15 completed all 8 sessions. Four intervention participants dropped out, one due to deterioration of his physical condition; patients also reported burden of the journey and subjective exhaustiveness. The authors state limitations of small sample size and non-randomized design.

  160. Depression and brain fog as long-COVID mental health consequences: Difficult, complex and partially successful treatment of a 72-year-old patient-A case report.2023 · combination: given with other treatments · 1 in the study
    Summary

    This case report describes one 72-year-old female with long COVID after COVID-19 infection, treated in a neurological day hospital and a psychiatric inpatient unit and followed as an outpatient. There was no comparison group. Between June 17 and July 8 2022 she was treated in a neurological day hospital without improvement in her health status. She then received outpatient psychiatric help and antidepressant therapy with sertraline 50 mg per day and mirtazapine 15 mg per day for almost 2 months, without significant improvement in her condition. In the psychiatric inpatient unit, between August 29 and September 23, 2022, she received venlafaxine up to 75 mg per day, trazodone up to 50 mg in the evening, nutritional supplements, enteral feeding, and non-drug therapy (visual art, music, drama, dance and movement therapy, occupational therapy, psychotherapy, physiotherapy). At hospitalization, PHQ-9 was 21 and CGI-S was 6; at discharge PHQ-9 was 8, CGI-S 3, and CGI-I 2. At the last outpatient follow-up visit on 01/5/2023, PHQ-9 was 5, CGI-S 3, and CGI-I 2. Mood, energy, anxiety, and sleep improved, but rapid fatigability, difficulty concentrating, unclear thinking, forgetfulness, and brain fog persisted; weight remained 48 kg with no weight gain, and she remained unable to resume work. Side effects and withdrawals were not reported.

  161. 0425 New onset insomnia following COVID-19 infection2022 · combination: given with other treatments · 3 in the study
    Summary

    This retrospective chart review described three patients without a prior history of insomnia who developed new-onset insomnia during or following COVID-19 infection and presented to an ambulatory sleep clinic. There was no comparison group and no randomisation. Patient 1's symptoms improved after 5 months with a combination of hydroxyzine and cognitive behavioral therapy for insomnia (CBTi). For Patient 2, hydroxyzine and trazodone were ineffective, and symptoms improved with zolpidem and CBTi. Patient 3 had a severe COVID-19 course requiring management in the intensive care unit, with insomnia onset coinciding; polysomnography found moderate obstructive sleep apnea and periodic limb movements, and the patient was treated with positive airway pressure therapy and a dopamine agonist, with plans to follow up to reassess insomnia severity. Harms and side effects were not reported for any patient, and no withdrawals were described. Funding and conflicts were not reported. The authors state that further work is needed to understand the prevalence of new-onset insomnia after COVID-19 and the best therapeutic approaches.

  162. Excessive eating and weight gain:A rare post-acute COVID-19 syndrome.2021 · combination: given with other treatments · 1 in the study
    Summary

    This case report described why the authors reported a rare occurrence of polyphagia following acute COVID-19 illness. The patient was one 41-year-old female who had fully recovered from acute COVID-19 pneumonia six months prior and was referred by her primary care physician at the COVID-19 treatment to a psychiatric facility. She received psychotherapy and behavioral management for polyphagia, including creating a timetable for eating and taking caffeine instead of porridge; treatment duration was not reported. There was no comparison group. The report measured appetite and BMI. By the time of writing, the patient reported a mild decrease in her appetite, and BMI was maintained. Harms and withdrawals were not reported. The authors concluded that polyphagia may be one of the rare post-acute COVID-19 syndromes and requires further research. They stated that more studies are warranted to understand the etiology, diagnosis, and management of post-acute COVID-19 syndrome-related polyphagia, and that the role of pharmacological drugs may require further studies.

  163. [NATURAL THERAPEUTIC FACTORS IN MEDICAL REHABILITATION OF PATIENTS WITH POST-COVID-19 AT OUTPATIENT TREATMENT STAGE].2021 · combination: given with other treatments · 64 in the study
    Summary

    This abstract reports a study at Nalchik resort of 64 patients with corona virus disease COVID-19 / Post-COVID-19 syndrome at outpatient treatment stage. Patients were allocated to a comparison group of 30 and a main group of 34. The comparison group received mineral water «Nalchik», exercise therapy, foam cocktails and rectal suppositories with thick licorice root extract. The main group additionally received natural aeroionophyto therapy along the route of mid-mountain natural park of Nalchik resort combined with exercise therapy and group psychotherapy in park curative grounds and nitrogen thermal baths. Assessment used the «Medical Research Council» (mMRC) scale, glycyrrhic acid level in blood serum, functional tests and cardiointervalography. In the main group, the abstract reports a reduction of apnea by 29,4% (p<0,01) compared with primary data, an average increase in adaptation capacity by 42,4% (p<0,01), an average improvement of physical activity by 36,2% (p<0,01), and normalization of hemodynamic parameters. It also states the result was significantly better (by 20-25%, p<0,05) compared to the treatment in the group of comparison, without naming the outcome. Duration, analysed sample size, side effects, harms and withdrawals are not reported.

  164. Case Report: Overlap Between Long COVID and Functional Neurological Disorders.2021 · combination: given with other treatments · 1 in the study
    Summary

    This case report describes one patient, a 23-year-old man who developed fatigue, episodic shortness of breath, nocturnal tachycardia, chest pain, attention and memory difficulties, fluctuating limb dysesthesia, and left arm weakness after asymptomatic COVID-19. He was evaluated at a post-COVID center and received a diagnosis of post-COVID-19 syndrome; after neurological examination, a diagnosis of functional neurological disorder was made, and he was referred to the authors' center for FNDs. The patient received psychoanalytic psychotherapy and targeted physical therapy for 4 months. There was no comparison group. Outcomes described were dysesthesia, motor symptoms, subjective cognitive complaints, return to studies and social activities, physical activity, post-exertional malaise, chest pain, and fluctuating muscle tension. After 4 months, dysesthesia and motor symptoms had resolved, and subjective cognitive complaints had improved significantly. The patient returned to his studies and social activities but had not fully resumed physical activity. Post-exertional malaise, chest pain, and fluctuating muscle tension in his back and left arm persisted. The patient had not fully recovered, as mild symptoms persisted limiting physical activities. Side effects were not reported. The authors do not report a formal limitations section.

  165. Biofeedback and cognitive behavioral therapy for Egyptian adolescents suffering from chronic fatigue syndrome2015 · combination: given with other treatments · 159 randomised · 96 started · 92 analysed
    Summary

    THIS STUDY enrolled 92 Egyptian adolescents with chronic fatigue syndrome (CFS) from schools in Eastern Province, Saudi Arabia, after 298 were screened and 159 found eligible; 63 lost follow-up and four were excluded because they switched groups. Participants were randomly allocated to an interventional group of 50 receiving CBT aided by biofeedback over 18 months in 40–60 sessions ranging from once up to twice weekly and tapered, or a control group of 42 treated conservatively and symptomatically. Outcomes were fatigue severity on the Checklist Individual Strength/Fatigue Assessment Scale, school attendance in hours/month, and self-rated CFS symptoms. At the end of trial, fatigue severity was lower in the interventional group (32.2 ± 3.8 vs 46.5 ± 14.2; difference in means 12.23, 95% CI 7.4–14.8, p=0.02), and school attendance was higher (92.8 ± 18.4 vs 66.6 ± 22.8 hours/month; difference 23.14, 95% CI 20.6–26.8, p=0.004). Within the interventional group, fatigue severity decreased by 23.1 (95% CI 19.2–25.4; p<0.001) and school attendance increased by 34.46 (95% CI 29.8–36.6; p<0.001). Within the control group, changes were not significant: fatigue 4.46 (95% CI 1.12–21.44; p=0.62) and school attendance 3.44 (95% CI 2.12–32.13; p=0.78). Self-rated unrefreshing sleep, headache, and myalgia improved (p=0.002, 0.005, 0.03); joint pains and tender glands did not (p>0.05). Harms were not reported for the interventional group; in the control group, 18 cases showed almost no changes or worsening in outcome parameters.

  166. Cognitive dysfunction and mental fatigue in childhood chronic fatigue syndrome--a 6-month follow-up study.2011 · combination: given with other treatments · 19 started · 19 with outcome data
    Summary

    Nineteen patients with childhood chronic fatigue syndrome (CCFS) and 25 healthy controls took part in a 6-month follow-up study. The CCFS patients received cognitive behavioral therapy (CBT) once a month plus pharmacotherapy for 6 months, with on average five sessions of 30–60 min. Healthy controls were recruited from the community and did not receive the treatment. The study measured performance status (PS) and Chalder’s fatigue scale, plus the modified advanced trail making test (mATMT). PS scores improved from 4.4 at baseline to 3.2 at follow up (P = 0.01). Fatigue scores showed no significant change: physical fatigue went from 14.7 to 14.5 (P = 0.854), mental fatigue from 9.6 to 8.2 (P = 0.275), and total fatigue from 24.1 to 22.7 (P = 0.407). On mATMT task E, reaction time improved from 59.6 s to 51.6 s (P = 0.014), and the difference in reaction time improved from 47.1 s to 38.4 s (P = 0.011); tasks A, B, and C did not differ significantly from baseline to follow up. Change in mental fatigue correlated with change in task E difference in reaction time (r = 0.653, P = 0.002), as did total fatigue (r = 0.639, P = 0.003); physical fatigue did not (r = 0.33, P = 0.168). Harms were not reported.

  167. Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome.2001 · combination: given with other treatments · 1 in the study
    Summary

    This case report describes one 25-year-old male who came to a hospital in August 1998 with general fatigue and fever (38.7°C) and was later diagnosed with CFS related to CMV infection. The report states that cognitive behavioral therapy was performed, with medication and relaxation for anxiety, depression and insomnia, and massage and hyperthermia for myalgia and arthralgia. The text reports that his symptoms improved after 3 months of therapy, but that he went home and his anxiety about rehabilitation to work and fear of CMV infection became stronger, and his symptoms deteriorated. A 10-day fasting therapy was then initiated; he drank two liters of water per day, and a drip infusion of Ringer solution (500 ml) was started when his urinary ketone body became positive. The fasting therapy transiently worsened his physical and mental subjective symptoms, and the text also states that his physical and psychological symptoms worsened during the 10-day fast. After the fasting therapy, the text reports that his physical and mental subjective symptoms subsided and his fatigue was alleviated; he gained self-confidence after fasting therapy. Stepwise exercise therapy was prescribed and he was discharged. There has been no recurrence one year after he returned to work. There was no comparison group; this is a case report of one patient.

  168. A multidimensional treatment plan for chronic fatigue syndrome1999 · combination: given with other treatments · 81 in the study · 64 with outcome data
    Summary

    This pilot study without a control group assessed a cumulative multidimensional treatment plan in 81 patients with chronic fatigue syndrome fulfilling Oxford criteria, referred to the Glasgow Homoeopathic Hospital. Treatment was added monthly over 6 months: a wheat-free diet with nutritional supplements, then homoeopathic treatment of allergies, then homoeopathic constitutional remedies, then psychotherapeutic techniques for self-image and inner resources. Outcomes were clinical evaluation and six questionnaires. Sixty-four patients completed the study. Of these, 45 (70%) reported clinical improvement with a positive effect on daily living; the same patients reported improvement in the six questionnaire scores, apart from 4 patients who did not improve their scores in two tests. No patient deteriorated. Mean monthly questionnaire scores declined steadily over the first four months and then steadied; scores after 4 months were significantly lower than on entry for the group as a whole and for the allergic, non-allergic and female subgroups, but not for the men. More women improved than men (38/51 versus 7/13), a difference reported as not quite significant. Patients with and without allergies were reported to improve to the same extent. Seventeen patients dropped out: 2 could not organize the wheat-free diet, 1 was a baker, 2 withdrew on religious grounds related to the ego-strengthening exercises, 4 improved but did not complete, and the reasons for the remaining 8 were not ascertained. The authors call for a randomized controlled trial.

  169. Eicosanoids and essential fatty acid modulation in chronic disease and the chronic fatigue syndrome.1994 · combination: given with other treatments · 29 started · 29 with outcome data
  170. Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome.2024 · how it is prescribed, safety only · 200 with outcome data
    Summary

    This single-cohort retrospective study with a follow-up survey investigated symptomatic treatment use and patient-reported improvement in post-COVID syndrome. It included 200 patients attending the post-COVID center of the University Hospital of Erlangen between December 2022 and July 2023, with symptoms persisting at least three months after SARS-CoV-2 infection; vaccine-related symptom onset was excluded. Baseline records captured symptomatic therapies from three months post-infection until presentation. A follow-up questionnaire was completed by 165 patients (response rate 82.5%), a mean 6.3 months (SD = 2.2) after initial consultation. Treatment duration was not reported. There was no control group; patients rated improvement within the same cohort for each therapy they used, using 0 = no improvement to 3 = very strong improvement. Among therapy users, strong to very strong improvement was reported by 12 of 38 for beta-blockers, 8 of 27 for antibiotics, 5 of 15 for plasmapheresis, and 8 of 73 for outpatient psychotherapy. Vitamins and nutritional supplements were rated 9 of 135. No between-group comparison was reported. Harms, side effects, worsening and withdrawals were not reported. The authors state that the study gives initial insights into utilization and patient-reported symptom improvement.

  171. PSYCHONEUROLOGICAL THERAPY FOR POST-COVID SYNDROME: A COMPREHENSIVE REVIEW OF METHODS AND CLINICAL EFFECTIVENESS.2026 · systematic review
    Summary

    Review of psychoneurological therapies for post-COVID syndrome in adults with persistent cognitive, emotional or neurological symptoms. No new participants were enrolled; eligible randomized controlled trials, observational studies and clinical reports published up to 2024 were summarized narratively. The review describes SSRIs, SNRIs, anxiolytics, antipsychotics, nootropics, CBT and psychodynamic therapy, mindfulness, physiotherapy and exercise, breathing, massage, acupuncture, social rehabilitation, TMS and ECT. It reports that in a randomized clinical trial (2021), SSRIs reduced depression and anxiety in 150 PCS patients, with 60% improving on the Hamilton scale after 12 weeks; venlafaxine improved cognitive function and reduced anxiety in 80 patients compared with placebo. CBT produced marked improvement in 65% after 8 weeks, and a 60% reduction in post-traumatic symptoms was observed in another CBT study. Acupuncture was followed by substantial improvement in 65%, social rehabilitation helped 75% regain social and occupational abilities, and physiotherapy improved endurance and reduced chronic fatigue in 80%. Harms mentioned include risk of dependence with benzodiazepines, mild headaches or localized discomfort with TMS, and short-term memory loss or cognitive disturbances with ECT. The authors state that individualized, combined strategies are most effective; they note that each strategy has limitations and requires further research.

  172. Rehabilitative efficacy of cognitive behavioral therapy-based intervention for chronic fatigue syndrome: A systematic review and meta-analysis.2026 · systematic review
    Summary

    This systematic review and meta-analysis asked whether CBT-based interventions improve fatigue, physical function and psychological health in chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis. The authors searched PubMed, Web of Science, Embase and the Cochrane Library from inception to March 2025 and included 15 randomized controlled trials with 2270 participants; follow-up periods ranged from 3 to 24 months. CBT-based interventions were compared with control groups. Outcomes included CFQ and CIS fatigue scores, SF-36 PF physical function, SCL-90 psychological health, HADS anxiety and depression, and adverse events. Pooled results reported lower CFQ fatigue (SMD = −0.44, 95% CI −0.57 to −0.32), lower CIS fatigue (SMD = −0.88, 95% CI −1.16 to −0.60), higher SF-36 PF (SMD = 0.32, 95% CI 0.23 to 0.41), lower SCL-90 (SMD = −0.44, 95% CI −0.62 to −0.26), lower HADS anxiety (SMD = −0.27, 95% CI −0.45 to −0.09) and lower HADS depression (SMD = −0.28, 95% CI −0.46 to −0.10). Short- and long-term follow-up analyses also reported CFQ and SF-36 PF improvements. For adverse events, the pooled odds ratio was 0.61 (95% CI 0.36 to 1.01, P = .06), reported as no statistically significant difference. The text also notes adverse events in White et al and worsening depressive symptoms in the intervention group in Sharpe et al. The authors state limitations including restriction to English-language RCTs and limited subgroup studies.

  173. Systematic Review of Randomized Clinical Trials for the Treatment of Long COVID Syndrome.2026 · systematic review
    Summary

    This systematic review asked whether treatments for long COVID improve outcomes. It searched MEDLINE through PubMed from 2020 to August 2024 and included 43 randomized clinical trials of people with long COVID. The trials compared interventions with control groups or other treatments and reported a primary outcome. Treatments included nutraceuticals, respiratory muscle training, supervised exercise or pacing, brain stimulation, and medications. Outcomes included symptoms, exercise capacity, Vo2 max, fatigue, cognitive functions, inspiratory pressure, pain, and olfactory and gustatory function. The review reports that all studies testing supervised exercises improved the primary outcome except for one; all but one brain stimulation study improved the primary outcome; and only 2 studies using medications improved the primary outcome. Nirmatrelvir/ritonavir did not improve symptoms; donepezil and lithium did not improve their primary outcomes; thermal water inhalation and a metabolic modulator did not improve the primary outcome. Creatine improved fatigue; vitamin C improved exercise capacity; inspiratory muscle training improved symptoms, exercise capacity and inspiratory pressure. Reported harms included 33% with adverse events (dry mouth) with amantadine, 16% nausea with creatine, 17%–37% adverse events with TMS, two to four percent TMS discontinuation, and 8% inspiratory muscle training discontinuation. The authors state the evidence was mostly low certainty.

  174. Comparative efficacy and safety of pharmacological interventions for the treatment of long COVID in adults: a systematic review and network meta-analysis2026 · systematic review
    Summary

    A systematic review and network meta-analysis examined pharmacological treatments for long COVID in adults, including trials on COVID-19 symptoms related to long COVID. Records were searched in PubMed/MEDLINE, Cochrane Library, Embase, CINAHL, PsycINFO and Web of Science from the beginning of 2020 to October 31, 2022. The review included 129 studies: 109 RCTs and 20 observational studies. The number of patients enrolled or analysed in the review was not recorded in the extracted data, and treatment duration or follow-up was not reported. Treatments included ivermectin mucoadhesive nanosuspension nasal spray (Aref 2021, 114 patients; Aref 2022, 96 patients), oxaloacetate, anticoagulants, hyperbaric oxygen and others; comparisons were against control (placebo/SOC) or other interventions. Outcomes included mortality, hospital admission, ICU admission, mechanical ventilation, symptom recovery, adverse events, serious adverse events, major bleeding, olfactory scores and thrombotic events. The extracted results contained no between-group result. Recorded harms included higher adverse-event odds with high-dose zinc (OR=21.87, 95%CI [1.25, 383.45]), high-dose vitamin C (OR=56.11, 95%CI [3.26, 966.29]) and tocilizumab (OR=9.64, 95%CI [2.76, 33.75]); major bleeding with treatment-dose anticoagulants (OR=1.86, 95%CI [1.19, 2.89]) and increased ICU admission with propolis. Stopping or dose change was not reported. The authors stated that some results came from a single study or studies with high RoB.

  175. Effectiveness of physical, psychological, and alternative interventions for post-COVID-19 condition: a systematic review.2026 · systematic review
    Summary

    This systematic review asked whether supervised physical, psychological and alternative non-pharmacological treatments help adults with post-COVID-19 condition. It included 27 randomized trials with 1,998 participants; trials were supervised and face-to-face and compared interventions with usual care, placebo/sham or active comparators. Interventions included cardiopulmonary rehabilitation, multimodal and unimodal exercise, CBT and lifestyle programmes, neuromodulation, oxygen therapies, acupuncture and balneotherapy. Intervention durations varied. The review reported that cardiopulmonary rehabilitation and multimodal exercise consistently improved cardiorespiratory fitness and walking capacity; CBT and lifestyle adjustments significantly reduced fatigue and subjective concentration complaints. Examples recorded: in 114 participants, CBT lowered CIS-fatigue by a between-group mean difference of −8.8 points (95% CI −11.9 to −5.8); in 70 participants, active HD-tDCS plus rehabilitation lowered MFIS total fatigue by a between-group difference of −14.03 points (95% CI −20.28 to −7.78). Findings for neuromodulation, complementary and oxygen therapies were heterogeneous, often showing no benefit over placebo. For example, HBOT did not produce significantly greater improvements than sham on any primary or secondary outcome. Side effects and withdrawals were not reported in the recorded data. The authors state that the evidence does not support definitive conclusions about the effectiveness of any intervention category.

  176. Cognitive Interventions and Rehabilitation to Address Long-COVID Symptoms: A Systematic Review.2026 · systematic review
    Summary

    This systematic review examined cognitive interventions and rehabilitation for adults with long COVID symptoms. It included 19 articles identified from MEDLINE, CINAHL, PsycINFO, Cochrane Trials, and Scopus, with a search date of July 25, 2023. The review summarized cognitive training, CBT, neurostimulation, combined neurostimulation and cognitive training, and multicomponent rehabilitation programs. Included studies had different designs; the review itself had no comparison group. In a 100-participant randomized trial, an amygdala and insula retraining program was reported to decrease fatigue and increase energy versus control. A 114-participant randomized trial reported CBT reduced fatigue versus care as usual and favored CBT on secondary measures. A 73-participant pre-post study reported higher cognitive scores in all assessed domains after computerized cognitive training. A 64-participant pre-post program reported 42.8% complete recovery and 68% varying improvement in cognitive function, plus significant improvement on the Barthel Index. A 33-participant program reported improved mood, self-efficacy, and participation but no significant fatigue improvement. A 12-participant program reported that all 12 gained insight and 11 reported increased work-life coping. One case report reported short-term memory decreased 15% to 22%. Stopping and side effects were not reported.

  177. Effectiveness of Non-Pharmacological Interventions for Fatigue in Long COVID: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026 · systematic review
    Summary

    This systematic review and meta-analysis included 13 RCTs with 1276 participants with long COVID. It compared non-pharmacological interventions—exercise training, cognitive behavioural therapy, non-invasive neuromodulation, and nutritional supplementation—with control conditions. Fatigue severity was assessed with validated instruments. The review reported that exercise training was the only modality associated with a statistically significant reduction in fatigue. For CBT, non-invasive neuromodulation, and nutritional supplementation, the review did not observe a statistically significant pooled effect. The difference in effects between intervention modalities was not statistically significant (p = 0.286). Harms were reported in several trials: two participants discontinued the exercise intervention (transient worsening of fatigue), and 2 participants of the training groups stopped (worsening of their symptoms in response to the intervention). In one trial there were eight AEs (four PEM, two musculoskeletal issues, one nausea and one atypical chest pain) and one unrelated SAE. In another, eight of the sixteen patients receiving active tDCS and nine of the seventeen assigned to sham tDCS experienced mild to moderate side effects such as burning or tingling. The review notes that overall certainty is low to moderate, with substantial between-study heterogeneity and limited RCTs for non-exercise interventions.

  178. Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review and Component Network Meta-Analysis.2026 · systematic review
    Summary

    This systematic review and component network meta-analysis examined CBT components and delivery formats for CFS/ME. It included 19 RCTs with 2429 participants identified through database searches. CBT was delivered individually, in groups, or via guided self-help; treatment duration was not reported here, and follow-up was a median of 48 weeks. Comparisons were minimal intervention (waitlist or usual care) or a nonspecific treatment effect component. Outcomes included fatigue, physical function, and depression immediately after treatment and at follow-up. For fatigue immediately after treatment, twelve trials including 1637 participants reported guided self-help CBT (MD −6.89; 95% CI −9.56 to −4.22; moderate certainty), individual CBT (MD −4.81; 95% CI −6.98 to −2.65; moderate certainty), and group CBT (MD −7.47; 95% CI −10.54 to −4.39) versus minimal intervention. Component analyses found goal setting (iMD −8.83; 95% CI −16.92 to −0.74), third-wave components (iMD −6.02; 95% CI −11.33 to −0.72), and cognitive restructuring (iMD −4.41; 95% CI −8.83 to 0.01) associated with reduced fatigue; psychoeducation was potentially detrimental (iMD 5.23; 95% CI 0.64 to 9.82). At follow-up, cognitive restructuring was associated with lower fatigue (iMD −2.69; 95% CI −4.32 to −1.07), better physical function (iMD 10.42; 95% CI 5.53 to 15.31), and lower depression (iMD −0.65; 95% CI −1.18 to −0.13); goal setting was associated with better physical function (iMD 18.76; 95% CI 5.77 to 31.74). The combination of goal setting, third-wave components, and cognitive restructuring via guided self-help had iMD −16.33 (95% CI −26.68 to −5.99). Numbers who stopped treatment or side-effect counts were not reported.

  179. Effectiveness and safety of exercise therapy in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a meta-analysis.2025 · systematic review
    Summary

    This meta-analysis asked whether exercise therapy changes fatigue and harms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The authors searched PubMed, Web of Science, Embase, and Cochrane to March 2024, with an update on June 7, 2025, and analyzed 13 studies with 1,305 patients: 659 in intervention groups and 646 in control groups. Interventions included aerobic training, guided graded exercise self-help, graded exercise therapy, gradual exercise, and Qigong forms. Control conditions included control, standard medical care, adaptive pacing therapy, CBT, and heart rate variability biofeedback. Outcomes were fatigue scale-14 (FS-14), multidimensional fatigue inventory (MFI-20), and adverse effects. The meta-analysis reported lower total, physical, and mental fatigue scores on FS-14 with exercise therapy than control; on MFI-20, physical fatigue and reduced activity improved, while general fatigue, mental fatigue, and reduced motivation did not differ significantly. Subgroup analysis reported conventional exercise was more favorable for total and physical fatigue, while Qigong was more favorable for mental fatigue. For harms, Clark et al. reported non-serious adverse events in ~1/4 of participants in both the intervention group and the control group, one case of serious adverse events in both groups, and no serious adverse reactions in either group; severe deterioration difference was not evident. Another study reported non-serious adverse events frequently, serious adverse events and severe adverse reactions relatively rare, and severe deterioration uncommon. The authors note publication bias and limitations.

  180. Cognitive behavioural therapy for the treatment of chronic fatigue syndrome in adults - a meta-analysis.2025 · systematic review
    Summary

    This meta-analysis examined cognitive behavioural therapy (CBT) for adults with chronic fatigue syndrome (CFS), excluding Oxford-defined cohorts, compared with non-CBT treatment. It pooled 12 studies with 1799 total participants. CBT was delivered as individual face-to-face, self-directed, or group CBT, for durations that varied across trials; comparators were non-CBT treatments. Fatigue was the primary outcome; physical functioning, anxiety, depression, pain, quality of life and 6-month follow-up were also assessed. All forms of CBT together did not significantly reduce fatigue (Cohen's d = 1.49, 95% CI -0.37 to 3.36, p=0.12). Individual face-to-face CBT showed a significant fatigue effect (Cohen’s d = 2.91, 95% CI 0.51 to 5.31, p = 0.02); group and self-directed CBT were non-significant. Self-directed CBT significantly improved physical functioning (Cohen's d = -2.76, 95% CI -5.06 to -0.47, p = 0.04); other physical functioning analyses, anxiety, depression, pain and quality of life were non-significant. At 6 months, fatigue and physical functioning were non-significant. Núñez et al. reported poorer physical functioning and bodily pain scores in the group CBT intervention group than comparator; Janse et al. reported approximately 15% and 26% adverse effects; Gotaas et al. noted 2% and 5%; no study reported serious adverse events. Dropout rates varied from 8% to 43.4%; average 18.8% intervention and 12.5% comparator. The authors state high heterogeneity and incomplete reporting limit certainty.

  181. Effect of nonpharmacologic therapies on depressive symptoms in patients with chronic fatigue syndrome: a network meta-analysis.2025 · systematic review
    Summary

    This network meta-analysis examined nonpharmacologic therapies for depressive symptoms in patients with chronic fatigue syndrome (CFS). The authors searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, Wanfang, CBM, VIP, and Sinomed for randomized controlled trials until March 26, 2025, and included 47 RCTs involving 4,028 participants. The review compared nonpharmacologic interventions with control conditions and measured depression or depressive symptoms with scales. Compared with control, the review reports significant differences for acupuncture (SMD = -1.91, 95% CI: -2.9 to -0.94), moxibustion (SMD = -2.91, 95% CI: -4.61 to -1.22), Tuina (SMD = -2, 95% CI: -3.64 to -0.38), diet therapy (SMD = -5.64, 95% CI: -8.98 to -2.29), electrical stimulation (SMD = 1.9, 95% CI: 0.03 to 3.78), Ap + Mox (SMD = 2.53, 95% CI: 1.17 to 3.91), and Ap + Mox + Ae (SMD = 3.16, 95% CI: 0.39 to 5.98). The review states that relaxation therapy, AER, RT, and Qigong did not markedly improve depressive symptoms, and psychotherapy did not show significant effects. Harms were not reported as counts; the review includes a statement that graded exercise therapy may exacerbate symptoms in certain CFS patients, a statement about exercise therapy, the patient’s energy limit, characteristic post-exertional malaise (PEM), and efficacy, and a statement that Tuina has no adverse reactions. The authors state heterogeneity, inconsistent depression scales, and medium risk of bias in most included studies, with some interventions from few small studies, so results should be viewed with caution.

  182. Applicability and adaptation of cognitive behavior therapy for long COVID neuropsychiatric symptoms: a review with insights from ME/CFS.2025 · systematic review
    Summary

    This narrative synthesis examined cognitive behavior therapy (CBT) for long COVID and ME/CFS. The authors state it is a narrative synthesis rather than a formal systematic review. A focused ClinicalTrials.gov search covering trials registered between May 2022 and October 2024 identified 189 potentially relevant trials, with 10 meeting final inclusion criteria. The paper did not give a treatment, duration, or follow-up for its own study; it summarized named studies. In the ReCOVer trial, CBT was reported to reduce severe fatigue compared with usual care (mean difference −8.5 points on the Chalder Fatigue Scale; 95% CI −12.3 to −4.7; p < 0.001). A living systematic review reported moderate-certainty evidence that CBT reduces fatigue (mean difference −8.4, 95% CI −13.11 to −3.69) and improves concentration (mean difference −5.2, 95% CI −7.97 to −2.43) in long COVID. In ME/CFS, one systematic review reported a fatigue reduction versus controls (g = −0.52, 95% CI −0.69 to −0.35); an individual patient data meta-analysis reported a fatigue-severity benefit (β = −11.46, 95% CI −15.13 to −7.79, p < 0.001) and no indication that patients meeting different case definitions or reporting post-exertional malaise benefited less. A brief outpatient program with cognitive-behavioral elements reported improved physical function (difference 9.2; 95% CI 4.3–14.2; p < 0.001); a concentrated group rehabilitation program reported 99% completion. The review also cited that 74.8% reported symptom exacerbation following physical activity, 21.0% mixed effects, and 28.7% no worsening.

  183. Psychotherapy in patients with long/post-COVID - A systematic review on the feasibility, acceptability, safety, and efficacy of available and emerging interventions.2025 · systematic review
    Summary

    This systematic review asked whether psychotherapy for long/post-COVID has been studied and what is known about feasibility, acceptability, safety, and efficacy. It searched PubMed, PsycInfo, and Web of Science on February 8, 2024 and included 12 studies of people with long/post-COVID; reported sample sizes in the recorded data include 16, 30, 33, 44, 51, 57 per group, 63, 64, 123, and 224. Treatments were psychotherapy, mostly CBT-based, often delivered within multimodal rehabilitation; one RCT compared CBT for post-COVID fatigue with care as usual. The recorded data do not state treatment durations. Outcomes included fatigue, pain, dyspnea, anxiety, depression, quality of life, cognitive symptoms, and physical functioning. Many pre-post improvements were reported. In the RCT, between-group differences favored CBT for fatigue, physical functioning, somatic symptoms, social functioning, and concentration problems at T1 and T2 (Cohen’s d=0.74 at post-treatment; Cohen’s d = 0.65 at six-month follow-up). Some findings were not significant: Hasting et al. reported no significant improvement in fatigue or sleepiness; Huth et al. reported no significant improvement in somatic symptom distress, depression, anxiety, or psychobehavioral features; Hayden et al. found no significant improvement in pain or anxiety at 6-month follow-up. García-Molina et al. reported poorer performance at 6-month follow-up in the intervention group. Harms included adverse events in Huth et al. (85.4%; severe 29.3%) and Kuut et al. (8 during CBT; 20 during care as usual; no serious adverse events); Compagno et al. reported no adverse cardiovascular events or clinical complications, and Fontana et al. reported no adverse events. Dropouts included 20.3% in Huth et al., 13 % in Kuut et al., twelve in Páez et al., 3 in Hayden et al., and two in Hasting et al.

  184. Systematic review of interventions for mental health, cognition and psychological well-being in long COVID.2024 · systematic review
    Summary

    This systematic review aimed to identify and synthesise publicly available research testing treatments for mental health, cognition and psychological well-being in long COVID. It included 33 documents representing 31 studies and 2477 participants recruited across four continents. The studies covered 7 psychosocial, 5 pharmaceutical, 3 natural supplement, 9 neurocognitive, 2 physical rehabilitation and 5 integrated intervention studies; 11 were RCTs, 2 non-randomised controlled trials, 10 uncontrolled trials, 7 case studies or series and 1 qualitative study. Some controlled trials reported significant group×time interactions: vortioxetine for depression and health-related QoL but not cognition; hyperbaric oxygen for total cognition and psychological distress only; high-definition transcranial direct current stimulation for cognitive and psychosocial fatigue, anxiety and QoL; and a programme combining non-invasive cognitive stimulation and guided mindfulness for mental fatigue, anxiety, depression, mood disturbance and several cognitive domains. Other trials reported no significant group×time interaction, including an adaptogen formulation and the ReCOVERY app. Many uncontrolled studies reported significant prepost improvements, but the authors state these cannot be definitively associated with treatment without a control group. Counts of people who worsened or stopped and side-effect counts were not reported in the recorded data; the authors note many studies did not report adverse events.

  185. Efficacy and Acceptance of Cognitive Behavioral Therapy in Adults with Chronic Fatigue Syndrome: A Meta-analysis.2024 · systematic review
    Summary

    This meta-analysis asked whether cognitive behavioral therapy (CBT) helps adults with chronic fatigue syndrome and whether patients accept it. It included 15 RCTs with 2015 participants; included trials were conducted in Europe (Great Britain, the Netherlands, Norway) and the US and were published between 1996 and 2021. CBT was compared with inactive or non-specific control groups. Outcomes were fatigue, depression, anxiety, perceived health status, and acceptance measures at post-treatment and long-term follow-up (3–12 months). At post-treatment, fatigue favored CBT (g = -0.52, 95%CI -0.69 to -0.35), with smaller effects for perceived health status (0.29, 0.11 to 0.47), depression (-0.36, -0.55 to -0.17), and anxiety (-0.34, -0.62 to -0.07). At long-term follow-up, fatigue remained significant (g = -0.41, 95%CI -0.65 to -0.18) and anxiety showed a small effect (-0.20, -0.36 to -0.03); depression and perceived health status were not significant. Acceptance estimates were non-completion 22% (95%CI 3–71), drop-out 15% (9–25), treatment refusal 7% (3–15), and average sessions completed 84% (56–96). Clinically relevant worsening due to CBT was described as rather rare. The authors note high risk of bias or some concerns and limited generalizability.

  186. The effect of massage on patients with chronic fatigue syndrome: A systematic review and meta-analysis.2024 · systematic review
    Summary

    This systematic review and meta-analysis searched PubMed, Cochrane Library, Web of Science, Embase, Wanfang Database, VIP Database, and China National Knowledge Infrastructure Database until November 2023. It included 32 randomized controlled trials with a total of 2594 CFS patients. The review compared massage therapy with other therapies; treatment duration was not reported. For the outcome effective rate, 28 studies involving 2170 patients were pooled: RR = 1.23, 95% CI 1.19, 1.28. For FS-14 overall score, six studies involving 360 subjects were pooled: MD = −1.59, 95% CI −1.84, −1.34. Mental fatigue score pooled three studies involving 193 subjects: MD = −0.85, 95% CI −0.99, −0.72. Physical fatigue score pooled three studies involving 193 subjects: MD = −1.30, 95% CI −1.60, −1.00. One study reported adverse reactions: local skin swelling occurred in 3 cases in the control group and 2 cases in the observation group; skin bruising occurred in 1 case in the control group and 3 cases in the observation group; nausea occurred in 2 cases in the control group and no nausea symptoms were observed in the observation group. These were described as temporary and not requiring medical treatment; no serious adverse reactions occurred. Withdrawals or worsening were not reported. The authors note most studies did not use blinding and all included literature was Chinese.

  187. Does the effect of cognitive behavior therapy for chronic fatigue syndrome (ME/CFS) vary by patient characteristics? A systematic review and individual patient data meta-analysis.2024 · systematic review
    Summary

    This systematic review and individual patient data meta-analysis asked whether the effect of CBT for ME/CFS varies by patient characteristics. Eight trials with 1298 patients were pooled; all were from the authors’ own research group. Patients were randomly assigned to CBT or a comparison condition, i.e. waiting list or care as usual. Fatigue severity was measured with the CIS-fatigue, functional impairment with the SIP8, and physical functioning with the SF-36. At the second assessment, data were missing for 106 patients (8.2%) on fatigue severity, 89 patients (9.2%) on functional impairment, and 78 patients (8.7%) on physical functioning. CBT showed beneficial effects on fatigue severity (β = −11.46, 95% CI −15.13 to −7.79); p < 0.001, functional impairment (β = −448.40, 95% CI −625.58 to −271.23), p < 0.001, and physical functioning (β = 9.64, 95% CI 3.30 to 15.98), p < 0.001. CBT led more often to clinically relevant reduction of fatigue and functional impairment and improved physical functioning than control. The effect on fatigue severity varied by age, functional impairment and physical activity pattern; adolescents, patients with less functional impairment and patients with a fluctuating activity pattern benefitted more. The effect on physical functioning varied by self-efficacy: CBT improved physical functioning in the high self-efficacy subgroup (β = 12.21, 95% CI 7.15 to 17.27) but there was no significant effect in the low self-efficacy subgroup (β = 4.72, 95% CI −4.37 to 13.81). No moderators for functional impairment were found. Side effects and worsening were not reported.

  188. Is the effect of cognitive behaviour therapy for chronic fatigue syndrome (ME/CFS) moderated by the presence of comorbid depressive symptoms? A meta-analysis of three treatment delivery formats.2024 · systematic review
    Summary

    This meta-analysis pooled data from six randomised controlled trials (n = 1084) of adults with ME/CFS to examine whether depressive symptoms moderate CBT effects differently across internet-based, individual face-to-face and group face-to-face delivery. CBT was compared with control; outcomes were fatigue severity, functional impairment, physical functioning and being no longer severely fatigued post-intervention. For fatigue severity, the three-way interaction was significant (p < 0.001), indicating moderation varied by delivery format. In internet-based CBT, patients with clinically relevant depressive symptoms showed less reduction in fatigue (β =-4.28, 95% CI -7.29 to -1.27) than patients without such symptoms (β =-10.54, 95% CI -13.17 to -7.91; Pinteraction = 0.004). Significantly fewer patients with depressive symptoms were no longer severely fatigued after internet-based CBT (22%) than patients without depressive symptoms (43%) (RR = 0.73, 95% CI 0.62 to 0.87; p < 0.001). In individual face-to-face and group CBT, moderator effects on fatigue severity were not statistically significant. For functional impairment, the three-way interaction was statistically significant (p = 0.080), but subgroup moderator effects were not statistically significant. For physical functioning, the three-way interaction was not statistically significant (p = 0.350). No side effects or withdrawals are reported in the text.

  189. Interventions for the management of long covid (post-covid condition): living systematic review.2024 · systematic review
    Summary

    This living systematic review assessed drug and non-drug interventions for long covid in adults. It included 24 unique trials with 3695 patients, predominantly from the Americas or Europe. One trial (n=114) compared an online CBT programme called “fit after covid” with usual care; moderate certainty evidence suggested CBT probably reduces fatigue (mean difference −8.4, 95% CI −13.11 to −3.69) and probably improves concentration (mean difference −5.2, −7.97 to −2.43). One trial (n=585) compared combined physical and mental health rehabilitation with one session of online advice and support; moderate certainty evidence suggested it probably increases recovery or important improvement (161 more per 1000 patients, 95% CI 61 more to 292 more), improves quality of life (mean difference 0.04, 95% CI 0.00 to 0.08), and reduces depression (mean difference −1.50, −2.41 to −0.59), with little or no effect on physical and cognitive function or anxiety. Intermittent aerobic exercise 3-5 times weekly for 4-6 weeks probably improves physical function compared with continuous exercise (mean difference 3.8, 95% CI 1.12 to 6.48; n=110). Vortioxetine for eight weeks did not improve cognitive function; coenzyme Q10 500 mg/day for six weeks probably did not improve quality of life (n=119); SIM01 might alleviate fatigue (200 more per 1000 patients, 95% CI 94 more to 336 more; n=463) but probably did not improve quality of life. No instances of post-exertional malaise were reported in the rehabilitation trial; effects on serious adverse events were very uncertain.

  190. Qigong and Tai Chi for ME/CFS: A Systematic Review of Randomized Controlled Trials.2024 · systematic review
    Summary

    This systematic review examined randomized controlled trials of Qigong or Tai Chi for ME/CFS. The search identified 5 Qigong RCTs (k = 5; N = 481), published from 2012 to 2023; no trials of Tai Chi utilized a randomized control design. All 5 studies were conducted outside the U.S., with k = 2 in China and k = 3 in Hong Kong. Sample sizes ranged from N = 40 to N = 150. Qigong sessions tended to last 60-120 mins, occur across 5-12 weeks, and include 10-16 sessions; all were delivered in groups and incorporated at-home practice. Controls were most commonly a waitlist (k = 3) or cognitive behavioral therapy (k = 2). Outcomes included ChFS, MFI-20, PSQI, HADS, SF-36, SF-12, neuropeptides, and telomerase. The review reports ChFS results including P < 0.001 and MFI-20 results including Xie 2023 general fatigue P = 0.003 and Xie 2022 general fatigue P = 0.516. Increased telomerase activity was found in the Qigong group compared with control (P = 0.029). Secondary outcomes were mixed; Xie 2022 PSQI total was P = 0.828 and Chan 2014 PSQI total was P = 0.064. No side-effect or withdrawal counts were recorded. The authors state limitations: no data were evaluated on the lineage or level of training of the qigong practitioners, and the conservative eligibility excluded ME/CFS-like illness, fibromyalgia, and Long COVID.

  191. Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis.2023 · systematic review
    Summary

    This systematic review and meta-analysis asked whether respiratory telerehabilitation helps adults with Long COVID-19. The authors searched MEDLINE, Scopus and PEDro from database inception until July 2023 and included 10 randomized controlled trials, with 866 patients with Long COVID-19. Trials compared respiratory telerehabilitation with no intervention, usual care, placebo, or face-to-face intervention. The review pooled quality of life, dyspnea, lung function, anxiety and depression, respiratory muscle strength, functional capacity, lower limb strength and adverse events. The meta-analysis reported significant differences in favour of respiratory telerehabilitation for quality of life (SMD = 0.59; 95% CI = 0.09; 1.09; p = 0.02), dyspnea (SMD = 4.95; 95% CI = 2.81; 7.08; p < 0.00001), respiratory muscle strength (MD = 13.71; 95% CI = 5.41; 22; p < 0.001), functional capacity (SMD = 0.75; 95% CI = 0.39; 1.11; p < 0.0001), and lower limb strength (SMD = 0.67; 95% CI = 0.15; 1.18; p = 0.01). It reported non-significant differences for FVC (MD = 0.21; 95% CI = −0.17; 0.60; p = 0.28) and anxiety and depression (SDM = −0.05; 95% CI = −0.23; 0.12; p = 0.55). For adverse events, the difference between groups was not statistically significant (OR = 0.53; 95% CI = 0.27; 1.02; p = 0.06).

  192. Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review.2023 · systematic review
    Summary

    This systematic review asked what psychological interventions have been studied in people with COVID-19 or long COVID-19 and comorbid emotional disorders. Searches were run in WOS, Scopus, PubMed, PsycINFO, Cochrane and CINAHL on June 14, 2023. The review included 43 studies with 2,359 adults; only three studies included long COVID-19 patients. Interventions included CBT and psychotherapy, meditation/yoga/breathwork, trauma work such as EMDR, and other approaches. Some studies had control groups, for example Cengiz (Control = 22; intervention = 22), Kong (control = 13; intervention = 13), and Mahendru (control = 42; experimental = 42); others were pre-post without control. Outcomes included anxiety, depression, stress, insomnia, PTSD, and COVID-19 fears. Findings were mixed. Cengiz reported no statistically significant difference between groups at post assessments (p > 0.050). Mahendru found no significant differences in anxiety (mean control = 1.81, mean intervention = 2.14, p = 0.528) but significant differences in depression and stress. Won reported no significant improvements in PHQ-9 and GAD-7 (p > 0.050), with a significant reduction in PTSD symptoms (p = 0.041). In Alkhamees, 2021, 1 participant dropped out of CBT after the 2nd visit. No side-effect counts were recorded. The authors describe promising results but note important limitations.

  193. Effects of traditional Chinese mind-body exercises for patients with chronic fatigue syndrome: A systematic review and meta-analysis.2023 · systematic review
    Summary

    This systematic review and meta-analysis asked whether traditional Chinese mind-body exercises (TCME), specifically Qigong and Tai Chi, affect chronic fatigue syndrome (CFS). It included 13 studies with n = 1187 participants; all were from China and conducted between 2012 and 2022, with a longest follow-up of 12 weeks. TCME was compared with passive control or active control. Compared with passive control, the review reports that TCME probably reduces fatigue (SMD = 0.85; 95% CI = 0.64, 1.07, moderate certainty), depression (SMD = 0.53; 95% CI = 0.34, 0.72, moderate certainty), and anxiety (SMD = 0.29; 95% CI = 0.11, 0.48, moderate certainty); it may improve sleep quality (SMD = 0.34; 95% CI = 0.10, 0.57, low certainty) and mental functioning (SMD = 0.90; 95% CI = 0.50, 1.29, low certainty), but did not improve physical function (SMD = 0.11; 95% CI = -0.26, 0.49, low certainty). Compared with active control, TCME may result in little to no difference in fatigue (SMD = 0.08; 95% CI = -0.18, 0.34, low certainty). At 12-week follow-up, TCME may reduce anxiety (SMD = 1.74; 95% CI = 0.44, 3.03, low certainty) and may result in little to no difference in depression (SMD = 0.96; 95% CI = -0.11, 2.04, low certainty) versus passive control. The review did not identify TCME-related serious adverse events; reported adverse events included muscle ache, palpitation, giddiness, knee pain, back ache, and dizziness.

  194. A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome.2022 · systematic review
    Summary

    This systematic review asked how adults with chronic fatigue syndrome fare after CBT or GET. It included 15 publications comprising 1990 participants from the UK, the Netherlands, the USA, and New Zealand. Treatments were compared with control conditions such as relaxation, medical care, and wait-list. Outcomes included fatigue, physical functioning, global improvement, and global worsening at post-treatment and follow-up. Treatment duration varied across trials and is not summarised here. Pooled analyses reported more improvement with CBT than control: 23% (95% CI 16–31) more participants improved in fatigue, 14% (95% CI 4–23) more in physical functioning, and 20% (95% CI 11–29) more rated themselves as improved; 8% (95% CI 1–14) fewer reported global worsening. For GET, 23% (95% CI 15–31) more improved in physical functioning and 26% (95% CI 19–32) more reported global improvement; 10% (95% CI 4–16) fewer reported global worsening. Individual studies reported worsening: 21% seriously deteriorated with self-help GET in Clark et al., 9% with CBT and 6% with GET in White et al., and 7% deteriorated and attributed this to treatment with CBT in Sharpe et al. Whether worsening was followed by stopping treatment is not reported. The authors state limitations include clinical heterogeneity, reliance on self-report, and possible limited generalisability to severe CFS.

  195. What treatments work for anxiety and depression in children and adolescents with chronic fatigue syndrome? An updated systematic review.2022 · systematic review
    Summary

    This systematic review updated searches from 2015 to 2020 in Cochrane Library, Medline, Embase and PsycINFO for studies of children and adolescents with CFS/ME and validated measures of depression and/or anxiety. Combined with previous reviews, 16 studies and 965 participants were included; follow-up ranged from immediately post-treatment to 21 years. Treatments included CBT, the Lightning Process, valacyclovir, pacing, gammaglobulin, placebo, and inpatient or specialist care programmes. An RCT compared Lightning Process plus specialist medical care with specialist medical care alone; the review reports adjusted mean differences in depression and anxiety scores at 6 and 12 months, for example depression −1.5 (−3.5 to 0.5, 0.1) at 6 months and −1.8 (−3.4 to −0.1, 0.04) at 12 months. An observational cohort of routine specialist care measured depression and anxiety at baseline but not post-treatment. CBT-type interventions had most evidence for improving comorbid anxiety and/or depressive symptoms, but delivery and modality varied. A trial reported a deterioration in school attendance in the pacing arm. The review reports insufficient evidence to draw conclusions, and no study specifically targeted depression or anxiety. The authors state the evidence is poor and insufficient for meta-analysis.

  196. A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Covid?2021 · systematic review
    Summary

    This mixed-methods systematic review asked whether post-viral fatigue interventions offer lessons for long Covid. Online databases were searched in October 2020, and 40 papers were selected. The included fatigue interventions involved 25 studies in CFS/ME, nine in fibromyalgia and eight in unexplained fatigue. Treatments varied widely and were compared with controls, typically usual care or waiting lists; fatigue severity was the main outcome. Intervention duration varied and is not quantified in the recorded data. The review reported mean differences for several interventions. The largest mean difference was for the Three Principles/Innate Health programme (MD -39.0, 95% CI -51.8 to -26.2, SMD = 1.670). Group-based CBT also showed reductions (MD -27.5, 95% CI -33.7 to -21.3, SMD = 1.170; MD -23.7, 95% CI -29.2 to -18.2, SMD = 2.266). Smaller mean differences were reported for GET (MD -11.5, 95% CI -17.6 to -5.4, SMD = 0.524) and self-regulation based physical activity (MD -9.9, 95% CI -16.3 to -3.4, SMD = 0.513). TENS (MD -6.0, 95% CI -16.9 to 4.9, SMD = 0.239), Tai Ji Quan (MD -0.4, 95% CI -9.6 to 8.9, SMD = 0.023) and supportive listening (MD 1.06, 95% CI -1.4 to 3.6, SMD = -0.111) showed little or no benefit. Doxycycline mean differences were positive (MD 6.3, 95% CI 3.7 to 8.8, SMD = -0.752; MD 8.75, 95% CI 6.36 to 11.14, SMD = -1.120). No side effects, withdrawals or worsening were reported in the recorded data.

  197. Cognitive and emotional variables predicting treatment outcome of cognitive behavior therapies for patients with medically unexplained symptoms: A meta-analysis.2021 · systematic review
    Summary

    This systematic review and meta-analysis asked whether pre-treatment cognitive and emotional variables predict CBT outcome in adults with medically unexplained symptoms, including chronic fatigue syndrome, fibromyalgia syndrome, irritable bowel syndrome, and somatoform disorders. It searched databases and references for articles published in English or German until August 2020 and included 37 eligible studies, of which 23 provided data for meta-analyses. CBT was the psychological treatment examined; treatment duration and any comparator group were not reported. The review measured associations between baseline patient characteristics and symptom intensity, physical functioning, or emotional and social functioning after CBT. A comorbid mood disorder predicted increased symptom intensity at the end of therapy (r = 0.32, 95%-CI: 0.19, 0.44), and a comorbid anxiety disorder was associated with higher symptom intensity (r = 0.18, 95%-CI: 0.12, 0.24). Symptom catastrophizing and worries predicted increased symptom intensity (r = 0.34, 95%-CI: 0.20, 0.46). Somatosensory amplification predicted low emotional and social functioning (r = 0.46, 95%-CI: 0.03, 0.75). Symptom acceptance and self-efficacy correlated with less symptom intensity (r = 0.25, 95%-CI: 0.35, 0.14). Negative affectivity did not predict the reported outcomes. Side-effect and withdrawal counts were not reported.

  198. Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.2021 · systematic review
    Summary

    This systematic review examined the cost-effectiveness of interventions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). It included 10 economic evaluations based on randomised controlled trials; searches covered MEDLINE (1946–2020) and EMBASE (1974–2020). The included evaluations examined CBT, GET, counselling, specialist medical care, adaptive pacing, guided support groups, fatigue self-management, treatment as usual, pragmatic rehabilitation, supportive listening and the lightning process, alone or with other care. Study sizes ranged from 100 to 640 participants. Outcomes were costs and health effects such as QALYs or fatigue scores. In the largest trial, CBT had a 59.5% likelihood of being cost-effective versus GET (34.8%), specialist medical care (5.5%) and adaptive pacing (0.2%) at £30,000 per QALY. One trial reported CBT was dominated by counselling for cost per improved fatigue score. GET versus CBT had an incremental cost of £193 and incremental effect of 0.71. GET was more cost-effective than usual care plus self-help booklet above £987 for a clinically significant fatigue improvement. For the lightning process plus specialist medical care, incremental cost was £390 and incremental effect 0.095 QALYs, with £1508 incremental net monetary benefit. Side effects and withdrawals were not reported.

  199. Systematic Review of Mind-Body Interventions to Treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.2021 · systematic review
    Summary

    This systematic review asked whether mind-body interventions treat ME/CFS symptoms and sought adverse events. It included 12 out of 382 retrieved references. Participants were adults (≥18 years old) diagnosed or symptom-matched with one of the ME/CFS case definitions. Interventions included mindfulness-based stress reduction/mindfulness-based cognitive therapy, relaxation, Qigong, isometric yoga, and cognitive-behavioral stress management. The review reports comparisons with control groups. Outcomes included fatigue, anxiety/depression, quality of life, and sleep. Compared with control groups, mental and physical fatigue scores improved significantly in four included studies using MBCT, isometric yoga, Qigong exercise, and Baduanjin Qigong. Two studies showed within-group fatigue improvement with an 8-week mindfulness therapy and a 10-week relaxation program. Anxiety and depression improved with Baduanjin Qigong after 16 sessions (9 weeks). Depression improved after 4 months of Qigong exercise and 8 weeks of MBCT. Anxiety improved after 8 weeks of MBSR/MBCT. Quality of life improved with Qigong exercise and cognitive-behavioral stress management. Sleep improved after 9 weeks of Qigong exercise. Three studies recorded adverse events such as deterioration of their symptoms, muscle ache, palpitation, dizziness, knee pain, backache, fatigue, and nervousness; the paper does not report whether participants stopped or changed dose. The authors state that small sample sizes, heterogeneous diagnostic criteria, and a high risk of bias may challenge the result.

  200. Acupuncture Treatment for Chronic Fatigue Syndrome2019 · systematic review
    Summary

    This chapter systematically reviewed acupuncture treatment for chronic fatigue syndrome (CFS) based on a broad literature search and the authors’ experiences. It reports 40 clinical research papers on acupuncture for CFS published over the last 10 years. The reviewed studies used simple acupuncture, electro-acupuncture, blood-letting acupuncture, acupoint application, acupoint catgut embedding, acupoint injection, auricular acupuncture, abdominal acupuncture, moxibustion, cupping and combined therapies. Examples include 32 CFS patients given acupuncture at acupoints versus non-meridian points, measured with the WHOQOL-BREF; 60 cases randomly divided into electro-acupuncture on acupoints or non-acupoints, 30 cases in each group, measured with FSS, SPHERE, VAS and SF-36, with the acupoints group reported better (P < 0.01); and 180 CFS patients randomly divided into 2 groups (92 treatment, 88 control) for acupoint injection. Reported rates included a total effective rate of 93.75% for electro-acupuncture plus auricular application, a total efficiency of 96.7% for auricular acupuncture in 60 cases, and a total efficiency of 94.34% for abdominal acupuncture. A reviewed RCT found no obvious difference between a low sugar low yeast diet and healthy eating. The harms text states auricular acupuncture with acupoint catgut embedding has fewer clinical side effects than traditional acupuncture, while excessive exercise may lead to immune function disorders and may aggravate CFS symptoms. Numbers who worsened or stopped were not reported. The authors state current research lacks a unified syndrome differentiation standard and a unified evaluation standard of efficacy.

  201. Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review.2018 · systematic review
    Summary

    This systematic review asked whether interventions for medically unexplained symptoms (MUS) or functional somatic syndromes (FSS), including fibromyalgia, irritable bowel syndrome and chronic fatigue syndrome, are cost-effective. The search covered PubMed, PsycINFO, NHS-EED and the CEA registry to 15 June 2018 and included 39 full economic evaluations in adult patients. Interventions varied: group CBT, individual CBT, graded exercise therapy, adaptive pacing therapy, multidisciplinary rehabilitation, counselling, educational and pharmacological treatments. Comparators included usual care, waiting lists, other physical or psychological treatment and other drugs. Outcomes were incremental costs, incremental effects and ICERs, using QALYs or clinical scales. Results differed by study: in CFS, CBT and GET dominated specialist medical care on average, with ICERs of €24,475 and €31,456 per QALY; APT had an ICER of €73,576 per QALY and SMC was preferred over APT for all outcomes. MRT appeared not cost-effective compared with CBT. In fatigue, graded exercise had an ICER of €1,377 per unit of clinically significant improvement on the Chalder Fatigue Scale, and counselling was dominated by usual care plus a self-help booklet. No side-effect or withdrawal counts were recorded. The authors state language restrictions and limited comparability; they describe heterogeneity across the included studies.

  202. Do evidence based interventions for chronic fatigue syndrome improve sleep? A systematic review and narrative synthesis.2017 · systematic review
    Summary

    The review was a systematic review and narrative synthesis of eight studies, with searches completed in March 2015. Included studies enrolled adults aged 18 or over meeting Oxford and/or CDC criteria for chronic fatigue syndrome (CFS) and evaluated CBT, GET, or combined approaches with a sleep outcome. Studies evaluated 12 weeks of individual graded exercise sessions (29), a 12-week group cognitive behavioural stress management programme (44), a 2-participant case study, pragmatic rehabilitation with 2 sessions (37), 2 sessions plus telephone contact (39), or 7 sessions (38) versus standardised medical care (34), 10 sessions of multi-convergent therapy (12), 10 nurse-led pragmatic rehabilitation sessions (95), and 24 weeks of individual CBT (161) or GET (160). One GET study found no significant difference in PSQI ratings; another reported significant improvements in sleep difficulties for CBT and GET compared with APT and specialist medical care. A CBSM pilot found reduced frequency, but not severity, of unrefreshing sleep. Powell et al. (2001) reported significant PR improvements at 3, 6 and 12 months; Wearden et al. (2010) reported improvement at 20 weeks but not at 70 weeks. The case study reported ratings decreased from 18 & 19/20 to 0. Thomas et al. reported a significantly greater number of participants with improved sleep in the MCT group. No harms events were recorded. The authors state that the small number of studies and differences in design, sample inclusion criteria and outcomes meant strong conclusions could not be made.

  203. What treatments work for anxiety in children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)? Systematic review.2017 · systematic review
    Summary

    This systematic review asked what treatments work for anxiety in children with CFS/ME. The authors searched Medline, Embase and psychINFO in July 2016 and included nine papers from eight studies of children under 18 years with CFS/ME and a valid anxiety assessment. None targeted anxiety as a primary outcome; six treatment studies measured anxiety as a secondary outcome. Four used CBT-type approaches, one a behavioural approach, and one compared intravenous gammaglobulin with placebo. Sample sizes ranged from 1 to 135. In Chalder et al, 23 participants (18 at follow-up) received a CBT-based rehabilitation programme; anxiety improved significantly at 6 months, and the 20 participants who completed treatment returned to school, with 19 of 20 attending full time. Lloyd et al enrolled 63 participants in telephone CBT; anxiety improved significantly (treatment effect estimate −0.49, p=0.003), school attendance improved from 24% to 49%, and fatigue reduction was not significant. Nijhof et al randomised 135 (112 at long-term follow-up) to FITNET internet-delivered CBT or usual care; full school attendance was 50 (75%) vs 10 (16%), and 63% were defined as recovered compared with 8%. Wright et al randomised 13 (11 at follow-up) to STAIRway or pacing; the anxiety difference was −1.60, p=0.6, and school attendance deteriorated in the pacing arm. Rowe et al recruited 71 (70 at follow-up) to gammaglobulin or placebo; anxiety reduced in both arms. The authors state insufficient evidence to conclude the best treatment.

  204. Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review.2016 · systematic review
    Summary

    This systematic review asked which treatments for depression are effective in children and young people with CFS/ME, and whether comorbid depression affects outcome. MEDLINE, EMBASE, PsycInfo and the Cochrane library were searched in February 2015; 9 studies met the inclusion criteria. No study specifically tested a treatment for paediatric CFS/ME with depression, and no study stratified outcome by depression severity. Included studies examined CBT-based rehabilitation (up to 15 hourly sessions; n=23), telephone CBT guided self-help (6 fortnightly 30-minute sessions; n=63, 52 at follow-up), 4-week multicomponent inpatient programmes (n=39, 19 at follow-up; n=16; RCT n=22 comparing aerobic and resistance training), and valacyclovir (n=15, 14 at follow-up; treatment 3 to 60 months, mean 27.9 months). Depression and fatigue were measured. There was no overall comparison group; the included RCT compared aerobic with resistance training. Chalder et al reported depression significantly improved; Denborough et al reported mean BDI was 21 pretreatment and 15 post-treatment and improvement maintained at 6-month follow-up; Gordon and Lubitz reported significant improvement in BDI and Fatigue Severity scores; both RCT arms improved in BDI; Lloyd et al reported improvements in depression at 6 months; Henderson et al reported depression symptoms decreased in depressed and non-depressed patients and all patients reported at least 80% self-rated improvement. Kawatani et al found no significant improvement in fatigue at 6-month follow-up; mood was not reassessed. Reported concerns included that SSRIs can increase suicidality and that exercise could exacerbate symptoms in patients with CFS/ME; Denborough et al reported internalising problems escalated above preadmission levels.

  205. An abridged version of the Cochrane review of exercise therapy for chronic fatigue syndrome.2016 · systematic review
    Summary

    This systematic review asked whether exercise therapy affects adults with chronic fatigue syndrome (CFS). It included eight randomised clinical studies that reported data from 1518 participants over 18 years with a primary diagnosis of CFS, able to attend an outpatient clinic, from all health care settings. Exercise therapy was compared with 'passive' control, treatment as usual, and cognitive behaviour therapy, with outcomes at end of treatment. For fatigue, seven of eight studies (842 participant) gave a pooled SMD estimate of -0.68 units (95% Cl -1.02 to -0.35) favouring exercise therapy. Individual fatigue reductions were 6.06 points (95% Cl -6.95 to -5.17), 2.82 points (95% Cl -4.07 to -1.57), and 6.80 points (95% Cl -10.31 to -3.28). Exercise therapy versus control showed physical functioning MD 13.10 (95% Cl 1.98 to 24.22), sleep MD -1.49 (95% Cl -2.95 to -0.02), and self-perceived overall health RR 1.83 (95% Cl 1.39 to 2.40). Versus CBT, one trial (298 participants) reported little or no difference in fatigue: MD 0.20 (95% Cl -1.49 to 1.89). Serious adverse reactions were rare: RR 0.99 (95% Cl 0.14 to 6.97) with 2 of 160 versus 2 of 159, and versus CBT RR 0.67 (95% Cl 0.11 to 3.96). Stopping treatment was not reported. The authors state no evidence suggests exercise therapy may worsen outcomes. They state the evidence was too sparse and/or of too low quality for pain, quality of life, anxiety or depression, and that a wide confidence interval made firm conclusions impossible.

  206. Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.2015 · systematic review
    Summary

    This systematic review examined treatments for adults with ME/CFS. It included 35 treatment trials in 45 publications; trials enrolled predominantly middle-aged women from ME/CFS specialty clinics and used CFS case definitions. Treatments were compared with placebo, usual care, wait-list, relaxation, adaptive pacing, CBT, or other therapies. In 2 fair-quality trials (n=324), rintatolimod improved cardiopulmonary exercise test tolerance (36.5% versus 15.2%; P=0.047), exercise duration (10.3% versus 2.1%; P=0.007), and exercise work (11.8% versus 5.8%; P=0.01). In a small trial of 30 participants, valganciclovir improved fatigue on 1 scale but showed no statistically significant differences for other measures. Trials of galantamine, hydrocortisone, IgG, isoprinosine, and fluoxetine indicated no beneficial effects but were limited by small numbers. Counseling and behavior therapies improved fatigue, function, quality of life, work impairment, and global improvement in some trials (low to moderate strength of evidence). A meta-analysis of 4 CBT trials found no statistically significant difference in SF-36 physical function (weighted mean difference, 10.42 [95% Cl, -3.86 to 24.69]); a sensitivity analysis found 6.02 [Cl, 1.05 to 10.88]. GET improved function (10.68 [Cl, 6.32 to 16.88]), fatigue (4 trials, n=619), and global improvement (relative risk, 1.58 [Cl, 1.24 to 2.47]). In the PACE trial, deterioration of physical function was 25% with adaptive pacing, 18% with usual care, and 11% with GET (P<0.001). Harms included galantamine: 90% reported harms and 2% serious events, none attributed to study drug; IgG headaches 93% versus 60%; GET serious adverse events 17 versus 7. GET withdrawals were 37% versus 22%, and 20% declined repeat exercise testing. Adverse effects were rarely reported overall.

  207. The effect of relaxation therapy on autonomic functioning, symptoms and daily functioning, in patients with chronic fatigue syndrome or fibromyalgia: a systematic review.2015 · systematic review
    Summary

    This systematic review asked whether relaxation therapy is beneficial for patients with chronic fatigue syndrome or fibromyalgia. It included 13 randomized clinical trials: 650 fibromyalgia patients in 11 studies and 88 chronic fatigue syndrome patients in 3 studies. Studies evaluated guided imagery/visualization; others used Ost applied relaxation, muscle relaxation, autogenic training, or group relaxation. Outcomes concerned pain, fatigue, and daily functioning; no studies assessed autonomic function. For guided imagery in fibromyalgia, the acute effect of a single session seems beneficial for pain reduction (moderate evidence), but evidence for the isolated effect on pain and functionality is conflicting and the content is debated. Pain did not change after a prolonged guided imagery program in Verkaik et al., 2014 and Menzies et al., 2006; Menzies et al., 2006 reported a larger improvement in functionality in the relaxation group than with usual care; Menzies et al., 2014 reported improved fatigue in the relaxation group while the control group reported worsened fatigue. In chronic fatigue syndrome, a multimodal program resulted in less fatigue than relaxation alone; at six months, increases in physical functioning and Karnofsky performance were equal between multimodal and relaxation groups; substantial self-reported improvement occurred in 70% (63% with drop-outs) of CBT patients versus 19% (17% with drop-outs) of relaxation patients; at five years no differences were found. Drop-outs were reported (for example, 17 of 70 in Verkaik et al., 2014).

  208. Differential effects of behavioral interventions with a graded physical activity component in patients suffering from Chronic Fatigue (Syndrome): An updated systematic review and meta-analysis.2015 · systematic review
    Summary

    This updated systematic review and meta-analysis asked whether behavioral and psychological interventions with a graded physical activity component affect fatigue severity, physical functioning, physical activity and psychological distress in adults with idiopathic chronic fatigue or CFS/ME, and whether trial characteristics moderate effects. Sixteen randomized controlled trials (N = 2004) were included; most were from the United Kingdom (n = 9) and the Netherlands (n = 3), in secondary–tertiary care (n = 11) or primary care (n =3). Interventions included GET, CBT with graded exercise, pragmatic rehabilitation and multicomponent approaches, compared with passive or active controls. Assessment was at post-treatment (M = 5.2 months) and follow-up (M = 11.7 months). Significant medium effects were found for fatigue severity at post-treatment (g = 0.61) and follow-up (g = 0.66). Physical functioning effects were g = 0.29 and g = 0.38. Physical activity was not significant at post-treatment (g = 0.11) but was at follow-up (g = 0.28); physical capacity was g = 0.27. Depression effects were g = 0.41 and g = 0.37; anxiety g = 0.28 and g = 0.25. Minimal contact interventions had additional beneficial effects upon fatigue (g = 0.96) and depression (g = 0.85). No significant difference was found between interventions with and without a psychological component. Some trials showed negative effects (g = −0.20, g = −0.10, g = −0.97). Drop-out in intervention conditions ranged from 0% to 35%; side effects were not reported.

  209. Is there effective behavioural treatment for children with chronic fatigue syndrome/myalgic encephalomyelitis?2013 · systematic review
    Summary

    This review asked whether behavioural treatments benefit adolescents with CFS/ME compared with usual care, measured by school attendance and fatigue. It searched Cochrane Library, PubMed, Ovid, Medline and EMBASE and included three RCTs. In Stulemeijer et al (2005), 36 patients in the CBT group were compared with 35 in the control group (usual care and wait list); participants in the CBT arm reported a decrease in the fatigue score of 14.5 (95% CI 7.4 to 21.6) and were attending an additional 18.2% (95% CI 0.8 to 35.5) of school classes compared with controls at 5-month follow-up. In Nijhof et al (2012), 67 patients in the intervention group were compared with 64 in a usual care control group; young people in the CBT arm attended 32.6% more school (95% CI 21.5 to 43.6) and had a fatigue mean difference of −18.3 (95% CI −22.9 to −13.7) at 6 months. In Al-Haggar et al (2006), 50 patients in the CBT group were compared with 46 in the control group; those in the intervention group attended an extra 23.14 (95% CI 20.6 to 26.8) hours of school a month and had fatigue scores lower by 12.23 (95% CI 7.4 to 14.8). The trial reported 159 patients initially but 63 were lost to follow-up. A GET pilot (n=22) reported a modest reduction in fatigue severity in both arms, GET group −0.42 (SD ± 0.31) and resistance training arm −0.12 (SD ± 0.60), but was not powered sufficiently. Side effects were not reported.

  210. Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.2013 · systematic review
    Summary

    This systematic review searched CINAHL, PsycINFO and Medline to May 2012, with a limited update in October 2012, for studies of interventions in children and adolescents with CFS/ME. It included 24 articles based on 21 studies, with variable designs and quality. In Wright (2005), 13 participants were randomized to a structured tailored incremental rehabilitation program or pacing; the review reports improvements in activity and school attendance with the program immediately after treatment compared with pacing. Viner (2004) reported 43% of the treatment group had complete resolution of CFS/ME compared with 4.5% with supportive care. Lim (2002) reported that before an inpatient program 94% attended school less than half-time, and 78% attended full-time or with occasional absences only at follow-up. Szyndler (2003) reported problem improvement or resolution in 31% by clinician rating and 86% by family rating. Van Geelen (2010) reported 52% nearly complete improvement and 48% no improvement. For harms, Rowe (1997) reported adverse effects common, and Nijhof (2012) reported no serious adverse events. The authors state that methodological inadequacies and inconsistent approaches limit interpretation.

  211. How to exercise people with chronic fatigue syndrome: evidence-based practice guidelines.2012 · systematic review
    Summary

    This systematic literature review asked which exercise modalities should be used for people with chronic fatigue syndrome (CFS). It included 12 studies of adults and/or children diagnosed with CFS by official criteria, and examined graded exercise therapy (GET) and cognitive behavioural therapy (CBT) interventions. Treatments were compared with control interventions such as flexibility or relaxation therapy, with adaptive pacing therapy (APT), or with different doses of GET. Outcomes were fatigue and physical functioning. The review reports that the included studies confirm a positive effect (P <0Æ05) of CBT and GET on fatigue and physical functioning. In the PACE study, CBT and GET were associated with significantly less fatigue (CBT, P =0Æ0027; GET, P <0Æ0059) and improved physical function (CBT, P =0Æ0002; GET, P <0Æ0001) compared with APT. A comparison of three GET intervention groups found no significant difference in fatigue or physical functioning, but a similar improvement (P <0Æ001) in all three groups compared with the control group. Flexibility or relaxation therapy alone did not significantly improve (P >0Æ05) fatigue or physical functioning. The authors conclude that exercise therapy should be aerobic and comprise 10–11 sessions over 4–5 months, with home exercises five times a week starting at 5–15 min and increasing to 30 min. Side effects and withdrawals were not reported. The authors state the findings should be interpreted with some caution.

  212. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: A meta‐analysis.2011 · systematic review
    Summary

    This meta-analysis asked whether cognitive behavioral therapy (CBT) and graded exercise therapy (GET) show positive effect sizes in chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). Twenty studies were included: five GET trials (N = 170) and 16 CBT trials (N = 1,457); one trial contributed an effect size to both groups, leading to a total of 21 effect sizes. Trials were identified through database and reference searching in April 2011. CBT and GET were compared with control conditions and with each other. CBT treatment contact across trials ranged from 6 to 16 hours. Outcomes were post-treatment fatigue, anxiety, depression and functional impairment. The pooled overall effect size was g = 0.26 (CI = 0.08, 0.43) for GET and g = 0.33 (CI = 0.23, 0.43) for CBT. Fatigue effect sizes were g = 0.41 for GET and g = 0.36 for CBT; functional impairment g = 0.39 for GET and g = 0.36 for CBT; depression g = 0.15 for GET and g = 0.32 for CBT; anxiety g = 0.01 for GET and g = 0.15 for CBT. There were no significant differences between the two treatment types on overall outcome or the four outcome categories. Across studies, a median of 12% of GET participants (range = 10–18) and 17% of CBT participants (range = 0–46) dropped out of treatment or did not complete post-treatment assessment measures. Worsening and side effects were not reported.

  213. Chronic fatigue syndrome.2011 · systematic review
    Summary

    This systematic review asked what the effects of treatments for chronic fatigue syndrome are. The authors searched Medline, Embase, The Cochrane Library and other databases up to March 2010, included 46 systematic reviews, RCTs or observational studies, and rated the quality of the evidence with GRADE. They list the treatments covered: antidepressants, cognitive behavioural therapy, corticosteroids, dietary supplements, evening primrose oil, galantamine, graded exercise therapy, homeopathy, immunotherapy, intramuscular magnesium, oral nicotinamide adenine dinucleotide and prolonged rest. The abstract gives no finding for any of them and names no included study, so no results are listed here.

  214. A systematic review of acupuncture and moxibustion treatment for chronic fatigue syndrome in China.2008 · systematic review
    Summary

    This systematic review searched the Chinese Journal full-text database in January 2007 for studies of acupuncture and moxibustion for chronic fatigue syndrome (CFS); 40 studies met the inclusion criteria. The included studies used filiform needles, sometimes with warming needle, moxibustion, ear points/ear seeds, cupping, Tuina, herbs, psychotherapy or music therapy; some entries list control groups receiving acupuncture, cortisone, herbs or moxa. Outcomes were recorded as Total Effectiveness (TE). Examples recorded in Table 1 include Li et al. (2005), n = 64, with TG/CG TE 30 (93.75)/24 (75.00); Guo (2005), n = 620, with TG/CG TE 303 (97.74)/179 (58.38); and Sun and Li (2006), n = 60, with TG/CG TE 28 (93.33)/23 (76.67). Uncontrolled study entries include Gao (1998), n = 21, TE 21 (100.00), and Zeng and Liu (1999), n = 38, TE 30 (78.95). For harms, the review states that 'only one study reported that one patient fainted during an acupuncture treatment.' The authors state: 'This review cannot be used to establish the efficacy of acupuncture and moxibustion in the treatment of CFS.'

  215. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.2006 · systematic review
    Summary

    This updated systematic review asked whether any intervention is effective for treatment, management or rehabilitation of adults and children with CFS/ME. The authors searched eleven electronic databases and included 70 studies, of which 59 were RCTs; comparisons were between treatment and control groups. Interventions included CBT, GET, rehabilitation, immunological and pharmacological treatments, supplements and complementary therapies. Outcomes covered physical, psychological, laboratory/physiological and quality-of-life measures. CBT and GET appeared to reduce symptoms and improve function based on RCTs. In a CBT trial (n=69), physical functioning, fatigue and symptoms favoured CBT (P<0.003) and school attendance favoured treatment (P=0.04). Another CBT trial (n=65) found no significant difference for fatigue, anxiety and depression, or disability. In GET trials, CGI and fatigue favoured treatment (n=49; P<0.03), and fatigue and depression/anxiety were significantly better (n=61; P=0.027). One GET trial reported withdrawal of one patient in each group because of worsening symptoms; eleven patients withdrew because of adverse events in a GET with or without fluoxetine trial. Galantamine (n=434) showed no significant differences; 130 patients withdrew, 389 reported adverse events and 88 withdrew. Acetyl-L-carnitine and propionyl-L-carnitine (n=90) improved general fatigue in PLC (P=0.004) and combined group (P<0.001), and mental fatigue in ALC group (P=0.015); 8 patients withdrew due to side effects. Staphylococcus toxoid (n=98) had 13 treatment-group and 7 placebo-group patients with side effects. Hydrocortisone/fludrocortisone (n=80) found no significant differences.

  216. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?2002 · systematic review
    Summary

    This systematic review examined the strength of evidence for mental health interventions in three common somatic conditions: chronic fatigue syndrome, irritable bowel syndrome, and chronic back pain. It also asked whether evidence from secondary care can be extrapolated to primary care. The search covered papers published between 1966 and September 2001. Sixty one studies were identified; 20 were classified as primary care and 41 as secondary care. The review reported that cognitive behaviour therapy and behaviour therapy were effective in both primary and secondary care in patients with back pain, although the evidence was more consistent and the effect size larger for secondary care. It reported that antidepressants seemed effective in irritable bowel syndrome in both settings but ineffective in chronic fatigue syndrome. Cognitive behaviour therapy was reported as effective in chronic fatigue syndrome in secondary care, although brief cognitive behaviour therapy was ineffective; in primary care patients, there was no difference in effectiveness between brief therapy and counselling. Some evidence of effectiveness of graded exercise in secondary care patients was reported. The authors noted methodological weaknesses: for most treatments they could draw only qualified conclusions. Side-effect and withdrawal data were not recorded. The authors concluded that treatment seems to be more effective in patients in secondary care than in primary care.

  217. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review.2001 · systematic review
    Summary

    This systematic review asked whether interventions for chronic fatigue syndrome (CFS) work. Nineteen specialist databases were searched, and 44 trials met inclusion criteria: 36 randomized controlled trials and 8 controlled trials. Treatments were grouped by type and compared with control conditions. Outcomes were classified as positive, negative, or no effect. Three randomized controlled trials of GET all showed an overall beneficial effect compared with control groups. Three of four randomized controlled trials of CBT found a positive overall effect; one controlled trial did not find overall beneficial effects. One randomized controlled trial found no effect of fluoxetine either alone or with GET. Hydrocortisone showed an overall beneficial effect in one randomized controlled trial and some beneficial effects in another. For immunoglobulin, two randomized controlled trials showed an overall beneficial effect, two showed some positive effects, and the largest reported no effect. Acyclovir showed a negative effect for one outcome. Randomized controlled trials of fludrocortisone, antidepressants, moclobemide, sulbutiamine, growth hormone and galanthamine hydrobromide found no effects. Oral NADH showed an overall beneficial effect in one randomized controlled trial. Harms included withdrawals from immunoglobulin therapy (2 due to severe constitutional symptoms, 1 due to a skin eruption, 1 due to mild but transient liver failure, 1 due to phlebitis, and 2 whose adverse effects were not reported), 3 withdrawals from acyclovir due to reversible renal failure, and 2 participants leaving the magnesium group after a generalized rash. CBT trials had a dropout rate of 19% (114/589), GET trials 18% (68/370), and pharmacological trials 11% (99/869).

  218. Digital Approaches for Managing Brain Fog in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Interventions, Monitoring, and Future Directions.2026 · review
    Summary

    This descriptive review asked how digital approaches are used for brain fog in ME/CFS. The search covered Scopus, Web of Science, and PubMed and included manuscripts published up to 31 December 2025. The review included 16 studies of people with ME/CFS; the reviewed studies' total number of participants, locations, and treatment durations were not reported in the recorded data. The digital approaches included symptom-tracking apps and wearables and other digitally delivered therapeutic approaches. There was no comparison group, and the review was not randomised. Outcomes concerned brain fog/cognitive dysfunction, subjective cognitive symptoms, objective neuropsychological performance, and broader symptom burden. The authors conclude that app-based platforms and multimodal digital trackers appear particularly suitable for capturing the fluctuating nature of brain fog but require stronger validation frameworks. They also state that evidence for direct improvements in objective neuropsychological performance remains limited, and that digitally delivered interventions generally focused on broader symptom management rather than directly targeting cognitive performance. The review cautions that excessive digital monitoring, prolonged cognitive tasks, or poorly designed interfaces may exacerbate symptoms rather than alleviate them. The authors state that the included studies were highly heterogeneous in terms of their design, digital modalities, and outcome measures, precluding quantitative synthesis.

  219. Using Tai Chi and Qigong to Treat Chronic Fatigue Syndrome: An Application of Artificial Intelligence to Traditional Chinese Medicine2026 · review
    Summary

    AI-assisted review of fourteen English-language publications identified via PubMed summarized Tai Chi and Qigong for CFS/ME: 5 completed randomized controlled trials, 3 study protocols, 3 systematic reviews/meta-analyses, 2 non-randomized interventions and 1 case series. Findings were reported study by study, not as a pooled review result. Dybwad (2007; 31 participants) reported Qigong improved work capacity (VO2max, p=0.01) and fatigue severity (p<0.05) vs no treatment, with no significant SF-36 differences. Chan et al. (2017; 108 females: 46 Qigong, 62 waitlist) reported increased adiponectin (median change 0.8 vs -0.1 mg/L, p<0.05) and lower anxiety (median 7.0 vs 10.0, p<0.05) and depression (median 5.0 vs 7.0, p<0.05; change -4.0 vs -1.0, p<0.001). Ho et al. (2012; 64 participants: 33 Qigong, 31 control) reported fatigue reduction (F=12.93, p<0.05, d=-1.5 to -2.1) and telomerase increase (0.102 to 0.178, p=0.033, d=0.52, F=5.03, p<0.05). Kong et al. (2023; 1,187 participants) reported fatigue SMD=0.85 (95% CI 0.64–1.07, I2=54%) vs passive controls and 0.08 (-0.18–0.34, I2=0%) vs active controls. Ho et al. reported no adverse effects; Kong et al. reported minor AEs; Wang et al. (2014; 1,776 participants) reported no serious AEs. Worsening and stopping were not reported. The authors state methodological limitations.

  220. EFFECTIVENESS OF THERAPEUTIC INTERVENTIONS FOR CHRONIC FATIGUE SYNDROME: A NARRATIVE REVIEW2026 · review
    Summary

    This narrative review summarized treatment studies in chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME). A structured search of PubMed and Google Scholar, with ResearchGate used only to retrieve full texts, was performed in June 2026 and covered publications from 2001 to 2025; of 132 identified publications, 54 were included. Treatments included CBT, exercise-based interventions, nutritional supplements (CoQ10, NADH, selenium, creatine, combination nutraceutical therapy), rituximab and rintatolimod. Five nutritional studies assessing 265 patients reported significant fatigue improvement (p < 0.001 to p = 0.038); three studies involving 192 patients reported significant sleep improvement (p = 0.008–0.018), while one study of 27 patients receiving CoQ10 + selenium found no effect on sleep (p = 0.480). Two CoQ10 studies involving 171 patients reported significant quality-of-life improvement (p = 0.001–0.048), whereas two studies involving 46 patients found no improvement (p > 0.05). In the RituxME phase III trial, clinical response was 26.0% (20/77) with rituximab vs 35.1% (26/74) with placebo (p = 0.22); adverse events occurred in 81.8% vs 64.9%. In exercise studies, deterioration in health status was observed in 27.6% (367/1331), and 2.1% discontinued treatment due to worsening health (3% GET vs 1% AM). No advantage of GET over comparator groups was found in three different studies. The authors state that included studies differed substantially in design, diagnostic criteria, interventions, follow-up duration and outcome measures, and findings were synthesized qualitatively.

  221. Digital Interventions Addressing Cognitive and Psychological Symptoms in Long COVID: Scoping Review of Multicomponent Approaches.2026 · review
    Summary

    This scoping review examined digital interventions for cognitive and psychological symptoms in people with long COVID. It included 25 (2.82%) records identified through a database search between December 2024 and February 2025. The records covered telehealth or telerehabilitation, virtual reality, mobile health apps, online psychological therapies, game-based cognitive training, neuromodulation (transcranial direct current stimulation), and multicomponent programs. No comparison was required for inclusion; comparators were reported when present. Outcomes concerned attention, memory, executive function, depression, anxiety, fatigue, and well-being. Reported effects were mixed. Telehealth or telerehabilitation records were summarized as improvements in quality of life, mental health (anxiety and depression), and self-efficacy, with mixed effects on cognition. Virtual reality records were summarized as enhanced emotional well-being and physical functioning, inconsistent effects on cognition, and some usability issues; some users reported side effects such as dizziness and headaches. Mobile health app records were summarized as gains in attention, mood, and self-reported recovery. Online psychological therapy records were summarized as decreased anxiety, posttraumatic stress disorder, and depression and high feasibility and acceptability. Game-based cognitive training was summarized as improved processing speed and task-switching and no sustained improvement in attention. Neuromodulation was summarized as enhanced cognition, mood, and energy levels in a small-scale pilot study. Multicomponent programs were summarized as broad improvements across mental health, cognitive symptoms, and physical activity. The authors state limitations including small sample sizes, lack of control groups, heterogeneity in outcomes and intervention protocols, and short follow-up durations, plus underrepresentation of older adults and underserved populations.

  222. Assessment and management of post-COVID-19 pulmonary complications: a rapid review.2026 · review
    Summary

    This rapid review assessed evidence on management and treatment of pulmonary complications in post-COVID-19 condition (PCC). It included 73 unique records from published and grey literature; these comprised guidance documents, secondary studies and primary research studies. Included primary studies involved adults with PCC and pulmonary complications, with individual study sizes that included 28 and 871 participants. Interventions included IHHT plus standard rehabilitation, nirmatrelvir plus ritonavir, hyperbaric oxygen, systemic corticosteroids, and multicomponent exercise rehabilitation. Comparisons included standard rehabilitation, placebo plus ritonavir, sham treatment, nonsteroid care, and usual care or control. Outcomes included 6MWT distance, Borg and PROMIS dyspnoea, RAND-36 physical function, FEV1, FVC, FVC % pred, resting oxygen requirement and adverse events. Doehner 2024 reported a significant between-group difference in 6MWT distance favouring IHHT plus rehabilitation (p<0.001). Geng 2024 found no between-group difference in PROMIS dyspnoea (p>0.05). Kjellberg 2025 found no difference in RAND-36 physical function (p=0.277) or 6MWT distance (p=0.62) with hyperbaric oxygen versus sham. Ntiamoah 2024 reported significant improvements in FEV1, FVC and FVC % pred in the steroid group only. Torres 2024 reported FVC % pred improved from 52±0.17% to 60±0.20% (p=0.019) and resting oxygen requirement reduced (p=0.005), with no significant change in 6MWT distance (p=0.50). Seo 2025 reported diarrhoea in 80% of patients with nintedanib; Ora 2023 reported no adverse events with sodium pyruvate nasal spray. The authors state study quality and risk of bias were heterogeneous and findings should be interpreted with caution.

  223. Treatments for Long COVID autonomic dysfunction: a scoping review.2025 · review
    Summary

    This scoping review included 11 effectiveness studies, 11 guidelines/position statements, and 15 unpublished/ongoing studies of Long COVID autonomic dysfunction. Among comparative data, an NRCS in Italy gave fexofenadine 180 mg/day plus famotidine 40 mg/day to 14 patients and compared them with 13 who received no antihistamines; follow-up increased heart rate was 29% vs. 85% (p = 0.0063) and abdominal disorders 14% vs. 62%. An RCT of 463 patients compared SIM01 with placebo: fatigue alleviation 63% vs. 43% (OR 2.273, 95% CI 1.520–3.397), GI upset 70% vs. 54% (OR 1.995, 95% CI 1.304 to 3.051); quality of life 76.0 vs. 74.5 (p = 0.17) and physical activity p = 0.37 did not differ significantly. Any AE was 9.5% vs. 10.8%. Single-arm studies reported pre-post changes: maraviroc plus pravastatin (18), SSRIs (95; serious side effects 31.6% [30/95], mild 54.7% [52/95]), a nutraceutical (51), multicomponent treatment with salt/water/compression plus bisoprolol (32), HRV biofeedback (13), inspiratory muscle training (26), and SGB (41; vagal response 7.3% [3/41], transient hoarseness 9.8% [4/41]). Review authors state existing studies are often small and uncontrolled.

  224. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management.2025 · review
    Summary

    This narrative review searched PubMed, Web of Science, Embase, and the Cochrane Library from inception to August 2025 and included 211 publications on ME/CFS diagnosis, pathophysiology, assessment, and treatment. It summarized pharmacological and non-pharmacological interventions. Reported examples include a double-blind, randomized, placebo-controlled trial of IVIG in 99 CFS patients that found an absence of dose-dependent efficacy; a Phase III rintatolimod study in 208 ME/CFS patients in which 51.2% of a severely debilitated subgroup (n = 21/41) had a ≥ 25% improvement in exercise treadmill test duration; a 12-week trial in 207 ME/CFS patients reporting significant reductions in fatigue with CoQ10 (200 mg) and nicotinamide adenine dinucleotide (20 mg); LDN showing significant improvement in 73.9% of 218 ME/CFS patients; and a pilot study of 55 ME/CFS patients in which oral minocycline produced favorable symptom improvements for 80% of treatment completers. A pooled analysis of 1,298 ME/CFS patients from eight trials associated CBT with significant reductions in fatigue severity and functional impairment. A pragmatic trial in 241 adolescents (aged 8–17) found no significant inter-group difference between GET and activity management for physical function on the Short-Form 36 at 6 months. A systematic review and meta-analysis reported a significant reduction in fatigue (Hedges’ g = -0.52) and an improvement in physical function with pacing compared with no treatment or routine care. Harms included GET-associated symptom exacerbation in a significant proportion of patients, and rintatolimod adverse events may occur. TCM findings should be cautiously interpreted because the available evidence is constrained by methodological limitations.

  225. Interventions for Long COVID: A Narrative Review.2025 · review
    Summary

    This narrative review synthesized evidence from 97 studies (n=8260, 103 publications) on interventions for common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues. The review included randomized and non-randomized studies and compared medications, rehabilitation, behavioral and mind-body programs, supplements, complementary treatments, and COVID-19 vaccination with placebo, usual care, no treatment, or other active comparators. For vortioxetine versus placebo, one RCT (n = 141) reported a significant reduction in depression symptoms (adjMD of −1.52; 95% CI −2.85 to −0.19) and improvement in quality of life (WHO-5, adjMD of 2.36; 95% CI 0.77 to 3.94), with mixed cognitive results. An RCT of “Fit after COVID” CBT (n=114) reported improvement in fatigue (CIS-fatigue: MD −8.8; 95% CI −11.9 to −5.8), cognitive impairment (CIS-concentration: MD −5.1; 95% CI −6.9 to −3.4), and physical function (SF-36-Physical Health: MD 7.1; 95% CI 2.9 to 11.3). Hyperbaric oxygen therapy (n=73) improved fatigue (SF-36 energy subscale, 18.2 vs 6.0, p=0.029) and sleep quality (PSQI, 8.1 vs 9.2, p=0.042) versus sham. Transcranial direct current stimulation (n=47) reduced physical fatigue (MFIS-Physical: p=0.034) but not overall fatigue (MFIS-Total: p=0.184). A COVID-19 vaccine study (n=453) found no statistically significant difference in fatigue, depression, or sleep quality. Adverse events included treatment-related reactions with vortioxetine (26.8% vs. 22.1%), non-serious adverse events with AXA1125 (RR 2.62, 95% CI 1.00 to 6.89), and similar adverse event rates with SIM01 (10% vs. 11%; p=0.63).

  226. CBT and graded exercise therapy studies have proven that ME/CFS and long COVID are physical diseases, yet no one is aware of that.2025 · review
    Summary

    This paper is a review/commentary, not a new study, and enrolled no patients. It argues that CBTplus and graded exercise therapy (GET) studies in ME/CFS and long COVID show the conditions are physical diseases. It discusses the PACE trial (n = 641), whose GET group had 160 participants, and reports that fitness did not improve; the same was seen in the CBTplus group. It also reports that CBTplus and GET did not lead to a reduction in CFS symptom count. It cites Dutch studies (8 months of CBTplus in adults, 5 months in adolescents, at least 16 weeks of guided self-instructions) that did not lead to an objective improvement of activity (actometer), and other studies showing no objective improvement in fitness according to VO2peak. In long COVID, the ReCOVer study found that 16 weeks of CBTplus did not lead to an objective improvement of activity (actometer). Adherence data include PACE dropout of 11% for CBTplus and 6% for GET, and the Stordeur evaluation (n = 655) with 41–62 h of CBTplus and GET over 6–8 months and a dropout rate of 2.8%. The paper states that the small, short-lived subjective improvement of fatigue after CBTplus and GET is not matched by an objective improvement of physical fitness or employment and illness benefit status. It does not report its own limitations.

  227. The PACE Trial's GET Manual for Therapists Exposes the Fixed Incremental Nature of Graded Exercise Therapy for ME/CFS.2025 · review
    Summary

    This review examined evidence used by White et al. about NICE guidance for ME/CFS; it did not enrol or treat participants. In the PACE trial, quality-of-life scores at 24 weeks and 52 weeks were 0.60 (GET) and 0.61 (CBT), and 0.59 (GET) and 0.63 (CBT), and CBT and GET did not have an effect on CFS symptom count. The review states 20% of PACE participants who improved subjectively deteriorated objectively (6MWT). In MAGENTA (n = 241; GET 123, AM 118), there was no evidence GET was better or more cost-saving than AM at 6 or 12 months; accelerometer activity fell at 3 and 6 months. GETSET showed no indication of an advantage or disadvantage of GET versus SMC for physical performance, and a significant difference at 15 months favouring SMC for fatigue. In Moss-Morris et al., subjective physical functioning improved 30% after GET while CPET deteriorated 15%. Reported harms included worsening in 58.3% (CBT) and 81.1% (GET) in an Oxford Brookes University study (n = 2274), and 14% (CBT) and 22.4% (GET) becoming bedridden; 82% of a 25% ME group survey (n = 437) were made worse by GET, and an Action for ME survey reported GET harmful in 60% of cases. A Dutch GET programme reported dropout of 55%, 73%, and 80% at 6, 9, and 12 months. The authors report no formal limitations section.

  228. From tradition to healing: the promise of acupuncture in managing chronic fatigue syndrome.2025 · review
    Summary

    This review asked how acupuncture and moxibustion are used for chronic fatigue syndrome (CFS). It reports no primary enrollment or analysis; its setting is not reported, and it summarizes other studies. It cites a study of 310 patients treated with acupuncture combined with psychotherapy, reporting a clinical survival rate of 88.7% and a rate of 97.7%. A multicenter, unblinded RCT divided 150 patients with CFS and idiopathic chronic fatigue into body acupuncture, Sa-am acupuncture, and control groups; after 5 weeks the body acupuncture group had a significantly lower FSS score than the control group, with significant improvement in SRI and BDI scores. Another RCT compared moxibustion and acupuncture and reported 88.9% versus 72.2%. A study of 72 CFS patients found electroacupuncture produced greater reductions in fatigue and more significant improvements in cerebral cortical function than routine needling. One study of 60 CFS patients used acupoint catgut embedding combined with ginger-partitioned moxibustion and reported significantly improved clinical signs and symptoms; another 60 CFS patients compared Chaihu Longgu Muli Decoction combined with acupuncture at back-shu points with traditional Chinese medicine alone, finding better fatigue and anxiety scale improvement in the combined group. A systematic review and meta-analysis included 16 studies with 1346 patients, and a network meta-analysis included 51 RCTs. The review notes local pain, bleeding, infection, and other adverse reactions may occur during acupuncture; five patients experienced acupuncture-related adverse events with relatively mild symptoms.

  229. Health care for patients with long COVID: a scoping review.2024 · review
    Summary

    This scoping review examined health care for patients with Long Covid-19. It included 13 studies identified in electronic databases, carried out in several countries and published in English. Included studies reported telerehabilitation with physical exercises, physical exercise interventions, outpatient pulmonary rehabilitation, standard physical therapy, cognitive behavioral therapy with antidepressants and non-benzodiazepine tranquilizers, and supervised concurrent training with or without inspiratory muscle training; an exercise intervention was reported at 8 weeks. Some studies compared supervised therapeutic exercise with a WHO self-management rehabilitation leaflet, physical training rehabilitation with standard physical therapy, and physical exercise with breathing training and controls. Outcomes included physical capacity, quality of life, symptoms, fatigue, dyspnea, and stress, anxiety and depression. The review reports improvements after telerehabilitation in physical capacity, quality of life, fatigue and dyspnea; improvement in fatigue after physical intervention; reduction in dyspnea after 8 weeks of physical exercise; increase in 6-minute walk distance and decrease in dyspnea after outpatient pulmonary rehabilitation; maximum inspiratory mouth pressure increased by 28%; MDP score after physical training rehabilitation was 42% lower than after standard physical therapy; and improvement in stress, anxiety and depression with CBT plus antidepressants and tranquilizers. It also reports that some fatigue and quality of life results did not show significant improvements compared to the control group, and that participants reported relapses when performing physical exercise. No side-effect counts were reported. The authors state the selected studies did not provide specific guidelines and that there is a clear gap in the literature on how to identify and clinically manage people with this condition.

  230. Understanding Post-COVID-19: Mechanisms, Neurological Complications, Current Treatments, and Emerging Therapies.2024 · review
    Summary

    This perspective review examined peer-reviewed literature, using a broad integrative search, on Post-Acute COVID-19 Syndrome (PACS)/Long COVID-19 and its neurological manifestations. It enrolled no patients; no number started or analysed, no follow-up, no treatment duration, and no comparison group were reported. The authors summarize named studies rather than presenting this review’s own trial results. In one named randomized controlled trial, CBT was reported to reduce fatigue in nonhospitalized patients. A named systematic review of stem cell therapy in COVID-19 reported decreased mortality and morbidity and suppression of inflammation, while some patients had fever after infusion. In mice, Tempol at 200 mg/kg/d was reported to produce a 2 fold decrease in titers of IL-1, IL-2, IFN-γ, and TNF-α and decreased NF-κB activation in the optic nerve. Mitochondrial transfer in Alzheimer’s disease mice was reported to increase cognitive performance compared with control; mitochondrial transplantation in diabetic cognitive impairment mice improved oxidative stress, neuronal apoptosis, and cognitive performance; and mitochondrial transplantation in Parkinson’s disease rats suppressed inflammatory cytokines. The authors propose antioxidant/vitamin supplements, stem cell therapy, and mitochondrial therapy for further research.

  231. Research progress on pathogenesis of chronic fatigue syndrome and treatment of traditional Chinese and Western medicine.2024 · review
    Summary

    This comprehensive review synthesized recent literature on Chronic Fatigue Syndrome (CFS) pathogenesis and traditional Chinese and Western medicine treatments; it did not enroll or analyze its own patient cohort, so setting was not reported. Cited studies described varied interventions. Shu et al. randomized 30 CFS patients to acupuncture or moxibustion at Zusanli and Guanyuan; after 4 and 10 weeks both alleviated fatigue symptoms by modulating the vagus nerve, with acupuncture showing superior short-term and moxibustion enhanced long-term clinical efficacy. Luo et al. studied 60 female CFS patients receiving 30-min or 60-min moxibustion three times per week for four weeks; 60-min moxibustion showed advantages for fatigue and depression. Qi Fengjun et al. allocated 60 CFS patients to massage or acupuncture for two treatment courses each lasting 10 days; massage showed significant therapeutic benefits. Liang Weili et al. divided 70 CFS patients; oral medication plus herbal-cake moxibustion was more efficacious than oral medication alone for fatigue and sleep quality. Borody et al. reported FMT therapeutic efficacy in 70% of cases (42 out of 60) with gastrointestinal symptoms. Adamson et al. observed improvement in 995 CFS patients after cognitive-behavioral and psychological interventions. Harms included lower incidence of nausea and diarrhea with moxibustion plus paroxetine than paroxetine alone; in a Norwegian survey approximately 80% of patients reported decline in health status after graded exercise therapy. The authors stated limitations including lack of rigorous trial design and safety data.

  232. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment.2024 · review
    Summary

    This literature review searched EBSCOhost Academic Search Premier, Proquest, Google Scholar, and the Cochrane Library in June 2022 for published treatments for chronic inflammatory response syndrome (CIRS), ME/CFS, and sick building syndrome. No patients were enrolled by the review; no comparison group, randomization, or follow-up duration was reported. The review reports 13 articles comprising 14 studies on CIRS treatment and also reviews CFS treatment studies. Named CIRS study sizes included 8, 13, 28, 14, 21, 156/111, 20, 35/4, 100, and 68/23. The review states the only treatment with documented clinical efficacy was the Shoemaker Protocol, described in 11 of the 13 articles; table entries list cholestyramine and vasoactive intestinal peptide as successful, while Rea’s antigen intradermal treatments had lack of objective data. CFS studies listed sizes including 49, 1518, 1030, 2036, 62, 409, 101, 171, 33, 32/18, 23, and 218; findings included some benefit for aripiprazole in 101 patients, high frequency of response for low-dose naltrexone in 218, and CBT/GET reported beneficial in six studies but noncurative. Reported side effects include constipation from cholestyramine, hyponatremia from desmopressin, and light-headedness from vasoactive intestinal peptides; medication intolerance was a barrier.

  233. Effects of graded exercise therapy and medical care on chronic fatigue syndrome2024 · review
    Summary

    This review article examined five studies published between 2013 and 2023, identified through PubMed, on treatments for CFS/ME in the working population. The interventions reviewed were GET, CBT, APT, SMC, and GES. The review reports that in White et al. (2013), with 641 participants over 52 weeks, recovery was CBT 22%, GET 22%, APT 8%, and SMC alone 7%; the chances of recovery were significantly higher for CBT and GET than for APT and SMC alone. In Sharpe et al. (2015), a follow-up of the 641 participants, 75% returned the long-term questionnaire and 44% received additional treatment; reduced fatigue and better physical and cognitive functioning were sustained for those originally assigned CBT or GET, while those initially assigned SMC or APT also improved. Clark et al. (2017) included 211 participants, with 107 assigned to GES and 104 to control; after 12 weeks, 34% of the GES group showed 8 points of improvement on SF-36 and 3 points on CFQ, compared with 14% improvement in the control group. Wilshire et al. (2018) reported that the GET group had better physical function ratings but not fatigue self-assessment, while the CBT group had better fatigue self-assessment but not physical function. Clark et al. (2021) reported that 78% returned questionnaires 15 months after commencement; GES improvements were sustained but without additional improvement and no significant difference compared to control. Side effects and withdrawals were not reported in the text. The authors state limitations concerning reliance on self-reported questionnaires and variability across studies.

  234. Graded exercise therapy and cognitive behavior therapy do not improve employment outcomes in ME/CFS.2023 · review
    Summary

    This paper is a review/commentary, not a new trial, and reports no own participants. It examines employment outcomes reported in studies of graded exercise therapy (GET) and cognitive behavior therapy (CBT) for ME/CFS, and discusses long Covid/PASC. In the PACE trial (641 participants), the percentage in the GET group reporting lost days of work increased from 83% at baseline to 86% at 12 months after randomization; in the CBT group the percentage was 84% both before and after treatment. In all study arms, the percentage receiving unemployment or disability benefits was higher after treatment. PACE reported that around 60% had improved and 22% had recovered after GET and CBT on subjective, self-reported measures; in the six-minute walking test the GET group showed a statistically significant but clinically insignificant improvement. Two other randomized trials, Prins et al. (278 participants) and O’Dowd et al. (153), reported no statistically significant differences in employment outcomes between intervention and control groups. Observational findings included Collin and Crawley (952 patients; subgroup of 394: 18% returned to work or increased work hours, 30% stopped or reduced work hours), a Belgian report (655 patients: employment status decreased; living from a sickness allowance rose from 54% to 57%), and Stevelink et al. (508 patients, 316 provided information: 9% returned to work, 6% stopped, net return-to-work of 3%). Vink and Vink-Niese found that standard interventions did not have an overall positive effect on work status.

  235. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.2023 · review
    Summary

    This scoping review searched six electronic databases up to 02/02/2022 and included 17 studies of pacing in people with ME/CFS. Designs were heterogeneous: RCTs, observational studies, a case series, and PACE trial sub-analyses. Pacing interventions included educational sessions, activity diaries, activity pacing self-management, and the energy envelope; comparators included relaxation therapy, pain physiology education, graded exercise therapy, cognitive behavioural therapy, and specialised medical care, while observational studies had no intervention. Outcomes covered symptoms, fatigue, physical function, pain, quality of life, self-efficacy, sleep, depression and anxiety. Findings were mixed. Antcliff et al. reported pacing improved mean scores of all symptoms; Kos et al. reported improved COPM performance (33% of group), satisfaction (42% of group), and CIS; Nijs et al. reported both improvements in CFS, COPM, and VAS and no improvement in SF-36, CFS, or CIS. White et al. reported pacing did not improve fatigue or physical function, but CBT and GET did. Geraghty et al. reported improved symptoms in 44% of respondents and worsened symptoms in 14%. Dougall et al. reported pacing worsened physical function in 25% of the group versus SMC 18%, GET 11%, and CBT 9%. White et al. reported recovery in 8% with pacing versus CBT 22%, GET 22%, and SMC 7%. Drop-outs were reported (Kos 25% experimental, 18% control; Meeus 5%; Nijs 22%; White 8%).

  236. The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.2023 · review
    Summary

    This review examined the draft IQWiG report and the three trials it used on CBT and GET for ME/CFS: Janse et al. 2018, GETSET, and PACE. The PACE trial was a non-blinded study with n = 641. The review reports ME/CFS and notes long COVID/post-COVID syndrome. Setting and treatment duration were not reported. Treatments included iCBT/odCBT/pdCBT, GES, CBT and GET, compared with SMC or APT. Outcomes included adherence, CGI change, fatigue, physical functioning, six-minute walk test, step test, employment status, quality of life, symptom count and harms. Adherence was 16% (odCBT) and 19% (pdCBT); in GETSET, 43 (42%) adhered completely or very well, 31 (30%) moderately well, and 30 (29%) slightly or not at all. CGI positive change was 14% (GES) and 6% (SMC). At 52 weeks, fatigue scores were 20.3 (CBT) and 20.6 (GET); physical functioning scores were 58.2 (CBT) and 57.7 (GET). CBT and GET did not lead to objective short-, medium- or long-term improvement on the six-minute walk test; the step test showed no objective improvement. CBT had no effect and GET a negative effect on employment status. Quality-of-life net improvement was 2.3% after GET over APT and 0.5% after CBT over APT. Symptom-count improvement showed no statistically significant difference (p = 0.0916; p = 0.23; p = 0.0986). Cited surveys reported 20 percent of respondents said CBT worsened health and at least 50% for GET; an Oxford Brookes survey (n = 2274) reported worsening in 81.1% (GET) and 58.3% (CBT).

  237. What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid review2023 · review · preprint
    Summary

    This rapid review asked what interventions or best practice support people with Long COVID, or similar post-viral conditions characterised by fatigue, to return to normal activities. It included ten relevant studies published between 2014 and 2022: systematic reviews, primary studies and guidelines. The primary studies covered Long COVID and CFS. One survey of 145 UK workers recovering from COVID-19 found that only 15% managed a full return to work. A longitudinal cohort of 111 patients with CFS after mononucleosis described a written self-management programme; there was an 18% increase in patients in employment from baseline (10% in employment) to follow-up (28% in employment). A case study of 1 patient with Long COVID reported improved depression and anxiety symptoms and improved quality of life and work and social adjustment after management therapy. A qualitative study of 8 healthcare professionals reported gradual return to work as a frequently mentioned accommodation. The reviews reported that exercise therapy, electrical nerve stimulation, sleep and touch therapy, and behavioural self-management may be beneficial; in one review exercise therapy may have a positive effect on fatigue compared with usual care or passive therapies. Four of five interventions in one review found statistically significant benefit, while music therapy combined with CBT reported no significant benefit. Side effects were not counted; one review was uncertain about the risk of side effects. The authors state little reported evidence of effectiveness and weak overall evidence.

  238. Treatment Harms To Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome2023 · review
    Summary

    This preprint is a review, not a new trial: “The following sections review the most recent studies of patient treatment harms following CBT and GET.” It reports no enrolled participants, no comparison group and no treatment given by the author. It summarizes patient surveys and trials concerning ME/CFS and PASC. Kindlon (2011) reviewed 10 patient surveys from four countries: 51per cent of respondents (range = 28%–82%, n = 4338, eight surveys) reported GET worsened their health, and 20 per cent (range = 7%– 38%, n = 1808, five surveys) reported similar results for CBT. Lapp (1997) followed 31 patients for 12 days after a maximal exercise test and found the average relapse lasted 8.82 days, with 22 per cent still in relapse at 12 days. White and Etherington (2021) reviewed ten trials and reported drop-outs in 74/679 (11%) participants after GET and 41/600 (7%) after control interventions (RR (CI): 1.51 (1.03, 2.22)). McPhee et al. (2019) received data from 38 clinics; no clinic reported any cases of treatment-related harm. White et al. (2011) reported two serious adverse reactions (SARs) possibly related to treatment; Wearden et al. (2010b) reported no SARs due to therapy. Kindlon (2015) reported more than 50% of pwME/CFS said CBT and GET fell short of significant improvements and often led to worsened health. The paper does not state limitations for this review.

  239. Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.2022 · review
    Summary

    This narrative review describes rehabilitative treatments for CFS/ME. It does not report a new study; it summarizes trials. The main trial discussed is PACE, a four-arm trial that recruited over 600 patients. PACE compared specialist medical care alone with specialist medical care plus CBT, GET, or adaptive pacing therapy. Outcomes included functioning, fatigue, and six safety outcomes. The review states that CBT and GET improved functioning and reduced fatigue more than specialist medical care alone or specialist medical care plus adaptive pacing therapy. It reports no evidence of harm from CBT or GET in PACE. A more recent trial of guided self-help based on GET found no significant differences in safety outcomes compared with specialist medical care. The review also notes patient group surveys reporting that rehabilitation and GET in particular made some patients worse outside trials, and that rigidly applied programmes not tailored to symptom severity and disability may lead to worsening symptoms. No patients, enrollment numbers, follow-up durations, or withdrawal counts are reported for the review itself.

  240. Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?2022 · review
    Summary

    This literature review searched PubMed, Medline, the Cochrane Database of Clinical Trials, Academia, and Google Scholar from January 1980 to December 2021 for studies of CBT and GET in adults with ME/CFS that reported work status before and after treatment. Nine studies were summarised, including the PACE trial (n = 641), Huibers et al. (n = 151), and Prins et al. (n = 278). In the PACE trial, lost employment after CBT remained 84% and increased from 83% to 86% after GET. In Belgian clinics, working decreased from 18.3% to 14.9% and incapacity benefits rose from 54% to 57%; in British clinics, working decreased from 30% to 18%. Huibers et al. found more patients back at work without treatment at 4 and 12 months. O’Dowd et al. and Prins et al. found no statistically significant difference in work status, and Prins et al. found no statistically significant difference in hours worked. Van Berkel et al. found GET had no effect on work status at 3 and 12 months. Dropout was 38% in Stevelink et al. and 33%, 59%, and 72% after 6, 9, and 12 months of GET in Van Berkel et al. The Oxford Brookes University study (n = 2274) reported worsening of symptoms in 58.3% with CBT and 81.1% with GET, and increases in patients bedridden and dependent on help from 12.6% to 26.6% with CBT and 12.9% to 35.3% with GET. The authors state that most clinical trials did not report on harms from the therapies.

  241. The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.2022 · review
    Summary

    This review examined the evidence that Flottorp et al. used to support CBT and GET for ME/CFS after NICE's updated guidance. The review enrolled no patients itself; it discussed trials in ME/CFS, including PACE (n = 641), Gordon et al. (n = 22), Chalder et al. (n = 63), Windthorst et al. (n = 28) and an Oxford Brookes University study (n = 2274). Reviewed treatments included CBT, GET, APT, SMC, graded aerobic exercise, resistance training, I-CBT and waiting-list or usual care. In PACE, the chronic fatigue syndrome symptom count showed no statistically significant difference between GET and SMC (p = 0.0916), GET and APT (p = 0.23) or CBT and APT (p = 0.0986); EQ-5D net improvement was 2.3% after GET over APT and 0.5% after CBT over APT. Gordon et al. found no intervention significantly better than the other for any outcome. In Gotaas et al., the physical functioning difference between I-CBT and control was 6.8 points, below the authors' 10-point minimal important difference, and dropout was 20.5% vs. 6%. Oxford Brookes reported worsening in 58.3% (CBT) and 81.1% (GET); bedridden status increased from 12.6% to 26.6% (CBT) and 12.9% to 35.3% (GET). GETSET reported 14% (GES) and 6% (SMC) positive change, with only 8% subjectively benefiting from GES and up to 59% not tolerating treatment well. No limitations of the review were stated.

  242. Therapeutic approaches in chronic fatigue syndrome2021 · review
    Summary

    This E-Poster presentation reports a literature search, not a patient cohort, on therapeutic approaches in chronic fatigue syndrome (CFS). The authors searched main electronic databases with a paradigm combining CFS and psychopharmacological treatment or psychotherapy and included papers published between January 2000 and August 2020. No enrolled, started, or analysed patient numbers, follow-up duration, or trial registration were reported. The review states that anti-inflammatory drugs, antidepressants, mood stabilizers, anxiolytics, immunomodulatory drugs, and antivirals have been investigated, but the trials had low-quality designs, used various definitions of CFS, and different criteria for monitoring efficacy. For CBT, the authors conclude it may be promising for decreasing fatigue severity but larger trials are needed. For GET, they conclude it may be of some use for improving patients' ability to engage in activities, with caution because of the risk of over-exercising that may exacerbate core CFS symptoms. No drug may be considered first-line treatment. The authors state larger trials are needed to validate pharmacological and psychotherapeutic recommendations.

  243. Patients' experiences and effects of non-pharmacological treatment for myalgic encephalomyelitis/chronic fatigue syndrome - a scoping mixed methods review.2020 · review
    Summary

    This scoping mixed methods review asked what non-pharmacological treatments for ME/CFS do and what patients find important. It identified 16 papers from European studies, searching January 2009 to January 2019 and updating to 18 March 2020. Effect studies examined CBT, activity pacing and multidisciplinary rehabilitation including CBT and GET; qualitative studies examined CBT, GET self-help, self-management education, multimodal specialist care and the Lightening Process. CBT findings included reduced fatigue: Janse et al. reported 43% in iCBT groups reached normal fatigue vs 15% in waiting-list controls; Nijhof et al. reported school attendance 84% vs 51%, and 75% vs 16% reached full attendance at 6 months; Tummers et al. reported 33% vs 9% with clinically reduced fatigue in one study. Activity pacing and rehabilitation effects were inconsistent; Nunez et al. found worse SF-36 pain scores after 1 year in the rehabilitation group. Pinxsterhuis et al. found no group difference in physical functioning after 6 or 12 months. Janse et al. reported no serious adverse events; Cheshire et al. reported some felt worse with GET. The authors state CBT relieved fatigue but long-term effects need more investigation, and activity-pacing and rehabilitation studies are scarce with inconsistent effects.

  244. Management of chronic fatigue syndrome/myalgic encephalomyelitis in a pediatric population: A scoping review.2020 · review
    Summary

    This scoping review examined peer-reviewed research on managing chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in a pediatric population aged under 18 years. The authors searched electronic databases and included 29 peer-reviewed research articles; no new participants were enrolled. The review grouped findings under nutrition/dietary components, exercise therapy, psychosocial factors, and multifaceted treatment. Included studies evaluated CBT with biofeedback, the Lightning Process plus standard medical care, aerobic graded exercise versus progressive resistance training, graded activity/exercise with family sessions, dietary changes, pacing versus STAIRway to Health, and other programs. Outcomes included fatigue severity, school attendance, physical function, anxiety and depression, quality of life, and global health. The review reports that included studies found lower fatigue severity and higher school attendance with CBT plus biofeedback, improvement with Lightning Process plus standard medical care, and no significant difference between aerobic graded exercise and progressive resistance training for physical capacity and QOL, while fatigue and depressive symptoms improved only in the aerobic group. No harms, side effects, worsening or withdrawals were reported in the recorded data. The authors state a lack of research in younger children and insufficient evidence for dietary modifications or supplements in prepubescent children.

  245. Graded exercise therapy does not restore the ability to work in ME/CFS - Rethinking of a Cochrane review.2020 · review
    Summary

    This review examined the amended Cochrane exercise review and the eight randomised controlled trials it included, with data from 1518 participants with ME/CFS from all diagnostic criteria. The treatments compared were exercise therapy versus no-treatment, relaxation and flexibility, or adaptive pacing. Outcomes included fatigue, physical functioning, objective exercise measures, quality of life, symptom count, and work. The review reports that exercise therapy probably reduces fatigue by 3.4 points on the Chalder fatigue scale (0 to 33) compared with no-treatment or relaxation and flexibility after 12 to 26 weeks; the effect after 52 to 70 weeks is uncertain. Physical functioning may moderately improve after 12 to 24 weeks (low evidence), and the effect after 52 to 70 weeks is uncertain; compared with adaptive pacing, exercise therapy may slightly improve physical functioning after 24 and 52 weeks. The authors report that objective outcomes in most included studies showed no objective improvement. In PACE (n = 640), 6MWT was 35.3 for no-treatment, GET had no effect on fitness, and symptom count did not differ significantly between GET and SMC (p = 0.0916) or GET and APT (p = 0.23). In an Oxford Brookes survey (n = 2,274), worsening after treatment was reported by 81.1% for GET, 85.9% for GET combined with CBT, and 58.3% for CBT combined with GET. In Wearden et al. (1998), 34.3% (23/67) complied fully with graded exercise versus 78.3% (54 of the 69 patients) with exercise placebo.

  246. Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified.2020 · review
    Summary

    This review examined Improving Access to Psychological Therapies (IAPT) treatment protocols and early treatment data for medically unexplained symptoms, specifically ME/CFS; it enrolled no patients itself. It reports Kellett et al. IAPT service data: 172 MUS patients were treated out of 10,469 referred. Moving to recovery for depression was 32.33% for LTC and 29.35% for MUS; for anxiety it was 30.43% for LTC and 29.03% for MUS. Reliable improvement for depression was 39.07% for LTC and 33.70% for MUS; for anxiety it was 47.14% for LTC and 45.16% for MUS. Overall reliable recovery for MUS was 17.39%, and deterioration was 4.32%. Seventy-eight patients dropped out during treatment stages and 61 dropped out before treatment or did not complete treatment; 45.25% of MUS patients treated by IAPT did not complete treatment or dropped out after entering, and 4.6% completed intensive CBT. In Collin et al., 435 patients were followed for 1 year post-CBT; approximately 1/3rd reported some benefits, 5.7% counted themselves as no longer having ME/CFS, and 90%+ continued to report ME/CFS. Geraghty et al. found the majority of patients did not report CBT to be helpful, most found GET unhelpful or detrimental, and the biggest percentage reported self-pacing or guided pacing as most beneficial. Deary et al. found null to moderate size effects for reducing somatic symptoms. Edwards et al. reported most interventions out-perform usual care, even self-help guides. The authors state many patients with MUS, particularly ME/CFS, are unlikely to benefit from attending IAPT.

  247. Child and adolescent chronic fatigue syndrome/myalgic encephalomyelitis: where are we now?2019 · review
    Summary

    This review examined recent evidence on CFS/ME in children and young people, including impact, treatment and prognosis. It reported no enrolment, follow-up or treatment-duration figures for its own study and did not set out a search date or number of included studies. The review described PACE, an adult randomized controlled trial, as comparing SMC alone with SMC plus APT, CBT or GET; PACE demonstrated that CBT and GET added to SMC performed better as outpatient treatments than APT added to SMC or SMC alone. GETSET, an adult self-help graded exercise trial, reported that guided self-help added to SMC had a moderate effect on fatigue but less effect on physical functioning for those waiting for clinic therapy. In children and young people, five systematic randomized controlled trials demonstrated benefit from CBT treatment, while there was little evidence for GET. Burgess et al. reported improved physical functioning and social adjustment after a home-based, family-focused rehabilitative approach for severely affected housebound adolescents, but no substantial improvements in fatigue in all participants. Crawley et al. reported the Lightning Process plus SMC compared with SMC in mildly and moderately affected adolescents. A large online CBT trial was described as in progress. GETSET identified no serious adverse reactions in self-help GET in adults with CFS/ME. No withdrawal data were reported. The authors stated that current evidence is hampered by different diagnostic criteria, the heterogeneous nature of the condition, and limited number of small studies; they also stated that the evidence base in CYP is more limited.

  248. Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities.2019 · review
    Summary

    This review asks why pathophysiological insights in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) might point to treatments, and it examines treatment data for antioxidant and anti-inflammatory options. It reports no primary enrolment or analysis; it discusses patients diagnosed with ME/CFS by international consensus or Fukuda criteria and reviews CBT, GET, curcumin, NAC, CoQ10, melatonin, probiotics/prebiotics and molecular hydrogen. For the PACE trial, it reports that a year of CBT produced modest and short-term reductions in fatigue of some 10% compared with an untreated control group and a non-significant worsening of distance walked in six minutes. It also reports that CBT and GET reduced self-reported fatigue by some 13% compared with no treatment after 52 weeks, that GET improved six-minute walking distance by 31m compared with no treatment, and that GET for 12 months was associated with a 67m improvement versus 22m with specialist medical care alone. In 60 patients selected by international consensus criteria, graded exercise over a 12-month period was reported to worsen physical function and pain. Hydrogen-rich water studies in Parkinson’s disease (1,000 mL/day over a 48-week period) and rheumatoid arthritis (500 mL of 1 ppm for four weeks) reported improvements versus controls. The authors state these data are promising yet preliminary.

  249. Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies.2019 · review
    Summary

    This review asked whether work rehabilitation and medical retirement strategies, including CBT and GET, restore work ability in adults with ME/CFS. It searched PubMed, Medline, the Cochrane Database of Clinical Trials and Web of Science for literature published before April 2019 and reviewed 38 CBT and/or GET studies that reported on work status. Treatments included CBT, GET, graded activity, pacing, and antidepressants. Outcomes were employment, work hours, benefits, and fatigue. In Akagi 2001 et al. (n = 94), those who worked increased from 15 to 27, but the dropout rate was 46% (43/94). In Fulcher and White (n = 66), 39% were working or studying at least part time at trial entry, compared with 47% after treatment. McDermott et al. reported 9.2% (9/98) returned to work full time and 6.1% (6/98) part-time. In the PACE trial (n = 641), lost employment remained the same (84%) after CBT and increased from 83% to 86% after GET; income benefits increased from 10% to 13% (CBT) and from 14 to 20% (GET). Wittkowski et al. had two of six patients drop out; Marlin et al. (1998) reported 69% (49/71) lost to follow up. The authors state limitations include different selection criteria and variable follow-up periods.

  250. Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent.2018 · review
    Summary

    This narrative review examined CBT for chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME), searching commonly used literature databases (e.g. PubMed, PsychINFO); it reports no enrolled or analysed participants of its own. It discusses efficacy and informed consent. Surawy et al. (1995) noted benefits using CBT in treating 100 CFS patients in clinical practice; Prins et al. (2001) observed a decrease in self-rated fatigue; Wiborg et al. (2010) reported reduced fatigue in three randomised trials was not mirrored by an increase in objectively measured physical activity. In the PACE trial, 22 per cent of CFS patients ‘recovered’ after CBT plus standard medical care, compared with 7 per cent who received standard medical care only. A Cochrane review reported 40 per cent with a reduction in self-rated fatigue following CBT versus 26 per cent in usual care, and only 16 per cent more patients reported benefit versus no-care. The review says benefits are not sustained over the long term and there is little evidence of improvements in physical function. Harms: the PACE trial found no significant evidence of serious adverse effects; Kindlon (2011b) suggested 20 per cent report adverse reactions; an ME Association survey (n = 1428) reported 8 per cent improving, 73 per cent no improvement, and 18 per cent deterioration after CBT alone. Drop-out was 16–20 per cent in CBT randomised controlled trials. The authors conclude evidence for success remains inconsistent to weak.

  251. Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review.2018 · review
    Summary

    This paper is a re-analysis of a Cochrane review of graded exercise therapy (GET) for chronic fatigue syndrome (CFS/ME). The review included eight randomised controlled studies and reported data from 1510 participants; the re-analysis examined those trials and objective outcomes. GET was compared with control groups or other interventions. In Fulcher, exercise capacity in the GET group improved by 4.3 per cent more than in its control group by 26 weeks, and patients reported improvement on a self-rated clinical global impression score of 1 or 2. In PACE, the net improvement in EQ-5D quality of life after GET over adaptive pacing at 52 weeks was 1 per cent; there was no statistically significant difference in CFS symptom count between GET and SMC (p = 0.0916) or APT (p = 0.23) at 52 weeks. The 6-minute walk benchmark was matched by 6.3 per cent in the GET group and 5 per cent in the SMC group, implying an effect of GET of 1.3 per cent (2/160). In FINE, there were no differences between pragmatic rehabilitation and GP treatment as usual on step test measures at 20 or 70 weeks. Wallman reported a 15 per cent drop in VO2max after GET. Harms included worsening of symptoms in 40 per cent of participants in one report; 37.3 per cent dropped out of the two graded exercise groups combined versus 21.7 per cent from the two control groups combined. The authors state most studies failed to report adverse reactions.

  252. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.2017 · review
    Summary

    This comprehensive review examines benefits and harms of treatments for CFS/ME and makes recommendations. It reports no single enrolled or analysed total. Among the included studies, a phase II rintatolimod trial had 92 patients and a phase III trial had 234 patients; a rituximab RCT had 30 patients, with sustained overall improvement in 67% of CFS/ME patients versus 13% of controls. The PACE trial had 640 patients; a recovery paper reported 22% recovered in the CBT and GET groups, compared with 8% in the APT group and 7% in the SMC-only group. A survey of 828 Norwegian CFS subjects reported pacing useful in 96%, and 79% of patients with experience of graded training considered it worsened their health. CoQ10 plus NADH was studied in 80 patients, with maximum heart rate p=0.022. The review also describes harms: three patients administered acyclovir withdrew due to reversible renal failure, and two out of 13 participants developed neutropenia. The authors state no firm conclusions can be drawn because the few RCTs were small-scale, with a high risk of bias, and used different case definitions; nutritional studies were very limited, mostly small and without long-term follow-up.

  253. PACE investigators' response is misleading regarding patient survey results.2017 · review
    Summary

    This Open Peer Commentary Article reviews patient survey data published between 2001 and 2015 on ME/CFS. Five major patient surveys by Action for ME and The ME Association are pooled. Surveys asked patients about availability, helpfulness, improvement, worsening, or disability benefits for therapies including GET, CBT and pacing. In Action for ME 2011a (977 respondents), 48 per cent responded ‘yes’ for GET and 66 per cent for CBT being available on the NHS, compared with 90–94 per cent for pacing, medications and fatigue/condition management. In The ME Association 2010 survey (3099 respondents), 82 per cent wanted pacing, 28 per cent CBT and 24 per cent GET. In The ME Association 2010 survey (n = 4217), 22 per cent reported improvement with GET, 26 per cent with CBT and 71 per cent with pacing; 57 per cent reported worse symptoms from GET, 20 per cent from CBT and 5 per cent from pacing. The ME Association 2015 reported a net increase in patients on disability benefits after GET courses (+13%) and CBT courses (+10%), compared with a net decrease after pacing courses (−1%). The author states survey limitations should be borne in mind.

  254. FITNET's Internet-Based Cognitive Behavioural Therapy Is Ineffective and May Impede Natural Recovery in Adolescents with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. A Review.2017 · review
    Summary

    This paper is a review, not a new trial. It reanalyses the Dutch FITNET trial to assess whether internet-based CBT can lead to actual recovery; FITNET was a randomised controlled trial involving 135 adolescents with CFS aged 12–18 years. FITNET compared internet-based CBT with usual care; treatment finished after 6 months. Primary outcomes were fatigue severity, physical functioning and school attendance assessed via questionnaires; actometer results were not reported. At end of treatment, the FITNET trial concluded that 60% had recovered with internet-based CBT and 8% with usual care. At LTFU (mean 2.7 years after treatment start), 58.9% had recovered, and the review reports no difference between recovery rates for different treatment strategies. Using 1 rather than 2 standard deviations, recovery would be 36% rather than 63%. The review also cites studies reporting harms: Moss-Morris et al. reported that in 40% of patients their health deteriorated as a consequence of exercise; Núñez et al. reported worse SF-36 physical function and bodily pain scores with CBT and GET. The authors state limitations including a protocol published years after the trial started plus a badly designed control group, more than 70% of the treatment group not having an infectious onset, and not publishing the actometer results. No FITNET discontinuation or side-effect counts are reported.

  255. Cognitive behaviour therapy and objective assessments in chronic fatigue syndrome.2017 · review
    Summary

    This review examined whether cognitive behaviour therapy (CBT) changes objective measures in people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). It did not enrol its own patients; it discussed studies that used objective assessments. The reviewed studies compared CBT with no intervention, a pragmatic form of therapy based on CBT in the FINE trial, or specialist medical care (SMC) with and without additional CBT in the PACE trial, where each group had 160 patients. Outcomes included an incremental shuttle walk, activity levels, timed step tests, the six-minute walking test, days lost from work, illness/disability benefits, step-test fitness, and the Borg scale. In the PACE six-minute walking test, improvement was 22 m with SMC and 21 m with SMC + CBT; the review states adding CBT produced no additional benefit. Days lost from work improved by 0.8 versus 1.6, with no significant advantage for additional CBT. Benefit deterioration was 18 versus 6, and the review says end-of-trial percentages were very close. Step-test fitness improvement was 0.15 versus 0.09 and Borg improvement 0.008 versus 0.011; both comparisons were called negligible. One cited trial reported that a quarter of patients in the CBT group dropped out. Side effects were not reported. The author concludes there is a lack of evidence that CBT produces any improvement in physical capabilities or other objective measures such as return to work.

  256. Practical management of chronic fatigue syndrome or myalgic encephalomyelitis in childhood.2017 · review
    Summary

    This narrative review summarises practical management of paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME). It reports no primary study of its own and describes no comparison group. The text covers diagnosis and referral, then treatments including cognitive behavioural therapy (CBT), activity management, graded exercise therapy (GET), sleep management, pain management, and management of mood, eating difficulties and weight. For CBT, the review reports that five randomised controlled trials of CBT for CFS/ME in adolescents have shown that it is an effective treatment approach. For internet-delivered CBT, it reports that the largest trial to date demonstrated that most children with CFS/ME will recover within 6 to 12 months, whereas for those who do not receive specialist care, recovery is much slower with less than 10% recovering at 6 months. For activity management, the review reports that most studies increase activity by 10%–20% each week. It states there is a limited evidence base for GET and that no trials investigate GET in the outpatient setting. It also notes a limited evidence base for melatonin and describes possible symptom increases when physical activity is increased.

  257. Assessment of Individual PACE Trial Data: in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Cognitive Behavioral and Graded Exercise Therapy are Ineffective, Do Not Lead to Actual Recovery and Negative Outcomes may be Higher than Reported2017 · review
    Summary

    The available text is an abstract of a paper described as an assessment of individual PACE trial data. It concerns Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The abstract does not report how many people were enrolled or analysed, where they were from, the study design, the duration of treatment, or the comparison condition. It names Cognitive Behavioral Therapy (CBT) and Graded Exercise Therapy (GET). The abstract records the PACE trial’s conclusion for CBT and GET and states that the trial yielded a 22% recovery rate. The abstract does not report a separate finding of the present assessment; it records the PACE trial’s stated conclusion and the 22% recovery figure. It does not report worsening, stopping treatment, side effects, between-group results, or before-and-after treatment results. The authors’ conclusion is not reported in the available abstract. Limitations stated by the authors are not reported in the available abstract; the available text is abstract only and lacks design, sample size and follow-up details.

  258. Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial2016 · review
    Summary

    This critical commentary and preliminary re-analysis asked whether PACE trial claims of recovery after graded exercise therapy (GET) or a special form of cognitive behavioural therapy (CBT) were justified. The PACE trial was an open-label randomised trial with more than 600 adult participants diagnosed with chronic fatigue syndrome (CFS) by the Oxford case definition. One group received no further treatment (Control); other groups received CBT, GET, or adaptive pacing therapy. Primary outcomes, obtained 52 weeks after treatment allocation, were self-rated fatigue and physical function. The commentary reports that PACE publications said 22% of CBT patients and 22% of GET patients recovered, versus 8% with adaptive pacing and 7% with Control. Self-rated fatigue and physical function improved in all groups, but significantly more so for CBT and GET. Using a definition almost identical to the original protocol, the authors calculated recovery in 7% of the CBT group, 4% of the GET group, and 3% of the Control group; rates for CBT and GET were not significantly higher than Control (Fisher’s exact p-values 0.199 and 0.770). They also report that revised criteria raised proportions meeting SF-36 physical function from 14% to 45%, Chalder Fatigue from 15% to 29%, and CGI from 12% to 34%; no recovered patient reached 589 m on the six-minute walking test. No side-effect or withdrawal counts are reported.

  259. The PACE Trial Invalidates the Use of Cognitive Behavioral and Graded Exercise Therapy in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: A Review2016 · review
    Summary

    The review examines the PACE trial and its follow-up articles from doctor and patient perspectives to assess CBT and GET in ME/CFS. The PACE trial was a multicenter trial in England involving 641 patients with ME/CFS. It compared cognitive behavioral therapy (CBT), graded exercise therapy (GET), adaptive pacing therapy, and specialist medical care. At 52 weeks, the review reports no difference in long-term outcomes between these treatments and a null effect. On the 6-minute walk test, the GET group walked 379 m within 6 min, an adjusted difference of 35 m beyond specialist medical care; the CBT group walked 354 m, 4 m beyond adaptive pacing therapy but 1.5 m less than specialist medical care. The review states these improvements did not reach statistical significance, for which an increase of at least 86 m was required. It reports that 22% of participants were considered recovered in both CBT and GET groups. Receipt of income benefits increased from 10% to 13% with CBT and from 14% to 20% with GET; illness/disability benefits increased from 32% to 38% and from 31% to 36%; income protection or private pensions increased by 100% in both groups. Harms reported in PACE included an increase in ME/CFS symptoms in 46%, musculoskeletal adverse events in 31%, neurological adverse events in 19%, and non-serious adverse events in 93%; 49% reported 4 and 51% more than 4 such events. Serious adverse events were 2% in CBT and 1% in the other 3 groups. 33 (5%) of 640 participants were lost to follow-up. The PACE authors stated recovery beyond 52 weeks was uncertain.

  260. Energy Conservation/Envelope Theory Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.2013 · review
    Summary

    This review provides the theoretical and conceptual background for the Energy Envelope Theory and reviews evidence of its treatment efficacy in ME/CFS. It summarizes rehabilitation studies using energy conservation, pacing, and buddy/mentor support rather than a single trial. In one study, twelve patients with ME/CFS were recruited; half received a buddy and mentor for four months and half were controls who received no intervention; recipients had significant decreases in fatigue severity while controls had significant increases. A randomized study of forty-seven participants found significant increases in self-esteem, well-being, mastery, work, energy, and interpersonal relationships. A thirty-participant randomized buddy study reported greater reductions in fatigue severity and increases in vitality. In a trial of one hundred and fourteen patients randomly assigned to four interventions, those able to stay within energy envelopes had significant improvements in physical functioning and fatigue severity. Pacing programs were also summarized: Goudsmit et al. found differences for fatigue, somatic symptoms, and self-efficacy maintained at 12-month follow-up; Wallman et al. reported 91% rated themselves better and none felt worse; White et al. reported APT had little effect. Surveys cited found 26% of 2,338 respondents felt worse after CBT, 33.1% much worse and 23.4% slightly worse after graded exercise, and 34% worse after graded exercise. The authors note limitations to patient surveys because fidelity of interventions is not always clear.

  261. Treating chronic fatigue syndrome - a study into the scientific evidence for pharmacological treatments.2011 · review
    Summary

    The paper reports a questionnaire survey of 94 CFS patients from Queensland and New South Wales, recruited through support groups and newspaper and email advertisements, plus a search for randomised controlled trials. Patients filled out a questionnaire on current medicines and supplements; no treatment was given by the authors, and the survey had no comparison group. The 94 patients used 474 different medicines and supplements. Commonly used were antidepressants (41%), sedatives (27%), B vitamins (47%), magnesium (24%) and co-enzyme Q10 (7%). The search identified 20 RCTs. Findings included no difference for fluoxetine on fatigue or SF-36, no difference between treatment and placebo on individual questionnaires, and no effect for several agents including phenelzine, moclobemide, valaciclovir, terfenadine, melatonin, ginseng, bovine liver extract and a polynutrient supplement. One hydrocortisone trial reported 87% rated themselves improved versus 17% on placebo (p<0.001); another reported 53% vs. 29% (p=0.04) improvement in wellness score. Harm notes included diarrhoea with high-dose oral magnesium, long-term adrenal gland suppression with adrenal hormones, addiction and loss of effectiveness with benzodiazepines and opiates, and hormonal/lipid changes with DHEA. No worsening or stopping was reported. The authors state limitations.

  262. Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?2010 · review
    Summary

    This review examined pharmacotherapy for chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME), focusing on non-antidepressant controlled drug trials published between 1988 and August 2009. It did not report one overall number of enrolled patients. In the methylphenidate trial (60 CFS patients), clinically significant improvement on the Checklist of Individual Strength concentration subscale occurred in 13 patients taking methylphenidate (22%) versus three taking placebo (5%; p = 0.01); the number needed to treat was 6 [95% CI: 4.6 to 8.6]. A clinically significant fatigue response occurred in 10 patients (17%) with methylphenidate versus no patients with placebo; the number needed to treat was 6 (95% CI: 3.8 to 14.4). No effect was observed on bodily pain, mental health, depression and anxiety, and no severe side effects were reported. Other reviewed trials reported no significant effect for aciclovir, no beneficial effects for ganciclovir, no differences versus placebo for oral terfenadine (n = 30), and no effect for immunoglobulin in a large RCT (n = 99). In a doxycycline RCT (n = 491), there were no statistically significant differences versus placebo; the doxycycline group had a higher incidence of nausea and photosensitivity. Two participants in a magnesium RCT (n = 34) dropped out, one because of generalized rash.

  263. Chronic fatigue syndrome, fibromyalgia, and related illnesses: a clinical model of assessment and intervention.2010 · review
    Summary

    This brief review and clinical model did not conduct a new trial. The author aimed to define chronic fatigue syndrome (CFS) and fibromyalgia (FM), review behavioral theory and intervention literature, and describe a clinical assessment and intervention model. No participants were enrolled, no setting or study size is reported, and no comparison group or randomisation is reported. The text concerns CFS and FM and discusses CBT and psychotherapy, graded exercise/graded activity, pacing and the energy envelope, relaxation, sleep scheduling, pleasant activities, and social support; no study treatment duration is reported. Named-study findings: Price et al., 2008 reported improvements in CFS for about 1 of 2 patients. Van Koulil et al., 2007 reported FM outcomes were somewhat less favorable and effect sizes were often not maintained at follow-up. Jason et al., 2007 reported balancing activity and rest yielded the greatest improvement compared with graded activity CBT, relaxation, and anaerobic exercise. Thieme, Turk, & Flor, 2007 reported baseline impairment predicted better response to OBT (graded activity-oriented), while greater affective distress predicted better response to CBT. Buckelew et al., 1998 reported improved self-efficacy with biofeedback-assisted relaxation. Edinger et al., 2005 reported nearly 50% reduction in nocturnal wake time. Jones et al., 2006 reported lower-intensity exercise programs had greatest effect. Friedberg, 1999 reported high-function participants were less likely than lower-function participants to show activity-inhibiting beliefs. The review states symptom exacerbations from assigned exercise are likely to be minimal or nil if assigned in small measured steps. No adverse event counts or withdrawals are reported.

  264. Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.2009 · review
    Summary

    This review did not run its own trial; it summarized published data on pharmacological treatment of chronic fatigue syndrome (CFS), identified through a PubMed literature search. The review covers antidepressants and other psychotropic agents in CFS. In included randomized, placebo-controlled trials, moclobemide vs. placebo (47 vs. 43) showed clinically global improvement 51 vs. 33% (OR = 2.16); KPI mean difference between two groups was 0.28 favoring MCB, and Vigor subscale on POMS mean difference was 0.51 favoring MCB. Overall response by subjective global impression was 51% with moclobemide vs. 23% with placebo. At 12 weeks, MIR failed to separate from PBO on FS; at 24 weeks, CBT + MIR showed significantly more reduction in FS scores than PBO + CBT, with an observed difference of 5.5 (95% CI = 15.4 – 22), whereas MIR + CBT failed to separate from PBO + CBT. Fluoxetine failed to separate from PBO on SFS and BDI scores, and failed to demonstrate benefit on listed outcome measures. The review lists harms: TCAs potentially induce sedation and orthostatic hypotension; MAOIs have hypertensive crisis; stimulant medications carry risks of misuse, abuse, withdrawal, and diversion. Authors state research does not support definitive conclusions about antidepressant efficacy in CFS.

  265. Antidepressants and cognitive-behavioral therapy for symptom syndromes.2006 · review
    Summary

    This review article examined antidepressant medications and cognitive-behavioral therapy for 11 somatic syndromes, including chronic fatigue syndrome. It did not report its own enrolments, analysed patients, setting, or follow-up; patient counts were not reported. The review described trials of antidepressants versus placebo and trials of CBT. Outcomes included global symptoms, pain, sleep, fatigue, mood, and energy. For CFS, the review reports that a systematic review found two interventions beneficial for improving but not curing symptoms: CBT and graded exercise. It reports that six of the seven RCTs of CBT on CFS found benefit, with an effect lasting for 5 years. Among antidepressant trials, two fluoxetine trials showed no benefit other than for depressive symptoms; one phenelzine trial showed improvement in multiple CFS symptoms, illness severity, and mood; and a moclobemide trial showed improvement in subjective vigor and energy. The review reports mixed evidence that antidepressants lead to overall improvement and states there is no randomized trial evidence demonstrating any efficacy for methylphenidate. The authors state that evidence for antidepressants in CFS is limited and insufficient for convincing conclusions.

  266. Practitioner review: chronic fatigue syndrome in childhood.2005 · review
    Summary

    This practitioner review discusses chronic fatigue syndrome in childhood and adolescence, drawing also on adult literature. It is not a new trial and reports no enrollment or analysis numbers. The authors describe assessment and management and focus on a rehabilitation program based on family cognitive behaviour therapy and graded activity, while also outlining pacing and supportive medical approaches. They state there are no randomized controlled trials demonstrating the effectiveness of this approach in children. They cite adult studies of cognitive behaviour therapy and/or graded exercise as improving disability and symptoms, and they cite open and clinical reports in children. For severely affected children, they cite inpatient rehabilitation based on the same principles as beneficial. For pacing, they state there is no empirical evidence for efficacy. They cite a supportive medical approach with low recovery rates: one-third over five years. They cite a randomized controlled trial of gammaglobulin infusions with a significant advantage over placebo but comparatively small gains, not routine practice. They state insufficient adult evidence for anti-depressants for CFS, with possible use for associated depression, insomnia and myalgia. The authors conclude that family cognitive behaviour therapy can be implemented and seems to hold most promise. They note no randomized controlled trials in children and little knowledge on pre-adolescents.

  267. Chronic fatigue syndrome: matching exercise to symptom fluctuations.2004 · review
    Summary

    This paper is a review of exercise for chronic fatigue syndrome (CFS), not a primary study; it reports no own enrolled or analysed participant numbers. It discusses Whiting et al23, a systematic review that included 44 studies and 2,801 patients with CFS, in which cognitive behavioral therapy (CBT) and graded exercise therapy showed promising results. An exercise training study22 in CFS patients lasting 4 to 6 months reported that the ability to perform aerobic exercise increased 13%; patients had less fatigue, a lower HR, a lower RPE, increased functional capacity, and fewer symptoms. In a large-scale study25, 1,092 veterans with Gulf War veterans' illnesses (GWVI) were randomly assigned to one of four treatment arms; neither aerobic exercise nor CBT had a significant impact on physical function, but both treatments, especially exercise, resulted in less fatigue, fewer cognitive symptoms, less distress, and improved mental health functioning. Clapp et al8 found no changes immediately after 30 minutes of light, intermittent exercise (three 10-minute bouts) or 1 week later; all10 patients believed they could not walk for 30 minutes without exacerbating symptoms. Reported harms include that exercise can provoke anxiety and a feeling of increased vulnerability to pain and fatigue, fatigue may be greater for the first few days, and a rapid introduction of overly strenuous exercise is likely to exacerbate symptoms. The authors state that CFS is difficult to study because patients are heterogeneous and symptoms fluctuate.

  268. Chronic fatigue syndrome: traditional and community-based approaches to rehabilitation.2004 · review
    Summary

    This narrative review summarised and critically reviewed existing studies of psychological and psychosocial rehabilitation for chronic fatigue syndrome (CFS), searching Medline, PSYCHINFO, CINAHAL, ERIC and the Science Citation Index. Reviewed treatments included CBT with graded activity, graded exercise, activity pacing, supportive counselling, multidisciplinary inpatient and community-based programmes. Sharpe et al. 1996 reported 73% CBT achieved satisfactory outcome vs. 27% usual care, 73% vs. 23% improved function by >10 points, and 63% vs. 20% improved work status. Fulcher & White 1997 reported 51% in the exercise group improved vs. 27% of controls. Wearden et al. 1998 reported exercise improved fatigue and functional work capacity at 12 and 26 weeks; fluoxetine improved depression at 12 weeks, not sustained at 26 weeks. Powell et al. 2001 reported all three intervention groups improved more than controls at one-year follow-up. Ridsdale et al. 2001 found no differences between CBT and counselling at 3 and 6 months; 53% of the original sample were fatigue cases at 6 months. Marlin et al. 1998 reported 61% returned to gainful employment, 27% functioned at a level equivalent to employment, and 12% remained on disability. Dropout rates included 42% in exercise + fluoxetine, 38% CBT in Prins et al. 2001, and 36% cognitive therapy in Ridsdale et al. 2001. The authors state current evidence for complete and enduring benefit of any single approach remains relatively weak, and many studies are limited by absence of a placebo control group, high dropout rates and selection bias.

  269. Psychological treatment of patients with chronic toxic encephalopathy: lessons from studies of chronic fatigue and whiplash.2003 · review
    Summary

    This review asked whether psychological treatment or cognitive rehabilitation helps patients with chronic toxic encephalopathy (CTE), using comparable evidence from chronic fatigue syndrome (CFS) and chronic whiplash-associated disorder (WAD). PubMed and PsychLIT were searched from inception to June 2000. Of 34 selected studies, 24 evaluated CFS, 5 WAD, and 5 CTE. Treatments included CBT, CBT plus graded exercise or graded activity, cognitive rehabilitation, relaxation, group therapy and other programs; comparisons included support groups, natural course, relaxation, counseling, controls and untreated patients. Outcomes included fatigue severity, functional impairment, quality of life, physical functioning, symptoms, work status, neuropsychological measures and satisfaction. In CFS, one quality A trial reported CBT was more effective than guided support groups or natural course for fatigue severity and functional impairment; other trials reported no significant differences between CBT and relaxation, CBT and counseling, or three brief treatment conditions. CTE cognitive rehabilitation studies were quality C and gave inconsistent results. Recorded harms were high dropout in a CFS trial, 33% dropout in another, refusal of therapy, and an increase of symptoms at 6-months’ follow-up after a CTE program. The authors state few treatment studies and no randomized controlled trials for WAD or CTE.

  270. Behavioral medicine approaches to somatoform disorders.2002 · review
    Summary

    This review examined research evidence on cognitive–behavioral therapy (CBT) for somatoform disorders, including chronic fatigue syndrome; searches covered 1970 to February 2001. In chronic fatigue syndrome studies, Sharpe et al. (1996) randomized 60 patients to CBT with graded activity for 16 sessions or usual treatment, and Deale et al. (1997) randomized 60 to 13 sessions of CBT or relaxation training. Fulcher & White (1997) randomized 66 to graded aerobic exercise or flexibility exercises and relaxation; Lloyd et al. (1993) randomized 90 patients across CBT with graded activity and DLE, CBT with graded activity and placebo, clinic visits and DLE, and clinic visits and placebo; Friedberg & Krupp compared group CBT with no treatment. Outcomes included the Karnofsky scale, a depression measure, and satisfactory or good outcome. At 7 months, Sharpe et al. found satisfactory outcome in 73% with CBT versus 27% with usual treatment (odds ratio 7.56). At 6 months, Deale et al. found good outcome in 70% versus 19% with relaxation (odds ratio 8.64). Fulcher & White reported good outcome in 52% with aerobic exercise versus 27% with flexibility exercises (2.72 [1.02–7.24]). Lloyd et al. found no differences between groups on the Karnofsky scale or depression at 3 months; Friedberg & Krupp reported no effect for group CBT. Dropouts were 0 in Sharpe, 3 CBT and 4 relaxation in Deale, 4 aerobic and 3 flexibility in Fulcher & White, and 1 in Group 3 and 1 in Group 4 in Lloyd. Side effects were not reported.

  271. Chronic fatigue syndrome in the psychiatric practice.2002 · review
    Summary

    This REVIEW ARTICLE concerns chronic fatigue syndrome (CFS) and reviews treatments for CFS, reporting cited trials rather than a new study. Vercoulen contrasted fluoxetine with placebo in 96 patients and did not find any significant effect on fatigue complaints or depression complaints. Wearden examined fluoxetine, placebo and physical exercise in 136 patients; fluoxetine gave a significant improvement of depression scores but a non-significant improvement of fatigue complaints, while physical exercise appeared to result in a significant improvement of fatigue complaints. Natelson studied phenelzine against placebo in 24 patients and found an improvement of fatigue complaints compared with placebo. Behan found a superior antidepressant effect of sertraline vs clomipramine in 40 patients, with no placebo group. Deale reported at final follow-up that 70% of the CBT group achieved a substantial improvement in physical functioning, compared with 19% of the relaxation group. Reference 38 found the number of patients showing clinical improvement was not significantly higher with hydrocortisone than with placebo; reference 39 showed a significant reduction in self-reported fatigue scores with hydrocortisone compared with placebo. Higher doses of cortisone in one study caused adrenal suppression in 40% of patients participating in active treatment. The authors conclude that antidepressants do not seem to have a positive influence on fatigue but appear beneficial for depression and social functioning; CBT and graded exercise show significant improvement and are the only treatments available for CFS patients; glucocorticoid therapy is not recommendable as a standard treatment. Limitations are not reported.

  272. Chronic fatigue syndrome: probable pathogenesis and possible treatments.2002 · review
    Summary

    This is a comprehensive review of treatments studied in chronic fatigue syndrome (CFS); no single cohort, setting or total sample size is reported. The review states no specific treatment has been found. It summarizes trials of aciclovir, immune treatments, hydrocortisone, other drugs, symptom-based therapies and cognitive behavioural therapy (CBT), mostly compared with placebo or another group. Intravenous γ-globulin 2g/kg bodyweight over 3 months resulted in improved general health (symptoms and functional capacity) but no change in quality of life and depression scores; a repeat study was unable to confirm these initial findings, and γ-globulin 1g/kg over 6 months showed only social functioning improved favouring placebo. In a randomised but not double-blind IFNα-2b study, five of 19 patients improved and three recovered completely. Two short-term placebo-controlled hydrocortisone studies, one 12-week and one 4-week, showed some improvement of fatigue or sense of wellness but a moderate risk of suppressing adrenal gland function. Nadide showed improvement of symptoms in 31% of patients compared with 8% in the placebo control group. Exercise significantly improved health perception and fatigue at 28 weeks. CBT on an individual basis proved highly efficient at 1-year follow-up, and a 5-year follow-up found some lasting benefits but not a cure. Harms include adverse effects with aciclovir and galantamine, and the review states CFS patients are often drug intolerant and adverse effects are common.

  273. Chronic fatigue syndrome and fibromyalgia: clinical assessment and treatment.2001 · review
    Summary

    This review examined treatment literature for chronic fatigue syndrome (CFS) and fibromyalgia (FM); it did not report its own enrolled participants, setting, or follow-up. It described studies of Ampligen, antidepressants (fluoxetine, amitryptaline), NADH, massage, essential fatty acids, cognitive-behavioral treatment (CBT) and graded activity-oriented CBT (GA/CBT), graded exercise, pacing/envelope theory, and other alternative or interdisciplinary approaches. Duration was reported only for GA/CBT trials: 13 to 16 sessions. Many cited trials had controlled, randomized, or crossover designs, but the review gave no single pooled comparison. In cited studies, fluoxetine had no effect on CFS or depression symptoms in one controlled study and only a temporary effect on depression symptoms in another; a later essential-fatty-acid trial failed to replicate earlier findings; and NSAIDs were not significantly associated with improved outcomes in a meta-analysis of 49 FM treatment studies. About one-third of patients responded favorably to NADH with at least 10% improvement in symptom scores. CFS patient ratings ranked antiallergy/antiyeast diets and biofeedback/stress management at 24–30% favorable to highly favorable. The review notes Ampligen reports of poor outcomes and adverse reactions, states drug hypersensitivity and adverse reactions are not uncommon, and says GA/CBT may trigger symptom flareups in clients without fear-based avoidance. It states that clinical-study participants are usually from tertiary care centers, so representativeness is unclear, and that controversy over theory-driven CBT for CFS remains unresolved. It also states low-level exercise should be discontinued if it worsens symptoms.

  274. Cognitive behaviour therapy for adults with chronic fatigue syndrome.2000 · review
    Summary

    This Cochrane review asked whether cognitive behaviour therapy (CBT) benefits adults with chronic fatigue syndrome (CFS). It included randomised controlled trials of adults with CFS who received CBT or a control intervention. Only three relevant trials of adequate quality were found; each made a different comparison, so no meta-analysis was performed. Trial participants in each of the three included trials were out-patients with CFS. CBT was compared with relaxation in Deale 1997, with routine medical care in Sharpe 1996, and with clinic/placebo in Lloyd 1993. Both Deale 1997 and Sharpe 1996 showed a beneficial effect of CBT at final follow-up for unsatisfactory functional outcome: OR 0.15, 95% CI 0.05 to 0.41 for Deale 1997 and OR 0.16, CI 0.06 to 0.44 for Sharpe 1996, with NNT 2.1 in both. CBT reduced fatigue compared to relaxation in Deale 1997. No significant difference in mood was seen between CBT and relaxation in Deale 1997; anxiety was reduced similarly in CBT and medical care groups in Sharpe 1996. There were few dropouts. In Sharpe 1996, less than one in ten of those who enrolled and received CBT declined to complete treatment. Lloyd 1993 provided insufficient POMS fatigue subscale data and no POMS anxiety subscale results. The authors state there is no satisfactory evidence for the effectiveness of CBT in the milder forms of CFS found in primary care or for group CBT.

  275. Cognitive behavior therapy for chronic fatigue syndrome: efficacy and implications.1998 · review
    Summary

    This review examined cognitive behavior therapy (CBT) for chronic fatigue syndrome (CFS). Butler et al. 1991 (case series, 32 patients) reported that a rehabilitative behavioral form with a mean of 8 sessions was followed by improvement from baseline in fatigue, disability, and depression; the table notes 18 patient refusals and 5 dropouts. Lloyd et al. 1993 (randomized controlled trial; 41 1 49 patients) compared a brief rehabilitative form (6 individual sessions) with medical care and found no difference in functional impairment at 3 months. Sharpe et al. 1996 (randomized controlled trial; 30 1 30; 60 patients recruited) compared 16 individual sessions with medical care: approximately three quarters of CBT patients had a good outcome at 12 months versus one quarter with medical care alone, fatigue, self-rated disability, depression, and timed walking distance improved more with CBT, and no patients dropped out. Deale et al. 1997 (30 1 30) compared 13 individual sessions with 13 relaxation sessions and found greater reduction in disability, fatigue, and depression at 6 months. A separate randomized trial found graded increases in activity substantially more effective than flexibility exercises for disability and symptoms; patients were not harmed or made worse, while another graded exercise trial in unselected patients had a high refusal and dropout rate. The authors state there is now good evidence from 2 independent randomized clinical trials to support CBT efficacy, that the treatment effect is substantial although few patients are cured, and that intensive individual CBT remains the treatment of choice.

  276. Chronic fatigue syndrome. A practical guide to assessment and management.1997 · review
    Summary

    This review proposes a practical, evidence-based approach to assessing and initially managing chronic fatigue syndrome (CFS). It reports no participants, setting, sample size, treatment duration, or follow-up; it is not a trial and has no comparison group. It discusses antidepressants, acyclovir, SSRIs, omega-3/fish oil, graded exercise/activity, and CBT. The review names a randomized trial in which CBT was no better than good quality medical care, and randomized controlled trials in which CBT was acceptable to patients and more beneficial than standard medical care or relaxation therapy. It names a trial finding evidence of benefit from an SSRI and another trial finding no benefit; it states that evidence for antidepressant efficacy in CFS is surprisingly scanty and advocates antidepressants for clearly depressed patients. Acyclovir is called ineffective; fish oil has not been convincingly demonstrated efficacious. The review describes gradual increases in activity and notes simple exercise programs may fail. Reported harms include marked sensitivity to antidepressant side effects, variable tolerance of serotonin re-uptake inhibitors, possible expense and harm from unproven treatments, and initial discomfort on resuming activity. The authors state uncertainty about CFS mechanisms and that etiological theories are not established.

  277. Chronic fatigue syndrome. 2: Treatment and future research.1995 · review
    Summary

    This narrative review discusses treatment approaches for CFS and offers a suggested clinical approach based on available research data and anecdotal clinical experience; it reports no study of its own. It describes a British study of 32 CFS patients without a control group in which symptoms and function improved in 22 patients (69%), with improvement maintained at 3 months follow-up. In a Sydney, Australia, controlled trial, fatigue, depression, and functional ability improved with CBT, but the improvement was no greater among participants than in the control group. A Boston research team reported fibromyalgia symptoms improved in 67% of participants in an SRT/CBT program compared with improvements in 40% of controls. The review also notes fluoxetine (20 mg per day for 8 weeks) has been shown to improve functioning and decrease pain in CFS patients, bupropion (300 mg per day for 8 weeks) was successful in persons who did not respond to fluoxetine, and a controlled trial of Ampligen-poly(I)poly(C,,U) shows promise. Listed harms include increased pain or fatigue after exercise, increased pain if stretching is introduced too early, and side effects for fluoxetine, nimodipine, and Kutapressin.

  278. Treatment of the chronic fatigue syndrome. A review and practical guide.1993 · review
    Summary

    This review examined treatment of chronic fatigue syndrome (CFS); no review-level enrollment or follow-up numbers are reported. It summarized pharmacological and nonpharmacological therapies, including antidepressants, antivirals, immune modifiers, vitamins and minerals, essential fatty acids, CBT and psychotherapy, and benzodiazepines. Among cited trials, Straus et al. 1988a randomized 27 patients to aciclovir or placebo; 11 in the aciclovir group and 10 in the placebo group reported improvement. DuBois 1986 reported 53 vs 32% improvement with intramuscular gammaglobulin in 19 patients. Lloyd et al. 1990b reported 43% vs 12% improvement with intravenous immunoglobulin, while Peterson et al. 1990 found no objective advantage. Cox et al. 1991 reported 80% vs 18% improvement with magnesium sulphate in 32 patients. Behan et al. 1990 reported 85% vs 17% physician-rated improvement and 84% vs 22% self-rated feeling better with Efamol Marine in 70 patients; McBride & McCluskey 1991 reported an unpublished 6-month trial in 98 patients that found no difference. Butler et al. 1991, an uncontrolled pilot in 50 patients, reported improvement in 70% starting and disability improvement in 60% completing; Lloyd et al. 1993 did not find CBT beneficial in a double-blind trial of 90 patients. Harms included considerable adverse effects with aciclovir; serious and life-threatening side effects with mismatched double-stranded RNA (hepatic toxicity, arrhythmias, severe abdominal pain); exacerbation of myalgias, arthralgias and palpitations with interferon-a; and worsening symptoms in 10 patients given prednisolone with or without azathioprine. The authors state no established recommendations, with antidepressants most promising but lacking randomised, double-blind, placebo-controlled studies.

  279. Non-pharmacological approaches to treatment.1993 · review
    Summary

    This review examines psychological (cognitive) and behavioural therapies for chronic fatigue syndrome (CFS). The text does not report how many patients were enrolled, where they were treated, how long treatment lasted, or the number analysed. It describes a randomized controlled trial of combined cognitive and behavioural therapy as currently in progress; the abstract gives no comparison-group numbers. Initial results are said to suggest that most patients receiving cognitive behaviour therapy improve, especially in terms of functional impairment. The abstract does not report a between-group result, worsening, discontinuation, or side effects. The authors state that it remains to be seen whether this therapy will prove to be more effective than standard general practitioner care. They also state that while there is evidence for this type of therapy in related syndromes, the evidence in CFS is inconclusive. A theoretical model in which psychological, physiological and social factors interact is described as plausible but not yet empirically proven. The authors conclude that cognitive behaviour therapy offers a pragmatic and rational therapy for patients with CFS. No participant counts, treatment duration, harms, or numerical results are reported in the abstract.

  280. Psychiatric management of PVFS.1991 · review
    Summary

    This review examined psychiatric management of post-viral fatigue syndrome/CFS rather than reporting one new trial. It described an open trial at the National Hospital in which 32 patients with CFS were treated with cognitive behaviour therapy; there was significant improvement in symptoms and functioning for 22/32 (69%), maintained at 3 months follow up. In that study 5 patients dropped out before treatment was completed, and One patient who completed treatment was clearly worse at the end; depressive disorder and attributing symptoms to physical rather than psychological factors predicted poor response. The review also described Strauss’s double blind placebo controlled acyclovir trial, which failed to demonstrate an effect greater than placebo; two acyclovir treated patients developed reversible renal failure. An uncontrolled study of combined antidepressant drug and psychological treatment was said to have produced promising results. The review states there are no controlled trials of antidepressants in CFS, only anecdotal reports. It notes clinical experience suggesting limited tolerance of side effects in CFS. The authors state the National Hospital study had no control group or independent outcome assessments and that its design could not distinguish antidepressant from psychological treatment effects. Treatment duration was not reported.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime